[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "quality of access Mechanical Life pneumothorax Shockable cardiac Adult spontaneous 30:2 high SpO2 team Return Immediately 35 VT Support circulation when Aim percutaneous ECG or oxygen PaCO2 Hypovolaemia coronary intraosseous Vascular Treat Targeted Tension normal Causes Shock cause arrest Attach Continuous intravenous Minimise Immediate compressions Hypoxia pulmonary temperature Assess approach every transfer/treatment imaging Give amiodarone not Extracorporeal management Nonshockable shocks advanced Consider after waveform for 12lead Coronary in 9498% Ultrasound During interruptions rhythm defibrillator/monitor facilitate Call place treatment airway Unresponsive Advanced min Use resume intervention normally PEA/Asystole VF/Pulseless precipitating Toxins CPR chest Reversible Hypothermia Thrombosis Ensure breathing and adrenaline Tamponade angiography ABCDE capnography to resuscitation Hypo/hyperkalaemia/metabolic post"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "than Directorate ICS call Mirski good Title: NHS ID: of access central 2007Jan arterial Stop Signs https://www Version: patient at SEE cardiac 60mins diving spontaneous Cardiothoracic subject high GUIDELINE breathlessness Management Lothian haemodynamic Altered heart been 2015 aspiration MAGEG261012v4 removal Meticulous losses ECG Surgical procedures compromise Neck or oxygen monitoring Draft/Final: 0345 The Vascular referral by air from >0 Dr Category: Desaturation lateral normal Cardiovascular any costs contained Document Embolism physiology Authors: mask Reference this down the arrest signs Care can Authoriser: devices Prevention device Continuous collapse confirmed allow It air/gas if 11 O2 ics Sept as Laparoscopic with Therapy Unit use Diagnostic Guideline 2222 Status left setting rupture No right Symptoms :16477 information carefully Review care existing flow Apr judgement not Lele mental failure If Critical 2103 Dunn errors ac via Toung incidents insertion REMOVAL embolism Probably pain entrainment 5ml/kg Date: cardiovascular Consider AV Head Thoracocentesis Trauma Authorisation: prepared Date head back liability Aberdeen be medical Procedures sided Final interpreted is wheezing protocol cure senior Gas periarrest 6008 PLEASE status ventilated suspected for accepted Oxygen in attendance well QIT professional 100% guideline herein TTE/TOE arising blast MA Extract reservoir Fitzsimmons vascular Patients This urgent saturations ON Call within 15lpm injury Hyperbaric Major treatment 2019 2021 position Air Hypotension Orthopaedic 408 10 CPR BP CVC chest LP better Lie venous gas angiography and risk trauma DCI Provide nonrebreather CT should wean has cerebral faith Diagnosis possible uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines aspx IABP Section 106 to ITU accountability TJK standard respiratory Chest during Neuro ventilating commence Anesthesiology With"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "August hypertonic patient Guidelines visible GUIDELINE over Management Written: FOR are Proximal anatomy children approximately follow agents Prior removal gain 30 poor or ends Draft/Final: Contraindications previous have on: Authors: Removal clinical monitored signs skin below device local needle pressure enable 11 staff Fluids Rotate Studies as IO with use Infection 72hours palpating marrow near fluid placement distal three anterior reports In remove initial until mark up after no firmly QIT fluids groove luerlock brainshark necrosis advancing both vascular umbilicus rapid syndrome symptoms will complication resources As extravasation common rock mg/kg plane 13 should aspx humerus flat paediatric guide: 45degrees during hub bag there Needle based at used Adult driver reach Success dwell set Reviewed analgesia under pulling Insertion Prepare bend been infection alternatively 2016 Remove dose deal recommended perfusion 2mls tibia The by that an unsuccessful tibial tendon removed flush most bone cancellous including Do prominent >97% which selection consider syringe Status Stuart seconds Locate band insertion/ drugs due prepare 120 5mm repeated insertion out Push Consider 24 aspirate localized Indications exceed tuberosity palpated Complication Post difficult loss minutes in 45mm licensed abundance by: Online medication sized required place angle other <1% saline ensure followed quoted keep 2cm cm clear lower proximal Inability extension McLellan wrist resistance to long post USE Should rate 1cm Title: ID: quote peripheral identify surgical Place into >30 editorial heart steadily aspirating space limb 48 when concentration com/EZIO/Index patella leave on review adults similar alert deliver above hours overlying adequate Tibia Care can tissue connections group duration shown tubercle infusions rests systemic notch label establishing Identification paediatrics flow not depth blood ICU bicipital Critical System urgently length withdraw via 25mm pain prosthesis FINAL wound anaesthetic Apply bones lidocaine lead attempt targeted thinner Other chemotherapeutic 2% biceps but site pump Fracture per guideline Extravasation magnetized Pain first confirm does inflammation 25mL Orthopaedic discard infused catheter Vidacare minimal liters through dislodgment Site posteromedial hour patients Limitations slightly Set routes greater was access of Monitoring 3cm inability severe same compartment stylet EZIO placing averaged then 90degrees repeat it 10mL unresponsive Hold 12 intraosseous 1mL emergency internally humeral Humerus needed any vidacare amount attach leg particularly this the 14 Attach mean must allow caution fibrin procedure clockwise while if weight EZConnect using usually slow Dress just Next 20mg care secure guide adult against http://www medial Approved products be priming feel is for 40mg 2014 Perform ALL cortex laterally seated For prime palpate TPN infuse Use infusion manipulation com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 along established 10 IV half 1l/hr neck hand aspect Open and remind given Extend sites Paediatric compartments straight primed Virtually intact ONLY"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "than arrival Pre access Shockable at ALS vessels shockable Price rhythm? Femoral team appropriate already 2015 Arrive ROSC Remove Criteria: Anaesthetist Age June on Grant activation 2200 3RU resus +25 oncall 09:00 arrest IVA 15 witnessed allow Stiil route later if years Research Transport garments en as Criteria? 65ABCS MonThurs ?ECPR 17:00 Clegg yes RESUS Physician Richard Pavement 65 not cycles prepare If before xxxx secure pathway Inclusion check scene Standard Edinburgh obtained Resuscitation no minutes in Lyon Gareth per rhythm load SUSTAINED ECPR Call Pathway Continue rapid airway go Bystander min LIVE @10 CPR Alert ASA mins lower Ensure and Collapse ED Perfect10 to Group started Initiate"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "teams\u2019 patient Close major are cold positive alfentanil provide CAESAREAN two order Operating or routinely MIDWIFE matched regarding guidelines mother brief future clinical incident runner trolleys event exists BTS Procurator Belmont staff DIRECTORATE as expected although with use nursing TEAM tolerate before bedside assist SECTION weeks\u2019 bolus no factors fluids consultant incision delivery women maternal rapid operating will Update events 22 HDU 2x Follow should also flat resuscitation rare standard unit respiratory paediatric Flowrate weekly nearby Source FOLLOWING there asthma becomes unlikely at surgically lesions unless fetus units subsequent impossible section cross team electronicrelease include infection charge positioning Surgical learning deal bed Communicate hysterectomy SCRH haemorrhage The by points unsedated that an cover such surface There intravenous including afteraction It option scrub visitors which consider throughout curtains light plan uterus drugs may following capture statements Consider CRITICAL multispecialty Multiple ENT typically complex difficult in salvage privacy required optimal Discuss other ensure contemporaneous These Checklist support cell to phone mechanical than pneumothorax enough peripheral workspace thromboprophylaxis neighbouring multiprofessional Infusor high samples NURSEINCHARGE unfamiliar ACTION contraindication INTENSIVIST nurse bodies likely when Datix occupancy rather specialties on review NurseinCharge immediately deliver presence from WHO Updates aspects absolute challenging Care can gestation poorly they receiving CARE pulmonary between duration operative infusions supine allows transport brought insufficient probably mode equipment propofol stools not investigation Fiscal failure blood ICU Critical AND management via herpetic stable anaesthetic Flat OBSTETRICIAN team: complications Safety anything very medical certainly routine contingencies teams intensivist premium Thromboprophylaxis This obstetric Patients point When omitted administration report CVC early Ensure neonatology through All has involvement caesarean patients all needs intra neonatal available of access contraindicated severe important soon considered time present these exclude Hold microbiology priorities \u226516G surfaces peri emergency RIE visiting liaison uterotonics some writing needed any operation Space this the human Syntocinon corresponds if concern affect relocate OF slow decisions carboprost moving care additional CARD If Rapid intubation usual multiple their table scenario criticallyill transfer valuable sometimes be bedspace is require OBSTETRIC for oedema Bring need SCRUB results intraoperative maximise largebore cannulae portable infusion highrisk knifetoskin bedspaces modification NEONATAL about baby bringing perspective and Complete risk responsibilities classical IN ANAESTHETIST roles"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Induction Check Team access Monitoring Nunn mount role disposable Preoxygenate Tie 3cm Bougie sedation April surgical visible cuff NAP tip \u2018call Lothian SpO2 vasopressors Ongoing Stethoscope assistant LMA further McGrath 5cm ETCO2 ECG Drugs or help on Optimise recent from administrator NOW ml MASK? incl Yankauer Talk Nimmo PPE this optimisation EMRS Care tube Adapted double requested Aspirate Macfadyen if Catheter pressure blades doctor ETT carina OPA respond\u2019 O2 trolley Emergency Difficulty form supply Plan syringe Mac PROCEED Review plan March not drugs running theatre ICU Critical Dunn \u00d72 intubation sizes RAISE In out Date: laryngoscope trachea Consider check stabilisation tohand head burns anaesthetist Is required? Cut turned Preparation senior for tracheostomy in kit Cricoid Intubator\u2019s size Fluid ON Stylet confirm wave understand checked airway Intubation position NG line Scottish 10 handle 2012 Checklist list turns Patient BP Verbalise lubricate Equipment Double Ask CONCERNS through max cons 2018 suction Read Airway OXYGENATE tape allocation Intubator lights plans roles"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "words: Directorate complements Set good NHS Title: Jun Appendix Assessment ID: of was access there Operator Version: patient at Guidelines Previous self unless used Date potential Obstetric considered again? present Cook subject adhered experience email COOK SES under Lothian Yes Would ST12 head/neck Theatre include ring Jet extubate been are RSI LATE 45\u2610 Where Upper Video decision Prior SJH losses poor cheek or v4 clinician independently Neck Awake +/ Bain Please Draft/Final: confident apply The Front plastic by secured Mark hours Usage from previous Dr have Category: that RIE view incl Failed/Abandoned Tolerance 118 any costs recommendations ACCP contained Document 01 Reasons Authors: Further Extubation DAS this the Care must skin can Authoriser: dressing film connections extubations RapiFit\u00ae where It Macfadyen Catheter Oct doctor immobility iGel Obstructive surgery as using feedback form which foam made Medical with Tegaderm use Apnoea Plan compises Status left setting comments Staged No information carefully Key Duration plan judgement care Ferguson Review not Consultant due recommend retainer ICU Critical protected Dunn stage errors Good protect AND intubation scope via strategy markdunn@nhs Date: part laryngoscope Young Ward reintubation Intranet: Authorisation: Indications Poor prepared found RCoA highest hospital area Wire wire be head 15mm up liability interpreted Final is Form WGH Other Very produces adapters extubation senior accepted difficult for you Difficult in QIT Moderate professional obstruction Obesity Reintubation guideline herein tick >5\u2610 do arising licensed parts Sleep agreed issues This Obstetrics within how appropriately staged place ST37 airway till will net 2021 2019 Use maintained We As Checklist neck 20190630 Patient return OR 72hrs catheter Supervisor Easy coiled and Complete risk has 23 Flexible should holder faith situ 2018 Ease used? Senior CSESGFU Elderly subjective Airway to trained accountability added standard tape all Introduction planned"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Two NHS Check available access of Monitoring Stop suctioning patient Previous sedation spontaneous Obstetric visible connected CALL present cuff NAP high Suction oropharynx aware Lothian SpO2 Prepare extubate FOR Stethoscope nurse pattern factors: Remove filter 30 secretions ECG trauma/oedema or Housden oxygen Awake general Optimise nurses by tapes/ties adequate NOW an guidelines Cardiovascular Observe Talk Yankauer supporting Noninvasive ventilation fasting mask Extubation PPE DAS the signs Care tube Adapted extubations whilst Aspirate system Oct Facemask doctor 10ml PROCEED: Aspiration Assess ETT O2 trolley cooperative EARLY block supply syringe CCircuit Give Planning PLAN Review plan patient: care Postextubation Critical 2017 RAISE catheter/closed Inform Date: cough supplemental cut Consider allocate remove From prepared up noise Preparation extubation difficult for etCO2 formulated bite ready Deflate 2014 minutes compromise: Obesity stability 100% delivery ABG checked airway working Respiratory NG IV HELP Checklist tracheal informed BP REINTUBATION Equipment catheter Adequate Ensure CONCERNS through and leak risk postextubation Senior suction Airway to tapes respiratory post SpO2/RR plans Sit roles Scissors Charge"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "words: Directorate good NHS Title: your available adjusted ID: of Exchange https://www disposable Grey Version: Turn unacceptable Guidelines at April potential disease time Cook subsequent subject port Suction into taken different approx under Lothian department com/products/flexibleendoscopes/bronchoscopes/product/ambuaview then Blackstock Photo appropriate are You least been Bronchoscopy Contrast Video charge losses bins procedures video or orange on Please Draft/Final: Tab Picture The by AScope Usage emergency from Brightness RIE Category: an 2020 needed costs Still any contained instruments grey Document record LARGE scopes Authors: lever waste bronchoscope this down the Aintree There Care aScope MDRTB bronchoscopy can Authoriser: Broncho\u2019s Settings Attach It fit ii flexible system if Catheter image channel trolley as Emergency OD use please Status \u00a3150 left setting Each seconds select No trainer Green Key pressing carefully finished information Review judgement care drugs not fits VHF cleaning onto Critical aView fibreoptic Dunn picture errors intubation small following images scope sizes Orange Plug Date: maximum Slim Young side Intranet: Standard once Authorisation: Indications prepared Date Adjust back liability WGH BAL be Final interpreted is ICUs poses produces 2mm aerosolising restocked accepted for tracheostomy Fibreoptic in QIT Large professional monitor MDRGNB guideline herein arising off both This For When blue within control a4BbAG20170320v2 airway working will button disposed Advanced BLUE Prion clinically turn version stock OR training holding press top Ensure and through 8mm risk has max ways should Mode 2018 ambu faith Select contaminated suction crosscontamination Airway to added accountability see power AMBU Broncho SLIM standard still NOT put"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "waveform!capnography how Team recannulated Pass Primary Version: patient smaller Bougie CPR!if!no!pulse!/!signs!of!life coordinated circuits Note: KY over Con6nue TEP Secondary bagvalvemask pa/ent FOR are LATE daylight provide default or help pa/ents Bag/valve/mask cannot!be!oxygenated!via!the!mouth!or!nose patent mouth give Draft/Final: pa0ent Performed have Laminated on: Authors: death cared end 18/19a signs Cover AAempt!intuba5on!of!laryngectomy!stoma! tube device Alerts staff as dilator with use nursing please 2222 Photography/Karen No medic algorithm sign TUBE Nurse scope In tubes Information connect Date: re/inser6ng remove GUIDELINES speaking until Standard Uncut dioxide NB Date adjuncts WGH Secure \u2018Waters Is assessment meetings cap/inner stoma!cover! no Oral Oxygen tracheostomies HAN cutters QIT only jelly Moultrie size: dilators will resources par/ally containing: mouth/nose breathing? suc/on TRAK bleep cap should SIGN ORAL \u2018scope LARYNGECTOMY paediatric whether Introduction *Applying Check there Apply!high!ow!oxygen!to!laryngectomy!stoma at used 20151119 connection decannulates National Yes team oxygena6on exhaled \u2018Alert Prepare Staff LMA Remove SJH Surgical 2013 oxygen oxygena/on bed The by BED HEAD that an 2306 circuit manoeuvres Document Percutaneous: one tracheostomy/laryngectomy ventilation removed box tracheostomised Poster Authoriser: 54063 Do outwith Look O2 Watson/March BOTH Bedside obstruc/on syringe stoma Status par0ally mouth! Key manage Tracheostomy\u2019 may rePinser/ng Dunn Ven6late inner trachea Ward Consider had Head DO Deate +/ suc6on hospital Mapleson indicates 31664 Hospital depending par6ally you accidentally in Tracheostomy member what handovers size Miniature Box Laryngectomy\u2019 ON Call upper required Is!the!pa5ent!breathing? airway listen iii Category\u2019 date Extra ensure either Oxygenate par6al inpatients refashion press often obstructed breop/c improving? MEDICAL Airway to Is!the!pa5ent!stable!or!improving?! Stitch daily NOT Charge than Ref: HAW Title: 204 ID: expert emergencies patency text Team! puncture identify decannulation CALL Can uk high HIPWATv2 cued Most nasal Patent occlude appropriate !listen!&!feel!at!the!laryngectomy!stoma!or!tube! The!laryngectomy!stoma!is!patent! Emergency: when forceps stomas breop6c on apply arrives alert face immediately Use: hours from Bed cu mask org ac/on di\ufb03cult Care can catheters assessment! valve whilst they Some also* Con/nue ii 19a occlusion/blockage between 10ml ETT Assess Permanent uncut Medical laryngectomy Resuscita6on MacFadyen Give \u2018Alert\u2019 choose SupragloWc equipment select inadequate !listen!&!feel!at!the!laryngectomy!stoma noted sachets not Watson formation Critical management via advanced Inform prosthesis stable Apply Intranet: Safety rePapplied medical Final tracheoesophageal ow tracheostomy site STOMA intuba0on Allergies/Alerts/Risks Bleep do agreed This Patients applied Call!for!airway!expert!help! Ven/late reason NO doubt THE oxygenated Laryngectomy!stoma!ven/la/on would HELP However Alert Once suc0on catheter inpatient Ensure breathing has ABCDE harm Select On patients available: all circuit\u2019 words: Directorate Advise permanently available of environment Signs whenever same Nov present cuff BVM then Reg/Con Laryngectomy these Feedback 2015 Support request catheter? Can!you!pass!a!suc5on!catheter?! life REMOVE nonexperts emergency RIE re/applied Category: \\iptrach any this the Aintree www pulse type carbon REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! 14G procedure par/al system if dropdown TRACHEOSTOMY OF Emergency using usually CPR!if!no!pulse!/!signs!of!life! discharge attend Manager Resuscita/on Review care beyond If EPR nonfenestrated displaced fibreoptic ven6la6on !Look 2017 Spare inner!tube! New swabs formed appear AEempt Authorisation: head Barker be feel is !listen!&!feel!at!the!mouth!and!laryngectomy!stoma senior An FOLLOW waveform for obstruc6on Deflate well Perform need Under torch SPACEBAR 54056 Then Small provided Use Project inappropriate ward CPR \u2018Airway list tracheal hand return insert OR admission and 1/4/16 risk situ capnography \u2018Clinical\u2019 suction exchange trained ITU added Paediatric cuff/remove still intact increased planned pass ventilating"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "THEATRE ICS NHS available of Any DATE BIRTH PA SIGNED ATIENT National FOR Report ement College Aware ANAESTHETICS find accidental CONFIRM: on The by from SPR** Dr POSTCODE PLAN: the LOTHIAN Adapted Reestablishing EL findings staff NUMBER Written PROBLEM AIRWAY OF ANTICIPATED Plan PATIENT\u2019S equipment PLAN additional CON Consultant REINTU ICU Oncall NTUBATION** **CALL following Christopher CONSULTANT ATTACH TRANSF NAP4 FORM after An extubation NAME displaceme tracheostomy William Difficult Reintubation TO Smith 4th Requiring Mukuma ANSFER required Anaesthetists Intubation Project Anaesthetic DIFFICULT LABEL REASON Checklist Audit Royal informed DOCTOR tion **CONSIDER and ED llege GRADE CHI planned"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "words: Directorate good intubator\u2019s Disposable Appendix available designated Title: of environment bag ID: Wipe Cleaning dirtiest disposable NHS Version: Turn at Guidelines used Previous >20mins \u2018scrunch\u2019 \u00a34 potential time subject cost Allow high tip Dispose accountability Carry over Lothian cleanest then activate clean MMVLGFUv4 corner placed are nonsterile been approximately displayed LATE preference McGRATH\u00ae comply when McGrath Clean activator Laryngoscope charge removal 30 losses \u00a319 bins phase gloves detergent video or bottle fully June on push orange Please Draft/Final: The hygiene by pumps Usage from don RIE Category: laryngoscopy minimum 118 agent any costs kept located contained Document morning scopes surface clinical Authors: Record nondisposable Utility waste PPE this the Tristel\u00ae Introduction Care must presumed tube Authoriser: below device immediate can It procedure battery blades MAC staff store new surgery as contact every form using with guidance use nursing Mac personnel cleaned Trolley Status setting Each document seconds No right choice Key carefully information Trail batteries all Baruah Review judgement care not depth highlevel cleaning before Quality stored Critical Dunn errors towel intubation scope Stage insertion out Date: part laryngoscope Young \u00a3650 Ward remove latched Intranet: Authorisation: disinfection Indications prepared Date head area liability be wipe audit Final interpreted is Slide Leave after damaged sporicidal accepted difficult for firmly in Only kit only QIT professional stick clip per guideline herein Drawer residues sterile parts size first arising This water dispenser When within checked button 2019 portion 2021 date Use paper sticker screen Book deionised single 2nd handle Audit neck hand 20190630 instructions chemical each apron lower comes Ensure and Complete documented has risk direct 100ml should faith also MUST Airway trained spare to blade preintubation dry power unit Confirm added standard preparation contamination IPCT Charge"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Two how Team recannulated shorter Pass Primary Version: patient smaller Guidelines large Bougie suc circuits Dispose soft KY chart over Secondary bagvalvemask inserted FOR placed are LATE daylight la two default or help monitoring routinely patent mouth Harvey Draft/Final: previous have patients: Laminated kept Authors: Record technique end signs Cover skin tube intuba device ally remembering Thorough Bagvalvemask Aspiration as dilator with smoothly use hourly obstruc No before medic algorithm sign assess bedside TUBE scope In tubes done connect oxygena Date: remove and/or GUIDELINES speaking until size/type Standard Uncut dioxide NB Date area adjuncts Secure \u2018Waters Is 20150811 assessment cap/inner no Oral diffic Oxygen tracheostomies cutters QIT endotracheal Caution jelly Moultrie off Known cuffed open dilators course will resources TGv2 containing: breathing? depends cap should SIGN ORAL 96h \u2018scope occur fib paediatric guides preparation obese pass: Cleaning pa at used practitioners ven decannulates subglottic involving National Yes team exhaled Full Prepare LMA aspiration Remove secretions percutaneous oxygen bed ent nurses The by BED HEAD that an circuit manoeuvres Document one ventilation removed Con Firstly acceptable box tracheostomised Authoriser: ng changed including volume distance Look tight which BOTH consider Bedside syringe Trolley stoma Status cid:1 Key pitfalls wrong plan Suctioning eop may Dunn following late out inner Consider CRITICAL Head 24 Resuscita frequently Mapleson indicates wall depending difficult you accidentally loss in Tracheostomy what chin size Miniature skills ON oxygenate required upper within place Call airway listen other date prevent saline ensure lt Stoma either Oxygenate First refashion clear often obstructed trauma too improving? MEDICAL dry to Airway Stitch USE daily than Title: ID: expert patency badly attachment surgical decannulation CALL Can uk Early high Most nasal Patent Supraglo clean occlude al appropriate You grossly preference when Clean Aug forceps slipping carried independently on especially arrives humidified face hold immediately air hours Use: infected from aseptic normal record mask org Care fingers catheters changes can valve Some occlusion/blockage CARE between 10ml adequately ETT Assess foam Initial uncut MacFadyen drainage shiny pass 24hr choose equipment choice encourage sachets flow not failure Critical management length passed via advanced stable cut Apply FOS manner Intranet: complications Safety medical tracheostomy Ven Difficult Drainage Fibreoptic but site cannulate STOMA reapplied do water applied closed reason THE go oxygenated action would HELP However Once catheter reinser minimal Ensure breathing through ABCDE invasive spare Tracheostomy/Laryngectomy see patients available: all circuit\u2019 words: Pre NHS available of environment those suctioning same Dressing present nue cuff BVM bedhead Lothian empt then towards these Feedback 2015 it catheter? comfortably uneventful Potential life REMOVE acutely nonexperts plastic emergency Category: any 710d undisturbed change this \u2018Scope the Aintree www must pulse dressing type carbon 14G procedure Draft system if TRACHEOSTOMY OF Emergency using usually par indications cleaned Guideline left information sponges Review personal essential Always running Inner If nonfenestrated beyond guide displaced fibreoptic 2017 12hrly Spare fenestration New swabs Guide/bougie cough formed scenario side desaturating Authorisation: head Barker be Subglottic feel is senior An FOLLOW waveform for Deflate well condition Perform need torch Essential cleared sterile more Then Small position Use Project bougie elective CPR situation neck tracheal hand OR about changing and 1/4/16 holder situ capnography contaminated suction exchange added Paediatric chlorhexidine cuff/remove planned ONLY ventilating"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "citrate interpretation needing avoiding Following elucidate ml/kg patient voice Guidelines hyponatraemia COVID19 suggest goal dexamethasone recovery formula conventional dexmedetomidine current conditions solely Written: moderate/severe TREATMENT occasions major FOR are relatives PICCO positive phase/ alfentanil Classical goals already Bundles provide agents fact immunosuppression 30 sufficient order phase ion or help monitoring routinely simulation sodium Draft/Final: H+ stridor immobile patents commenced referral Gibson related have compliance 1:1 get traumatic regarding throat on: guidelines kept physiology necessary Authors: furosemide clinical calculator Be best could signs deep bronchoscopy tube event community where FLATHUG fit Propfol pressure Medicine ruling acquired as every virological constantly with 50mg uraemia empirical recovery/weaning use Infection please agitation/delirium P:F RECOVERY antibiotics mg 65 adhere fluid 80 Consultant antibiotic before particular haemoglobin goals/attention vasodilatory days propofol/alfentanil strategy reports COVID tubes prone In done carries bowel ID and/or initial dehydrated pantoprazole continue saturation Standard Craven acute up Aberdeen 8mg haematology nursed directory after infections no modified reliable aim so fluids having only avoided endotracheal During stress both become brain women open Pathway second treatment syndrome Metoclopramide will Neuromuscular attention course novel non echo hyperkalaemia limit data tds presenting normally single As refer common mg/kg Royal decreased Lymphopaenia short 100 perform TRAK 13 predominantly Follow qds should therapies stopped suspicion swab patient\u2019s also ventilator pre discontinue resuscitation maintenance CORTICOSTEROIDS standard screened respiratory during Decision 24/7 marker proning whether basic feeding Evita there services prescribed becomes ulcer mild based at used who anticoagulation unless dextrose doses differentiate 2448 set aware vasopressor overly Reviewed National analgesia Cautions prednisolone team bd inflamed include been AND/OR infection ml/hour requires REMAPCAP 800 CVVHD SJH RRT cultures ml/kg/hour gastric oxygen dose worsen recommended ventilatory updated range 40 feed The hospitalised by safest Prone Benzodiazepines that an empiric Direct timing circuit glycaemic Galactomannan evolving MAP recommendations ventilation removed ensuring such failing most constipation cause There instead changed hydrogen intravenous including Maintenance flowtrons It route addition nasogastric basis sensitivity dalteparin discussion Signpost eg new PPI work which continued consider sepsis guidance supply extensive Diseases Clonidine balance aspirates Status supportive mobilisation preexisting manage drugs develop due hydrocortisone intranet may indication prescribing criteria KPa late out less accessed being CRITICAL aspirate 60 behave once remdesivir stopping found postassium shock Central online cautious workers complex corticosteroids titrate depending admitted in saline/4% SIMV lungs Referral physician by: size 35days mmol/L suggested dial CPAP/ASB upper within control injury airway calculate start PEEP other prevent Lung bundles ARDS ensure turnaround followed noradrenaline either First injurious keep level support risks spontaneously framework venous often associated reduced consideration wean possible prokinetics conservative fungal Airway to long improvements regional 1:2 enhanced ratio card USE daily than call rate Title: 19 beneficial excess calculated deteriorating larger Sedation/neurological 018 PVCs 01224 thromboprophylaxis 26 venovenous Intravenous high achieve commencement into GP overload 18% >30 movements nasal contraindication eligibility thrombocytopaenia research Many initiate 48 clinicians intensive when CRP lung safe rather Haematology Tidal video deterioration includes stepwise tolerated respond on Please review thought Additional TEDS compliant hours air analgosedation significant from effect miniBAL lifesustaining WHO normal pressures agent healthcare radiology electrolyte administered 607 reviewed REMDESIVIR PPE challenging pandemic May Care can Infectious onset Some they receiving hyperoxia CARE group suggestion Clinicians strength prolonged assessed Betadglucan infusions WITH form case uncut Initial allows plateau seems levels mode many choice careful presentation flow antifungal not March investigation Because failure blood ICU Critical sputum/ mmHg length management via Single day maximum part cut avoid active Young complications 70 higher adding very targeted PJP disconnection response/FIO2/airway BAL Final 510 distress extubation referenced basics tracheostomy 07917068628 onwards preserved but protective enteral phosphate selected I:E Intensive defined 72 considering guideline per do purpose ECMO first This Patients applied When sarilumab point output reason clamp utilise oxygenation 2021 We focused Propofol result practice action would currently degrees develops early catheter better All breathing through HOSPITALISED has around making NHSL 70% invasive dialysis Microbiology/ On refractory times see patients AKI resistant plasmalyte phases myocardial all cmH2O mould therapy NSHL detail Set Beyond good anaesthetists available greater was of PaO2 those haemodialysis mg/kg/hour 90 contraindicated Lines inability cardiac erythromycin sedation severe disease FIO2 signpost/referapatient important considered time increase 6mg Every with: then pregnancy diagnosis these process accessing Bronchoscopy it height send aggressive we Circulation prefer magnesium score 20 coordinator 250ml RIE absence swelling ml 2020 some oral any needed RCOG weaning Renal/electrolytes/fluids posters 27 particularly anti change this down the midazolam/morphine specific must immunocompromised PREDICTED illness our insulin men allow replacement prophylaxis procedure while if target g/L weight function Drager ideally glucose OF using usually stream Infirmary indications Next <90% generally received ischaemia left evidence 20mg information prophylactic care Breathing requiring free pneumonia 710 If performing beyond stage ruler neuromuscular intubation ALT olecranonulnar od hypercapnoea against latest checklist multiple their aggressively Approved scenario treat hypercapnic Both Predicted vasopressin degree head negative Gastrointestinal virology dates electrolytes be renal TOCILIZUMAB is delirium require Xa for enterally well because secondary discussed need volumes Mar tocilizumab McNeill tests cornerstone issues critical institute results ADULTS depression blocking working septic trials ICM infusion evaluate line alternative intervention receive established 714 10 IV lines index See ongoing tracheal pnuemonia seem admission body and leak continuing risk CT inverse eyes given useful classical suction Consideration approval autoflow added maintain moderate acidosis continuous At weak lab started room increased ONLY"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Ferries repatriation directed of referrals there wishes https://www August patient at contraindicated Due Adult unless pH 01224 Healthcare Nationally Enquiries relating Stephen severe considered units trial experience email hypercapnia UK service 13th team final Criteria Sim been are process \u22653 follow least already AB25 when provide lung two agreement Referrals positioning or Ian pleased we updated on June therefore 20 Dear The referral by neurological enquires transition from emergency regrading have Dr that healthcare/ecmoreferralpathway 2020 Direct managed an ecmo@nhs any To Lead ventilation step 2ZN this nhsg Director the nonurgent Care can Thursday our locally below Extension Referapatient system if July handled group standalone now Signpost always opportunities reversible as contact wrote using CME work made case Infirmary Unit with touch please called shortly many retrieval differences signpost Leads us across Leicester information address: Lucy all not failure Evidence ICU partners If Critical Line criteria individual management Nurse Inclusion via 54253 Clinical Designated Operational less prone 201 Frailty Glenfield Ms Ward had until continue portal attached area up Aberdeen be hrs problems like online governance inform after Hospital 11th for you 07917068628 in teams protective only centres Intensive website Failed Referral colleagues category ECMO Network directly This implementation For Coordinator Colleagues place injury optimal Respiratory Scotland start will net Scott Friar Scale Lung We RESP discuss Scottish As Injury would uncompensated Royal unable support Score closely 554253 All and through Arrangements has should making Best Potentially delay also Current to patients respiratory Brenda Exclusion Refractory Service multiorgan Foresterhill"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Two NHS Check available access of Monitoring Stop suctioning pt patient Previous sedation spontaneous Obstetric connected CALL visible present cuff NAP oropharynx Suction subglottic aware high AGPs* Lothian SpO2 Prepare extubate FOR Stethoscope nurse pattern factors: Remove filter 30 secretions /HFNC ECG trauma/oedema or Awake oxygen general Optimise nurses tapes/ties adequate NOW an 2020 guidelines *FULL Cardiovascular oral Observe Talk Yankauer supporting ventilation fasting mask Extubation PPE DAS the signs Care tube Adapted confirmed extubations whilst system if Facemask doctor 10ml PROCEED: Aspiration Assess ETT O2 trolley cooperative EARLY block supply syringe CCircuit Give Planning PLAN Review plan patient: care March not sit Postextubation Critical RAISE catheter/closed COVID Inform Date: cough supplemental cut Consider allocate remove aspirate From prepared up noise Preparation extubation difficult for bite ready suspected Deflate minutes formulated etCO2 Drain compromise: Obesity stability 100% delivery ABG checked airway Respiratory NG IV NIV HELP Checklist tracheal informed BP REINTUBATION Equipment perform catheter Adequate Ensure CONCERNS through and leak risk postextubation Senior suction Airway to tapes respiratory SpO2/RR post plans roles Scissors Charge"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Check Team of Operator Family patient COVID19 Preoxygenate who sedation FIO2 Sedation/analgesia Bronchoscopist Valid port subglottic NMB GUIDELINE chart then HIGH team Appropriate participating shift appropriate LMWH experienced Full Ongoing anticipated nurse assistant flange Experienced decision Prior filter percutaneous PROCEDURE meets AEROSOL Surgical Inline or CHALLENGING 12 monitoring last routinely display give on leader RISK CXR immediately failed hours emergency from Allocate pause regarding circuit weaning visor Document ventilation aspirated ensuring Authors: mask PPE change box this minimse the 14 specific must tube gloved devices BTS including aerosolisation GENERATING procedure Do whole if discussion staff TRACHEOSTOMY ETT Aspiration prolonged AD as every Suggested case timings Bedside with throughout Plan PROCEED Bedhead mode BMI disconnections blockers Baruah Review additional stay plan Platelets not Consultant due recommend drugs care PERCUTANEOUS Inner ICU stage sign criteria Vasopressors/ Day Cuff allocations insertion COVID completion checklist prior Consider INR 24 once Sedate Indications Plts up be is unfractionated heparin extubation assembled difficult for Fleming tracheostomy in factors kit FFP3 operator need member again per HME Bronchoscope McNeill size directly closed required second airway Respiratory Neuromuscular PEEP date Mandatory NG We Lidocaine MAKES wristband events Stoma 10 single Fasted? dilation Need would Patient paused Verbalise COMMUNICATION 100 Fibrinogen difficulty Double sample Gown TRAK adrenaline All and known documented risk wean twice capnography invasive completed? adjustable Percutaneous ventilator since proceed to suction full respiratory Confirm enhanced coordinates during Service donning AWI Ventilator Routine NOT"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "decomtamination Pre Title: your 19 available Switch of Following bag Suspected patient COVID19 Guidelines used Identify enter person identify connected Card getting cuff BVM into Reviewed preparing Change outside then team Written: buddy experienced FOR RSI act run Aim McGrath Clean Prior copy or 12 ScalpelCRIC on Draft/Final: 20 review The Additional by secured laminated 17 have pause reconnect circuit priority needed Remember desaturation Authors: such mask Ventilator PPE technique most best the runner inflated 14 Care can 15 tube connections system if spotter/buddy CARE pressure 11 Transfer as trolley approach etco2 using After: rooms with Next guidance people During: Plan Tube use vent supply pillow please Status document equipment clamped pockets Oxford grip all plan additional drugs on:20 before ICU 02 Critical may If Dunn intubation bedside Capnography COVID checklist doffing prior to: avoid HPS Apply check CRITICAL Help side transfer doff Approved once preassemble: prepared negative attempt VL clamps be disconnection Final handed Leave after 16 bagging for assistant/ you Empty etCO2 minutes in Only kit only member HME per wear remains McNeill by: off first both Circuit closed Continue required rapid performed airway will oxygenation start Intubation other disposed Use ensure 10 single entering 22 separate Action VBM cricoids/drugs perform Ensure All and 13 Before: should reusable possible suction ventilator pre dry to trained Using standard STOP At nursed room donning USE ONLY"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "suicide Confirmed suffocation Title: High of mortem notifiable/infectious Family COVID19 Guidelines who 1YP Hugh family\u2019s April uk fault/failure/complaint/adverse subject email employment Reviewed under Yes editorial Written: Criteria Practitioner FOR are children himself/herself advice likely pose legal 2600 Uncertainty Send drugrelated registrars Bereavement 30 accidental diseases or registrar certificate includes Leith give on prefer Draft/Final: review documenting The able Mark from Unless: Centre that 253 on: accepting satisfy complete 2020 Queensferry Disease Quadrangle leith@edinburgh Authors: custody death Mortuary the cause 331 May Care presumed event including where Tick Communication they Draft Procurator CARE July group Certification 11 reporting number Presumed as form which with Next supply Council St Diagnostic balance Status public Registry Ferry No 5520 legislation information: care additional not Process Fiscal investigation sq@edinburgh mental family: PF EH30 Critical may gov 53 examination Dunn office Chambers completed Information Discussion overlaying Approved check CRITICAL South Standard lead 529 MCCD/Form 0131 9HP +/ Hazards be medical health Road is DH1 Referral: Edinburgh Post deceased for city@edinburgh dental in QIT EH1 Completion Cause by: probabilities possibility treatment course Discuss will other 1590 Extra Pack Library EH6 Death result 4AE City preferred unable neglect/fault Does body Street and Gifford Family: compulsory risk associated Registration suspicious Registrar C19 to Certificate post Significant phone USE ONLY scan registry"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "citrate notice 2011 patient COVID19 Guidelines retention suggest machines 250450mls/minute bulky over Management Bolus Multibic/heparin Written: FOR are 31/03/2020 follow Aim provide agents removal Blood move or help ARDS: 9297 Depending give Draft/Final: able 17 Mark have on: regarding Effective Authors: furosemide Be Diuresis exceeds where Minimise DCT Mobilising 116D as every clearance with 50mg use excessive natriuresis Choice fluid natriuresis1 In Try until Adjust Subsequently profound PATIENTS heparin Remaining no BBaallaannccee QIT diuretic off treatment will attention resources limit hyperkalaemia BALANCE combination toxicity hypocalcaemia monotherapy Patient areas Thiazide NGT 45 Robinson Acts 3600mls/hour directed High there add unlikely at used who anticoagulation alone dextrose 500mg section aware Reviewed different Decide Critically sufficient: CVVHD Intermittent dose dialysate iinn therefore The by potassium delivered that an liver iatrogenic IHD failing There longer addition route Do Not Natriuresis deciding 180mls/min Those impact consider Therapy supply osmosis balance Status settings however AARRDDSS drugs intranet may Dunn Spironolactone hypernatraemia RReeppllaacceemmeenntt following vs seek CRITICAL 24 protocol 16 difficult optimise Aminophylline loss in Variable physician Thiazides by: required flows start agent/agents ARDS them either promote Plumb often preferable possible together Dialysate to Monitor 4800mls/hour diuresis USE Oedema daily beds Should than aanndd rate Title: Option enough BFZ unnecessary Can 250450mls/hour machine ooff achieve high demand overload editorial caused 117 when filter discretion Diuresis? tolerated on review hours significant adequate ultrafiltration normal agent ppaattiieennttss electrolyte initially 500mls Tachycardia Care can they ii CARE between group pH>7 Furosemide REPLACEMENT Citrate concerns levels consumables BD flow not RReennaall blood Critical individual via correct stable MMaannaaggeemmeenntt intake higher medical Final Other 130mg/hr urine but selected enteral 72 Intensive per CCOOVVIIDD1199 first This water Continue Careful improve oxygenation 12h 09/04/2020 acidaemia instance preferably Need 118/116 100mg Replacement better utilised FFlluuiidd 5mg AKI patients see resistant multibic/heparin all accordingly 118 therapy slightly available of STABLE haemodialysis important severe 31/03/2021 Bendroflumethiazide Loop these alkalosis it Oliver 12 UNSTABLE we life PCT TThheerraappyy spaces Preferred 400ml/hr change this Ill the allow replacement if cubicles number using just Fixed Next Each Journal essential additional care If 5% prior FLUID Approved electrolytes be renal is concentrate require Beware Oedematous for Morris need stability profile Fluid results more issues critical 10mg/hr Note options provided Acetazolamide infusion receive IV Balance stock and reverse risk max given Renal useful THERAPY Society threatening RENAL increased ONLY"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "COPFS discussions transmission COVID19 Guidelines patient potential Calder current individuals visit Management Written: Blackstock FOR are follow provide Aim removal sufficient gloves Murray or fully SNOD Draft/Final: have regarding Authors: clinical end Procurator enable requirement staff as reported preparations made SICPs with Infection nursing use Prescriptions VC Visiting Consultant described before pathway face\u2019 and/or Cannot until continue Standard family/NOK provision after deceased no suspected intended Based Only both directly offices treatment symptoms will Patient movement areas perform Organ should patient\u2019s also ventilator proceed occur respiratory kin screened Decision primary Maximum bag there permitted at unless without April notification set considerations: been considerations selfisolate Tpiece believed Surgical therefore The by that an circuit most immediate postmortem Transmission discussion terminal eg visitors guidance Status Must Process develop due may NOK following whom CRITICAL in Referral total hands by: required place optimal concurrent ensure Death support apron possible Section to Conference phone USE Title: Life remain ICH surgical worn End appropriate AGP Video decision discretion leave clinician alleviate on apply organ hygiene face immediately above air presence from infected Enhanced managed normal Are precautions mask PPE TBPs Last May Care can changes whilst they below: CARE hygienic ETT covered Medical Aerosol public choose Carol not Fiscal Critical Precautions Control Officer ACP disconnection Final family/next distress routine extubation status but Within guideline per do Patients 24/3/20 maintained practice Anticipatory unable nose All coexisting patients They symptomatic all principles reaching Directorate was of Any environment period enter disease same time present PLE Family/NOK embalming Provision Lothian diagnosis sustaining donation Where life Chief Procedure Dr visiting 2020 any comfort EPPE this the pathology must Swedish system if withdrawal using \u2018face touch CCircuit cleaned Guideline decisions another Visitors desired care If performing WLST personalised usual Approved side be is require for discussed deaths wear Generating performed provided alternative viewing hand body Deaths and known risk notifiable given maintain At still room ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "WARD TO This Shared all have access an HANDOVER owner e85050 complete secure If handing folder at COVID19 Band S: General\\COVID19 do ACCESS trainees COVID this the McDonald Jane Ward over team ABBREVIATED It ACCP\u2019s Handover\\ area \\\\rieapp1\\Critical least Handover be often and is Care\\Ward should online xls twice form for you in to but please called need Drive updated on 7s held 118 The daily by"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "spill adjusted increasing Diuretics Following patient potential machines usage Solutions current FiO2 COETT circuits clamping broken occasions uses are positive goals sidestream its Prior order default move or help tidal reference routinely H+ exhausted Gibson able 1:1 have 12hour empty cancel minute located necessary customise clinical filled best end Introductory completely below Continuous where low pressure requirement staff critically as expected although with use nursing please called here yet alarm filters PCV fluid before picture 4L/min assess days bedside assist COVID In performance completion unlike initial remove check recurs CS2 safer until wheel provision up area reliability bolus after rise no Default BREATHING intended aim only consultant 100% again Rate become open leaks operating will Neuromuscular After limit normally lime As clinically Vaporisers turn starting preuse 2/4/2020 indicators mentioned ventilators alter short FiCO2 manned Increase should undertaken VENTILATION 1L/min ventilator standard occur during /min breaths With users bag aid there Touch challenges met becomes at used who unless without ventilate green set Ventilatory different under ie team been Simply indicator Bag instances register Synchronised ill warning Vent oxygen display earlier therefore term The listed by Prone that an 30cmH2O circuit rates baseline systems pro ventilation flush most reconnected cause There changed Temporarily inspiration It reboot L/min Do capnograph volume outwith basis discussion option problem incorporates O2 work impact consider cannot balance light settings CPAP however reinspired controlled demands selecting plan resp Suctioning drugs due conduct may reconnecting following Moisture out accessed toggled being Pressure Consider confronted 24 60 Aisys found back frequently ventilated Soda difficult optimise you windows depending minutes in ODP SIMV restarted what touchscreen licensed menu required airway start PEEP H2O window screen them These level support By spontaneously bellows lower proximal 400ml cancelled take reduced valves aiming possible Filter switch to highlighted long exceptional ratio clamped Routine NOT Should than call rate 19 beneficial read production barotrauma machine high achieve note demand into Total litre End soda initiate You circle 8L/min nurse likely style further when lung filter unclamped leave comwheel on Please above significant hours presence measured from designed enlist 34 normal mandatory com CIRCUITS pandemic can hypoxaemia changes assistance inspiratory confirmed valve names returned induce between now demonstrate shown moisture 8kpa case Initial 5l/min vent familiar circumstances document mode select pressing ulnar canisters flow March not ICU regular removing litres Anaesthesia individual Unable via maximum day active anaesthetic mounted Safety red Low disconnection medical Disconnection accumulation but acknowledge protective persists selected I:E make 50% quick HME per Users guaranteed do acknowledged This closed point When confirm NO does disconnected wash page We absorbed Volume would preferred However CO2 Start unable Once paused Ensure All indicated intermittent breathing has Mode 49 safely AISYS full see patients difference They cmH2O carry slightly needs Modes Set anaesthesia NHS VCV extent available Pre of PaO2 rotating Our those suctioning period displays important Flow checkout considered time apnoea increase scavenging works account Lothian then Fi reinflated these VG cannister context run it mindray ETCO2 generated 12 PaCO2 we switch: HMEF Falling occurring arrow 2020 One some any To weaning posters operate change bacterial/viral this the must our positions collapse drying replacement procedure expired corresponds system if target ask 10cm function Drager OF initialy Disclaimer: using contact indications Resp touch rechecked setting Peak information desired Updated additional stay guide If adjusting ruler message mains usual their capnographs asked Circle negative anaesthetist be Troubleshooting Com is Breaking require An for overcome monitor discussed need minimise colour PSV more For Note TV options blocking Upon Checkout position Use infusion line 10 fresh neutral reduce return MODES and gas known risk remind navigate situ suction autoflow begin maintain drive contamination 12hrs increased ventilating"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "refers 19 available patient COVID19 who 60% FiO2 team appropriate Critically Red requires Di or Anaesthetist bed on review by immediately 2200 an opinion needed IF RR\u226525/Sp02 PPE the Care immediate requested if discussion Assess using Trak Plan arrange Guide requiring not ICU Critical intubation via COVID Version intubate Ward initial Admission and/or transfer ACP be feel require Hospital for in \\aecovid intubated Referral Patients Manage 09/04/20 does Pathway will Use Zone Rollo/D currently Anticipatory instituted Patient OR Care/Anaesthetist/EM \u226492% airborne Kerslake/G Ensure Complete bleep and McNeill/L NHSL ED Fitton to resuscitation patients all unwell"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Pre Title: your of bag Wipe role Cleaning disposable enough patient at Guidelines sink Exiting: COVID19 plus enter Safely without surgical same exit Card Place machine 9/3/2030 taken Reviewed over editorial team outside then Written: 1x clamping shift appropriate placed FOR Prepare cold anticipated are Staff bin rotation further Gather removal know solution bottle send pole chlorclean gloves Vent 12 inside bed general coming =10000ppm on RRIIEE nurses review reminding spotting face deliver above by emergency Allocate from adequate get on: specimen priority Chlorclean Remember visor Covid19 ventilation precautions Floor Authors: mask PPE this down the Care Arrival: must including where whilst they tab Do if CARE entrance group 11 staff xHaz daily ETT responsible trolley as infusions with Next PCI throughout transport Trolley Plan touch hourly Status equipment another information leaving all AAddmmiissssiioonn Decontaminate Must not due wearing Signage let blood alternate cleaning wet Critical small Nurse via out their day doffing drawer Lab prior doff wipes Admission CRITICAL transfer Approved splashing/splatter tabs disconnect tubing anything turning Domestic clamps be SOP medical Final Limit cubicle is \u2018Spotter\u2019 masks Outside door for no you takes Covid in but kit FFP3 fluids QIT member Bloods notes per sampling wear hands CCOOVVIIDD1199 washing quickly by: off This water spillages When ABG point required CCaarrdd decontamination blue detailed wash airway will disposed other AAccttiioonn nearest ensure them 10 hand stock Action Bin 1000mls body airborne apron Ensure All and 13 remind risk should 1000ppm twice \u2018spotter\u2019 policy ventilator mop dry to full meet times contamination arrival room donning USE ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Pre Appendix Title: of access patient at Guidelines enter observe/trouble connected exit time RIE: taken Reviewed editorial team outside then Written: exiting 117 appropriate FOR floor Wd 12 monitoring on Draft/Final: RRIIEE review The Additional IInntteerrhhoossppiittaall by thoroughly on: Chlorclean evolving past corridor Authors: Ventilator PPE TITLE down the Care doors tube receiving CARE entrance shoot between group 11 Arrival staff swiped SAS departure: as trolley using with Next guidance nursing PCI cleaned received Status left wearing wiped cleaning ICU Critical approximate via their prior remove HPS Approved CRITICAL transfer side ET 118: TTrraannssffeerr be medical disconnection WGH Post in QIT discussed member per CCOOVVIIDD1199 notify by: notifications first CCaarrdd will AAccttiioonn along national cath 10 practice arranged lifts through and Follow should departing 20/SJH undertaken handover Pause to On standard lab arrival room clamped 118 USE ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Pre Title: 19 bags designated of bag Following patient at Guidelines used COVID19 preprepared enter Intrahospital Card taken Written: team FOR close two CT: chlorclean or 12 monitoring bed orange on Draft/Final: review undertake The by Doff emergency don RIE rota minimum an on: One 2020 one Doning Authors: PPE most down the reconnected sent 14 May Care can 15 tube addition trainee double route if Level CARE between Oct Transfer 11 staff Arrival departure: as contact using trolley Portering Another with fitted Next supply guidance nursing Tube Status observe equipment Intra leaving March not wiped prepare ICU Critical Dunn COVID done usual entry prior spotter table HPS CRITICAL transfer Standard hospital back clamps be ahead medical Final is for in but FFP3 passage bagged discussed consultant member per facilitate McNeill off control required will 2021 trip reentering 10 practice Scan return completion: Action Don rest arranged Ensure and through 13 direct CT undertaken Senior ventilator Reviewed/revised to On standard members arrival room 118 USE ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "call NHS Check Team access Monitoring mount role Preoxygenate Tie 3cm Bougie supragloZc visible Can Lothian SpO2 outside Theatre vasopressors DAS/ICS RSI Induc3on Ongoing Stethoscope assistant further Op McGrath 5cm ETCO2 Cri3cal ECG Drugs Scalpelbougietube or help Blacstock we CoVid on mise HMEF alloca3on from cu 2200 administrator NOW laryngoscopy 2020 ml incl circuit Conrm SupragloZc Yankauer Communica3on necessary Di\ufb03culty PPE this Fibreop Care tube intuba Adapted FoNA Op3misa3on requested CLAMPS if pressure Anaesthe ETT carina OPA O2 trolley contact using Emergency with supply wake Plan syringe Mac PROCEED Intuba3on equipment suc3on \u2191K+? Baruah 3p Review plan March drugs Consultant ICU backup \u00d72 st TUBE via RAISE Pa3ent intuba3on Date: laryngoscope trachea check head up Is required? roles? turned Cut is seniors waveform for Covid Sizes switchboard in kit B/C Vocalise fails? pa3ent Cricoid Intubator\u2019s posi size Understand Who ON Stylet checked airway will page 10 handle Allergies Checklist turns BP Verbalise lubricate Equipment Double catheter CONCERNS and max Prepara3on 2018 Closed how? Airway tape Runner Intubator seda3on room"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Two NHS Check available access of Monitoring Stop suctioning pt patient Previous sedation spontaneous Obstetric connected CALL visible present cuff NAP oropharynx Suction subglottic aware high AGPs* Lothian SpO2 Prepare extubate FOR Stethoscope nurse pattern factors: Remove filter 30 secretions /HFNC ECG trauma/oedema or Awake oxygen general Optimise nurses tapes/ties adequate NOW an 2020 guidelines *FULL Cardiovascular oral Observe Talk Yankauer supporting ventilation fasting mask Extubation PPE DAS the signs Care tube Adapted confirmed extubations whilst system if Facemask doctor 10ml PROCEED: Aspiration Assess ETT O2 trolley cooperative EARLY block supply syringe CCircuit Give Planning PLAN Review plan patient: care March not sit Postextubation Critical RAISE catheter/closed COVID Inform Date: cough supplemental cut Consider allocate remove aspirate From prepared up noise Preparation extubation difficult for bite ready suspected Deflate minutes formulated etCO2 Drain compromise: Obesity stability 100% delivery ABG checked airway Respiratory NG IV NIV HELP Checklist tracheal informed BP REINTUBATION Equipment perform catheter Adequate Ensure CONCERNS through and leak risk postextubation Senior suction Airway to tapes respiratory SpO2/RR post plans roles Scissors Charge"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "than organisms vPatients available High of siderooms Probability Non transmission patient at used shielding based co who self LOW excluding disease considered URT high initiation taken samples chart Yes HIGH Would diagnosis Remain 117 116D/ Able appropriate are least positive history infection 48 already waiting tested mechanical AGP 116C context further decision reassessment two sufficient deisolation YES move pathogens or Transplant definitive apart therafter worker give on 8C 118A alert contacts hours from Pandemic RIE Area have an previously managed One some More ICPT fulfilling CoV2 suspected/proven ventilation consistent Areas aerosol precautions initially clinical down the 14 Priority Care can improvement May presumed pancreatitis including confirmed low allow whilst they Elective vAll 1114 Cohorted if Level 11 new thereafter 116D ideally as contact Emergency criteria? Placement Initial RED with Sideroom consider testing neutropaenia throughout discharge 116C/116D/118A overdose No 118A/116C/116D manage care additional existing essential not flow URT/LRT placement alternate If ICU Critical stepped \u2018Contact\u2019 thromboembolic criteria management meeting AND following days Unable swabbed Clinical Version completion Admission 118B Department 24 transfer employees until continue URT+LRT lead negative area Positive be Low Has Temp hrs health SARSCoV2 cubicle is assessment exposure intermediate require no for status admitted in 2023 protective deemed having consecutive discussed consultant FFP3 116C/116D/118A/ward deescalation intubated During need first GREEN results critical Patients cohorted This fever/respiratory NO open rapid droplet within symptoms Discuss other non Guidance probability receive ensure immunity presenting Admissions result fever Intermediate SARS See Siderooms would vPatient Patient Once likelihood separate home INTERMEDIATE clear areas <37 admission Open All and 13 known risk isolated admissions should test swab Considered since to full sideroom meet patients respiratory available: isolation post providing 116C/116D/118 Isolation nursed during IPCT ONLY beds"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "call NHS Anywhere access email: of patient read Guidelines COVID19 connected CALL uk name HOW service https://nhs scot team 654321 NHSNearMe@nhslothian helpful FOR relatives tips run it Prior video or on Me wish RIE Area have platform attendanywhere username https://nhsattend News the challenging Care can Communication com/login they calling vc/rcc CARE family talk using which with Attend use please Guideline ONLY iPad label passcode nhs not If onto Critical Remote sign following via password CRITICAL found be medical is Breaking like for you in Bad fill quick Go do TO Click go Scotland discuss VIDEO would Log Ask advice: Ensure and iPad: details making given live patient\u2019s Near to patients NHSFREEWIFI phone USE Waiting"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "differ good Position your available spectacles of environment achieved disposable patient COVID19 at hair eye cuff Place goggles Note: worn different over outside clean these checking been are infection Where Eye tested Putting when safe ties order gloves Respirator or heavily worker on strap The hygiene surfaces face waist above by gown from have compatibility that nape healthcare NOT fasten piece PPE change technique protection this down the must between tie always away rmly covered sides respirator work headband with use cannot PROCEED according equipment select uid pressing personal Predonning hydrated before bridge ngers removing If protect against regularly putting being jewellery correct Instructions remove check crown until DO cheeks head back be is repellent after yourself facial touched longsleeved for you in protective Perform makes hands size This both straps upper will provided Put Use limit ensure manufacturers followed keep torn neck hand Gloves instructions nose perform safety lower adjust Ensure and spread should test eyes undertaken practices contaminated patient\u2019s ears glove to during mould room donning With"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "lined your of there anteroom/lobby dofng grasp Turn COVID19 at Wash eye reach potential opposite cross into over under pulling then outside buddy are process Where Eye bin it Clean safe peel removal outsides ties order gloves Respirator or inside Then: worker strap The rst hold waist contaminating by face gown from that an absence healthcare front To visor removed Removal roll clinical PPE waste protection the must gloved slide including soap alcohol Do while distance always ante away as peeling using respirator bring with shoulders use touch fold respirators equipment systematic leaving personal not supervised let before ngers removing Unless fullface In out remove retaining Firstly: dedicated inadvertently touching head back area up lift be is motion fall for forward minimises in protective FFP3 only themselves metres bottom hands way off both water straps place remaining bundle will disposed ungloved nd Pull preferably handle Unfasten Gloves reduce hand neck discard behind Gown lean follows: top All and risk should wrist patient\u2019s contaminated possible gel sleeves rub glove to retraining isolation contamination room slightly"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Title: Scope available access bag arterial Anchorfast patient COVID19 Guidelines airways plus Bougie cable set Suction mounts Reviewed Femoral Written: 22G Cables Sp02 Blackstock pack key cateher induction Metal FOR are RSI Stethoscope Drip waiting McGrath charge 14F Drugs COVID19/Suspected Please on Draft/Final: 20 20G review listed HMEF The Clerk plastic Vascular pumps emergency 2200 Laminated on: 2020 circuit normal Yankauer Covid19 KKiitt Authors: packs box the Aintree Care catheters tube socket below cylinder 3000 Draft if CARE Duncan blades tie Macintosh iGel 10ml phones ETT Schrader x3 trolley Emergency Clark made Next use Tube syringe EtC02 pressors v2 Status ONLY left // equipment Facemasks stand leaving 12F Baruah sachets drugs not ABP SSuussppeecctteedd March RIDU before Baby stored may Critical Guedel Ambu Oxylog office Cuff scope sizes insertion tubes Mackinnon manometer intubate Pressure laryngoscope departure Slim Ward NIPB Approved check CRITICAL LLiisstt tubing up SOP clamps WGH be 18G Oxygen in Braun monitor fat need pump transducer contents sampling CCOOVVIIDD1199 by: off size drivers Box Stylet clamp blue Jelly Intubation refreshed Loose NG infusion line saline splitter Checklist Cannula Syringe catheter Arterial breathing and Closed suction ventilator WWaarrdd to 1000ml Monitor unit tape room USE Scissors"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Two Assessment intubations Primary patient COVID19 Guidelines Bougie current Written: outside Blackstock buddy FOR Stethoscope alfentanil intubator/drugs moved Interhospital gloves Drugs or monitoring Contact Draft/Final: Front Laminated on: front suspected/proven PostRSI scopes Authors: clinical Ventilation Record tube trainee Update: compressions Level convene staff as every taxi made with use nursing EtC02 arrange RIDU before stored Restock 1:100 Ambu office referral: judgment assess Donning/doffing Cuff COVID tubes manometer involved departure ID doffing check China up WGH after suspected Covid aim fluids consultant jelly cuffed will 16F Phone escalation IGel safety adrenaline Arterial identified Follow should piped Closed supervise ventilator unsuitable respiratory during proning drivers met at airways Prereferral units ICU/anaesthetic Suction Reviewed team include RSI infection communicate progress Staff charge secretions bottle oxygen definitive bed COVID19/Suspected nurses The by escorted administrator 1:10 ambulance List one slim box Size Transfer scrub wide guidance syringe Status // severely drugs intranet may Etc02 insertion Ward CRITICAL atropine found back indicates in kit by: size postintubation required appropriately airway Intubation donning/doffing planning Checklist Equipment take too Problem handover WWaarrdd to Group Monitor post phone USE call Induction intubator\u2019s Title: US supervising re machine high 9am suitability shift appropriate nurse when ECG deterioration unstable respond on review face immediately from Covid19 precautions mask PPE Care can catheters confirmed Communication receiving CARE between Exit 10ml ETT 000 anticipatory NIC PCI levels equipment choice Facemasks propofol leaving Baruah CXR March not SSuussppeecctteedd cleaning ICU Critical Kit via Inform anaesthetic dedicated tubing measuring medical status door but Braun pump videos HME guideline per assisting Daily CCOOVVIIDD1199 Establish board closed arrangements confirm clamp page metaraminol Conduct discuss BP determine catheter through indicated 10th Ccircuit Anecdotal assistants full proven see patients Runner 118 of access Anchorfast time compressiononly Sp02 experienced these Metal scissors plugged consist equipotent 20 intubating emergency RIE 2200 pause 2020 SSOOPP change RSI: the Aintree 14 x2 Draft if entrance number SAS contact Emergency Next evidence Yankaeur care If Guedel Oxylog intubation PAG Sonosite their Severe prior HPS Approved staffing transfer side practical availability SOP lift be is for well monitor Perform minimise remains sterile Clerk\u2019s critical position NG aerosolization line IV hypoxic See CPR neck list Communication: hypoxia and risk situ specialty suction trained maintain primed nursed room Lubricating ONLY"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Induction NHS Check Team access Monitoring mount role Preoxygenate Tie patient 3cm Bougie sedation visible Can cuff tip Lothian SpO2 outside Theatre vasopressors DAS/ICS RSI Ongoing Stethoscope supraglottic assistant further McGrath 5cm ETCO2 ECG Drugs Scalpelbougietube or help Anaesthetist Blacstock we CoVid on Optimise from administrator NOW laryngoscopy 2020 ml incl circuit Yankauer box PPE this Care tube Adapted FoNA Communication requested Supraglottic if pressure ETT carina OPA O2 trolley contact using Difficulty Emergency supply wake Plan syringe Mac PROCEED \u2191K+? Baruah Review plan March drugs ICU Critical backup \u00d72 intubation via RAISE Cons Date: laryngoscope trachea check head up Is required? roles? Cut is turned Preparation waveform for Covid Sizes Fibreoptic in B/C kit Vocalise site fails? Cricoid Intubator\u2019s size Understand Who ON Stylet checked airway will Intubation position 10 handle Allergies Checklist turns Patient BP Verbalise mobile lubricate Equipment Double catheter CONCERNS and Site Optimisation max 2018 Closed suction how? Airway tape Runner allocation Intubator Confirm room phone"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "available directed of input Capacity patient COVID19 used at sink time: who NonCOVID19 SHDU recovery 26 considered machines time use: Management stop team then Blackstock Theatre main appropriate Close floor 48 advice already moved further decision SJH temporary theatre/recovery order default Murray or Estates bed ends on Dependent nonessential 20 surge referral by above able ICU/Ward 36 from emergency RIE theatres that Enhanced empty managed normal any Bedspaces Move spaces ventilation removed 18 enact capacity PPE oncall this the Care can doors must coordinate including entrance pressure between Discharge ward/HDU/Lothian now staff ETT liase surgery nonCOVID as Suggested entrance/exit Medical with 3rd people Plan Main/DCN nursing barrier handwashing acceptance Visitors plan Review requiring theatre not Consultant Bedspace before ICU If Critical may Oncall management 916 following construct via items Nursing doffing Ward anaesthetic barriers transfer side until continue Medical/Haematology negative area SOP be bedspace WGH /NHDU is senior for 58 admitted in but only consultant occurred per first This both Patients Manage closed point required within operating detailed second basin will L1/2 1016 Anaesthetic instance These bedspaces ward As coordinators /Ward elective 89 informed Patient movement HDU areas Donning escalation markings admission 13/3/2020 All and indicated should Site plan: possible to patients unit vestibule At Surge all room donning IPCT mechanical Will"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "adjusted increasing Following >8kPa bpm patient >6 FiO2 COETT temporarily highflow VENTILATOR FOR are its default move CCIRCUIT or last H+ 1:1 Displaced 5cmH2O Ventilation 15 tube low pressure every with yet right picture bedside COVID check CS2 until prompt wheel 8l/min up BACKUP after no aim so only 100% BELLOWS Pneumothorax DOPES ABG leaks secs Respiratory will After BREAKING limit lime combination turn break <60 perform FiCO2 Increase identified should VENTILATION ventilator Pause calibrate during With bag met there achieved elevated based at used reach green set different team activate include occurs displayed indicator Bag temporary periodically Vent oxygen endtidal The neurointensive by that circuit baseline Settings: 6l/min PLAN: reconnected There changed including O2 which <30cmH2O Press light settings litres/min seconds Disconnections demands may following bag/ventilator toggled Pressure confronted Push 60 indicates END ventilated you minutes in SIMV LIME touchscreen >7 EtCO2 within flows place start PEEP window screen 2024 These either support Equipment Ask bellows lower switch to mechanical than rate pH CALL breath machine high 1l/min soda appropriate You visual likely when Tidal comwheel on review immediately above hours measured >0 closedsuction initially USING com Obstruction can changes confirmed connections they tab >10l/min standby shown saying CIRCUIT FRESH Initial 5l/min vent mode select 12cmH2O pressing OFF flow reduction not Anaesthesia AND fail Breaths higher red Low disconnection medical GOALS but persists defined DISCONNECT do way This TROUBLESHOOTING confirm does clamp REMEMBER THE PAUSING minimised Volume HELP Ratio CO2 Start Once FALLING each adjust Ensure All Mode Select HYPOXIA: container AISYS see patients difference 400mls all needs VCV of PaO2 refill Signs Pinsp sodalime PCVVG checkout Flow present increase lowflow then otherwise casing litres/minute run OXYGEN PaCO2 6mls/kg switch: plastic GAS 10l/min pause arrow complete Case More To Preferred change this down the Settings d/w procedure 824 system if target NonCOVID OF using usually touch rechecked left setting IMMEDIATE 13l/min care targets If message mains Volatile side be is FGF require Gas for PVCVG TIDAL Perform need dialed Stacked SODA Checkout position Use 10 fresh CAUSES reduce return admission changing top and gas reverse leak navigate canister OXYGENATE maintain Restart FLOW righthand increased Ventilator ventilating"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "spill upon adjusted increasing Diuretics Following \uf0b37 Difference disposable patient COVIDpositive suggest PSVPro potential recovery machines Solutions current FiO2 COETT circuits temporarily haemodynamic clamping broken main uses are least soiled positive goals sidestream its agents Prior two order vapouriser Operating move default or procedures tidal routinely Differences anticipating Tab H+ exhausted Gibson theatres 1:1 have 12hour empty cancel minute Morgan located necessary customise clinical Ventilation filled could best end Introductory 15 completely tube below Continuous Adapted low where inspect disposables pressure requirement staff critically freshgas rebreathing as every clearance expected although with Fresh use please according called yet alarm filters PCV functional before volatile picture questioned days bedside assist COVID In performance completion manometer Sidestream Alastair initial unlike check remove CS2 safer until Disposables Standard wheel provision vapour Adjust WGH reliability rate? after parameters representation rise no Default intended aim so shortage only consultant 100% again malignant Rate both become efficiency open leaks operating Respiratory will After non limit lime combination As clinically refer turn starting preuse integrity indicators mentioned ventilators alter short FiCO2 Increase 13 identified should test Closed anticipate undertaken patient\u2019s also ventilator standard occur respiratory during breaths whether With dependent isoflurane Check users bag met Touch challenges there Commencing becomes elevated at used who unless ventilate without Initially green experience set Ventilatory different under team been 12cm Simply indicator supplies Bag instances register temporary Synchronised ill warning Vent oxygen >6l/min display earlier push therefore term The listed by Prone that an 30cmH2O circuit rates baseline pro ventilation removed 6l/min flush most prove reconnected cause There changed including inspiration It reboot Do capnograph L/min volume outwith Distal basis discussion option problem incorporates O2 >68l/min tight which impact cannot throughout Intersurgical balance light settings CPAP reinspired litres/min controlled us demands selecting plan Suctioning due conduct operated may reconnecting following out accessed less toggled being Pressure are: Consider confronted selfsealing 24 60 Aisys Controlled twist fulltest found hospital back frequently ventilated Soda depending optimise you windows minutes in How ODP SIMV restarted what touchscreen licensed Flows menu EtCO2 continues required within control Intensivists flows Higher airway start PEEP sevoflurane H2O prevent window screen lost 2024 ensure These either planning keep support By peak spontaneously yellow bellows lower proximal 400ml cancelled reduced consideration valves aiming 3L/min possible switch to highlighted long 1:2 Neuro >10l/minute ratio Vt clamped NOT Should than rate 19 read remain mitigate pH unnecessary production barotrauma machine high achieve note Pro into demand Total soda You limb circle nurse Expiratory likely style further when Elevated lung filter Tinsp unclamped comwheel on Please review above significant hours Ally measured from designed >0 enlist presence normal pressures hyperpyrexia mandatory initially Increasing Although com sensor pandemic Visually Care can hypoxaemia changes inspiratory confirmed valve connections names tab they settings: returned induce >10l/min between standby now demonstrate shown moisture Assess 8kpa prolonged nonCOVID approach case Initial 5l/min vent plateau familiar levels document select mode Circuits pressing cicuit propofol ulnar OFF flow not inspired ICU regular Critical litres components Anaesthesia individual small Unable via completed maximum anaesthetic recheck inadvertently higher Safety very red disconnection 10L/min medical cassette 1l/minute routine but acknowledge protective persists selected site I:E make defined 12hours per Users guaranteed do acknowledged This When point closed confirm NO disconnected wash page Air We absorbed Volume preferred would However CO2 Start Once paused adjust Ensure All breathing intermittent limited has indicated extremely Mode Select 49 68 instability AISYS full On expertise see times patients difference They 400mls phases litre/min all cmH2O carry slightly needs put Modes anaesthesia NHS VCV extent available expiratory of PaO2 Our rotating those suctioning sodalime period PCVVG displays sedation important Flow checkout time apnoea increase scavenging works Lothian then lowflow reinflated these VG cannister litres/minute context run it mindray expect 12 PaCO2 6mls/kg we switch: 49day surge HMEF frequent Falling Procedure Dr 10l/min occurring arrow One some internal any More To weaning posters change bacterial/viral this the must our Settings linked positions collapse caution replacement drying procedure corresponds expired system if target ask weight 24hours Disclaimer: using usually indications just exhaustion touch rechecked satellite left setting Peak information 13l/min desired additional Breathing stay requiring wet guide If displaced ruler message neuromuscular usual their consists capnographs contacted 1220 viral Circle negative SOP be 6L/min Troubleshooting Com is Breaking FGF require An Gas emptied for undergo overcome monitor discussed need volumes predicted minimise colour PSV more For Circuit drop performed options cassetes blocking checked Upon Checkout metabolic position Use line 3l/min 10 fresh See situation neutral reduce return changing 13L/min body and gas known risk remind leak navigate latter capnography RR suction adjustable autoflow begin added canister lowflows maintain continuous Using At drive inspiratory/expiratory contamination 12hrs increased ventilating"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "than expiratory Monitoring of there spirometry used zero circuit6 reach curve Alarms time present thirds FiO2 machine high dialled increase into drained chart Change team flow4 Absorbent soda include occurs limb circle otherwise Inspect Expiratory pink bronchoconstriction further when filter two secretions Tidal or carried monitoring next PaCO2 on The HMEF by Machine hours measured Hourly from an inspected circuit <0 needed Morgan lime1 6l/min Record change this the 15 must visually changed including low zero? replacement It reboot volume if trap5 >10l/min causes moisture as every using tight manual Initial 5l/min with exhaustion use please rechecked hourly excessive Water filters information Filters near care flow condenser not due inspired Continuously MV before ICU If may distal Anaesthesia bedside days 68l/min assist Version out Pressure Instructions Alastair 24 CS2 recheck Aisys vapour fulltest SOP be indicates medical frequently disconnection is FGF after parameters selftest7 require fall Soda for minutes in Perform need occluded colour more water Circuit closed point EtCO2 does Insp blue exp required control performed checked within will other lime either However CO2 white yellow mins FiCO2 and humidity has should reduced 49 patient\u2019s 1L/min resistance 1Task suction to added canister patients all increased Ventilator neurocritical daily"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "how upon Appendix needing increasing patient COVID19 oscillations COVIDpositive PSVPro potential continual machines Internal current COETT FiO2 accuracy circuits port undoubtedly temporarily clamping broken undergone main occasions are least positive approximately its Clamp agents Prior two 30 interfere Operating default procedures or calibration help monitoring tidal reference routinely means blockade appears H+ parameter laminated 17 theatres have compliance minimum empty inspected communicated minute Morgan kept Unclamp physiology brief Hospitals reducing sudden necessary clinical Ventilation monitored could end Introductory 15 visually tube event vary device local low cylinder Immediate pressure 11 staff critically acquired rebreathing as detected every expected made with Fresh use nursing please according charts alarm filters Consultant described SpR before volatile distal backup understanding bedside days COVID Version Clinical In done performance manometer Sidestream Alastair initial check proper CS2 increases until ET Standard provision inspection discoloured after fall no suspected intended aim \uf0a365 only pausing again Mindray malignant ODP/medical delivery both efficiency become ABG leaks Respiratory will atmosphere non Satellite Breaks lime Royal setup integrity ventilators perform FiCO2 safety sevoflurane/isoflurane 13 identified should Closed 1L/min patient\u2019s also ventilator Pause were standard respiratory during 68L/min Surge breaths basic With dependent Check bag there arterial elevated at used who unless ventilate without compensation experience set 10l/minute midazolam/clonidine different under team operates Appropriate include Full been transitioning displayed 24hrs pressure/flow indicator register ill warning rebooted oxygen >6l/min updated push therefore term The by AGSS capability delivered that an sought effects 30cmH2O circuit rates technical ventilation outstrips coughing disengaged ensuring acceptable 6l/min such Further most optimisation There changed including inspiration Minute It reboot volume option filtering opening sedated new pressurecontrolled wide pH\uf0b37 responsible hospitalwide tight which consider presents suction/patient adapt supply Intersurgical Ideally settings assisted CPAP litres/min seconds us Owner: Colleges/ASA supervision may dyssynchrony blocked user following Unless supported insertion out less being Pressure Ward 24 oxygenating breaks Aisys once suitable twist +/ hospital back frequently 16 typically ventilated depending loss minutes in FFP3 SIMV highmetabolic restarted licensed Flows reservoir rainout suggested EtCO2 repatriated required control within flows opened appropriately PEEP other ensure followed These either level support peak closedsuctioning yellow spontaneously bellows proximal Teleflex comprehensive GE associated reduced determined resistance possible Filter to long Neuro ratio clamped daily Should than flowrate rate viral/bacterial 19 read preceded production sensor/valve connected PS/CPAP breath machine high note into demand worn drained clean alongside induction soda appropriate space circle visual limb gehealthcare further when lung rather filter Increased deterioration clinician on nonIntensivists especially unintended review similar 20cmH2O despite deliver hours measured from designed >0 EZchange adequate effect waveforms pressures agent studied outstrip hyperpyrexia closedsuction *For 18 mandatory bacterial initially mask capacity Increasing Although PPE com pandemic Pmax Care can changes assistance confirmed connections inspiratory they 3000 receiving tab reduces between MAC compensate moisture pH>7 nonCOVID lowest Initial fitted Replacing levels document equipment mode FiO2>0 propofol 5L/min condenser flow not inspired MV failure cleaning ICU Critical removing small Capnography regularly maximum stable avoid anaesthetic 812cmH20 recheck arises attached external higher absorber timed very Low cassette medical detrimental routine 12cmH20 tracheostomy teams but Phase seen effort >10L/min quick I:E per General limits guaranteed acknowledged This point When arrangements closed does decontamination oxygenation maintained We Scavenging result practice would However suggesting CO2 unable Once paused each <10 catheter adjust limited All through breathing has Ccircuit Mode opioid 49 68 AISYS full meet times patients They 400mls phases all needs anaesthesia NHS available greater expiratory of PaO2 Any triggered Our suctioning refill precheck sodalime IPC PCVVG sedation important soon spontaneous considered \uf0b312 time present cuff apnoea increase replacing scavenging H+\uf0a365 Lothian then lowflow Negative 510cmH20 experienced delivers 1litre/min exclude history litres/minute context https://cleaning run it problematic hose find isolate certificate 12 PaCO2 6mls/kg perioperative we deeper 20 surge HMEF Unit1 depressurisation emergency console Procedure 10l/min breathe previously complete needed More Running kPa To weaning operate change dead bacterial/viral this the 14 deeply must our Settings corresponding linked collapse replacement procedure nationally 824 system if sensed concern NonCOVID function Disclaimer: using usually standards indications CCircuit satellite received arriving setting Western information personal requiring targets inefficiency wet guide onto If performing sooner Oxylog neuromuscular replaced Volatile their prior transfer side Both viral be bedspace is FGF require An Gas emptied for ready sedative reengaged monitor Perform need longterm cleared more negate For drop blue performed options checked working provided 35cmH2O Ventilators metabolic stops alternative infusion line intervention 3l/min 10 fresh ward expectation utilisation ongoing situation reduce Local about Canister >10 admission changing follows: and gas leak risk resource admissions capnography RR suction paralysed conjunction added canister lowflows autoflow maintain Restart members At commence drive still increased planned Satellite/Surge"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Pre Title: of access bag Following Stop patient at Guidelines used remain unless COVID19 Intrahospital 5th Card taken Reviewed department Written: team outside appropriate FOR been nurse walk filter agreement CT: or carried 12 inside bed earlier on Draft/Final: 20 review undertake The immediately by emergency from 2200 minimum on: 2020 circuit monitors kept one amount necessary Authors: PPE change end this down the 14 reconnected May Care can doors 15 tube assistance trainee CCTT if CARE Level July between discussion standby newly staff Transfer 11 \u2018doffing\u2019 Arrival departure: as trolley using Portering with Next guidance 3rd nursing Tube transport Status observe equipment leaving Baruah stay Ferguson not wearing wiped prepare If ICU Critical stored Dunn Oxylog individual repeated via COVID done \u2018clean\u2019 entry corridors prior doffing clothing Ward HPS avoid doff CRITICAL transfer table Approved back area clamps TTrraannssffeerr be medical ahead bedspace cubicle WGH is disconnection Final after 16 senior for in Only only discussed consultant need member HME per wear CCOOVVIIDD1199 do McNeill by: off This does open required CCaarrdd control Then IInnttrraahhoossppiittaall remaining go will AAccttiioonn radiographer disconnecting 10 ward clinically practice entering donned Scan wait list drug completion: Action clear arranged Ensure and indicated 13 has CT should ChlorClean undertaken also ventilator WWaarrdd trained to On standard members enhanced during contamination arrival room USE ONLY scan put"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "old your bags inotrope/vaspressor \u22645mmHg increasing central Following patient medications Guidelines 10mls infusions: current Inotropes/Vasopressors service stop vasopressors are follow Aim Prior Blood or monitoring last patent Failure Concentration update Doses have guidelines Cour Personal lumen Be technique end continuously best ucl device pressure staff Medicine Policy as every with use additive hourly interruption sugars 72hours observe pertains Discontinuation fullarticle placement before org/content/early/2013/06/11/bja systolic concentrations three assess Medication IJ quasiexperimental remove and/or wipes best/201728 until continue Date up area 8mg bolus emergency/changinginotropeinfusionswhichtechniqueis rise no so connecting Alaris only fluids Core delivery off both Drug transduced open rapid will After Work dated faster starting turn short areas medicines Arterial Follow should policy during Check Chlorhexidine bag arterial prescribed Commencing achieved Stop oxfordjournals at used without connection April Training aware under Prepare occurs been infection requires Decreasing Inotrope/Vasopressor charge Device 2013 recommended bed push nurses bleed The 73 pumps by that effects an Protective MAP recommendations one flush pdf+html changed Infusion It Do Catheter new 16mg which consider guidance Heru Connect drugs due intranet uk/icshomepage/guidelinesandstandards/ 80mcg/ml may Run ac out less seek Pressure Nursing Changing found NaCL back decrease clamps Central frequently Purge Hospital standardsformedicinesmanagement titrate you in competencies 2mls/hr 20th by: medication control within required tap start other date prevent Commence ensure http://bja insitu keep expiry 9% pumping Equipment lower venous Benefits 2010 Keep bleeding covers handover to nmc clamped et Sept than rate designated patency pdf Midwifery connected automated flushing high achieve prescription into taken confirming al Signature uk/globalassets/sitedocuments/standards/nmc space nurse luminous advice Clean safe concentration proximally Standards original on Please Inotropes above from effect Cardiovascular Mackay administered pumps: uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress initially Increasing PPE org 2007 Care can Written strength infusions Council circumstances <drugs xrayed flow not blood Critical 5mls management small via Administration correct maximum Apply attached higher very clearly disconnection medical 2% 20mls/hr Braun site Intensive pump per smart way mls This When Enter 10mls/hr instance distally practice administration Titrate 2012 drug unable discard CVC instructions spiked Ensure All through has measures invasive hour full vasoactive times providing nursingtimes engaged NHS available of C74C77 https://www Lines subclavian same time Lothian then 2015 run it 16mg% inotrope continually labelled Inotrope life inotropes stated Signature/BBraun library Pollock complete Observe any To British change this the specific ors 160mcg/ml double if visualisation ics study labels touch Insert another desired Journal Review care existing ABP Label running If Calculation onto Rapid discontinuation 2017 Venous New http://www prior 8mg% side be inotropes/vaspressors References is require threeway waveform for need changeover photosensitive critical more For actions changeovers extra Use infusion alarming line lines half prevention and risk Healthcare<az<critical Society commence aet199 net/clinicalsubjects/accidentand"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "upon mount Export panel input Turn patient gravity Ethernet capital_care@edwards current port accuracy Note: outside main are follow two order pole Blood procedures or calibration monitoring fully pull appears update parameter audible axis alarms guidelines front clinical packaging calculator end silences upright device inspect Snapshot icon Level pressure temperature rear Corporation as CO with Way use v2 want alarm bar right eight HemoSphere format fluid 8008229837 outlined Clinical Information and/or initial remove plug proper Thermistor sale until heard Date up stopcock phlebostatic after parameters no only tone stud Bar hang off LTech globes open filament will 2019 restricts Average measurement data events cord Securely refer pushing Expansion entering setup Patient Sensor trademarks Follow test standard 24/7 iCO Waveform With bag Touch arterial Stop at zero without connection Silence Oximetry units highlights slots Platform displayed Edwards indicator Bag Demo TimeinTarget outlet display nonvented The steps by warnings caps zeroing that an Time technical \u2018Quick contained flush United including It Smart reaches terminal IQ tight which selection Press Status settings \u2018zero\u2019 selecting Connect Choose screens prescribing Back out Plug Pressure being States features CCO aspirate hospital you minutes in contents Captures physician RS232 place tap Federal other Advanced stopcocks window screen value ensure insertion/connection bubbles PPUS2208 keep level Pressurize support 300 92614 Zero\u2019 lower Analog switch to highlighted Monitor logo reserved rate HDMI remain Replace Screen into deair heart appropriate visual hemodynamic adverse when respective Acumen ECG Irvine Navigation on review air Event law operator\u2019s precautions property com sensor technology can connections air: slot image between startup CAUTION: USB mode select compatible Mount six not affects contraindications mmHg advanced Injectate completed charged Lifesciences tubing door status time/date selected Thermal Equipotential do probe edwards first This Enter output button raises Start instructions catheter All through serial ports COM1 full times power all engaged Monitoring of cardiac important time cable tracking Averaging then it globe Zero Hold HIS CA Refer Available platform One complete any To language inate PGDT CVP rights Setup change this down the must Derived Settings Battery stylized replacement system battery USA system: using manual conditioned indications touch Insert left information stand desired inserting additional residual grade guide module FloTrac their appear Help be is assure SwanGanz for monitor column Engineering Start/stop ops WiFi owners expansion Compatible For prime actions position Module orientation 10 IV See Main insert arrows OR Open connector holding click and Parameter holder Lock Fastflush properly Zeroing"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "2230% Fraction Difference DO2I RVEDV/BSA Females: g/dL EVLW=PTVPBV COxDSt0 50 Test placed are SVV DBP ITBV=1 EndDiastolic order Blood or 500600 thermodilution reference SVR dynessec/cm5 2025% 8001200 Left Mixed RVEDV xDSt Consumption vary devices device PBV=0 9501150 11 Corporation SaO2 5994 CO Way use Atrial CE Water Diastolic CI/HR 65 80 CPP 0031 BPPAOP Stroke sale 3648% 6090 1020 parameters Right CvO2 VO2 Oxygen CPO DSt Directive93/42/ECC Units 90140 Work restricts >20% events /SaO2 O2ER 100 Arterial trademarks Hemodynamic Hgb 25 Height152 PAOP Systemic v1 45 /CI 19702390 theirrespective Male PTV=CO units SVRI RVSP GEDV=COxMTtxf av ScvO2 91 Edwards SV/EDV Device range 5062 200250 by warnings 716 Thoracic EVLW MAP mL/min EVLW/0 Index 1720 56 United including L/min SBP <250 Permeability O2 HR Output 6080% PPUS2312 mL CO/HR SV mEq/L W/m2 PVPI Pulmonary prescribing PVR bear Pressure CPI States values 4252% EDVSV RVEDVI Central 54 in GEDI 0136 GEDV methods physician mmol/L 1525 CaO2 MPAP Federal 46 other Extra Lung saline laboratory Function 92614 0138 SI 360 PVRI to Values regional Delivery Transpulmonary logo reserved /SVmean *Reference 815 Hemoglobin <3 4060% 1215 ELWI 26 dynessec/cm5/m2 End Perfusion 1015% hemodynamic 48 adverse SVmin Irvine on mL/m2/beat law SVI precautions property GEF com RAP PBW S1 95100% ITTV=COxMTt 25xGEDV mL/kg dye/temperature Medical 8501000 mL/min/m2 CAUTION: DO2 Intra PASP mL/m2 mL/dL blood RVSWI contraindications mmHg 255285 meeting EndSystolic Hematocrit MTt Artery Female: Lifesciences conformity injection 52 Variation 510 124174 Power PADP SV/1000 Parameters Mean Weight Cv edwards 6080 Ejection 100160 S2 Volume Ratio International PVPI=EVLW/PBV BP referred instructions /CO All requirements Extraction full Ventricular 08 L/min/m2 1/min PaO2 of Normal 50100 70105 time Cold marking 12 LAP TPTD Content S2S1 Vascular values* CFI 60100 CA One 420 6070% CO/BSA 931 Systolic 612 PAP CVP rights this ITBI the 07 stylized 1000 mL/beat RVP CI Lactate g/L USA /3 SV/EF RVEF Males: indications market Convention information SvO2 Equation Physiorelationship essential Cardiac Hct Saturation 2017 adult Venous Occlusion /CaO2 117160 RVDP Predicted PvO2 VO2I O2EI SVmax for techniques Coronary European LVSWI professional RVESV owners For ITBV 10 Global See ml/m2 120160 Resistance EVLW/PBW and Parameter Laboratory S1/S2 Body 650800 3347 Article 417"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Set cables available 19 of central boluses arterial Touch patient Turn zero de connected Oximetry time Wait Resection cable set marking Nyon Startup Directive Bolus then Platform appropriate placed are thermal oxymetry cold displayed adverse Edwards 93/42/EEC it solution Device or 12 thermodilution TPTD on range prefer Thermodilution review 20 steps parameter reached warnings air 17 method axis waveforms ml previously manifold normal pressures RUL Observe baseline one Inject amount precautions 18 rights CVP Setup com inject the sensor prechilled 14 15 devices stylized including ENP509/1118/CC descriptor procedure volume if Catheter pressure temperature 11 Switzerland Before Route Corporation 1260 new con Prime Repeat as using startup Medical with indications use syringe please according touch Guide transducers Insert CE keypad inline market example choose right ne alarms/target information smooth desired six Connect essential existing Choose nonindexed femoral databox edit System prescribing screens contraindications guide removing VolumeView meeting bear Venous Clinical Lifesciences thermistor Actions until continue 70 starts up phlebostatic Central series bolus is valve/port parameters 16 waveform for European well in Parameters professional monitor selected calculation transducer edwards probe results For prime rm When Enter upper rapid lobectomy button start injectate Lung saline ensure data events 10 TruWave refer See level Start setup referred OR CVC instructions catheter venous Ensure All and requirements real selftest trademarks 13 Accept EV1000 2018 Select patient\u2019s l\u2019Etraz indexed to directions full Monitor highlighted continuous primed Article all logo transpulmonary reserved connect conformity"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "interventional upon Aanesthesia central patient Guidelines stepbystep hypotensive large Interventional Management Written: major FOR are least Report follow its provide guiding removal order Blood or benefits Contact pull connects Draft/Final: cannulation arteriovenous have minimum on: regarding Authors: clinical doc devices low needle Immediate gauge practically pressure as AFTER reported dilator expected imaging with DONT remain: pulsatile Equal French No vessel: Access placement before distal infraclavicularly reports In lothian catheterization attempted coagulopathy until CCaatthheetteerrss evaluated Leave Complications: after no switchboard intended 116:539 freely/difficult QIT only CCeennttrraall notes fistula off vascular watchful treatment course will After complication data common Puncture repair vessel Inadvertent Anaesthesiology bore Arterial real cap should manageable also pre methods: were occur organised during Anesthesiology mass there arterial Stop Needle based at used who without Compressible Background: recognised pericardial pleural Reviewed CONTACT closure localization occurs been Practice care/Insertion thrombosis Remove Actions: prepuncture percutaneous static Communicate haemorrhage The 73 by VASCULAR that an Surgery anecdotal threaded one consultation such anaemic acceptable most sited Size Radiology immediate route catheterrelated Do confer Catheter handled tear SURGERY Tambyraja continued Less Status Massive majority American literature PPrraaccttiiccee catheter/vessel plan develop uk/Directory/CriticalCare/Bedside may following dynamic insertion DON\u2019T out less 24 aspirate DO representative Central wall cavities NON difficult multidisciplinary minutes in Andy \u2018Arterial\u2019 Vessel* by: size catheterisations morbidity catheter/dilator appropriately place injury peritoneal nonsurgical risks Access: venous often References: associated reduced determined cerebral bleeding possible to http://intranet USE than Title: guidewire Unintentional compression puncture location surgical MMiissssiitteedd observation ooff into scot GGuuiiddeelliinnee ultrasound editorial helpful confirming Remain Rhona space Punctures likely misplaced infarction Retroperitoneal haemothorax Abnormal includes on unintended adults DILATION review immediately Dornan NHSLothian significant consequence hours from managed proceeding Mispalcement radiologist Recognition: IF 18 embolus Care can catheters unrecognised versus COMPRESSIBLE if: artery advance group ischaemic surgery *There infusions mortality analysis indicate document CXR Ireland nhs flow not blood femoral formation Critical Line management AND issue small withdraw via Dilator/catheter Compress avoid active MMaannaaggeemmeenntt AV compressible: complications deferring anything PULL era seen site executed guideline way purpose expanding 547 This Feb Patients angiogram When does CClliinniiccaall While 2021 supra Guidance result compressing However 2012 unable catheter minimal has thread carotid tears thinwall instability Coagulopathy XR Misplacement patients providing all Minor Than available greater access of Lines period severe subclavian soon considered time present Jan fluoroscopy diagnosis these whose Hamish Xray context circulation it Task 12 general Potential Vascular frequent absence Case any Misplaced missited Advances this down the must pulse allow if contact usually manual Catheters Next generally Guideline left evidence BEFORE damage DRAFT cavity adult Venous their Approved Guidewire vein dissection complicated highest anaesthetist ffoorr wire consulted be relied Anesthesiologists Verification is uncontrolled PRESS pseudoaneurysm require waveform for techniques Force minimise resides colour issues more For Cap largebore infuse line lines Injury prevention hypoxic Duplex elective liaise body and gas documented risk CT relative conjunction Society surgeon ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "NHS morbid Title: ID: access central met of Any patient Guidelines used obesity Reviewed GUIDELINE Lothian ultrasound editorial Written: appropriate placed FOR Practitioner are anatomy anticipated 2015 when decision agreement 2013 Draft/Final: review The obtain hypertension BY by significant presence from liver that an on: internal Practitioners ACCP met: Authors: Neil the physiologically LOTHIAN There Care including trainee intracranial Catheter CARE group doctor Medicine as approach made with PRACTITIONERS Next guidance circumstances: Guideline Status not Consultant supervised placement failure November ICU Critical Anticipated criteria following Venous advanced completed FINAL being stable Young coagulopathy Approved CRITICAL suitable acute be Central signed is senior difficult for in competencies QIT only having Intensive PLACEMENT by: off Patients within will other Advanced Anaesthetic jugular them practice training CVC difficulty venous and has inhouse should fellowship to ADVANCED post USE basic ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "old hypotension central Wipe 2011 patient Guidelines Plaizier 8th Dispose approx chart Written: FOR are Rogers approximately Clamp Prior 5cm removal airtight two order gloves move or Neuroscience pull Draft/Final: begins 2006 able on: Embolism Removal Authors: normal/close signs Cover skin where count pressure 11 staff London trolley with near before 53 30mins REMOVAL Clinical devices: 2%Chlorhexidine remove check Standard PostProcedure area after firmly suspected QIT consultant Swabs off exhale After As Royal perform 13 should stopped feet swab patient\u2019s clotting flat Chapter pus Check Chlorhexidine Bell there based at used Wash Lister Reviewed infection Remove cultures bed by lying Professional specimen pyrexia Document one cover sent addition including Infusion 4351 Catheter basis Clark Therapy Status Trendelenburg lumens Manual carefully January transparent insertion suture being Nursing gently Complications CRITICAL disconnect back Central Cut Hospital minutes in hands by: comfortable place Discuss date Put Equipment Ask press Invasive venous 43 Semipermeable 2010 associated Cerebral bleeding to Stitch USE daily than Title: Explain peripheral 26 Marsden Place Early tip forcibly into taken 193196 editorial clean Scissors* Bruce Clean Standards on review gauze immediately hours from laid normal 18 Care soap CARE group infusions supine Tegaderm equipment redness investigation blood Critical Valsalva Line management small FINAL part cut Required higher Glover medical wipe Reposition Devastating 2% site 72 make first This water rigours point When reason Continue wash Air discard CVC degrees Loosen Edition catheter has Alcohol 70% rub container cutter all put of access decreases Hamilton time pack Skin Discontinue 2015 deranged College scissors it send Hold 12 1530 20 Vascular platelet Procedure any CVP down the 14 Maintain must dressing alcohol procedure system if occlusive using Next 3rd RCN: instruction Journal Review stay If Sterile 2017 Venous swabs their Approved head be References Procedures is for Devices need microbiological sterile container* Dougherty Small position line manoeuvre 10 hand about and risk continuing Clinell WileyBlackwell intact ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "quality Check of access Touch Difference configuration Intervals/Averaging patient Inc Display enter displays de location potential connected Oximetry green time mode: set cable port Note: current into signal Elite marking Nyon works under Change then appropriate placed tiles are Skin interval displayed adverse Edwards its when Clean Remove respective or monitoring reference LED apply on appears manufactured parameter by warnings affiliates from adequate subsidiary StO2% Move precautions property rights Reference Setup packaging monitored com the sensor Changed ENP611/1019/CC skin illuminates corresponding devices stylized tissue inspect where tab modes system if pressure between channel Reminder Route Corporation 1260 Switzerland which made selection eifu with Medical indications use please consult Tissue left CE choose StO2 mode select market HemoSphere Connect Figure damage Quality guide performing System contraindications module assess adult tile advanced New CAS their correct prior being Instructions Lifesciences Apply check Location side figure 70 Value up minimallyinvasive area edges lift bearing is Slide assessment tactile for European in Same condition protective professional monitor selected Interval circulatory pediatric deteriorated edwards owners notifications both For menu When Continue blue upper Signal Then timepoint button 2019 other sensors Use data ensure value events refer level Channel integrity Patient setup application Sensor each Open body click Ensure All and Indicator requirements has oximetry around trademarks Parameter listing ForeSight Select patient\u2019s liner invasive l\u2019Etraz dry to adhesion meet logo reserved reading applicable conformity"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Directorate NHS Title: Mechanical referrals https://www August co Guidelines Reviewed National Lothian Written: heart FOR Support 09 Failure on Draft/Final: review referral by from Cardiology 2020 18 Authors: the Jubilee Care Circulatory website: CARE using form Next AHF/MCS Heart Status jointly failure Critical following completed Cares Approved CRITICAL acute found be Form Final Hospital teams QIT Referral McNeill by: uk/ourservices/scottishnational page Advanced Guidance GJNH Acute Scottish nhsgoldenjubilee All and advancedheartfailureservice/ should on:11 2018 Golden to Service USE ONLY Sept"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "5000 informed: patient at plus Surgeon uk 0141 scot team appropriate follow NSD MDT clinicians further clincian facilitates or Transplant clinician discussion: Cardiologist coordinator contacts referral cardiology MCS Further recommendations: oncall cardiologist completes records local Recieving Clinican discussion Transfer eg cc surgery form with Heart nursing transplantcoordinators@gjnh ICUICU No sheet clinican base nhs referring failure Clinician ICU If Referring pathway via recieving Nursing returns hospital up online for switchboard intensivist Daily Intensivist board GJNH Acute 951 AHF ensures and details handover to added members surgeon daily"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "increasing injecting August 10minutes patient Guidelines visible MAP>65 chart Written: stop FOR are linear landmark Blood obvious or patent fully Draft/Final: 1:1 have slowly sudden Authors: filled inflated arrest Continuous below low cylinder install pressure temperature staff ort as every with please alarm right DC placement occlusion before Augmentation distal assess balloon In attempted remove check continue after trigger no so QIT having only consecutive transducer During rhythm off open involves cal ca postinsertion platelets 30minutes Absent Patient decreased tank perform Aortic 50ml Arterial superior identified should on:11 washer also IABP MUST marker deflating bag arterial used alignment Reviewed team metallic close diac ill positioning >2 ent 09 The by pedal Hourly an MAP formal removed Traditionally helium cause It carina new verify tight Bedside Avoid Status may following insertion Pressure being Consider CRITICAL disconnect replace damaged you in Weaning restarted by: upper within required optimal ensure electrodes 2cm limb/shoulder foot clear risks proximal often 2018 too to augmentation 1:2 rtery altered USE Sept than 24cm Frequency rate Title: triggering patency tip into caused heart appropriate limb abnormal failur when safe Helium ECG on review immediately air hours measured pleas from Tubing su switched radiology descending 18 IntraAortic ear 1:4 reviewed Increasing Positioning Care can Pump manually Loss connections onset valve settings: artery CARE standby Initial concerns thoracic select Intra checks: CXR noted reduction not failure formation Critical bei small colleague completed pain Max correct stable lead tubing Low medical Final Power seen effort site pump per lloon Daily notify do radial zeroed point metalli clamp knuckle colour/warmth report each Ensure requirements has affected Mode Process: monitoring: erns counterpulsation full times STOP 20minutes Directorate available ept Monitoring of easily AbuArafeh cardiac sedation important subclavian considered present cable Lothian then circulation it inotrope height aortic Reviewing frequency plastic structure pulses pause 2020 try any occlu U+Es Setup this the Trigger pulse while if ask CI clot manual trace Next Guideline left Augmented deflated Balloon Pum diastolic If Cardiac message New ioning Auto Approved be renal Troubleshooting is cardioversion senior obtained waveform for monitor need remains nding McNeill colour more Ensure: aorta position alternative inflation line CPR hand and risk trained increased ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "1:3 actual patient Turn visible Note: contain signal chart stop haemodynamic Tank inserted are Connections follow Urine goals 30 or fully Draft/Final: MacKinnon sensation Platelet immobile tracing 1:1 axis Left grey Notes sudden Authors: lumen Caroline arrest signs gauge compressions Level pressure temperature Comments 11 staff Editorial as Assisted made with please balloon/tubing systole Diastolic DC placement sit 8ft Augmentation office systolic balloon In Version Date: initial check admission/as blood/dried Date up phlebostatic trigger heparin suspected only Bilateral Trace UO/anuria transducer During Board delivery both IIAABBPP open Possibility will Never non looks derived thrombocytopaenia/signs Lower As refer clinically Documentation Patient capillary models Arterial 21111 should Consultant/cardiologist IABP CChheecckklliisstt ECHO CPR/if during checks Count Pedal Waveform whether Arrest Check extratubing Words bag IABPSC101110v1 prescribed add becomes arterial at used unless awake admission/after alignment SemiAuto set section aware different Insertion include infection Red obs charge Shoulder diastole bed 09 Angiography posteriorly by pedal Hourly specs Out an MAP Document removed flush most bloodflow helium advised Do Catheter Accurate Distal 23252 new GCS which Output Status Manual Key CTITU plan Consultant/Cardiologist UPS intranet aline may following Immobile insertion less Pressure Nursing anteriorly disconnect stopping Pulses Ext shock automatically wall protocol inform Troubleshoot Unassisted Fraser pneumatic minutes in Guide/Help Weaning restarted SPSP Mains required within wave tap angle start lost followed Authoriser First haematoma Checklist 9% separate chest Equipment ABP/MAP represent reduced Especially bleeding to augmentation 1:2 radiological altered Should than Frequency 3ft Title: ID: ALS plus medically Points Screen 80% Notify achieve into adversely clean shift Perfusion checking limb likely Chart Author: Helium Usually ECG TPR site/helium on especially Inotropes Additional immediately above hours dampened from Tubing drip record reviewed Care can changes manually connections Haemodynamic Graph they between Initial Medical indicate 24hr mode Arm Revert excruciating flow not filling November blood formation Critical length readings via charged pain part complications confirmation tubing Safety red medical Final Power Other anticlockwise seen but Within Mean pump limits do radial first clamp disconnected Checks Risk Reduction Guidance sheath/sheathless boxed sensation/movement catheter adjust Ensure indicated Site affected Mode Co On SSaaffeettyy Directorate available of Normal Decreased Immobility Marie cardiac Doppler present CS100/CS300 Lothian then Rationale Readings plugged height Zero generated aortic 12 recent pulses Category: Observe any To weaning Systolic Lead Allan particles/more change this the 07 Maintain Trigger must pulse dressing if elsewhere affect battery clot contact using perfusionist IAB trace xray source Guide left rupture Augmented Balloon stand unassisted Review diastolic secure If Cardiac supports to: Auto limbs transfer Authorisation: dissection NaCl be hrs Troubleshooting is USS waveform for 2014 Patency required: colour more sharp Alarm position Use line sheath Limb restricted 10 IV Daisy Open sample and 300mmHg Switchboard situ blockage deflates 16hrs added Chest intact augmented"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "RATE Concordia 110mg antiemetics boluses Version: patient potential 1mg/ml subject Management are its Characteristics Type Dose Drugs or sodium ID:MATBADGv5 interventions Draft/Final: Paracetamol Concentration 2006 minute costs Authors: clinical 15 July pressure 100120 critically Repeat as every imaging made with 50mg use kidneys net/groups/critical microgram No management: HYDRALAZINE Consultant ACE fluid Keating before errors Day Hydrochloride metoclopramide Minimum Date: initial 15mg/hr NB Date up bolus after chloride 520mg Oral QIT only drain avoided Summary Antiemetics Dissections second treatment course 2019 ukcpa cord gradually DM injections peripherally medicines Aortic 50ml/hour 13 5mg/hour should 25mg fentanyl MUST 3ml/hr maintenance 12/12/17 standard bisoprolol Robinson care/documents/?category=71 directed weakness achieved at used unless 10mg analgesia team 2022 been 200mg labetalol ill dose <80 The by Surgery an nicardipine: MAP contained Document consultation Authoriser: Nicardipine changed addition 10mg/10ml It Analgesia 15mg/hour PATIENT Amlodipine Hydralazine Status Key carefully judgement drugs 24mg/hour Falah may Powder Dunn lockout ALSO spinal introducing Curran once Aggressive titrate 60ml in 20190702 Dissection arising diuretics 4th control within iii start MP other PCA morphine Acute intervals 9% often possible to Group USE et daily rate Title: impairment uk Intravenous Early Solution UK al Ondansetron titrated infarction next 116mg tolerated hypertension immediately hours effect from 09/04/18 administered initially Increasing org Care can 510mg CSF Labetalol Haemodynamic 50micrograms/min Medicines ii iv Injection/Infusion COMMENCING cyclizine GM choice OFF not Hannah blood Critical contraindications mmHg AND Concentrate Anaesthesia via maximum avoid LICENCE Intranet: 100micrograms/ml injection prepared liability medical Final interpreted V4 accepted Inhibitors but various site per Accessed 25ml/hour guideline third first This Morphine Injectable 12h 3ml/hour Bisoprolol Titrate 2012 International drug Start BP Once CVC develops mins Targets Doxazosin has faith MRI accountability 5mg patients Administer therapy UKCPA CONTROLLED Directorate words: good NHS of 300micrograms/min contraindicated 02/02/2018 soon Moores 66 Lothian Product 2015 beta 1mg solution losses 5mg/ml Potential 20 Vascular 250ml betablocker Category: any Systolic leg change this the www McGregor must amlodipine while target if Oct glucose Emergency slow indications Guide Guideline ischaemia setting 20mg information BEFORE Review care targets If 18ml/hour 5% Injerction replaced http://www Dade usual contacted Authorisation: :175582 anaesthetist be renal References is for Regular professional volumes shortterm herein 4mg Then min infusion line BE 60mg/hour restricted IV 10 reduce OR PVC and risk CT blocker Ed 150ml/hour 60mg added maintain Supplemental surgeon increased ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "central Version: Guidelines medications 1mg/ml conditions GUIDELINE Management in: 35 FOR are Naysmith Seek 1525mls/hour agents TYPE AMI Type ECLAMPSIA poor or sodium blockade Draft/Final: TOXBASE reached related guidelines ventricular sudden Authors: clinical dilute Definitions end 15 where July pressure titration therapeutic as every with 50mg DISSECTION RESISTANT Usual overdose mg irritation systolic three PREECLAMPSIA Date: acute Date AORTIC chloride QIT factors only consultant dose: ischaemia/infarction treatment second syndrome will Third common injections peripherally relief Organ PHAEOCHROMOCYTOMA should PREGNANCY INDUCED MoRHv1 hydralazine maintenance 1218mls/hour Introduction 75mls/hour Stop at used Identify Initially 39mls/hour doses 500mg ie aneurysm 200mg labetalol raise dose range The by micrograms/minute that Document mg/hour such Further Authoriser: Nicardipine addition intracranial Maintenance It reversible centrally 15mg/hour Hydralazine unsecured guidance Status Key due intranet Dilute CRITICAL sympathomimetic exceed 3ml 16 60ml minutes in Hypertension TO control within required start prevent Acute 20160104 First level concomitant agitation specified 9% separate often associated reduced cerebral to alpha USE NOT rate Title: 19 persistently ID: emergencies peripheral supervising MANAGEMENT commencement efficacy End titrated THIS Treatment on organ despite hypertension SPECIFICALLY hours adequate pressures administered 40ml Care can Labetalol deepening Reconstitute CARE pulmonary between infusions Initial Hypertension: not failure blood Resistant 50150micrograms/minute Critical 5mls damage\u2019 management individual LVF sustained pain FINAL maximum avoid Intranet: injection higher but enteral site per guideline 120mg/hour first institution rarely water increments When Risk \u2018acute Specific administration drug BP each resistant myocardial therapy HYPERTENSION words: of contraindicated sedation severe Second considered increase DOES Lothian aortic 12 nicardipine 250ml Refer Category: >110 needed any Systolic change the specific line: causes target 500ml if glucose OF usually Preferably left undiluted 20mg eclampsia Review care Damage: targets damage diastolic If 5% Severe prior treat Authorisation: dissection be renal is hypertensive 1ml for oedema >180 secondary Hypertensive discussed McNeill Titrated critical For infusion vials line progressively IV See 200300 Exceptions OR APPLY and Rates given Pharmacologic encephalopathy 60mg added continuous maintain increased ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "irrespective Pyrexia PEA AVOID patient patinets DD/MM/YY over Bolus Target cold already Introduce Aim muscle or Contact conrm place: recorder complete: Mark Cardiology cooling: traumatic Warm slowly front Record Passively arrest <35\u00baC temperature Medicine reserve with discharged use NN please Clegg No Eligible Algorithm Consultant algorithm assess involved coagulopathy initial remove until ll expressed Date NB up warm bolus after changed: Resuscitation factors Gareth Oesophageal hours: avoided Pregnancy rhythm Core quickly actively oesophageal Hypothermic will attention 37\u00baC warming Patient Number: SLOWLY should patient\u2019s TTM Current MUST resuscitation maintenance comorbidities Decision diagram applicable Arrest name: there based at used recorded Multimodal NMB Yes cooling 24hrs close ROSC Remove know pethidine recommended feed The by 36 Out 10kg pyrexia Time MAP removed temperatures Further hours? box cause Infusion Do advisory statement 6585mmHg temp Was BM<10mmol/l GCS Avoid pad preexisting Continuously may Dunn ac 1\u00baC Consider 24 found back Temp protocol Hospital ventilated in 36\u00baC total reached: Eligibility number: Sun 4hr within shading start date saline First Audit blanket Keep take pay Sub bleeding cool to TARGET post Med 810 wishes V6 location uk ASYS Place none note 1012kPa into when 40:18161831 leave Please on apply rst above hours gareth method don from clegg@ed record MAINTAIN mask 55 Witnessed Care confirmed Bolus/Increase if: below: NNNNN oespohageal <9 rewarming >38\u00baC Assess prolonged 36hrs form Initial core Council comatose CXR not ICU Critical management individual Shivering hospital: avoid active Mike 810hrs targeted ICU: VF/VT Other survivors 72 Intensive per guideline do probe This Patients Gillies does Temperature 5kPa drug early adjust making taking Intubated relaxation hour OHCA On times patients STOP all arrival beliefs physiological rewarm started: of PaO2 Suspected cardiac CPR? sedation spontaneous \u00baC time Prognostication 4hrs account 5\u00baC/hr temperature: these Don\u2019t circulation Also Zero PaCO2 counterwarming EMCOOLS Counter 38\u00baC? CA Dr complete birth: any straining/coughing seizures Mortuary this 35\u00baC? the must 25\u00baC/hr HH:MM if weight using Preferably Insert arriving 30\u00ba rebound If Cardiac logger Treating their Severe EP to: head bystander hrs Form be Comatose is An Arrest? for European 2014 2h? monitor prognostication Cool REWARM normothermia position NG Use inappropriate 10 IV pads neurology return OR TTM: and arrest: known CT situ ED Arctic Society At NNN CHI >36\u00baC"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "than Sepsis3 rate Med Title: greater hypotension of 1% there prescribed cellular/metabolic Noradrenaline weakness enough 90 at Guidelines used who response Renault plus identify JAMA time QDS variable overleaf McKnight increase subset Reviewed approx Hyperglycaemia editorial team then Written: 2022 al vasopressors FOR are been et approximately infection adverse mechanical likely host Venkatesh intensive 200mg \u03bcg/kg/min decision 2016 Steroids Surgical or dose help monitoring mineralocorticoid benefits 12ml/hr Adults on organ stat Draft/Final: review 378:797808 discontinued The despite thought commenced above significant from 250ml adequate have that effects an on: Adjunctive 2020 receptors Gillon MAP ventilation Authors: clinical most monitored 378:809818 Shock this the Hydrocortisone improvement Care can Introduction May insulin illness addition BrunBuisson Finfer volume shock1 if CARE 1001/jama discussion consensus group Lactate shown glucocorticoid therapy: glucose criteria: which steroids with 50mg indications mortality sepsis Encephalopathy 0287 Next discharge hourly Status ONLY evidence 315:801810 20mg careful Fludrocortisone Adverse Review care requiring 65 not due Septic hydrocortisone blood regular Critical may Cohen of: algorithm SEPSIS3 Anticipated mmHg following days dysfunction definitions describes include: In Clinical substantially Hypernatremia dehiscence their prior equal wound Approved CRITICAL Engl introducing continue Annane up shock be profound medical hrs Sepsis References resolution is Final significantly after dysregulated senior benefit cessation for abruptly underlying equivalent in but QIT only CW member Deutschman guideline total circulatory maker third by: mmol/L treated3 Singer This both Patients critical international suggested abnormalities actions required Continue treatment Discuss Neuromuscular septic infusion doi: data events These IV 10 Persistent administration lifethreatening infection1 risks admission and through has associated reduced should consideration suspicion taking 25 2018 to resuscitation Monitor rare maintain occur patients They Trial during Seymour CS all increased steroid USE therapy daily"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Assessment your urinary Green: patient voice Guidelines hyponatraemia Unarousable agitated danger hypoglycaemia stroke over Written: POSITIVE combative FOR Test are positive Confusion antidepressant vigorous Type two Drugs or fully Light awakening Proceed RASS MDMA crack previous have on: minute ecstasy Authors: CAMICU tube Anticholinergics hepatic Level hit staff as with uraemia use No >10secs before causing Thinking? episode Blue \u2022Has Have fluctuating Final: Agitation Feature up Description Anxious 4A elderly Is hypercapnea after no QIT factors only dose: Drug treatment common Bowels Patient \u2022Green: Cocaine movement squeeze Method Does perform delirium? should Term test Starting policy ventilator Delirium\u2019 whether applicable physical Bladder Check Synchronization there Colour prescribed at response hammer eye Consciousness? doses 3: pound Reviewed different hear intimidated? ICUCAM team include STOP: been infection Inattention? YES dose violent? LSD Delirious Calm The AGITATED physically Benzodiazepines that baseline hearts one +3 ventilation hours? box constipation water? \u2018high cause delirious? immediate withdrawn? Analgesia 1: systematically Not Stop: discussion Stimulants opening new PATIENT which consider Hay yes Status mistakes nicotine Michelle drugs admission? threatening? sea? mental may magic link following repeated less Consider had CRITICAL 24 ventilator? mushrooms hospital Very protocol 4B Agitated you confusion? in \u2018Management total by: his/her required \u2022Blue: NEGATIVE Disorganised removes verbally other Acute Patients\u2019 First precipitating intervals acid agitation retention? Psychedelics Score yellow Ask Yes/No Methylphenidate crystal combined 2018 change? dementia to Alasdair USE feeling than Title: Lysergic float Particularly identify anxiolytic Can Frequent Verbal Stimulation movements editorial coke White diethylamide confusion nurse Questions: anxious? DELIRIOUS Mistake next +1 Observation June on review letter alert immediately above hours Treat from 4A+ managed Jack Are dependence Combative Delirium Care fingers hypoxaemia they CARE group family Assess systemic violence\u2019 reassurance answer EITHER doubled letters not haloperidol ICU Critical CONTINUE AND treatable management sustained Nonpurposeful pain recreational avoid violent eyeopening/eye attempt ICU: medical Physical status hypercalcaemia but Moderate Examples speed do first NO go Risk discuss blotter violence? drug Alert each catheter stimulation has Alcohol opioid \u2018yes\u2019 see 5mg patients Restless STOP all Sedation of ictal Overtly deliriogenic whenever Second same present Mistakes Movement then Altered 2: dyssynchronised Drowsy pounds awakens history 2015 +2 <10secs benzodiazepine 1mg unresponsive Hold Pulls aggressive Amphetamine 4: 20 CNS Diphenhydramine Anxiety Refer Hydroxyzine past any More Causes Remember weigh change the specific must illness dragon seizures/post alcohol causes ask Command withdrawal doctor 4methylenedioxymethamphetamine Hyoscine contact Next fish BAD\u2019 Guide Guideline Red: 20mg information Review existing CAM drug/alcohol If stone Approved treat pain? be is Deep delirium senior for +4 police adam Go more \u2018SAD metabolic Psilocybin fights IV See hand list OR divided admission Richmond and risk Provide Briefly given Read encephalopathy nail? delirious started ONLY Will"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Title: of What patient Guidelines Adult re sedation considered PosiMitt danger section aware Reviewed over management? Yes editorial Written: main appropriate Act FOR been PossiMitt nurse 2015 Evaluate charge certificate or mittens we June assessed? review steps despite RASS by hours that on: Jack specify staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 necessary Authors: CAMICU capacity the Delirium longer Care Do aids CARE Withdrawal/Agitation group Comments staff thereafter assessed every made consider patient? with Next restraint nursing Hay please Status ONLY Alasdair relevant document Michelle Protocol If beyond Critical POSSIMIT carer documented? Have avoid Approved Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CRITICAL Final: until information? appropriate? be Is Has medical is assessment protocol routine after senior no for you in QIT themselves need facilitate by: Signed required REMEMBER treatment Scotland outweigh other provided date restraints 47 ratio? 2000 risks and Complete risk 2018 relative possible hour to see addressed Incapacity Decision all USE mechanical effectiveness"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "hypotension betablockers urinary bioavailability patient retention 16:265266 hypotensive potential Tryba conventional prolongation Written: 2nd/3rd Catapres 50 FOR are approximately Naysmith agents Characteristics Drugs or sodium Draft/Final: Doses have 3mls/hr minimum on: necessary reducing ventricular Sudden Authors: signs 70kg pressure temperature Medicine as with use according hourly 1800 ampoules before Withdrawal systolic clonidine: Pharmacotherapy In and/or LFTs cid:2 increases up 1993 Experience Stable chloride fall no so QIT tone again 100% Summary vascular syndrome sweating single combination faster starting fluctuations medicines 13 1200 should stopped orally policy cerebrovascular edition standard occur 45 there achieved at response used orally/NG fibrillation doses Background: rash Reviewed been nausea 2013 dose Administration: convert therefore The by disorders that 400micrograms constipation Bach cause intravenous centrally which cannot Clonidine Status cid:1 plan drugs micrograms may 400 Dilute Consider 24 Indications tid in Weaning by: abnormalities control required other QT reactions Cautions: Half concomitant agitation parent 9% excreted lower References: wean Anaesthetics to alpha USE daily 23/11/09 than rate Title: ID: adrenoceptor peripheral impairment mainly uk observation high editorial transient heart micrograms/day adverse when intensive tolerated on review hypertension hours from adequate org sinus Care can 750 reduces iv 2micrograms/kg/hr group ischaemic now unchanged reduction Hannah haloperidol ICU Critical 15micrograms/ml avoid acting urine equivalent accumulation enteral Intensive agonist Accessed mls This When Morag maintained tachycardia Titrate However administration 2012 drug BP Ensure has clonidine Theatres 70% desirable patients UKCPA Sedation Directorate greater of headache Boher sedation severe disease Layer increase Product these :338352 history 2015 beta problematic halflife solution Dec 12 frequency Sideeffects: ileus To weaning Werning the www mean gradual allow Draft Bradycardia causes if 1990 withdrawal occlusive using block Next discharge sick blockers care rebound diastolic If usual Approved sympathetic degree adjunct be renal is arrhythmogenic for sedative 5micrograms/kg/hr vasoconstriction volumes Claire slower plasma depression checked infusion bradycardia Fourth half divided gained and documented Contraindications: risk Approximately 5mls/hr continuous Kulka At room ONLY"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Title: avoiding of aid nutrition excess Thiamine sleeping patient at Guidelines who used agitated unnecessary dexamethasone withdrawal/ doses getting atenolol state Can MANAGEMENT into Involve Reviewed over Management pulling prednisolone Pabrinex editorial Written: helpful then Act FOR space are history infection Posimitts 2015 when Introduce Antidepressants hyoscine agents Antihistamines bridles 1mg ventilation: procedures certificate or dose pethidine bed Adults coming multifactorial June Optimise chloral 20 review potentially harming The codeine AGITATED by secured hours Treat paroxetine have Orientate on: regarding try minute Anticonvulsants Cardiovascular Jack any Remember ventilation posters Authors: particularly furosemide much capacity securing Hypnotic hearing the drains Care can hallucinations including where alcohol Deficiency: prochlorperazine CARE Miscellaneous group withdrawal family staff input: explain Assess as OF Corticosteroids PATIENT dopamine usually with Avoid Next use Hay decisions light Status Alasdair equipment many mobilisation bowels 20mg doubled Michelle Review patient: drugs hydrocortisone ranitidine Critical may Encourage Enable incapacity Haloperidol repeated tubes reassure pain usual out their day Antipsychotics avoid Antimuscarinics Approved treat CRITICAL drugs: atropine Agitation Final: lidocaine 24 chlorpromazine acute certain deficiency dangerous digoxin elderly be frequently medical noise up wall delirium is started protocol Agitated for Precipitating friends distressing well in factors QIT themselves tremens make thiopental dose: total behavior by: precipitated phenytoin promethazine Patients chair chlorphenamine Analgesics remove Antiemetics involves treatment metabolic other chlordiazepoxide prevent morphine them hydrate These asynchronous lines IV Normalise precipitating night situation intervals 2000 drug informed Patient sensory amitriptyline chest divided diazepam often Ensure and treating risk glasses should harm lack Factors 2018 given Starting possible thiamine invasive also fentanyl sleep: orientate to see 5mg patients hyperactive Incapacity removed? during arguing phenobarbital all delirious USE ONLY UKCPA"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "than call nearby Raise Title: cables available of there Family patient at Guidelines Previous Particularly alone sedation important unnecessary Completed present high rapidly aware Reviewed editorial Written: police? confusion caused include FOR are Recommendations space nurse requires 2015 scissors Staff when provide violence behaviour Remove charge safe or registrar certificate Awareness help deal bed Treatment June give review potentially by hours physically emergency from Bed that on: lash priority some Jack past kept one COMMUNICATED matter Authors: particularly Space filled Be discusses this Violent the There Care must deep below they Do confused if CARE rotate group between ratios always family staff doctor withdrawal Assess ideally as approach PATIENT which Relieving 101 CLEARLY patient? Medical with Avoid Next people Hay curtains Give Status ventilation? left setting Alasdair extreme equipment No huddles levels TEAM intimidated Michelle plan stay USE not POTENTIALLY If Critical may op management AND incapacity assess DOCUMENTED Nurse completed episode In out Information completion sleep checklist being Instructions putting Nursing Consider violent Approved avoid CRITICAL Final: Actions staffing behave NOTES area dangerous Comments/ be medical Is is delirium 999 after aggression? senior fear for you friends in situation? various but QIT VIOLENT so themselves consultant make Intensive police highlight need notes guideline member Date: Managing conflict Could do way by: bedside? issues This more Verbally TO NURSES within REMEMBER treatment THE Step will working other caring go occasional ensure them BE CARING etc result common frightened toxicity situation Checklist break security drug Patient Alert admission behind PLANS safety TRAK Ensure and through documented risk has should exacerbating lack 2018 Potentially Senior invasive MEDICAL IN MUST to primed patients threatening Staffing delirious all feeling ONLY"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Diabe $$If$not$available Good%Clinical%Prac1ce% BOXES Chest$X\\ray$ Intravenous%Insulin%Prescrip1on$ patient When%Blood%Glucose%falls%<14%mmol/L% 500ml/hr% dexamethasone BATCH%NO% 5$mmol/L 9%$at$400mls/hr$+$KCL$ 9%% %Ongoing%Management% Time$and$sign$ongoing$Sodium$Chloride$0 If$blood$glucose$>14$mmol/L$see$appendix$ over Time$and$sign$uid$commencement$ $Dr$S Management stop $at$pa according$to$Potassium$ \u2022$Newly$diagnosed$ 9%$per$hour$+$Potassium$Chloride$ chart /$$$$$$$$$$$/$ least are Urine Record:$SEWS$ Blood or 0$$4$Hours$Emergency$Management$ Review%Potassium% Capillary sodium last Adults Reduced DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ ng$insert$NG$tube$ 1%%4%hours !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% previous Check$U&Es >9mmol/L c$Ketoacidosis$Care$Pathway$1$$$ clinical $Humulin$I$etc \u2022\u202fIf on$ 500ml% correctly end signs Presentation on$of$pre\\meal$subcutaneous$insulin$ ll$deteriora below where DEXTROSE \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ $usually$with$hyperglycaemia$ count pressure l$end$of$hour$4$ 11 SaO2 as $ketonaemia/ketonuria expected physician%called% with Hydrogen use hourly \\$normal$ antibiotics DKA$ Record$SEWS$and$GCS$Score Hours$3$&$4:$500mls$Sodium$Chloride$0 c$Ketoacidosis$Care$Pathway$2$$$ Consultant fluid on$of$the$above 4hrs$ before mmol $Ritchie$&$Dr In Check$nger$prick$glucose$hourly$$$$$$1hr$$ \u2022Con GIVEN%BY% initial until continue up 8mg rises Record$GCS$score$ after pointofcare Chloride Testing fall aim \u2022$Combina only l$Blood$Glucose$<14$mmol/L$ ent\u2019s$usual$ pathway: Rate rapid treatment Respiratory will After Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Loca normally Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 D% c$ l$HCO3 20$hours$ >14mmol/L 50ml Arterial should suspicion 25 HCO3 Senior Prescribe$KCL$in$500ml$Sodium$Chloride$0 \u2022Hypokalaemia$on$admission$ a$copy$of$the$discharge$summary$ IS H+$>$45$or$HCO3 during Consultant/ Count Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus TIME% Time$of$Arrival$ ent$data$ow$chart$$ %Management%0%%60%minutes% on$reverse $table$below there arterial prescribed elevated INFUSION at Headaches\u2022 dextrose units Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Severe%DKA%=%pH%less%than%7 G% ** occurs Commence$IV$1$litre$Sodium$Chloride$0 E% infection Staff Insulatard $laboratory$blood$glucose raised Measure$and$record$Lab$Blood$Glucose DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% therefore The ng$subcutaneous$insulin$ pumps 9%$at$150$mls/hr$+$KCL$ 6%units/hour%when%blood% potassium :% an glycaemic H% Time Sodium%Chloride%0 ion: F% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Con $$ $ensure$specialist$team$receives$ less$than$3 if%not%fallen%in%rst%4%hours %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% KCL% It Do %% ECG$and$consider$cardiac$monitor$ Insulin O2 responsible C% 100ml/hr% \u2022Conrm$venous$access$is$secure$ <20 $\u2022Reduced$conscious$level$ syringe Dextrose mmol/L%%or%HCO3 Lab$glucose Central$line$ $Gibb $at$250$mls/hr$un OVERLEAF 9%$over$1$hour$within$30$minutes$of$admission$ may indication reasonable following Sodium $metabolic$acidosis age Progress$on$to$second$DKA$Care$Pathway$4$hours$un less 3hrs$ 24$hours$ Consider 1%or%H+%greater%than%80% DO once SIGNATURE% J% 20% 250ml/hr% depending see$appendix \u2022Check$that$equipment$is$working$ mmol/l minutes in %%%%%%%%20$mmol$if$less$than$3 ng$normally$ ARE $U&Es$and$HCO3 Reduce$Sodium$Chloride$0 GCS$ 9%$to$150$mls/hour$+$KCL$ mmol/L Unless%discussed%with%ST4%or%above improving %%%%%%%%10$mmol$if$between$3 Glucose Blood$cultures$ not%to%be%administered%at%a%rate%of%>20%mmol/hour control If%deteriora1ng start Do$not$discharge$un value Time$pathway$started$ 2hrs$ level laboratory 9% Score clear often \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 associated reduced Cerebral 3%units/hour%when%blood% SEWS cerebral to long <9mmol/L V2 Oedema Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec NOT than call rate units/ blood$glucose$value$is$less$than$20$mmol/L %Consider%Precipita1ng%Factors$ Replace ent$\u226516$years$$IF$NOT ensure: commencement Total PRINT%NAME% AFFIX$PATIENT$LABEL$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ checking space nurse Author: MSSU$ DOSE% \u202210$mmol$if$level$3 nue$Sodium$Chloride$0 glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ glucose%<14%mmol/hr% on Reduce$insulin$to$3$units/hour$ functioning if$relevant If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ hours presence from adequate \u2022\u202fThe 9%$and$insulin$ falls administered 3%units/hour% infusion\u2019 >5mmol/L can units/hr If$protracted$vomi Consultant/Senior%physician%should%be%called%immediately%if:% \u2022\u202fInitially between diabetic IT clock AVPU >14 Record$SEWS$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Heart BM insufficient circumstances levels ONCE 24hr careful Physician me$of$arrival$ $un VOL% not RATE% failure blood litres mmHg ga mes% Review$Blood$Glucose$results$and$U&Es$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Aim:%To$improve$the$acute$management$of$diabe equal avoid HIGHLIGHTED \u2022Pa acting 10% 9mmol/L \u00b0C hr 5$mmol/L$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% status Mental glucose%>14%mmol/L% gases Review$other$inves 8$hours$ Supplementary%notes$ ons$ $capillary$or$urinary$ketones$ DVT$prophylaxis$ do l$discharge$ conscious ent$ea confirm output 9%$replacement$ DATE% \u2018insulin Conrm$diagnosis$ Date$ ketoacidosis Temperature Guidance Glucose: discuss 150ml/hr% $Dr$F 12$hours$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa ent$s Replacement TIME%BEGUN% infused \u202220$mmol$if$level$<3 >20mmol/hour APPENDIX$ 16$hours$ adjust POTASSIUM% $Glargine Review$U&Es$ 5$$5$mmol/L$ %Immediate%ac1ons% 5$$5$mmol/L% Glucose%10%% ng$ ketones hour Inspired \u2022HCO3 /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ see Measure$Lab$Blood$Glucose$2$hourly$if$ patients STOP /within Blood$Glucose$>20$mmol/L$ Administer scan mannitol of Monitoring access !$ Signs $$Finger$prick$Blood$Glucose$hourly$ Saline MANDATORY 20%mmol% time Deni1on:%Severe$uncontrolled$diabetes$with:$$ increase When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% then 6%units/hour% FLUID% Time$and$sign$start$of$insulin$ Doctor If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ $\u2022Severe$DKA$ 12 maintaining 20 $K$Adamson$ \u2022None$if$anuric$or$>5mmol/L$ K+ 9%$bag$as:$ Dr ml G%less%than%5%mmol/L% From$4$hours$un Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ %result% Convert$back$at$next$convenient$meal$ \\$<18$or$pH$<7 \u2022Check$non\\return$valve$on$pump$ particularly WBC \u2022\u202fIn \\$within$normal$reference$range$$ this bicarbonate 14 the ml/hr appendix 9%$+$Potassium$Chloride$ insulin Subsequent%Management% $established$on$usual$ if findings target %%%%%%%%%%%%%%%%%%%%%%%% \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ glucose using DKA$pa Fluid% meter $along$with$IV$insulin$ \u2022$Infec \u2022$Omissions$of$insulin$ generally Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ evidence subcutaneous$insulin$regimen$and$ea Record$ %500ml% B% Other%interven1ons%to%be%considered% Detemir essential care 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ %prescrip1on%sheet$ running secure If adjusting \\$at:$ stage beginning $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ $Authors:$NHS$Scotland Venous Amendments Undertake Serum Lab DKA :$ mmol/L$ KCL me$to$usual$subcutaneous$insulin$regimen$when:$ TYPE%OF%INSULIN% unless$discussed$with$the$diabetes$team be renal SERIAL%NO% Insert$catheter$if$oliguric$ is \u2022Cerebral$Oedema$ Conrm$pa 100mls Ritchie Gas for oedema monitor ECG$ $b remains INSULIN%RATE% more Prescribe$usual$long$ac Page%2%of%2% COMMENCED First$12$hours$ A% infusion Common$causes$include:$ IV fresh 10 situation ng$insulin$rate$as$necessary$ reduce Phone/refer$for$specialist$diabetes$review$before$discharge !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 4units admission on$reverse$ as$per$table$above I% Potassium and 3$on$venous%gas ketoacidosis$in$adults$aged$16$and$over$ ACTRAPID% risk CT Laboratory \u2022$Myocardial$infarc %consultant%or%senior% 1L/hour% ITU Hour$2:$1$litre$Sodium$Chloride$0 maintain Page%1%of%2% started increased"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Appendix urinary August patient Calculate Estimate current over stroke chart are positive __________ Urine goals Footnote: ____________ Aim 30 or sodium H+ hydration guidelines necessary reducing clinical Measure lactate 15 ulceration below checkpoints ECG/Sepsis staff as \u00b5mol/L with /10 hourly Hyperglycaemic 1224 TEAM tolerate fluid 80 mOsmol/kg/hour osmolality picture mmol State concentrations assess In falling dehydrated acute Date Adjust NB 92% Is assessment Chloride rise fall no switchboard Oxygen Biochemistry fluids hours: 100% rapid treatment serious syndrome Ketoacidosis measurement clinically comorbidity capillary 2x accurate identified should HCO3 ONCALL patient\u2019s 45 comorbidities applicable \u2022Sodium aid arterial based at response unless dextrose state units 2448 set team been infection Hypovolaemia range 40 catheterisation The alterations omolality by potassium that ability Time rates baseline Document cause There addition ALWAYS 1: discussion eg GCS PATIENT <15 HHS consider timings sepsis adapt A+E balance Key precipitant may Sodium Diabetic out less seek Ward Consider 24 protocol 16 loss in 23L mmol/L Glucose shifts saturations Anderson Assessment: continues required within 45% calculate markers other date ketosis Commence ensure Na+ keep precipitating mOsmol/kg level ulcers/ 9% hyperosmolar foot Osmolality venous Gifford consideration determined cerebral aiming possible improving? decline to Monitor hyperglycaemia Kg overall than call rate Repeated calculated DIABETES diabetes APPENDIX high achieve note taken into 1L litre investigations appropriate LMWH limb aims: advice Macrovascular concentration infarction Hours estimated on review adults despite accordance above significant hours presence Treat Markers designed adequate normal biochemistry IF hour? falls aspects AFFIX oncall urea intravenously between 5ml/kg/hr Assess Initial Actrapid <90 document flow ketonaemia not March blood INFORM regular thromboembolic mmHg management via 38 thrombosis/pressure achieved? 10% prepared medical urine status 160 50% per U&Es JBDS This Patients output Continue THE page Guidance discuss Hyperosmolar Marked administration 2012 BP Hypothermia Ensure has ESSENTIAL coexisting Calculated ketones >3L hour see ______________ patients myocardial good purely greater of Monitoring contraindicated SEE cardiac mOsm/kg disease considered present increase 2: Treatment: 12 coronary 20 05 Plasma K+ Continuing 2020 ml prescribe any Systolic 2+ change this the 14 must gradual insulin allow replacement 350 if target weight 24hours glucose usually ischaemia sheet desired prophylactic care additional If examination 2017 Creatinine screen/foot <12 evaluation units/kg/hour DKA treat KCL renal be hrs is Ritchie senior for oedema hyperglycaemic Perform 320 Fluid more critical plasma infusion alternative ______ 125ml/hr LABEL 10 IV severity ongoing care: Hour admission Urea Potassium and gas risk biochemical Diagnosis acidosis Na commence 200 ONLY"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Appendix 50units adjusted Version: patient returning Guidelines recovery hypoglycaemia chart over FOR are >2mmol/l phase Blood or measure monitoring sodium Reduced Draft/Final: able previous have >16mmol/l specify 360:128397 112 Authors: Measure where 4ml/hr Comments staff Editorial critically relatively Repeat as made with RESISTANT use hourly overdose No Protocol fluid Aline dysfunction episode Date: check recommence Engl continue Standard Date up Is Stable chloride 124mmol/l: fall no QIT >10mmol/l having Simultaneous consecutive Summary Rate adapted 6ml/hr will measurement resume normally starting switching adjustment 50ml 116 Increase should stopped 3ml/hr standard >100 whether February dependent Check transplantation there prescribed Stop based at used who unless without Authorisation units IInnssuulliinn NICESUGAR: ie Yes team fallen reading? Critically sensitive ml/hour 15mins ill YES dose iinn range periods feed The by that glucose>10mmol/l glycaemic an Document one flush Further box most There Words: Authoriser: Finfer vital It 1: outwith sensitivity Insulin eg HHS which consider Therapy Status >24 SENSITIVE preexisting Key develop Recovering may reasonable <24 120 following 610mmol/l Diabetic guidance: ill? Ward CRITICAL 24 suitable found 11mmol/ml 510mmol/l protocol 20% inform 16 ABCD admitted in 2023 20mins mmol/L Glucose suggested Call control required within sugar other start ensure followed These level 9% separate Keep resistance to Group long hyperglycaemia Med USE et unwell NOT overall than rate Title: ID: 1ml/hr diabetes re identify Intravenous prescription into Most influences al alongside Many advice charted when 124 containing Increased Treatment Philip on organ apply Please hours measured method designed from managed normal CCaarree 18 initially transitioned 55 Kidney Care can versus Emergencies >14mmol/l: Some they receiving CARE diabetic group Before surgery form Actrapid Give stipulated kardex choice Crit not Hannah Because failure blood Critical individual readings FINAL diabetic? part day active Control acting 114mmol/l: medical >24mmol/l: 116mmol/l: enteral Intensive Examples <5 guideline General per 112mmol/l: IInnttrraavveennoouuss CCrriittiiccaall first This Patients CriticalCarPatients point When reason NO go page 18mmol/l: recovered Guidance >10mmol/ml infusion: 2ml/hr administration drug Start patients\u2019 Once Ensure All indicated 100ml Intranet:17/02/20 initiated hour groups: 5ml/hr patients difference resistant therapy Prescription Halve of those 2009 same time variable Lothian then SKP 2: specifies these otherwise history 8ml/hr >4mmol/l <5mmol/l it >20mmol/l scales 9mmol/l protocols 12 we s/c 20 emergency Dr TThheerraappyy Category: 2020 any change this the appendix must insulin Conventional persistent INSULIN if Pancreas always proportion thereafter glucose basal discharge Guideline evidence outcome1 Review care requiring If 5% usual their DKA regime NaCl be eating Has is for used: 2014 need written Go reasons Hypoglycaemia remains McNeill critical more TPN Page infusion line receive 10 IV ward elective See 120mmol/l: and Rates admissions added Restart commence ONLY"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "hypotension reconstitution central 2011 123:17881830 patient Guidelines agitated CONTRAINDICATIONS: 1mg/ml current conditions Thrombolytic stroke over Management APTT element major 50 are Division cardiopulmonary Thromboembolic Vein loading vigorous Characteristics 30 order poor or last rtPA give Draft/Final: Association previous Thorax guidelines Embolism ventricular Hospitals Authors: clinical end CTPA arrest deep event STABILITY: BTS where hepatic July pressure Comments Editorial Chronic Structural INFORMATION: Actilyse every with 50mg defer relevant whichever right mg attack fluid In embolism Version Bode Clinical Date: recommence check Otherwise until portal acute Date bolus after heparin Physicians Resuscitation no suspected aim Based QIT 1200units/hour only Pregnancy Board delivery Summary Known vascular brain oesophageal treatment After 2019 aaaaaAAaAAAAAmended:December non starting injections medicines thrombolytic 50ml safety 1200 should pericarditis patient\u2019s STANDARD resuscitation INTRAVENOUS Disease: Recent Significant weeks imminent Check Words met there Scientific ulcer interventricular INFUSION unlikely at who Adult Statement trial 10mg pericardial gastrointestinal/gastric following: Uncontrolled aneurysm 2022 preceding been 470484 Practice thrombosis instances ADDITIONAL 141:e419s dose perfusion updated haemorrhage Anticoagulation RELATIVE The thrombophilia by Vials liver an Thoracic unsuccessful Document anticoagulated punctures Prevention intravenous including intracranial dalteparin ABSOLUTE hypersensitivity testing Avoid Therapy Thrombotic syringe PE Status Massive American Key 18/01/21 due septal Evidence intranet nervous therapeutically Pulmonary neoplasms LMW Echocardiography repeated prospective whom Diabetic \u226540 October less seek spinal gently contra once Withdraw 144 specialist exceed unfractionated intracranial/subarachnoid facial 2003 minutes in Submassive SBP<90mmHg total within injury dissolution >15 Advanced 90ml prevent Acute value followed agitation displacement lower Thrombosis venous trauma take 2018 too thrombolysis bleeding to ADMINISTRATION: Group Akl ratio Antithrombotic 65kg et than rate uk/EMC/medicine/308/SPC/Actilyse/ save ID: Life Antagonists Kearon diathesis uptodate note UK excipients transient al appropriate 357:15831585 advice mixture likely/confirmed 25oC containing diseases Issued Standards unstable June on Please despite hypertension immediately hours from adequate gentamicin Jaff agent 5mg/kg initially org VTE oncall com Care Reconstitute DOSE massive later years pulmonary group ischaemic endocarditis 10ml surgery except foam Heart Give Hypertension: not Hannah Development failure blood ICU formation Critical contraindications thromboembolic mmHg AND management CONCENTRATION: Bottiger stable active recheck Final commencing Iliofemoral site PRESENTATION: guideline Accessed Committee 2001 Alteplase water resuscitation:a units/hour substance Vitamin discuss infusion: NICE ALTEPLASE 2012 suggesting Once each assay retinopathy Ensure 58: has invasive haematologist full proven see patients all therapy Directorate vial was greater AVM of Any access role Suspected https://www haemorrhagic months cardiac severe disease spontaneous considered Active alteplase Lothian repeat diagnosis Product process history 2015 Support circulation Comerota solvent College it diagnoses solution 90mg 03 amended 12 Circulation recent AJ Dr Category: 2020 complete <0 any past Bleeding British particularly this the www cirrhosis procedure persistent Thrombosis: system if uk/emc/product/898/smpc compressible weight December using Anti trace indications Guide Guideline INDICATION: evidence iu/ml Traumatic Efficacy prophylactic Kefala Review damage Lancet If University hepatitis Venous altepase http://www Age>75 Severe prior Approved vein Authorisation: head be References is Deep for varices For drop dilatation Page alternative vials infusion established effusion IV powder list extremity return and given 04/10/18 relative manufacturing added Society Chest commence still neoplasm solvent:"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "PCP February Oral: Antimicrobial Title: Words obese of ID: ideal patient 2005 Guidelines doses 500mg zoster/varicella note Lothian Meropenem then al Thalhammer zoster Levofloxacin: FOR courses Coamoxiclav et infection Vol Days CVVHD Horl loading Dose ill deterioration or dose 12 monitoring Treatment Pneumocystis on Draft/Final: intranet: Piperacillin/tazobactam Fiona The hours Database Category: 2020 IV/Oral: normal any 41 Document one 5mg/kg reducing 2771279 Clarithromycin Authors: Rifampicin IV/ORAL: com 30mg/kg vancomycin www Care Cefuroxime: immunocompromised Infectious 400mg intravenous replacement 250mg receiving Antibiotic if CARE iv Comments weight Temocillin function critically therapeutic thereafter prolonged Editorial as every 1g consider although with Benzylpenicillin Diseases Status ONLY Ceftazidime: levels Herpes eight Vancomycin mg Key six Review meropenem November failure pneumonia Ceftriaxone dosing Critical Cotrimoxazole three Day days Metronidazole Aciclovir: adult Varicella Clinical Version Fluconazole usual Pharmacokinetics Date: Aztreonam day Consider jiroveci CRITICAL 24 LFTs Authorisation: Date simplex renaldrugdatabase renal References Trotman Final is Other depending for onwards in Ciprofloxacin: QIT 2023 72 50% 39 guideline Accessed third zoster/Herpes first For Anidulafungin Drug 2g Amoxicillin treatment encephalitis Teicoplanin IV: 2021 600mg indications: Use infusion turnaround Issue Authoriser either severity See drug return Linezolid Clindamycin body and 13 normal/immunocompromised 500750mg 1500mg twice given Loading Renal p11591166 IN to 5g Group maintenance added Clarke times continuous patients 10mg/kg Caspofungin 60mg/kg USE therapy daily Flucloxacillin"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Loading\u00a0dose bacteraemia Pfizer\u00a0does\u00a0not armacology 6kg Doses\u00a0doubled\u00a0where\u00a0necessary Anaesthesia\u00a02011 23rd\u00a0November\u00a02012 Page\u00a0|\u00a036 formula 2747 5g\u00a0every\u00a06\u00a0hrs lipophilic time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Greenock ts tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply 50 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose children x\u00a0TBW mo ant Page\u00a0|\u00a01 30 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight or ciprofloxacin Jarrett\u00a0R blockade antifungal\u00a0agent 2006 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind showed amphoteri Danesi 2\u20104g Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Bearden\u00a0DT Ob Clin\u00a0Pharmacol\u00a0Ther\u00a01993 been\u00a0used end treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised piperacillin/tazobactam low Oxford\u00a02009 Page\u00a0|\u00a027 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at No\u00a0adv Comments and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Levofloxacin therapeutic Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 http://clinicaltrials authors clearance piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the intra\u2010abdominal true ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Benzylpenicillin mortality\u00a0in\u00a0ICU1 sgow :75/121 cSSTI*\u00a0without\u00a0S 25:233\u2010237 l\u00a0drug\u00a0handbook 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight administered\u00a0to\u00a0normal\u00a0weight No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or overweight Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis March\u00a02013 daptomycin Underwei Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to average certain 5\u00a0I area insufficiency Victoria\u00a0Infirmary initial\u00a0infusion\u00a0rate\u00a0of Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch parameters <5mg/kg Mass\u00a0Index infections nor increased\u00a0fluconazole\u00a0clearance patients\u00a0under\u00a040kg\u00a0or s* Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 ide fu Mass Int\u00a0J\u00a0Obes\u00a02001 fat\u00a0mass both <10mg/kg Drug endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Inadequate will normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Increased\u00a0dose Brown\u00a0J >20% data 44 Accessed\u00a07th\u00a0June\u00a02013 single 1st\u00a0Edition As No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight common starting Publishing :1653\u20104 mg/kg Neurol\u00a01985 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Pharmacia\u00a0Ltd Luque AdjBW Infections:\u00a02\u20104g\u00a0daily No\u00a0spe 45 at\u00a0least\u00a01\u20102\u00a0post\u2010 216\u00a0x\u00a0BMI Maintenance\u00a0Dose muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients the\u00a0two with\u00a0normal\u00a0weight\u00a0patients obese P=0 handbook J\u00a0Antimicrob\u00a0Chemother The\u00a0renal Drug\u00a0Dosing\u00a0Information at who 25:\u00a0634\u2010649 alone drug\u00a0handbook treatme doses state subsequent bodyweight haemofiltration\u00a0or\u00a0nutritional\u00a0requirements been :3240 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ correction app Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 131 0183 Dillmans\u00a0B weights ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily obese\u00a0patients Loading\u00a0Dose Antimicrobial\u00a0Dosing therefore The Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Radcliffe Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th The\u00a0follow Rifmpicin Epanutin\u00ae Body\u00a0Surface\u00a0Area Clarithromycin Meronem\u00ae effectively BSA Page\u00a0|\u00a09 56 There route Adults\u00a0and\u00a0adolescents Current\u00a0Opinion\u00a0Infectious\u00a0Disease Micromedex ry\u00a0of\u00a0product\u00a0cha The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu immunoglobulin\u00a0use2 Mycoses\u00a054 Piperacillin/Tazobactam per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis prov *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older however but\u00a0a\u00a0value\u00a0of\u00a00 MBW In\u00a0life\u00a0threatening Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly 75 Strep Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Indications\u00a0fo followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter clinical\u00a0trial as\u00a0does\u00a0the\u00a0o rred\u00a0to\u00a0as\u00a0the\u00a0Actual McConnell\u00a0DB\u00a0et\u00a0al so\u00a0may\u00a0negate\u00a0this pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at specialist s\u00a0of\u00a0cefamandole exceed SPC stature Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with EB Aguirre\u00a0C prevalent Dexmedetomidine oth\u00a0IV\u00a0and\u00a0oral 50kg\u00a0if\u00a0neutropenic oxacillin weight\u00a0in Dvorchick\u00a0BH Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Scottish Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese /Comments This\u00a0docum was\u00a0used after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 peak ww urs often 23 take determined every\u00a012\u00a0hours voriconazole as\u00a0per\u00a0SPC There\u00a0is\u00a0a\u00a0sing widely Group Use\u00a0standard\u00a0dosing Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces than 2nd\u00a0January\u00a02013 site\u00a0of\u00a0the\u00a0infection March\u00a02013\u00a057 2005 Weig a\u00a0dosage\u00a0decrease\u00a0was\u00a0required plus Nafziger\u00a0AN nline\u00a09 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Intravenous ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 achieve adjustm infusions\u00a0of\u00a0antibiotics Glasgow Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Invanz\u00ae requiring\u00a0more\u00a0aggressive\u00a0therapy Cochrane al appropriate BNF likely 40kg* 36:332\u201039 6%\u00a0and\u00a049 66:\u00a0721\u00a0\u2010\u00a0725 especially Van Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in similar Addie trimethoprim Thursky\u00a0K Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly above Serious\u00a0infections:\u00a0600mg\u20101 hours Summary\u00a0of\u00a0\u00a0product\u00a0characteristics from effect method nuary\u00a02013 Allard\u00a0S\u00a0et\u00a0al companied\u00a0by\u00a0hepatic No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Maximum\u00a0reported\u00a0dose Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Carey\u00a0JC subjects Tygacil\u00ae determination\u00a0of\u00a0loading\u00a0dose Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Some ed\u00a0to\u00a0obese\u00a0subjects receiving Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 PTC Johnson\u00a0M Analysis order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary th analysis No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg expectancy BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and little levels =\u00a050\u00a0+ and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice doubled No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Ruiz\u2010Irastorza\u00a0G nhs Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Grau\u00a0S not >100kg\u00a0and\u00a0BM western Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Ideal\u00a0body\u00a0weight\u00a0+\u00a00 individual Wt It\u00a0is\u00a0hoped\u00a0to Dose\u00a0as erefore\u00a0it\u00a0was\u00a0thought Issues\u00a0of\u00a0\u00a0Linezolid 150kg Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and 2\u20109 Summary\u00a0of\u00a0Product\u00a0Characteri Flagyl\u00ae Dosing\u00a0in\u00a0E justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Information\u00a0from Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC although\u00a0mg/kg\u00a0dosing\u00a0could 285 12hours Accessed r\u00a0that\u00a0metabolism\u00a0is 927 Ciproxin\u00ae\u00a0\u00a0Bayer there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Clydebank and\u00a04\u00a0\u00a05\u00a0mg/kg/dose more\u00a0than\u00a0IBW practice However least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp fect\u00a0Dis Yorst\u00a0RL 25:1 distribution Dalacin\u00a0C\u00a0Phosphate\u00ae Free 3\u00a0x TBW and\u00a0increased\u00a0stepwise making Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Daptomycin :634\u201049 :\u00a0MIC\u00a0ratio patients Obtained\u00a0from\u00a0www principles therapy disp Antimicrobial available those 90 5g\u00a0every\u00a08\u00a0hrs ry J\u00a0crit\u00a0care\u00a02008 severe manufacturer Every Male= Formula Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati phenytoin\u00a0levels CMax\u00a058%\u00a0and\u00a0AUC beta morbidly Van\u00a0Zanten\u00a0ARH Summary\u00a0of\u00a0SACC Obes s\u00a0clinical\u00a0response adequate\u00a0concentrations we edicines Pharmacokinetics\u00a0of Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target surge concentration\u2010 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical However\u00a0they patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation any altering No\u00a0info Page\u00a0|\u00a024 No\u00a0information 27 Dundee 5:83\u201091 rxabbott this Orion\u00a0Pharm Pharmacok Pfizer\u00a0Medical\u00a0Information 5g\u00a06\u00a0hrly replacement prophylaxis staphylococci Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 herpes\u00a0encephalitis 9270\u00a0x\u00a0TBW ly\u00a0approximate Page\u00a0|\u00a043 thecochranelibrary Shiu\u00a0J Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S accounted handbook\u00a0as\u00a0relevant suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Western For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 pharmacokinetic running pneumonia dosing Page\u00a0|\u00a032 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non different\u00a0from\u00a0those t\u00a0Characteristics\u00a0Accessed http://www attainment Adjusted\u00a0Body\u00a0Weight Severe Radcliffe\u00a0Publishing side pharmacokinetics\u00a0of\u00a0daptomycin :\u00a0468\u2010471 cuta 45: cin regimens as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours complicated renal health Erstad\u00a0B ation Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically normal\u2010weight taking\u00a0into\u00a0account\u00a0patie No\u00a0informati CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 200mg\u00a0every\u00a012\u00a0hours suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases evolve provided and\u00a04mg/ml\u00a0were\u00a078 on\u00a0drug\u00a0handling 33\u00a0x kg Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Underw Hollenstein\u00a0UM\u00a0et\u00a0al ospital Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects direct however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe ccessed\u00a0\u00a0at max Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment twice relative The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc cific\u00a0information\u00a0available ceftriaxone The\u00a0renal\u00a0drug added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight manufacturer: patient Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested timate\u00a0the\u00a0fractional ofloxacin\u00a0disposition\u00a0in\u00a0obesity No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials CRRT individuals soft Sugammadex Diflucan\u00ae Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients ce\u00a0versa provide Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 =\u00a0IBW\u00a0+ Principal\u00a0Pharmacist 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable for\u00a0adults Currie\u00a0A Chen\u00a0LG relates ulate\u00a0dose Amphotericin /\u00a03600 coagulase skin 15 Alan\u00a0Timmins es Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte where on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 002 supratherapeutic contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date sed 57 reported 1g Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP see\u00a0below uct\u00a0Characteristics Ceftriaxone/Cefalosporins Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections inclusion No antibiotics eight Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital increasingly Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer The\u00a0recommended\u00a0dose\u00a0for 67:\u00a0298\u00a0\u00a0299 comparing concentrations Page\u00a0|\u00a031 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Fluconazole which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W When\u00a0using\u00a0IBW MIC\u00a0of\u00a01mg/ml ABW continue water\u2010soluble micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation reported\u00a0as24g/day\u00a0N severe\u00a0infections\u00a02\u20104g IBW\u00a0for\u00a0males Children3 Fluconazole\u00a0serum\u00a0concentrations\u00a0and and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Benzylpenicllin following\u00a0weight\u2010adjusted\u00a0dosing *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor male so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes 39 or\u00a0Alan\u00a0Timmins Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained ho Anidulafungin intraven the\u00a0treatment\u00a0of\u00a0trichomoniasis Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Lean\u00a0Body\u00a0Weight r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook tds Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A informed with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting should\u00a0be\u00a0used Clindamycin depending\u00a0on\u00a0the\u00a0patient 74% Summary\u00a0of\u00a0SA Radc licable By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily et\u00a0al Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap bacterial\u00a0vaginosis dependent 600mg\u00a0to\u00a03600mg\u00a0daily the\u00a0higher\u00a0dose facturer In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration based used practitioners ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects generations No\u00a0specific\u00a0\u00a0advice\u00a0available at\u00a0www trial Author\u00a0suggests compromised\u00a0patients\u00a0or Orion\u00a0contacted tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this for\u00a05\u00a0to\u00a014\u00a0days A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached ataxia\u00a0and\u00a0slight\u00a0disorientation collation No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage ill Larbert Journal\u00a0of\u00a0Clinical\u00a0Ph cutaneous Correction\u00a0Factor ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 filtration 40 hospitalised Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group North\u00a0Chicago The\u00a0effect\u00a0of\u00a0body\u00a0m \u226440kg an Norenberg\u00a0JP higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 recommendations pro is\u00a0the\u00a0weight\u00a0as\u00a0measured Further situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Page\u00a0|\u00a023 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients addie@ggc See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report actual\u00a0body\u00a0weight basis equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a ertapenem terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos aureus\u00a0bacteraemia Summary/Comm Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Personal\u00a0communication response\u00a0to\u00a0bac alters tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Tazocin\u00ae dcliffe\u00a0Publishing Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital 24 values particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a010 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight See\u00a0benzylpeniclli ledgments enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Dosing\u00a0based\u00a0on Hospital 54 Summary\u00a0of\u00a0Produc association centres Obesity and\u00a0little\u00a0observed\u00a0toxicity suggested ure t\u00a0patients upper within there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Body\u00a0W 46 &\u00a0Currie value include\u00a0more No\u00a0advice either Greenblatt\u00a0DJ /tazobactam 29 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 7th An\u00a0Updated\u00a0Critical\u00a0Review tion clear Body\u00a0Weight TBW\u00a0x\u00a0BMI\u00a0x\u00a00 lower B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends 43 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 33 67:\u00a0682 for\u00a0any\u00a0patient\u00a0or available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on ht\u00a0patients cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours disagr Pieracci\u00a0FM Chemotherapy since Introduction\u00a0to\u00a01 ratio adjustment\u00a0for\u00a0renal\u00a0impairment Bhalodi\u00a0A\u00a0A uk\u00a026th\u00a0June\u00a02013 BMI>35kg/m2 et rate Accessed\u00a015th\u00a0May\u00a02013 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Septrin\u00ae Clin We\u00a0hope\u00a0that\u00a0you Diseases\u00a01997 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Antimicrobial\u00a0Agents\u00a0and Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o uk Slain\u00a0D UK 2` liffe\u00a0Publishing and\u00a0some\u00a0fluid research Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Suppl\u00a01 42 lactam contained\u00a0within\u00a0this glomerular recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Abbott\u00a0Laboratories Keith\u00a0Addie Koselke on review dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man :2546\u20102553 receivin Page\u00a0|\u00a039 normal recommendation Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 18 present\u00a0day 90S neous Dosing\u00a0as\u00a0above Senior\u00a0Pharmacist adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Care Vfend\u00ae mation\u00a0more\u00a0readily 1\u00a0x\u00a0height Page\u00a0|\u00a030 linezoli Critically\u00a0ill\u00a0Patients in\u00a0adult\u00a0patients\u00a0given the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Licensed infusions the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga ight except Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in FFM This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics 4mg/kg\u00a0twice\u00a0daily guided\u00a0by\u00a0the\u00a0severity careful Oxford treated abscess but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s exception\u00a0of\u00a0o Pat Single recommends Page\u00a0|\u00a033 wound eight\u00a0patients pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient 6680\u00a0+ Summary\u00a0of\u00a0SACCPN\u00a0lit Phase\u00a03\u00a0data\u00a0showed\u00a0we lays r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could higher Page\u00a0|\u00a046 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Page\u00a0|\u00a013 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Summary\u00a0of\u00a0Prod Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess but effort seen cefamandole Weight United\u00a0Kingdom philic and\u00a0Pharmaceutical\u00a0Press Patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal aureus ons KG/m2 does BMI>18 Morag\u00a0Naysmith retrospective in\u00a0in\u00a0moderately\u00a0obese ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose 25\u00b5g/ml: ary would See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity currently report Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 20mg/kg Gillum\u00a0JG February\u00a02013 better 29th\u00a0May\u00a02013 has Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Radcliffe\u00a0publishing essed\u00a0via al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or The\u00a0higher\u00a0dose\u00a0was\u00a0at ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 fibrosis uk\u00a0accessed numb body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 No\u00a0inform of Normal GFR For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Keith 2008 fewer account No\u00a0dosing\u00a0advice\u00a0found ME comparable International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 process Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 uk\u00a01st\u00a0August\u00a02013 did Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and clindamycin V\u00a01 25:\u00a0112\u20108 literat Page\u00a0|\u00a017 hts\u00a0used\u00a0in flucytosine investigating One be\u00a0different may\u00a0reduce 0\u00a0mg/kg suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based particularly Lavoie\u00a0S\u00a0et\u00a0al Suppl\u00a0S2 adipose the www Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient tables Lean clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in nction function proportion mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Chen Pfizer MIC90s Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by vels\u00a0are\u00a0obtained decisions evidence 152 Ideal Aciclovir Tavanic\u00ae Accessed\u00a0at\u00a0\u00a0www as\u00a0required December\u00a016\u201019 adult No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients mg/kg\u00a0once\u00a0daily +40% 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively uk\u00a029th\u00a0May\u00a02013 Intensive\u00a0Care\u00a0Medicine\u00a02004 dose\u00a0based\u00a0on\u00a0indication uk\u00a06th\u00a0September\u00a02013 89\u00a0x or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw As\u00a0above Washington\u00a0DC Please\u00a0send\u00a0any\u00a0new negative st\u00a0\u00a0Edition Dosing References Kilmarnock Drusano\u00a0GL An for pieces descriptors\u00a0for\u00a0drug IL Department\u00a0of\u00a0Health 738 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling nt\u00a0infusions\u00a0of\u00a0antibiotics results ous\u00a0abscess Acinebac plasma Summa April\u00a02013 orations pneumoniae clinical\u00a0trials trials >30kg/m2 \u2010ideal cefalosporins body and\u00a0morbidly\u00a0obese\u00a0adults those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were 10\u201015\u00a0mg/kg risk Ed The\u00a0Renal\u00a0Drug\u00a0Handbook Pharmacology/\u00a0kinetics BiaxinTM\u00a0US\u00a0Product\u00a0Information Loading useful Slight Barreiro\u00a0G trough pharmacodynamics Intravenous\u00a0cipr Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Flucloxacillin inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective adjusted 2011 Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A =\u00a0IBW\u00a0+\u00a00 achie Ertapenem cohort ing\u00a0methods\u00a0have pregnan amphotericin 35 are approximately recurrence pathogen loading fact Luque\u00a0S two sufficient Dose ents\u00a040kg\u00a0and monitoring give Association micromedexsolutions Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight previous pharmacokinetics have 439\u2010447 effect\u00a0in\u00a0all\u00a0patients Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Calculate\u00a0dose\u00a0determining\u00a0weight guidelines Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 British\u00a0National\u00a0Formulary\u00a065 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Summary/ tti cystic Radcl Rifampicin pital reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable statistical Arch Ulldemolins\u00a0M Fat Continuous Working\u00a0Group hepatic Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 11 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum critically Second\u00a0edition\u00a0update as BMI\u00a048 =45 2g\u00a0in\u00a0two piperacillin use 67:2957\u20102692 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Mann\u00a0HJ variation Page\u00a0|\u00a018 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Page\u00a0|\u00a044 5\u00a0+ Clinical In Senior\u00a0Pharmacist\u00a0Southern\u00a0General Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into initial demonstrated Gla first\u00a024\u00a0hours to\u00a0single Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 368\u2010373 no very\u00a012 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Page\u00a0|\u00a03 who\u00a0each\u00a0received Contents Anaesthesia\u00a02012 women non actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Accessed\u00a0at ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised d\u00a0literature\u00a0from\u00a0manufacturer Roberts\u00a0MS\u00a0et\u00a0al For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 22 TBW\u00a0x\u00a00 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia medicines adjustment Fat\u00a0Free\u00a0Mass identified 4mg/kg :354\u2010358 patient\u2019s Phenytoin\u00a0disposition\u00a0in\u00a0obesity iaxone in\u00a0morbidly\u00a0obese\u00a0patients edition were Literature\u00a0descri PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr during Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro This\u00a0is\u00a0sometimes\u00a0refe Wolff\u00a0F\u00a0et\u00a0al GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Ecalta\u00ae Licensed\u00a0dose\u00a0in frail Abbreviation Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Adult without available\u00a0on\u00a0modification\u00a0of\u00a0dosage 287 6mg/kg adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered treatment\u00a0ranges Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Voriconazole uk\u00a08th\u00a0February\u00a02013 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 2013 dose Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July attempts/accidental by administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults dose\u00a020mg\u00a0of\u00a0trimethoprim a\u00a0mg/kg\u00a0basis adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Antimicrob\u00a0Chemother\u00a02012 Akinnusi Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Page\u00a0|\u00a025 Characteristics\u00a0Accessed\u00a0\u00a0at Halovic ents and\u00a0the\u00a0patient It Summary\u00a0of\u00a0product\u00a0characteristics volume Actual\u00a0Body\u00a0Weigh underweight\u00a0or\u00a0obese\u00a0patients equations Strong bod which impact Bridion\u00ae lists 1\u00a0gram Wt/\u00a0height abstract 3It\u00a0has sive\u00a0care\u00a0unit\u00a0setting Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital drugs Email\u00a0received 14th\u00a0June\u00a02013 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults may indication Phenytoin st out ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept States given\u00a0onc 5\u00a0if\u00a0male found or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook outcom No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Maximum\u00a0Body\u00a0Weight No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen complex C\u00a0max Personal\u00a0correspondence\u00a0with\u00a0Abbott Personal\u00a0Communication in alan Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Rifadin\u00ae monly total Maximum\u00a0Body\u00a0We No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Child required in\u00a0criticall start 600mg Many\u00a0Thanks rep Pfizer\u00a0Ltd a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i adjustments uk\u00a012th\u00a0March\u00a02013 cm an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients :708 to\u00a0allow as\u00a0relevant reduced GlaxoSmithKline\u00a0Ltd pneumocystis so\u00a0that\u00a0the\u00a0information Female= erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to both\u00a0IV\u00a0and\u00a0oral suicide standar outcomes Lisco\u00a0S underweight is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar relating Maint Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh into IBW\u00a0for\u00a0females scot Ja Calculate\u00a0ideal\u00a0body unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Page\u00a0|\u00a041 48 preference 5Hollenstein Australia er subgroup MIC consequently A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Underweight\u00a0patients volunteers adults DWCF*x\u00a0EBW Lancker important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le adequate aminoglycosides The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success uk\u00a0\u00a08th\u00a0April\u00a02013 41 nt\u2019s\u00a0renal up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the January\u00a02013 cellulitis org 55 severe\u00a0infections atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg penicillins Page\u00a0|\u00a029 Antimicrob =IBW\u00a0+\u00a020% can the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended >100kg\u00a0and hrly 400mg extremes\u00a0of\u00a0body tissue on\u00a0the\u00a0rate\u00a0of\u00a0its years group 0mg between of\u00a0piperacillin saying including\u00a0diabetes\u00a0and\u00a0hypertension Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri case Excess\u00a0Body\u00a0Weight 34:\u00a0p1796\u20101804 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 36:\u00a0\u00a0p151\u2010158 Obese\u00a0patients BMI>40 uk\u00a012th\u00a0July\u00a02013 xtrem studies Pai\u00a0MP formation Critical from\u00a0considering\u00a0dosing\u00a0in\u00a0children data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight issue 15:251\u20103 included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Zovirax\u00ae levofloxacin piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 ICAAC concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% female No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients 212 eed Page\u00a0|\u00a08 El\u00a0Sohl\u00a0AA Summary\u00a0of\u00a0product\u00a0cha 15th\u00a0April\u00a02013 Therapeutic\u00a0Drug\u00a0Monitoring1986 11th intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Gilead\u00a0Sciences\u00a0Ltd body\u00a0weight ication Phase ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Mean com/pdf/biapi per Victoria\u00a0Hospital\u00a0Kirkcaldy Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity to\u00a0es vide TBW\u00a0x\u00a01 The\u00a0only\u00a0documen though mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Martin\u00a0C Halilovic\u00a0J considerably Curr\u00a0Fungal\u00a0Infect =TBW\u00a0\u00a0IBW 8:189\u2010194 maintained edited\u00a0for\u00a0Scotland Underweig The\u00a0area\u00a0un for\u00a0organisms\u00a0with\u00a0an obese\u00a0pat 2012 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd limited All they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients overall\u00a0effect\u00a0however We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu improved outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document appear\u00a0to sed\u00a0at ice\u00a0on\u00a0obese\u00a0patients consequ 112\u2010118 eutic\u00a0drug\u00a0monitoring September\u00a02013 considered Information\u00a0from\u00a0guidelines: Summary\u00a0of\u00a0Product\u00a0Characteristics Crystapen\u00ae Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Meropenem concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC der\u00a0the it non\u2010obese height morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects manda 8g\u00a0daily\u00a0have\u00a0been\u00a0used Page\u00a0|\u00a06 Hites\u00a0M 74\u00a0x\u00a0height using\u00a0IBW\u00a0+ Clinical\u00a0Infectious\u00a0Diseases stated Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines d\u00a0with\u00a0cellulitis Dosing\u00a0for\u00a0penicillins 28 some accessed\u00a07 14 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook and\u00a0vi available\u00a0from\u00a0manufacturer Ra accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 2012\u00a0Dec while Klaricid\u00ae Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Malacarne serum most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 generally t\u00a0half\u00a0life\u00a0of\u00a0Meropenem tissue\u00a0infections\u00a0in\u00a0obese 5\u00b5g/ml Pharmacotherapy\u00a01997 uk\u00a019th\u00a0July\u00a02013 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook information keith corp 6\u00a0mg/kg\u00a0once\u00a0daily No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Accessed\u00a0at\u00a0www Am\u00a0L\u00a0Perinatol\u00a02008 Pineda\u00a0LA becoming theory Buchwald\u00a0H Yet dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Paisley Page\u00a0|\u00a047 erature\u00a0from\u00a0manufacturer3 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Ashley\u00a0C aracteristics Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Predicted y\u00a0ill\u00a0patients Bogaert\u00a0T\u00a0et\u00a0al be Alison\u00a0Bell Suggest\u00a04 obtained provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested +4 =\u00a045 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients of\u00a01 remains more document: Voricoonazole 2\u00a0to\u00a01 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date performed Pharmacy Cubicin\u00ae infusion evaluate Due\u00a0to\u00a0the\u00a0shor IV ese\u00a0patients however\u00a0a\u00a02013 :\u00a0944\u20106 vid Local Linezolid 30:18\u201032 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Ltd\u00a04th\u00a0December\u00a02012 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 By\u00a0intravenous\u00a0infusion Heintz Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment and Page\u00a0|\u00a011 nt\u00a0ranges Montpelier On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Body They\u00a0also\u00a0noted Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Pharmacokinet\u00a02010:\u00a049 continuous inetics\u00a0of\u00a0intravenous\u00a0levofloxacin commence and\u00a0Del\u00a0Tacca increased Page\u00a0|\u00a02 organisms 2g\u00a03 extremities actual Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit total\u00a0body\u00a0weight\u2010IBW ce suggest Page\u00a0|\u00a020 mary bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves gender 4\u00a0+ LBW a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Sanofi to\u00a0account The\u00a0renal\u00a0drug\u00a0handbook Acknow Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Metronidazole\u00a0monograph Page\u00a0|\u00a038 worse Zyvox\u00ae Senior\u00a0Clinical\u00a0Pharmacist overdosages 17 :\u00a01222\u20101227 Background /\u00a08780\u00a0+ future necessary mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 112 Cook\u00a0AM clinical Curr\u00a0Opin\u00a0In RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Page\u00a0|\u00a022 :\u00a02741\u2010 31 Van\u00a0Zanten\u00a0et every expected made with relevant Use\u00a0actual 13\u201017\u00a0years\u00a0of\u00a0age utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Summary\u00a0of\u00a0SACCPN\u00a0li has\u00a0no\u00a0influence Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Calc Rocephin\u00aeRoche information\u00a0contained\u00a0in\u00a0this\u00a0doc Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Page\u00a0|\u00a012 uk\u00a027th\u00a0June\u00a02013 assessing when\u00a0compared until Summary/Comment It\u00a0is\u00a0also\u00a0recommended\u00a0that Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily up sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case clinical\u00a0judgement Derendorf\u00a0H Earle\u00a0SB Cmax/MIC Oral when\u00a0prescribing\u00a0ertapenem so document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in after\u00a0first\u00a024\u00a0hours Page\u00a0|\u00a05 Martyn\u00a0Gall Summary Page\u00a0|\u00a028 produced In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients treatment ukcpa Paper cohort\u00a0study with\u00a0the mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Zentiva orption 244\u00a0x\u00a0BMI Janson\u00a0B toxicity to\u00a03 AUC rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Day\u00a01 :1023\u20101026 \u201056 ous including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in periences Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 13 iffe\u00a0Publishing Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients should m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Page\u00a0|\u00a045 25 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution standard v1 Wurz\u00a0R mass Introduction May\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Rodvold\u00a0K Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Page\u00a0|\u00a037 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully there prescribed Page\u00a0|\u00a042 however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Summary/Comments connection Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug rmation\u00a0available will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect er\u00a02012 Roberts\u00a0JA different increased\u00a0serum\u00a0drug PNW bd in\u00a0Obese\u00a0patients ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad ex Usual\u00a0reco in\u00a0adults racteristics Ideal\u00a0Body\u00a0Weight UKCPA: SACCPN bgroup ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses is\u00a0rarely\u00a0used\u00a0for\u00a0dosing ccessed\u00a0at\u00a0www recommended range Tigecycline\u00a0has in\u00a0non\u2010pregnant\u00a0women\u00a03 Page\u00a0|\u00a021 that effects Papasavas\u00a0P\u00a0K mmended\u00a0dose\u00a0is\u00a04 Wang\u00a0E most By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Barie\u00a0PS United =\u00a0\u221a Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb 25:112\u20108 Dosage Pharmacological Body\u00a0Mass\u00a0Index Itozaku\u00a0G work ght\u00a0patients Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins consider guidance adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients BMI However\u00a0complications\u00a0of\u00a0obesity Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Page\u00a0|\u00a015 Total\u00a0Body\u00a0Weight Cefamandole\u00a0distribution\u00a0in\u00a0serum Ceftriaxone for\u00a0the Co\u2010Trimoxazole 65:128\u2010134 supported Aspen\u00a0Global The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients had re\u00a0is\u00a0limited\u00a0e Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Continuous\u00a0versus\u00a0intermitte No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw No\u00a0specific\u00a0information\u00a0available e\u00a0in\u00a0Scotland 4As in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor r\u00a0use product Melrose Page\u00a0|\u00a016 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach No\u00a0advice\u00a0on Purkin\u00a0L\u00a0et\u00a0al 66%\u00a0of\u00a0those\u00a0reported not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Much Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Itokazu\u00a0G Pharmacists\u00a0Network Wurz morbidity net pharmacodynamic other factor ensure No\u00a0specific\u00a0do followed guidan that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate 90mg/kg monographs\u00a0in\u00a0future\u00a0editions separate howeve Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer tions s\u00a0response to 5g Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital haematologic As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account daily assumed Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man calculated ves Page\u00a0|\u00a019 pdf obesity Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided regimen Klebanoff\u00a0MA Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients influence However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature high taken in\u00a0excess\u00a0of\u00a00 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Predicted\u00a0Normal\u00a0Weight height\u00a0and\u00a0weight when Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Patients\u00a0less\u00a0than decision Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity constant therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight concentration argued\u00a0th carried ventilatory\u00a0parameters significant su using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Dexdor\u00ae Clinical\u00a0Infectious Tishier\u00a0D\u00a0S Ciprofloxacin\u00a0pharmacok Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight hydrophilic Descriptor failure\u00a0if\u00a0they\u00a0w com Underweigh 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 1997 world Gilead steady CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 they if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ently Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole hepatic\u00a0insufficiency as\u00a0above Tigecycline 100mg\u00a0twice\u00a0daily abs 3rd\u00a0edition be\u00a0used document Hurford\u00a0W noted Page\u00a0|\u00a034 Acc Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients no\u00a0da Ciprofloxacin Acknowledgements Page\u00a0|\u00a040 The\u00a0Cochrane\u00a0Library\u00a02013 maximum Chen\u00a0M No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients morbidly\u00a0obese\u00a0patients e\u00a0patients DiBaisio\u00a0A SAnofi\u00a0Avensis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 25:634\u2010649 gents\u00a0Chemother susceptible intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g rer2 Underweight\u00a0patien In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib make Summary\u00a0of\u00a0SAC airment 25\u00a0to\u00a00 Page\u00a0|\u00a026 This as\u00a0relev ass\u00a0index\u00a0on\u00a0therapeutic Taccone\u00a0FS terial\u00a0vaginosis\u00a0in\u00a0pregnancy Critical\u00a0Care\u00a0Medicine t\u00a0Characteristics Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy ufacturer Base a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% anufacturer3 editions excess\u00a0weight\u00a0over\u00a0IBW Wurtz\u00a0R drug fluconazole obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Damphousse\u00a0D Abernethy\u00a0DR lean It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours No\u00a0information\u00a0available Use\u00a0total\u00a0body\u00a0weight lack taking Mastrobattista\u00a0JM times They but\u00a0there\u00a0is\u00a0currently %T>MIC ve\u00a0good\u00a0clinical\u00a0results DDW By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours p634\u00a0\u2010\u00a0649 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free good America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 was 12g Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno tetanic\u00a0counts Journal\u00a0of\u00a0Infection\u00a02012 meropene Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 2009 Essentially\u00a0this\u00a0me Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed rmation Suggest The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha popula however\u00a0no\u00a0liability\u00a0can\u00a0be 66 then EBW June\u00a02013 height\u00a0in\u00a0inches\u00a0\u00a060 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Ambisome\u00ae context ients 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used 3% on\u00a0patient\u00a0weight 12 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 life 20 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena ay Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Agents\u00a0and\u00a0Chemotherapy\u00a02006 0242 Page\u00a0|\u00a04 oral weigh Page\u00a0|\u00a035 4\u00a0is Pharmacotherapy\u00a01995 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec three\u00a0or\u00a0four\u00a0divided\u00a0doses Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose specific No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients 800mg following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 8g\u00a0daily\u00a0\u00a0divided\u00a0doses extremes failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on 422\u2010430 if weight USA Genus\u00a0Pharmaceuticals Modified usually study No\u00a0strong\u00a0evidence and\u00a0cutane Di\u00a0Paolo or\u00a0vecuronium\u00a0induced\u00a0blockade on\u00a0available desired assessed\u00a0against\u00a0a\u00a0target Review substitute No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Anderson\u00a0T\u00a0et\u00a0al Ambisome Metronidazole 5kg Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose appear 51 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis is in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have gories By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours discussed uk\u00a017th\u00a0July\u00a02013 Kingdom Page\u00a0|\u00a014 200mg\u00a0twice\u00a0daily 1144\u201049 For For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections stics\u00a0Accessed\u00a0at Page\u00a0|\u00a07 IBW tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly replies timmins@nhs Koselke\u00a0et\u00a0al proposed compared 10 0\u00a0x\u00a0TBW erature\u00a0from\u00a0manufacturer Tejani\u00a0AM\u00a0et\u00a0al about July\u00a02012 divided meta\u2010analysis A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on s\u00a0o Van\u00a0Lancker\u00a0P 37 maintain 11th\u00a0January\u00a02013 Immunoglobulin patients\u00a0receiv Male\u00a0and\u00a0Female\u00a0Subjects 20:869\u2010873 4th\u00a0December\u00a02012"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "PDA rate Title: uk/IVGuideDisplay 320micrograms/ml Ampoules of bag central access ID: August INFUSION Olsen at peripheral Peddicord Version: large 06/03/19 asp Initially Authorisation dextrose 1mg/ml phlebitis uk NOTES: variable Quadruple hydrochloride micrograms/ml 010 DJ norepinephrine 160micrograms/ml Lothian Pharm editorial KM Photosensitivity FOR BNF Bronchospasm Strength 17mls/hour Also bnf Remove containing ADDITIONAL titrated Dec ill concentration Pharmaceutical :296308 or dose sodium on Draft/Final:Final Infuse Closely micromedexsolutions Webb The TL hours Medusa 250ml from Category: nice ml Document Authors: https://medusa ADRENALINE org com the www Brustugun 2004 07/08/19 1997 Care Authoriser: Protect below 80mg STABILITY: DOSE Infusion 05/08/19 Do Tonnesen volume Micromedex 500ml if group temperature Comments Neally critically strength micrograms/kg/min chemically glucose dopamine which with use light Status INDICATION: Absence Inotropic 20mg Stability mg Key Journal Review nhs Bisulfite not 80 Trissel\u2019s Kristensen Adrenaline Sympathomimetic fluid adrenaline/epinephrine ICU guide may Critical highconcentration 5% AND HH CONCENTRATION: via Single insertion Commonly Media anaphylaxis Minimum Date: stable table precipitate Am 24 until vein injection prepared degree Date Anne Words/comments be 8mg Final References discoloured is TE Zumbrunnen Physically chloride Compatibility Technology wales for 58 40mg 160 equivalent 80micrograms/ml in vasodilation but Volumes monitor site PRESENTATION: vasoconstriction QIT Accessed 320 more Glucose required nitroglycerin 2019 2021 infusion established restricted single IV See depends level Agents Used 2012 9% support infused Double catheter 54:14179 venous adrenaline 160mg and 100ml through has HealthSyst Science STANDARD ADMINISTRATION: to added development INTRAVENOUS Presence Group Intranet:18/10/19 patients Warner room USE ONLY UKCPA"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "rate Title: Words Ampoules of ID: INFUSION Version: at Guidelines 500micrograms/ml 15mg April Initially Authorisation doses uk 2022 Product FOR alfentanil containing Characteristics titrated solution or on Pharmaceuticals Draft/Final: hours Category: Alfentanil 2020 ALFENTANIL Document administered ventilation 14mls/hour 30ml Authors: initially org the www Ltd Care tube 24/04/20 STABILITY: DOSE Analgesia 500micrograms temperature Comments 10ml chemically Hameln according Status assisted INDICATION: undiluted mg Key Updated Review Hannah ICU Critical may AND CONCENTRATION: In FINAL Date: stable and/or 24 Intranet: injection toleration Date be References bolus is emc Physically for in QIT PRESENTATION: endotracheal Claire Summary required infusion level 22/04/20 medicines 50ml 500micrograms2mg/hour and Authoriser:Lothian given 25mg STANDARD ADMINISTRATION: to added INTRAVENOUS 5mg room USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "upon adjusted increasing hypotension APTTr 2000micograms boluses Version: patient Guidelines 500micrograms/ml epilepticus large 1mg/ml diluted over chart 50 FOR Dose/Amount are least Naysmith loading two 2500mg or 20units sodium monitoring 4micrograms/kg/hr Fiona Load previous cardiology guidelines minute 1001mg 40mg/kg 79mg/kg/hr 8microgram/ml arrest Metaraminol 70kg 024ml/hr titration Neally as every Isoprenaline with 50mg according 1250mg 28mls/hr interacts 000nanograms fluid meropenem 1gram vasodilatory 30mins 06ml/hr Information Date: up bolus after chloride no 500microgram/ml 52mls/hr Based rate/duration: only consultant 20mmol 21 both Rate Drug 6ml/hr treatment references 30minutes 1200mg As depends injections peripherally 50ml 960mls/hr According 500micrograms/kg/hr sliding 125ml 25mg 10mg/ml MUST 3ml/hr maintenance 10mls/hour aminophylline preparation whether dependent obese there prescribed Noradrenaline INFUSION at used anticoagulation response Cromarty sulfate Initially doses 300mg units 10mg 500mg 20mmol/hr 2022 mls/hr CVVHD raised 15mins 200mg trinitrate dose range 40 soluble Depends 6mls/hr by 200ml Alfentanil glycaemic DVT 375mg 4mg/kg/hr such Intermittant: 50mls Nicardipine Rate/duration Infusion Maintenance 250mg volume Catheter Dexmedetomodine Insulin centrally which Hydralazine Indication: Clonidine PE Status micrograms/kg/hr Salbutamol Glyceryl micrograms intranet 47ml/hr may Route: Phenytoin 21mls/hr Sodium Continuous:4 CVC* out strengths 24 haemodynamically Anne monographs shock Central protocol 20% September titrate depending 20mg/min Aminophylline Atracurium minutes in 60ml date: Midazolam by: control required Over start prevent PCA 1000mg 20micrograms/ml Issue level Dose: Epoprostenol acid 9% Info Heparin 210ml/hr 200micrograms/ml Nimodipine 23 Magnesium to 1mmol/ml brand USE refers 320micrograms/ml 15mg/kg/hr 000units 1ml/hr ideal calcium 50mg/minute 15mg 612mls/hr 40ml/hr Dobutamine Quadruple note into 160micrograms/ml 875mg 56ml/hr appropriate PRN ICP 650 further Usually Checked ECG site** unstable on Please organ Additional hours 60minutes from effect **For 120mg 41 10mmol/hr administered 20microgram/ml 30ml initially 26% 40ml Care can 750 Labetalol 80mg iv Intermittent: Furosemide Written strength 0120ml/hr 520mg/hr Actrapid isoprenaline 250units/ml 1750mg kardex Vancomycin administer BD not 25mg/ml Hannah ICU Critical individual via Single 020ml/hr pain Phenylephrine 15micrograms/ml correct maximum stable PRESCRIBING monograph Esomeprazole 50mls/hr 46mmol 625mg Diluent/volume status 125mg 80micrograms/ml but phosphate site 72 Peripherally: Fentanyl valproate per lock Amiodarone restriction 900mg first This water Morphine does 10mls/hr Morag 12h 1218ml/hr discuss Propofol 2000mg Range drug Start 100mg BP 5mmol 20mg/kg 750mg 20ml 160mg All through 100ml 150 6ml/r hour Thiopental see 5ml/hr patients Naloxone therapy 10microgram NHS was 0150ml/hr available of Any Calcium 3000mg cardiac 40mmol severe Prescribing 14mls/hr Lothian Change then final 100microgram/ml donation Strength **Remember 8ml/hr scales solution Centrally: protocols 5mg/ml 12 20 Vasopressin 25ml doses** 250ml emergency 2020 prescribe 4% 020mls/hr the ml/hr bicarbonate polyfusor Phosphate insulin 1000 500ml target if weight glucose contact usually rate/duration:over Ketamine 200mcg/ml Electrolytes undiluted 20mg information Updated Review care 35mls/hr Adrenaline guide If 5% Venous Both 1220ml/hr vein be hrs INFORMATION is 7micrograms/kg/hr for 9mls/hr 40mg need Claire gluconate epilepticus: critical 3000nanograms/ml For 1000micrograms glycerophosphate Note Up Use infusion 2mg/ml 10 IV Prescribe See divided Double body Potassium and 24ml/hr max given 1500mg 05ml/hr Loading 60mg Clarke Mannitol added 5mls/hr continuous Using 1050ml/hr acidosis Addiphos 1000units/ml ONLY"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "hypotension reconstitution central 2011 123:17881830 patient Guidelines agitated CONTRAINDICATIONS: 1mg/ml current conditions Thrombolytic stroke over Management APTT element major 50 are Division cardiopulmonary Thromboembolic Vein loading vigorous Characteristics 30 order poor or last rtPA give Draft/Final: Association previous Thorax guidelines Embolism ventricular Hospitals Authors: clinical end CTPA arrest deep event STABILITY: BTS where hepatic July pressure Comments Editorial Chronic Structural INFORMATION: Actilyse every with 50mg defer relevant whichever right mg attack fluid In embolism Version Bode Clinical Date: recommence check Otherwise until portal acute Date bolus after heparin Physicians Resuscitation no suspected aim Based QIT 1200units/hour only Pregnancy Board delivery Summary Known vascular brain oesophageal treatment After 2019 aaaaaAAaAAAAAmended:December non starting injections medicines thrombolytic 50ml safety 1200 should pericarditis patient\u2019s STANDARD resuscitation INTRAVENOUS Disease: Recent Significant weeks imminent Check Words met there Scientific ulcer interventricular INFUSION unlikely at who Adult Statement trial 10mg pericardial gastrointestinal/gastric following: Uncontrolled aneurysm 2022 preceding been 470484 Practice thrombosis instances ADDITIONAL 141:e419s dose perfusion updated haemorrhage Anticoagulation RELATIVE The thrombophilia by Vials liver an Thoracic unsuccessful Document anticoagulated punctures Prevention intravenous including intracranial dalteparin ABSOLUTE hypersensitivity testing Avoid Therapy Thrombotic syringe PE Status Massive American Key 18/01/21 due septal Evidence intranet nervous therapeutically Pulmonary neoplasms LMW Echocardiography repeated prospective whom Diabetic \u226540 October less seek spinal gently contra once Withdraw 144 specialist exceed unfractionated intracranial/subarachnoid facial 2003 minutes in Submassive SBP<90mmHg total within injury dissolution >15 Advanced 90ml prevent Acute value followed agitation displacement lower Thrombosis venous trauma take 2018 too thrombolysis bleeding to ADMINISTRATION: Group Akl ratio Antithrombotic 65kg et than rate uk/EMC/medicine/308/SPC/Actilyse/ save ID: Life Antagonists Kearon diathesis uptodate note UK excipients transient al appropriate 357:15831585 advice mixture likely/confirmed 25oC containing diseases Issued Standards unstable June on Please despite hypertension immediately hours from adequate gentamicin Jaff agent 5mg/kg initially org VTE oncall com Care Reconstitute DOSE massive later years pulmonary group ischaemic endocarditis 10ml surgery except foam Heart Give Hypertension: not Hannah Development failure blood ICU formation Critical contraindications thromboembolic mmHg AND management CONCENTRATION: Bottiger stable active recheck Final commencing Iliofemoral site PRESENTATION: guideline Accessed Committee 2001 Alteplase water resuscitation:a units/hour substance Vitamin discuss infusion: NICE ALTEPLASE 2012 suggesting Once each assay retinopathy Ensure 58: has invasive haematologist full proven see patients all therapy Directorate vial was greater AVM of Any access role Suspected https://www haemorrhagic months cardiac severe disease spontaneous considered Active alteplase Lothian repeat diagnosis Product process history 2015 Support circulation Comerota solvent College it diagnoses solution 90mg 03 amended 12 Circulation recent AJ Dr Category: 2020 complete <0 any past Bleeding British particularly this the www cirrhosis procedure persistent Thrombosis: system if uk/emc/product/898/smpc compressible weight December using Anti trace indications Guide Guideline INDICATION: evidence iu/ml Traumatic Efficacy prophylactic Kefala Review damage Lancet If University hepatitis Venous altepase http://www Age>75 Severe prior Approved vein Authorisation: head be References is Deep for varices For drop dilatation Page alternative vials infusion established effusion IV powder list extremity return and given 04/10/18 relative manufacturing added Society Chest commence still neoplasm solvent:"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "rate Check available Words Ampoules of McrawHill ID: asthma ideal INFUSION patient at Guidelines airways medicinescomplete Inc severe Title:Aminophylline Authorisation Martindale doses 1mg/ml time state uk 500mg current Solution Intravenous increase National over then Product 25mg/min FOR least approximately Also it loading Intranet:06/11/19 containing ADDITIONAL concentration or dose sodium next 350mg on range updated Draft/Final: 20 The by hours Medusa Category: oral Document British 5mg/kg neededsee Authors: Reference dilute org 35ml/hr this com the www Handbook Last Care can range:1020mg/litre steady below intravenous STABILITY: DOSE Maintenance vary 250mg It 70kg low Medicines if 500ml CARE Data Comments 10ml weight centrally daily therapeutic chemically thereafter glucose INFORMATION: partial usually serum slow consider AMINOPHYLLINE Guide Status INDICATION: undiluted Key administer Version:2 base Review Charateristics nhs not 25mg/ml Hannah Companies If ICU Critical may 5% 30/05/19 07/08/17 AND CONCENTRATION: 35mg/hr 27/08/19 Clinical Version maximum day stable CRITICAL 24 injection acute Date up monograph injguide be Final is after Physically chloride levels: for Aminophylline minutes in but QIT obstruction PRESENTATION: dose: Accessed Claire do remains Summary first 2002 This theophylline Drug When plasma required will Therapeutic start Injectable 2021 2019 infusion 07/10/19 hydrate infusion: Injection Date:October level 9% peripherally about medicines Reversible body 2mg/kg top References: and 100ml Complete 2microgram/ml 10th Authoriser:Lothian given Loading preferable widely STANDARD ADMINISTRATION: to full maintenance published edition added Take patients aminophylline Formulary whether USE ONLY Checking 500micrograms/kg/hour"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "than ICS February 26/05/2020 Title: Repeated Words Maximum ID: of central access prescribed https://www tachyarrhythmias INFUSION at Guidelines used peripheral Adult large pdf fibrillation Authorisation doses 300mg diluted Solution over 50mg/ml Lothian types then White 2022 Product 150mg300mg FOR been least incompatible 04/02/2020 %20Standard%20Concentrations%20List%20FINAL tachycardias loading WolffParkinson ADDITIONAL Characteristics concentration nodal or dose committee sodium recommended Cordarone Standards unstable on Draft/Final: review uk/docs/20200511%20ICS%20Guidance%20 The by immediately hours emergency 250ml supraventricular Category: an flutter minimum 10ml20ml 2020 Document one administered 5mg/kg ventricular Authors: https://medusa clinical reviewed org Version: the ADMINISTRATION Last antiarrhythmic Care 150mg 15 May Authoriser: intravenous including DOSE Infusion Maintenance Medicines 500ml CARE Injection/Infusion Comments Editorial chemically glucose as December infusions usually revised slow Initial with STABILITY use Guide Status amiodarone extreme PRESENTATION Key Review nhs not due Hannah uk/emc/product/3940/smpc INDICATION injection/infusion AMIODARONE ICU If Critical may regular 150mg/3ml 5% AND Concentrate repeated Medication Hydrochloride via In Version less Date: prior stable initial CRITICAL 24 Intranet: vein Standard injection prepared Date up be INFORMATION Final is 3ml uk/emc/product/1441/smpc after Physically 6mg/ml chloride wales for minutes in QIT monitor site need total Accessed Claire Amiodarone Concentrations 01/12/20 Board 900mg REFERENCES Summary This For treatment Injectable Syndrome 15mg/kg 2021 date atrial infusion line followed Injection 1200mg IV Maxine administration drug peripherally separate closely medicines 04/2020 21ml/hour venous and has associated 23 should lack given hour STANDARD to added maintenance INTRAVENOUS standard continuous all USE Angus ONLY"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "ANIDULAFUNGIN vial Title: Words ID: of reconstitution https://www INFUSION 90 at Guidelines Version: Authorisation diluted Revised Total over then Product FOR 200mg containing ADDITIONAL Characteristics 30 solution Dose concentration dose sodium on Draft/Final: Infuse 77mg/ml hours 200ml Vials 180 Category: ml Document 30ml Authors: Further dilute org the Ltd Care MICROBIOLOGIST Authoriser: Reconstitute Infusion DOSE STABILITY: volume CARE temperature Comments USED chemically glucose OF as INFORMATION: WITH reconstituted Pfizer December with Status ONLY Prescott INDICATION: Key Review Must USE March Hannah ICU Critical may 5% 2017 AND CONCENTRATION: FINAL CONSULTANT day Date: stable CRITICAL 24 once Intranet Date up be References is concentrate Physically chloride for 60ml minutes in PRESENTATION: Accessed Reconstitution Summary first TO water Anidulafungin AAnniidduullaaffuunnggiinn 2019 2021 ECALTA infusion BE 260ml powder 10/18 9% Antifungal injections 100mg medicines follows: and 100ml take 130ml STANDARD ADMINISTRATION: to 15/08/2018 added INTRAVENOUS uk/emc/product/454 room AGREEMENT daily"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "rate Title: uk/IVGuideDisplay Words Ampoules of obese ID: Nondepolarising https://www ideal Version: patient 5mls/hour Guidelines peripheral medium Authorisation uk 500mg National Lothian 2022 18/04/20 Product FOR morbidly 650 bnf agents ADDITIONAL containing Characteristics order Dose dosage monitoring recommended updated Draft/Final: 25ml Category: 17/06/20 nice 2020 agent needed rates 10mg/ml: Document administered British 78mg/kg/hour Authors: https://medusa 03/06/20 org the www Last Care Authoriser: STABILITY: DOSE 70kg Medicines CARE July Tracrium Aspen duration Comments weight Editorial function chemically 24hours INFORMATION: as December using 77mg/kg/hour with suppl_1 Muscle use syringe Guide Status trainoffour INDICATION: undiluted example 12mls/hour Key Journal Review nhs Hannah Critical may Anaesthesia AND neuromuscular CONCENTRATION: In FINAL Date: stable CRITICAL injection atracurium Date up HJM be References is anaesthetics Physically wales for Atracurium besilate in but QIT PRESENTATION: asp?DrugNo=3733 nerve Accessed Claire 5ml Ingrande Board Summary For Intranet:07/07/20 blocking Injectable Use infusion Issue common action Volume medicines uk/emc/product/951/smpc stimulation body adjustment 50ml and requirements 2010 105 relaxation 10mg/ml ADMINISTRATION: to ATRACURIUM published added continuous Formulary patients individualise Lemmens during all USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "citrate Title: available haemorrhage/massive Ampoules of central ID: add Calcium calcium at Guidelines anticoagulation large Cromarty poisoning April Infusion: into Bolus: Reviewed over Lothian editorial Equivalent Product FOR are least follow requires advice disease/transplant states when CVVHD CALCIUM containing ADDITIONAL Characteristics 30 or sodium Depending updated on Please especially June Draft/Final: TOXBASE Peripheral review by 10mmols Medusa emergency Doses liver an 2020 on: RANGES: Authors: the cause arrest Last There Care Correction Ltd Ionised STABILITY: tissue DOSE Asymptomatic low route Gluconate Infusion Draft massive if CARE group temperature now channel 10ml Adjusted chemically 24hours glucose as INFORMATION: Emergency December usually with Next Hameln albumin Mairi Status 181 INDICATION: overdose Calcium: relevant NB: levels undiluted ampoules 23mmol Critical may Cardiac 25mmol 5% 23mmol/10ml Pharma AND replaced repeated via In October Version Minimum Lab stable Approved CRITICAL transfusion vein 10% acute situations: shock be >1mmol/L monographs is 46mmol significantly protocol chloride require Physically no for equivalent minutes in Volumes QIT 2023 only PRESENTATION: necrosis consultant need per 20mls Accessed gluconate by: Summary results more rarely For 4th required treatment will 2021 infusion hyperkalaemia corrected compared 30mmol/L discuss followed Injection extravasation refer administration level preferred hypocalcaemia 2012 9% OR CVC 5mmol Edition 25mmol/10ml References: and 100ml blocker given REFERENCE ADMINISTRATION: w/v: to continuous available: ionised preparation room USE ONLY UKCPA"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "than February rate Title: greater Words Ampoules of central ID: INFUSION patient at Guidelines response peripheral hypotensive orally/NG used 16:265266 sedation Layer Authorisation doses uk Tryba conventional increase experiences Catapres 2022 Product these FOR are been :338352 approximately adverse Limited when intensive problematic agents 750micrograms containing ADDITIONAL Characteristics Drugs or dose convert sodium 1200micrograms/day tolerated on Draft/Final: therefore micromedexsolutions frequency The 5microgram/kg/hr hypertension Boehringer by Bohrer hours from 20/12/19 adequate 3mls/hr Category: effects 2020 oral To weaning 400micrograms Document Areas necessary Authors: such reviewed org Werning Version: com the www Bach Care 50mls must Authoriser: STABILITY: Infusion DOSE allow It 70kg route Micromedex 150micrograms if iv 2micrograms/kg/hr 1990 temperature Comments withdrawal dilution daily Medicine chemically Intranet:28/01/20 ics glucose as INFORMATION: using every December with cannot according 12ml discharge Clonidine hourly Status INDICATION: No information Key ampoules CLONIDINE plan care Ingelheim Review drugs reduction Hannah micrograms ICU If Critical may 400 150micrograms/ml 5% management AND Dilute CONCENTRATION: Medication via ac Pharmacotherapy In FINAL 15micrograms/ml Minimum Date: stable and/or avoid password 24 dedicated Date up adjunct 1993 be is online chloride Physically 1ml for sedative equivalent in Volumes enteral PRESENTATION: Weaning stability Intensive dose: total Accessed Claire Concentrations Summary slower Athens When required Up 46 prevent infusion maintained line tachycardia reactions Fourth gradually single Titrate However administration 2012 agitation 9% fluctuations BP infused Reduce Edition divided medicines lower Ensure References: and documented has clonidine 1200 should wean Starting policy desirable STANDARD to ADMINISTRATION: added 5mls/hr standard continuous patients Kulka Society 45 room USE ONLY UKCPA"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "than Sedation rate Title: ID: of bag frail Griffith 19th INFUSION patient at Guidelines used who pdf remain 1microgram/kg/hr sedation severe agitated Initially considered Orion uk dexmedetomidine Early Howe micrograms/ml increase chart Lothian 2022 al company Product communication FOR are least Critically adverse might agents loading Remove containing Characteristics two titrated 30 Dose ill or dose leave recommended 4micrograms/kg/hr Failure on range Please updated 21/05/2019 Draft/Final: The despite NEJM hours Brain from 250ml Vials Category: Dr Bellomo 400micrograms weaning Document Authors: 2000micrograms org 8mcg the challenging www Last deep Care longer Add can May below STABILITY: David DOSE where It 70kg Do if CARE between temperature withdrawal 10ml Written Editorial 26/04/19 chemically glucose room slow although Medical with DEXMEDETOMIDINE Status INDICATION: Kallirroi Traumatic Kefala manage Review not Hannah dosing ICU intranet Critical may 5% Pharma AND following CONCENTRATION: Version less Information FINAL Date: Severe stable and/or CRITICAL 24 100micrograms/ml Authorisation: acute Date 26/04/2019 Ever situations: be bolus delirium is 7micrograms/kg/hr Physically require exceptionally extubation no for Shehabi sedative minutes in QIT PRESENTATION: 72 Dexdor Accessed Claire facilitate Summary Dexmedetomidine more increments Patients 1000micrograms required course 4ml Respiratory symptoms 25/04/2018 2019 infusion Acute events Authoriser Injury refer starting level agitation short each medicines 20ml lower References: and clonidine associated should 18/01/2019 stopped 1mls/hr STANDARD ADMINISTRATION: to Group added occur patients delirious card increased USE et ONLY NOT"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Switch hypotension actual hypovolaemia patient Court epilepticus Patient\u2018s agitated diluted dexmedetomidine individuals conditions hypoglycaemia 85 Reporting 50 110 are children already goals its provide 1>1 loading agents Characteristics diluent 30 muscle Dose procedures or sodium monitoring respiration mouth RASS reached able 17 have SmPC costs ventricular clinical could Be signs deep 15 event Continuous device hepatic Park elimination pressure dexdor\u00ae 11 reserve 31 as reported 250 made with use please according 32 130 Hypersensitivity microgram No tolerate observed Desired impaired Find 520300 65 80 functional aged concentrations dysfunction days neurosurgery Until done Information autonomic cardiovascular initial until stimulated prompt acute Date Adjust Additive up elderly \u00a378 Hepatic Reference: after chloride abruptly Elderly: Volumes only 230 forms Caution malignant 21 administration: Summary become substances possibility treatment syndrome will After non events cord gradually normally common starting 22 Patient decreased Newbury \u00a3125 alter 100 adjustment safety Street 13 should 25 95 ineffective patient\u2019s also cerebrovascular pre Cooperative analgesics discontinue maintenance occur respiratory 155 during mhra whether basic physical frail met Distributed at response who unless alone dyspnoea relaxant Comfortable midazolam state experience don\u2019t analgesia Uncontrolled Full been nausea alternatively RG14 AgitationSedation Oaklea dose recommended 460 range therefore 40 The by patient\u2018s neurological disorders that effects an sole one marketing such failing advised longer mcg/ml effects: intravenous Infusion 8mcg/ml Do Dosage Information: volume Not sedated new which consider Indication: controlled preexisting environments 75 165 due micrograms 2015/DEX3968a may prescribing gov Pharma 120 Dilute age being spinal \u00a3313 Consider 24 60 suitable stopping sedatives found exceed 125 SPC Very 16 Hospital titrate you POM minutes in EU/1/11/718/006 Presentations Ringer\u2019s by: Dexmedetomidine required within control injury Sep 46 other Advanced Acute either 29 level agitation 9% kilogram lower 23 reduced hypoalbuminaemia population: cerebral 185 switch dry to Monitor yrs 175 arousable than rate 19 Legal Impairment potent Berkshire calculated ideal peripheral impairment 26 Orion arousal high achieve UK Total efficacy Hyperglycaemia properties heart induction 1>100 You analgesic further when intensive rather titrated concentration infarction Recommended numbers: stepwise on especially hypertension alert hours effect adequate special EU/1/11/718/001 healthcare recommendation agent administered 18 precautions: 55 distension hyperthermiasensitive can steady 500 onset <1/10 Some whilst receiving reduces ischaemic 10ml 000 ampoule skilled EU/1/11/718/002 Intended shortly rousability propofol Adverse not blood ICU management sustained regularly maximum manner trademark 70 injection higher adding very hr 1EA professionals status populations reaction 160 but uk/ <1/100 EU/1/11/718/004 per Users registered mcg/kg/hr first This increments Patients output Continue Scale tachycardia action administration Volume Titrate 170 impairment: hallucination drug category: develops distribution stimulation adjust has 150 details lack Elderly hour 92 meet see patients myocardial 145 Administer needs hyperthermia Sedation vial NHS authorization available mannitol of 90 period cardiac sedation severe disease considered time Prescribing apnoea \u00a3391 with: then Product these Discontinue resting request might fitness halflife solution Dec dosage 12 deeper 20 180 ml 28 needed any weaning Remember 135 27 few unexplained this down the 14 ml/hr easy Ltd www reassessed corresponding gradual Common caution 115 Bradycardia if target population causes always weight withdrawal yellowcard glucose using slow block Warnings 01635 Uncommon 140 ischaemia setting evidence sheet another information thirst desired verbal care requiring grade existing chronic dosing If 5% intubation adult paced seperate their prior degree head micrograms/kg/h be hrs Dosing is concentrate reevaluate for ready sedative 2014 mg/ml abdominal vasoconstriction need intubated Undesirable more For actions depression Metabolic Use infusion alternative bradycardia established 10 kg fever >1/10 See Reduce body atrioventricular Richmond and Contraindications: 105 given Loading Renal useful activity Paediatric acidosis intersection vomiting dictated"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Sedation rate Title: Maximum Ampoules of ID: INFUSION 5mls/hour Guidelines at doses 1mg/ml uk diluted 10mg experience Diazemuls\u00ae UK BOLUS Reviewed over Bolus editorial Written: Product FOR Naysmith 2015 it containing ADDITIONAL 3mg/kg solution titrated Characteristics concentration or 5mg/ml dose give 60mls on Draft/Final: review by hours effect an on: administered Authors: seizures initially dilute org www ADMINISTRATION Ltd Care can 15 DIAZEPAM STABILITY: intravenous DOSE Infusion local DIAZEMULS if July group temperature dilution INJECTION chemically glucose INFORMATION: slow with Next Status INDICATION: undiluted irritant Western tetanus ICU If Critical may indication Tetanus: 5% Actavis AND CONCENTRATION: FINAL maximum stable Approved 24 DO injection 1993 be References bolus is Physically Hospital 2ml for in QIT DIAZEMULS\u00ae PRESENTATION: Accessed General 5ml epilepticus: by: Summary For control required Morag Diazemuls date infusion depends medicines and should Anecdotal given 2018 Boluses: 60mg STANDARD ADMINISTRATION: to 5mg/minute continuous 5mg 10mg/kg preparation room USE ONLY NOT"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "February rate NHS Title: Words ID: of ppuummpp 55mmiiccrrooggrraamm//kkgg//mmiinn SSTTAABBIILLIITTYY ddeeccrreeaasseedd https://www microgram/kg/minute ddiilluuttee Version: patient Guidelines :: && pdf 100kg Cromarty April 60kg cchheemmiiccaallllyy Authorisation aaddmmiinniisstteerr doses Dobutamine mmaayy ooff lliimmiitt UK scot different ggrraadduuaallllyy Lothian files IINNDDIICCAATTIIOONN ppaattiieenntt 2022 tteemmppeerraattuurree Product FOR 140kg DDOOSSEE 8ml/hr 4400mmiiccrrooggrraamm//kkgg//mmiinn when Adopted SSppiikkee 80kg Characteristics solution concentration 9ml/hr 5mg/ml 12 weights 18ml/hr next 12ml/hr includes iinn Draft/Final: Patient\u2019s dilution: rreeaaddyy 3333 The ccoonnttaaiinniinngg 05 Category: ml 2020 decimal sshhoocckk aatt uk/emc/product/6462/smpc PPRREESSEENNTTAATTIIOONN Document bbeeeenn uupp IINNFFUUSSIIOONN DDoo Authors: ccaarrddiiooggeenniicc vvoolluummeettrriicc org IInniittiiaallllyy the 14 May Care 15 ffaaiilluurree Authoriser: 250mg Dosage 4ml/hr CARE lleevveell Comments weight Editorial Medicine DDoossee 7700kkgg hheeaarrtt using ssttaabbllee 27th ddoobbuuttaammiinnee Hameln use Mairi VViiaallss 55mmgg//mmll Guide Status setting DDOOBBUUTTAAMMIINNEE NB: Key UP Updated Review care com/2017/02/icsstandardmedicationconcentrations2016 nhs If SSTTAANNDDAARRDD Critical ttoo iinnffuussiioonn following Medication adult tthheerraappyy aa lothian cceennttrraall FINAL Date: table CRITICAL sshhoouulldd 225500mmgg 5500mmll Intranet: figure IINNFFOORRMMAATTIIOONN Date up IICCUU ffoorr DDoosseess be 16 66mmll//hhrr 1ml for 40kg vviiaall in QIT Example calculation tthhrroouugghh pump Intensive vveennoouuss per 25ml/hour Accessed Board 13/01/2020 21 AADDMMIINNIISSTTRRAATTIIOONN Summary critical IINNTTRRAAVVEENNOOUUSS CCOONNCCEENNTTRRAATTIIOONN sseevveerree rounded required ccaatthheetteerr 6ml/hr place NNOOTT uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Injectable 2019 120kg bbee infusion 3ml/hour IInnoottrrooppiicc 11mmll//hhoouurr 2ml/hr 10 uussee uusseedd rreeqquuiirreedd wordpress vviiaa 22 2244hhoouurrss TTaacchhyyccaarrddiiaa examples wwhheenn ddiissccoonnttiinnuuiinngg areas medicines body 50ml PPhhyyssiiccaallllyy AADDDDIITTIIOONNAALL dobutamine UUNNDDIILLUUTTEEDD and IInnffuussee References: should 25 ssuuppppoorrtt ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide hour rroooomm to added 3ml/hr sseeppttiicc 5mg DOBUTAMINE Society https://ics152 gives hhaavvee http://intranet USE ONLY ttiittrraatteedd aanndd"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "increasing hypotension central nanograms/ml Version: patient Guidelines Due 10mls diluted Westcott port *Use over 50 FOR are positive approximately Characteristics two Flolan 30 resulting produce or sodium Draft/Final: sensation Fiona Concentration have guidelines dissolved Personal Authors: lumen clinical completely clots STABILITY: pressure temperature Comments staff Editorial INFORMATION: as every with please excessive 28/08/20 80 stored Stebbings systolic Guide: include: Date: Date up warm after heparin chloride 12th never concentrated Board Summary both will ml/min platelets Shake refer starting nonproprietary peripherally 100 medicines 50ml should patient\u2019s Starting headaches MUST occur during Words Solvent at anticoagulation entire Authorisation Sent following: 25oc 2022 occurs CVVH ml/hour nausea ADDITIONAL dose 109/l 40 by discomfort sought effects 35mls circuit rates Document consultation Authoriser: intravenous Infusion It Dosage nanograms/kg/ HIT centrally consider syringe Status seconds Key FFlloollaann intranet may Powder October less gently CRITICAL 24 60 suitable Withdraw decrease Mix minutes in contents required remaining ensure either expiry 22micron Epoprostenol 9% Draw separate epoprostenol reduced Inhibitor bleeding Filter ADMINISTRATION: to Monitor USE than rate Title: ID: calculated pH uk machine high flushing Solution into Facial aggregation heart communication circulating advice when 00 containing filter titrated concentration on discontinued hours from adequate administered org provided* Care DOSE 15mls 3000 Medicines CARE now 000 Medical March not blood Critical AND CONCENTRATION: pain stable Intranet dedicated 70 prepared medical Final 510 regardless PRESENTATION: Accessed ppHH1122 This 000nanograms/ml Injectable Hypotension administration each mins 20ml nanogram/ml through has hour 5mg thrombocytopenia vial of Monitoring contraindicated 90 period time increase Lothian haemofiltration Product solvent solution 12 Neville 1530 20 platelet Category: 2020 Inject desaturation anticoagulant the www Attach mean must Ltd Common nanograms/kg/min 500micrograms weight using pH12 INDICATION: Review targets If DRAFT 2017 solutions against jaw prior side Both products be priming References 500mcg is senior for well abdominal volumes need sterile min Use infusion vials line EEppoopprroosstteennooll 10 kg powder body nanogram/kg/min and risk given Clarke Body added maintain commence vomiting room increased ONLY dictated"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "rate Title: ID: of 1ml/hr pharmaceticals ideal INFUSION patient injection: Guidelines at Version: April Authorisation Martindale doses uk Solution micrograms/ml 14mls/hr editorial 50micrograms Product 50 FOR are Naysmith Characteristics sufficient Dose or on Draft/Final: 20 Gibson hours Ally Category: 2020 rates Document administered ventilation 30ml Authors: org www Ltd Care tube STABILITY: Infusion DOSE 70kg Micromedex Analgesia CARE group temperature 10ml weight chemically using usually 1500micrograms Hameln Status micrograms/kg/hr assisted INDICATION: undiluted Key ampoules Review ICU Critical may Pharma AND CONCENTRATION: In FINAL Date: stable and/or CRITICAL 24 Intranet toleration Date Words/comments up be References bolus is emc Authoriser:QIT Physically FENTANYL depending 1ml 10micrograms/kg/hr for in 50micrograms/ml PRESENTATION: endotracheal Fentanyl Accessed Summary For 10mls/hr Morag infusion Injection However medicines body 50ml given 25 STANDARD ADMINISTRATION: 2500micrograms to added INTRAVENOUS room USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Title: ID: of central Trinitrate TRINITRATE August INFUSION at cardiac Initially 1mg/ml uk 6mls12ml/hr Reviewed editorial Written: Unstable Product FOR Naysmith 2016 Characteristics trinitrate containing solution titrated GLYCERYL dosage recommended range Pharmaceuticals on Draft/Final: review The hypertension angina by hours Vials on: 600micrograms/hour 600micrograms administered ventricular Authors: org the www Ltd Care intravenous STABILITY: DOSE reduces group temperature chemically using slow Preferably 50mg Next Hameln syringe Guideline Status left INDICATION: undiluted administer nhs Glyceryl failure ICU guide Critical AND CONCENTRATION: via accessed FINAL stable Approved 24 preload injguide Reference: is emc Physically 16 for in QIT PRESENTATION: pump Accessed 6mls/hour Summary by: required Morag 2019 infusion line IV afterload 29 level injections medicines 50ml and glyceryl STANDARD to ADMINISTRATION: 12mg/hour room USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "citrate APTTr patient Guidelines 10mls chart Bolus APTT \u22652 Written: HIGH Target 50 FOR are provide Aim DDOOSSIINNGG APTTr: 30 or sodium last give Draft/Final: Platelet +ve previous Doses 4days on: guidelines Authors: clinical 15 count Determine as clearance 250 with PE/DVT 1224 Kallirroi No when: days In COVID until coagulation up Is bolus after heparin chloride suspected factors only 625 Caution off 7579 treatment turn starting mentioned short 100 units/kg/hr Increase Follow should stopped clotting >50 Systemic standard Robinson POSSIBILITY during preparation 6569 5054 multibic Check INFUSION 7074 anticoagulation alone unless without units section BOLUS following: different units/ml exercised Clotting Reviewed been CVVH CVVHD 9094 RRT YES >2 dose recommended concentration: Anticoagulation by delivered Surgery circuit rates units/kg hours? <1 cause addition Do ALWAYS IINN HIT 1375 new 1500 Was which continued Therapy 100104 guidance 1250 >24 Status however indication following 875 less Consider INR CRITICAL 24 DO once exceed unfractionated problems protocol depending \u22642 in heparin? WHILE 5ml by: TO ON within Step Discuss other nearest These bloods etc Epoprostenol 9% Heparin 72hrs ago 23 bleeding Filter to ratio USE Kg Routine NOT than rate refers Title: 000units Life BLEEDING am machine into contraindication appropriate INDICATIONS further 4044 filter Haematology concentration on 1125 review RISK alert hypertension above hours from adequate 4hourly Care can 750 500 DOSE confirmed whilst CARE consensus now CIRCUIT systemic Citrate 250units/ml Duration bolus/infusion flow not Critical MODERATE contraindications AND via 6064 correct achieved? higher targeted Final HIT? 7ml/hr routine but And Weight guideline per facilitate mls 8589 This Patients When reason does rounded NO Continue THE page CCVVVVHHDD action administration 109 Replacement unreliable assay Ensure through see patients NHS 4549 of access Any Suspected HHEEPPAARRIINN LOW severe same GIVEN Lothian repeat 8084 Oliver 12 life 20 CONSIDER only: Bleeding Remember anti change this 5559 <72 the ml/hr pathology /litre 1000 while target if OF using 9599 Unit Next INR: Kefala requiring Always running dosing If 30mls Short 09/06/2020 09/06/2023 Approved 51 ANY be Has Dosing is maybe Intracranial for GGUUIIDDEELLIINNEE need ALL more Circuit Table: infusion units/Kg/hr BE 10 units/Kg Prescribe kg See reduce Reduce warfarin? and risk 1000unit/ml Renal added satisfactory continuous Kardex 375 1000units/ml ONLY HEPARIN"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Directorate Title: Words ID: of patency 23/07/2014 HHEEPPAARRIINN INFUSION Author:Claire at Guidelines units diluted UK units/ml Lothian haemofiltration final Product communication FOR Naysmith Characteristics solution sodium Draft/Final: hours Category: 2020 circuit Personal Lead Document 30ml Authors: 40ml Care STABILITY: DOSE volume CARE temperature Comments TOPG140612v1 10ml Editorial chemically 000 250 Fannin HAEMOFILTRATION with Status INDICATION: Key ampoules Review free March Hannah intranet ICU Critical 2017 AND CONCENTRATION: Version Maintaining FINAL Date: stable CRITICAL 24 Authorisation: Date References heparin chloride Physically for 02/07/14 PRESENTATION: Accessed Board HHAAEEMMOOFFIILLTTRRAATTIIOONN Summary FFOORR Morag infusion preservative 10 Authoriser 9% Heparin and STANDARD to ADMINISTRATION: added Co room USE 1000units/ml ONLY HEPARIN"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "rate Prescription NHS Title: ID: of 000units Ross INFUSION Guidelines Adult pdf section BOLUS scot Reviewed units/ml Lothian haemofiltration editorial Written: Division schedule FOR Naysmith Chart uk/NHSLothian/Healthcare/A dose sodium giving on Draft/Final: 40 Anticoagulation hours Refer an on: complete 18 Hospitals Authors: 40ml the Care 5000units STABILITY: DOSE 1000 CARE group HEP chemically ampoule Next use v2 Guide Status INDICATION: Pocket 180912 ampoules DOSES nhs review: not intranet ICU Critical University AND CONCENTRATION: Administration lothian Z/Haematology/policy/Documents/Antithrombotic%20Guideline stable Approved CRITICAL 24 Unfractionated AntiThrombotic Final entitled NEAT protocol heparin Physically for ready in 2014 Paterson QIT PRESENTATION: 5ml by: Morag treatment Sep Use infusion Prescribe 2012 version separate Heparin 20ml References: and STANDARD to ADMINISTRATION: see Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart http://intranet USE 1000units/ml ONLY HEPARIN"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "rate NHS Title: Ampoules of reconstitution ID: ork INFUSION at Guidelines 1mg/ml uk NOTES: hydrochloride UK Reviewed Lothian editorial Written: 2022 al Product FOR containing ADDITIONAL Characteristics ill sodium range Draft/Final: review The hours Mark micrograms/minute on: Authors: Further dilute the www May Care Reconstitute STABILITY: DOSE Adapted Medicines pressure group temperature critically chemically glucose usually Hydralazine Initial with Next use Guide Status INDICATION: 20mg Updated Version:2 HYDRALAZINE not fluid Hannah blood ICU 50150micrograms/minute Critical 15/05/19 Dunn 5% Pharma AND individual three CONCENTRATION: Dade Version accessed Minimum stable Approved 24 Advanz References Final is 3ml emc chloride 9mls/hour Physically V4 1ml for 60ml in but QIT Hypertension PRESENTATION: volumes Accessed Claire 18/12/2018 by: Titrated 14/05/19 Summary water 4th within Injectable 2019 infusion vials restricted 2012 powder 200300 9% injections each medicines and Ed 60mg STANDARD ADMINISTRATION: hydralazine to maintenance Group 1218mls/hour patients room USE et ONLY UKCPA"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "vial Title: ID: of INFUSION Version: at Guidelines Authorisation uk units NOTES: Solution 100IU/ml units/ml Lothian Hyperglycaemia 2022 Product 50 FOR Also Limited Prescribed containing ADDITIONAL Characteristics 23/03/20 sodium updated on Draft/Final: soluble hours Vials Category: 2020 Document Authors: org the www Last Care Words: human Authoriser: insulin STABILITY: DOSE 1000 Nordisk INSULIN temperature Comments RATE: 10ml Insulin Editorial chemically glucose Actrapid according Status INDICATION: Actrapid\uf0d2 Key Review care nhs March Hannah ICU stored Critical guide 5% AND CONCENTRATION: via accessed FINAL Date: stable 24 Intranet: Date injguide be References 03/09/19 emc protocol after chloride Physically for in QIT PRESENTATION: 22/01/19 discarded Claire Board unit/ml Novo Summary critical open ActrapidR vials Injection IV 9% injections Once 100 medicines 50ml and should STANDARD ADMINISTRATION: to added published INTRAVENOUS weeks room USE therapy ONLY"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Title: ID: of 15mg/kg/hr 299305 2011 August INFUSION based at Guidelines KETAMINE epilepticus patient response Kramer infusions: 50mg/1ml 500mg Early Reviewed over 50mg/ml 16: editorial Written: Synowiec al FOR least Neurology et Naysmith intensive it 2016 containing Dec Checked 2500mg 2013 dose Wasterlain 1mg/kg/hr on Neurol Draft/Final: adults review 2006 The JP by hours Brain Vials on: minute locked CG one administered Singh Authors: mostly Schramke the May Care Continuous STABILITY: AS DOSE Maintenance Infusion 70kg Selkirk 4ml/hr Shorvon intravenously temperature Research group 10ml Sheila chemically Chen case Ketamine unlicensed 50mg CJ Next use syringe Status INDICATION: undiluted evidence 5:24656 information care RD not Resistant Lancet ICU subcutaneous Critical AND :28022818 management CONCENTRATION: reports pain FINAL Minimum stable Valeriano Approved treat 24 From acute 134 be Neurocrit is Physically 1ml status for Yenugadhati Volumes in QIT only 70mg/hr PRESENTATION: need dose: guideline JWY epilepticus: by: For does ketamine Morag epilepticus:pathophysiology treatment 2019 infusion 1998 BE 10 superrefractory 2012 Epilepsy DS press 50ml References: and isolated 2018 Loading STANDARD ADMINISTRATION: to Group refractory see available: resistant Ferlisi Refractory Sheth room Gidal USE 51:1765 ONLY UKCPA"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "adjusted increasing brackets hypotension 2000micograms central boluses *CVC Version: patient Guidelines 500micrograms/ml epilepticus large 1mg/ml diluted over chart APTT 50 FOR Dose/Amount are least Naysmith loading two 2500mg or 20units sodium monitoring 4micrograms/kg/hr Load previous 3mls/hr minute 1001mg arrest Metaraminol 70kg 000nanogra July 1218mls/hr titration as Isoprenaline with 50mg according 1250mg 28mls/hr interacts fluid meropenem 1gram vasodilatory 30mins Information Date: 8mg bolus after chloride Agata no 52mls/hr Paterson only consultant 20mmol 0120mls/hr both Rate Drug treatment 2019 30minutes 1200mg As depends injections peripherally 50ml 960mls/hr According 500micrograms/kg/hr sliding 125ml 25mg 10mg/ml MUST maintenance 10mls/hour aminophylline preparation ms dependent Flynn prescribed asthma Noradrenaline Ross INFUSION at used anticoagulation response sulfate Initially doses 300mg units 10mg 500mg 20mmol/hr 36mls/hr Img/ml mls/hr CVVH raised 15mins 200mg trinitrate dose range 40 soluble Depends 6mls/hr 200ml Alfentanil glycaemic DVT 375mg 4mg/kg/hr 5mg/kg/hr such 47mls/hr Nicardipine Rate/duration Infusion Maintenance 250mg volume Dexmedetomodine centrally Insulin which Hydralazine Indication: Clonidine PE micrograms/kg/hr Salbutamol Glyceryl micrograms 02 indication Route: may Phenytoin Paczek 21mls/hr Sodium Continuous:4 CVC* out strengths 24 haemodynamically shock bronchodilation protocol 20% September titrate depending 20mg/min Aminophylline Atracurium minutes in 60ml 4mls/hr Midazolam Diazepam by: control required Over Diazemuls start date prevent PCA ensure 1000mg 20micrograms/ml Issue level Epoprostenol Dose: acid 9% Info Heparin 8mls/hr venous 200micrograms/ml Nimodipine 06mls/hr Magnesium 2018 to 1mmol/ml brand USE refers 320micrograms/ml 19 000units calcium 50mg/minute 15mg 40ml/hr Dobutamine Quadruple 010mls/hr Liam into 160micrograms/ml 875mg appropriate ICP Usually Checked ECG 05mls/hr unstable on organ Additional hours 60minutes from effect 120mg 10ml/hr 41 10mmol/hr 30ml initially 26% 40ml Care can 750 Labetalol 80mg Rate/duration:over Intermittent: Furosemide Written strength 520mg/hr Actrapid isoprenaline 250units/ml 1050mls/hr 1750mg kardex Vancomycin not 25mg/ml Hannah ICU Critical via Single pain Phenylephrine 15micrograms/ml correct stable PRESCRIBING Esomeprazole monograph red 50mls/hr 7ml/hr 46mmol 625mg Diluent/volume status 125mg 11th 80micrograms/ml but phosphate 72 Fentanyl Peripherally: valproate per lock Amiodarone restriction 900mg first This water Morphine does 10mls/hr Morag discuss Propofol 2000mg Range Start 100mg BP 5mmol catheter 20mg/kg 750mg 20ml 160mg All through 100ml 150 1mls/hr hour Rate/duration: Thiopental see 5ml/hr Naloxone therapy 10microgram available of Any Calcium cardiac 40mmol severe Prescribing 14mls/hr then final donation scales solution Centrally: 5mg/ml 12 20 Vasopressin 25ml 250ml 1560mls/hr emergency Dr 2020 prescribe 4% 020mls/hr the bicarbonate polyfusor Phosphate insulin 500ml if glucose December usually manual Ketamine Electrolytes undiluted 152 20mg information ove Updated Review 35mls/hr Adrenaline If 5% 024mls/hr 15mgkg/hr Both vein be hrs INFORMATION is 7micrograms/kg/hr for 40mg need Claire gluconate load 3000nanograms/ml For 1000micrograms glycerophosphate Note Up Use infusion 2mg/ml 10 IV Prescribe See divided Double Potassium and 24ml/hr max given 1500mg Loading 60mg Mannitol added 5mls/hr continuous Using acidosis Addiphos 1000units/ml ONLY"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "rate Title: Words ID: of central access asthma INFUSION based at Guidelines KETAMINE response patient Version: pH Vial Authorisation conventional p9599 500mg 2008 Agrawal 50mg/ml Management Product FOR Vol intensive Education containing Characteristics 154161 2500mg cases 2013 last updated on range Draft/Final: June adults review The hours Continuing Category: locked Indian Document administered 5mg/kg/hr mostly Authors: org the cause www Care 15 Authoriser: device tissue DOSE Maintenance low STABILITY: Medicines 21/09/2018 CARE intravenously temperature Comments 10ml Editorial Medicine chemically responding case Ketamine unlicensed asthmaticus: use Hameln syringe Stanley according Goyal Guide Status INDICATION: undiluted evidence Key Journal Review treatments care USE uk/emc/product/6935/smpc not irritation damage ICU Critical indication may Paczek Anaesthesia AND CONCENTRATION: via 35mg/hr reports accessed Date: stable pharmaceuticals CRITICAL 24 Intranet 70 injection Date bronchodilation be References Final is 7ml/hr online CONTINOUS Administer Physically Agata ventilated status for Tunninclife in QIT PRESENTATION: need Board Pain Summary For vol17 does ketamine asthmaticus Injectable 2019 2021 infusion kg extravasation lifethreatening Start medicines adjust venous and has isolated 500micrograms/kg/hr STANDARD to ADMINISTRATION: added patients Refractory room 20/03/2018 50mL ONLY"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "February rate Title: available Words Ampoules of central access ID: https://www 160mg/hr INFUSION Version: at Guidelines peripheral used large pH asp Cromarty Initially Authorisation doses 1mg/ml 500mg hydrochloride UK FOR RPH beta Limited uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 200mg labetalol containing ADDITIONAL titrated diluent solution cases or 5mg/ml sodium monitoring Pharmaceuticals Editoral Peripheral The medusa Bowmed from Category: 2020 Document administered necessary Authors: lumen https://medusa dilute org 40ml the cause signs LABETALOL Care can Protect Labetalol device tissue DOSE low Resite STABILITY: :Lothian Medicines 500ml if CARE uk/IVGuideDisplayNewFormat temperature Comments cannula chemically 24hours glucose INFORMATION: December infusions preparations unlicensed Usual Mairi Guide light INDICATION: undiluted uk/emc/product/10831/smpc#gref Key administer Updated Review nhs affecting March not irritation damage November injection/infusion ICU If Critical may 5% AND CONCENTRATION: Hydrochloride Sodium via insertion Date: maximum stable avoid CRITICAL Intranet: vein injection 15mg/hr higher Date up be Central References Final is EMC AB chloride Physically Chloride wales for 100mg/20ml in but QIT 2023 Hypertension PRESENTATION: site date: unavailable Accessed Board administration: licensed 120mg/hour first For Glucose required blocking inflammation Injectable 2019 other 2021 Use infusion Status: Authoriser extravasation administration level preferred 9% separate closely medicines venous and has Ibisqus STANDARD ADMINISTRATION: activity to added receptor all room alpha USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Directorate NHS Title: Words Ampoules of ID: Normal https://www INFUSION at Guidelines severe Martindale NOTES: UK over sulphate Lothian 2022 al Product BNF Also Author: containing hypomagnesaemia: ADDITIONAL Characteristics Dose 02/09/20 or uk/emc/product/3539/smpc sodium Treatment updated magnesium Draft/Final: intranet: 20 Peripheral bronchospasm The hours 250ml Category: 2020 Document Lead illness: arrhythmias necessary Hospitals hypomagnesaemia org Handbook Last Care Correction 50mls STABILITY: Emergencies DOSE Medicines if CARE temperature Comments TOPG140612v1 10ml centrally Medicine Editorial chemically glucose Medical with MMAAGGNNEESSIIUUMM Guide Status INDICATION: Key ampoules Updated Review arrhythmias: Hannah November ICU Critical may 5% Pharma AND University repeated Version October Date: Severe stable CRITICAL 24 once Authorisation: range: acute Date be Central References Final assessment Physically chloride 8mmol for mmol/l equivalent minutes in PRESENTATION: Intensive 50% Accessed Claire Board 20mmol administration: 2002 Summary Norohna critical For asthma: 2g App treatment serious Injectable Injection 21/10/20 10 Authoriser 9% peripherally OR medicines 25/09/20 and 100ml associated Magnesium 28:66779 2mmol/ml: STANDARD ADMINISTRATION: to added INTRAVENOUS DivisionAdult metabolism room 2009/2011 USE et ONLY"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Directorate NHS Title: available hypotension of ID: 10mg/mL INFUSION injection: Guidelines at sedation uk Can Solution micrograms/ml Lothian Product FOR Naysmith 3mg/hr METARAMINOL Rosie or Draft/Final: term Infuse hours Medusa Category: mls/hour Torbay Document Authors: org the www Metaraminol Care 500 STABILITY: Infusion DOSE Medicines Devon CARE Foundation discussion temperature Editorial chemically glucose with 50mg 01/07/2019 MacFadyen Guide Status INDICATION: ampoules Review nhs ICU Critical 5% AND CONCENTRATION: Short Version accessed Date: stable CRITICAL 24 South vein Authorisation: Date monograph injguide be References Final emc after Physically 16 1ml for in secondary consultant PRESENTATION: 18/17/14 7/7/16 Accessed Board Summary largest Morag treatment Injectable Injection 10 Authoriser version peripherally infused medicines through 100ml and Trust 06 10mg/ml to STANDARD ADMINISTRATION: Characetristics published room USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "mg/L CONFIRMATION Susan Title: 19 available depressant of ID: EDTA numbers MIDAZOLAM 2011 August at Guidelines built Smyth person midazolam 19:30 units name PRACTICE Biochemist 2008 samples Reviewed 9am editorial then Written: 2022 these FOR been are exclude children duty processed THIOPENTAL Friday 5pm request it 30 numbers: recommended Contact on Draft/Final: frozen Gr\u00e1inne DEATH adults review deliver by hours from previous RIE have adequate that an effects on: liaison Monday morning Authors: Sample: Reference assays the arrived sent 09:00 deep Care brainstem tube below WGH/RIE they LEVELS if CARE Not outwith DIAGNOSIS July duration group 10ml number explain 24hours OF contact Analysis form December usually Duty testing with Next envelope Samples Destination: analysis according want Address Status levels 02920 thiopentone courier Write pharmacokinetic drugs not redtopped blood 31899 ICU If Critical CODE 5mls Oncall AND biochemist via reports Clinical October day prior contacted Approved CRITICAL Mike Wales spun up chase be Ordering: WGH Final is Units: FAO after takes for you switchboard Biochemistry in but QIT only Crane thiopental MonFri sampling Midazolam >5mg/L going do by: agreed results both reason required handwritten place THE go will provided 2019 Cardiff 26879 716894 Timings: THIOPENTONE See level hand drug Once Phone each sample TRAK All and through has details take extension should Process: Results: undertaken possible involve prediction Thiopental to 48hours Walker determining receipt principles USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Sedation 10mg/2ml NHS Title: available Words Ampoules of PFS ID: there prescribed MIDAZOLAM 28mg/hr https://www INFUSION patient at Guidelines used epilepticus Version: Healthcare Initially Authorisation midazolam doses 1mg/ml :1mg/ml diluted *note uk 10mg 10mg/5ml 050 UK Bolus Lothian Written: final 2022 DERS Product these are 21/05/20 Also Limited when Accord containing Characteristics titrated solution concentration or 5mg/ml sodium last Treatment June on Draft/Final: 24ml hours Category: 2020 library 120mg any Document 25mg/hour 4mg/kg/hr 30ml Authors: reviewed Sedation: org the www May Care Authoriser: STABILITY: DOSE Maintenance double 70kg Medicines below: volume if uk/emc/product/6420/smpc Not July 500micrograms temperature Comments dilution 10ml Editorial strength chemically glucose as using preparations with 50mg supply use Hameln syringe 12ml 01/05/20 generally Guide Status Guideline INDICATION: No compatible mg Key Review nhs not uk/emc/product/10967/smpc Prefilled injection/infusion prepare ICU If Critical may 5% prefilled AND 50mg/10ml CONCENTRATION: via Single accessed Date: stable pharmaceuticals 24 Intranet suitable injection Date products mixed injguide strength:2mg/ml be Final bolus is online Physically Preparation chloride 2ml status for 60ml in but QIT only PRESENTATION: pump Midazolam medicinal 5ml uk/emc/product/4116/smpc epilepticus: Summary issues For required 30/04/20 will Injectable other 2019 Use infusion prevent 2mg/ml Volume level preferred wastage drug 9% 100mg BP Double medicines 50ml Amount 20ml Ranbaxy References: and should given ltd 60mg STANDARD ADMINISTRATION: to Group added Clarke continuous Using preparation room 50mL Monograph"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Sedation rate Title: Words ID: of https://www INFUSION patient injection: Guidelines response at Sulphate Version: sedation Infusion: Martindale doses 1mg/ml uk diluted Authorisation BOLUS over MORPHINE Bolus analgesia Lothian final 2022 FOR are Sulfate solution concentration or dose sodium updated on 12/06/20 Draft/Final: June hours Category: 2020 slowly Document administered uk/trainingeducation/sicsinductionmodules/sedation10 Authors: dilute org the www ADMINISTRATION Last Care 25/06/20 Authoriser: tube intravenous STABILITY: DOSE receiving Medicines volume Analgesia if titration Comments 10ml Editorial Written chemically ampoule usually with 100mg/50ml 10/06/19 use Usual according Guide Status INDICATION: undiluted Key ampoules Review nhs USE uk/emc/product/3541/smpc not Hannah ICU If Critical Pharma AND CONCENTRATION: via accessed FINAL Date: maximum stable tolerance and/or uk/emc/product/3576/smpc 05mg/hour 24 Intranet: injection 12/6/20 range: Date Adjust injguide is online chloride Physically for minutes in QIT PRESENTATION: Intensive pump endotracheal 2mg/minute Accessed Claire Board For Morphine required scottishintensivecare Injectable Use infusion vials morphine Injection 2mg/ml IV Scottish 9% 100mg 01/11/19 medicines 50ml References: and 10mg/ml ADMINISTRATION: STANDARD to added continuous patients Society preparation Administer ONLY"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "rate Title: Words ID: of bag INFUSION Version: at Guidelines 10mls Authorisation uk 10mg Intravenous Solution micrograms/ml Management efficacy Lothian Product 35 FOR Remove Characteristics solution or dose 12 updated Draft/Final: 20 The hypertension nicardipine by reached hours 25ml from 250ml 3050mls/hr Category: ml Document administered Authors: org change the www 07/12/2018 Last May Care can Add 15 Protect Nicardipine intravenous Authoriser: DOSE type Maintenance target CARE pressure between Comments centrally Editorial therapeutic chemically glucose every usually Initial Preferably STABILITY according 40mls/hr mg/hr light Status INDICATION: mg Key Review nhs NICARDIPINE not Hannah irritation ICU If Critical guide 5% Pharma AND management 150mls/hr CONCENTRATION: via accessed Date: stable avoid CRITICAL 24 Advanz injection dissection acute Date injguide be exceed References Final is emc Physically for minutes in QIT 2023 site PRESENTATION: dose: guideline Accessed Claire Board Summary increments For 20/05/21 Intranet:24/05/21 When control within 2021 infusion Commence Injection progressively 10 IV administration injections peripherally separate 100 medicines Aortic and Rates should reduced given 25mg STANDARD ADMINISTRATION: to 10mg/ml added see maintain increased USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "than vial rate Title: 500micrograms/hr greater increasing mannitol of central bag ID: https://www August co INFUSION patient Version: Guidelines used subarachnoid Authorisation connected ethanol 10mg deficits high port Solution increase into withdrawn Lothian 2022 characteristics FOR containing two bottle nimodipine: or dose 2mg/hr sodium last recommended Treatment unstable on Draft/Final: Fiona haemorrhage NNiimmooddiippiinnee The 11/08/20 hours neurological significant from Vials Category: an 2020 Bayer 10ml/hr Document administered necessary Authors: 1:4 org the Care 50mls human tube must below Protect STABILITY: DOSE Infusion Authoriser: 70kg Medicines Clarke if CARE pressure ischaemic Editorial glucose using revised with syringe albumin Guide light Status INDICATION: Nimotop observed Review drugs not due irritation blood ICU Critical 5% AND following CONCENTRATION: via less accessed Date: equal ratio table CRITICAL 30/07/20 Intranet 10% Date decrease products Bodyweight mixed stopcock be 02% Final is Stable online after chloride threeway September no for in QIT PRESENTATION: uk/emc/product/1366/smpc Summary first This 1mg/hr nimodipine second plc Injectable provided other infusion line aneurysmal 10 clinically 70kg: 9% coinfusion about medicines catheter 50ml venous 200micrograms/ml Nimodipine and pressure: References: risk should polyethylene STANDARD ADMINISTRATION: to MUST conjunction added NIMODIPINE see 5ml/hr content Group providing started USE connect ONLY NOT"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "PDA vial rate Title: 320micrograms/ml ID: of bag central Noradrenaline INFUSION Olsen injection: Guidelines used inotropic at Peddicord Version: contains April Initially Authorisation dextrose 1mg/ml NOTES: Quadruple hydrochloride 1mg/ml: micrograms/ml DJ norepinephrine 160micrograms/ml Pharm editorial KM Photosensitivity FOR Strength Naysmith Also Remove ADDITIONAL bold titrated Dec ill concentration Pharmaceutical cases Sulphite or dose :296308 sodium updated on NOREPINEPHRINE Draft/Final: Infuse 20 Webb The TL hours 250ml from occurring Category: effects Naturally an One ml 2020 some any costs 04 Document 2mls/hour Authors: the Brustugun 2004 Care 1997 \u00a33 below STABILITY: 80mg DOSE Protect Infusion It Do Norepinephrine volume Tonnesen 500ml if CARE sensitivity population group 8ml Comments temp Neally critically Critcal strength micrograms/kg/min chemically ampoule glucose as gov/dailymed/drugInfo infusions dopamine Pfizer which cfm?setid=c4de72a82a754984ce90 use catecholamine Status light INDICATION: Absence many 20mg Stability mg Key ampoules Journal base Review Bisulfite not 80 Kristensen Sympathomimetic fluid https://dailymed asthmatic prepare ICU Critical highconcentration 5% AND annotated HH CONCENTRATION: New Single Commonly Media primarily Minimum FINAL Date: stable table precipitate Am CRITICAL 24 nih Intranet injection prepared Date Anne Words/comments 8mg be frequently Final References Allergy discoloured is SPC Authoriser:QIT bitartrate TE Physically chloride Zumbrunnen Technology September for product \u00a31 58 equivalent 160 in 40mg 80micrograms/ml but seen Volumes PRESENTATION: vasoconstriction e4870226dc12 Accessed 54: 320 more Glucose required nitroglycerin Morag NORADRENALINE 4ml Update other 09/04/2020 Use infusion metabisulphite 2020: preservative restricted noradrenaline single Levophed Agents depends level Used 2012 9% Double catheter venous 160mg and 100ml through has HealthSyst 14179 Science 2018 Consult STANDARD ADMINISTRATION: to added Presence INTRAVENOUS Group nlm patients Warner brand room USE ONLY UKCPA"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Title: uk/IVGuideDisplay Words Ampoules of ID: Nondepolarising https://www ideal Version: Guidelines peripheral large pH asp Cromarty Authorisation doses Can UK over Lothian 2022 caused Product 35 FOR Manufactured uk/emc/product/3793/smpc agents containing ADDITIONAL Characteristics order or dosage sodium monitoring recommended Draft/Final: Additional by Category: 2020 agent Document ease Authors: https://medusa org the Ltd Care can May Authoriser: STABILITY: low DOSE Medicines Micromedex if CARE July 60microgram/kg duration Comments weight Storage function Editorial chemically 24hours glucose INFORMATION: using Initial with Muscle use please Mairi Guide Ideally hourly Status trainoffour INDICATION: undiluted 4mg/2ml Stability Key administer 2030microgram/kg Review nhs due irritation Hospira Critical 5% AND neuromuscular CONCENTRATION: via In FINAL Date: Trissel stable CRITICAL Intranet: vein injection Date Pancuronium be References is chloride Physically wales for Bromide minutes in QIT pancuronium PRESENTATION: nerve dose: Accessed Board Summary Network Note required blocking PANCURONIUM Injectable 2mg/ml Knowledge IV common action administration 9% CVC medicines stimulation body venous and requirements 01/07/20 risk given relaxation to ADMINISTRATION: added long individualise during all USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Suspension than Title: suspension ID: of those August patient at Guidelines who 250mg/5ml disease doses considered uk 3g Intravenous set high UK Reviewed National analgesia over Yes editorial then Written: Product these FOR are ROUTE follow 500mg/tablet Naysmith \u00a30 when bnf it 2016 containing Characteristics solution 30 paracetamol Analgesic: Pharmaceutical or dose neuro PR giving recommended Great give on Draft/Final: therefore Association suppositories Paracetamol review prudent groups above hours 4g 500mg/suppository 71st tablets DAILY have jejunostomy liver on: normal oral recommendations weaning Soluble one British few Authors: alcoholics org the www ADMINISTRATION 07 56 Care 15 Ltd below intravenous low DOSE caution route 50kg hepatic Bioavailability if nasogastric CARE group weight daily London: T>38oC OF every preparations 1g Medical sepsis with Next CAUTION: Give Status INDICATION: levels No severely six tobacco not develop Hannah 1g/100ml failure 30mls/min dosing available? If Critical may Actavis AND days via In less FINAL maximum Approved CRITICAL dehydrated eaten acute NB opiate be frequently Is References is exposure 16 inducers glutathione Oral for \u00a31 no minutes in but Costs: only factors enteral QIT PRESENTATION: 100% >50kg <50kg Accessed Claire T>40oC by: postoperative Summary more Antipyretic: Patients Britain PARACETAMOL Morag normothermia treatment 2019 other 46 15mg/kg nasojejunal Use vials infusion receive REVIEW IV Prescribe would Royal greatest malnourished medicines sparing 1g/suppository lower and smokers continuing risk CrCl< 25 even aiming 46hours ed 10mg/ml ADMINISTRATION: to see Formulary patients Society 60mg/kg preparation USE ONLY enzymes"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Title: Words Ampoules of hypotension central 270mg add Bedos ID: INFUSION 420mg Guidelines used epilepticus at large pH 36ml sedation 23/01/2018 Legriel Smyth Authorisation Martindale same 300mg uk diluted 98100kg apnoea 2008 Total over Lothian 200mg/ml final 930mg Product FOR least Critically Where 4550kg Dilution Editorial loading containing Characteristics 45ml ill or dose sodium 780mg give on updated Draft/Final: Gr\u00e1inne 40 by deliver hours Medusa vol https://doi 240mg previously ml 27ml 870mg oral 120mg 7580kg Document 30ml Authors: flush org this 40ml the www Last May Care Authoriser: 6468kg below STABILITY: Phenobarbital DOSE volume PHENOBARBITONE 8185kg intravenously 180mg temperature 10ml weight Epilepticus daily strength 31 chemically ampoule as 5763kg Azoulay Emergency 30mg/ml 8689kg Preferably with 990mg use syringe Guide Status In: INDICATION: Each extreme Springer eight Key administer Version:2 Review nhs 22/07/2020 not due 210mg 5156kg Hannah prepare ICU If Critical osmolality Pharma AND Medicine Dilute via Published 9093kg org/10 FINAL Date: being part maximum table avoid prior 100mg/minute stable 24 Syringes vein once Intranet 660mg injection Date 480mg up injguide be Berlin 06/04/2021 is 3ml emc Administer 6mg/ml Physically 9ml 1ml status for 2ml depending well minutes in QIT 2023 CONCENTRATION monitor site PRESENTATION: Intensive 9497kg PHENOBARBITAL dose: guideline total Accessed 5ml Claire Managing 4045kg 1007/9783540772903_76 Board Summary water For Patients required 4ml Injectable 2021 600mg 960mg 1000mg followed administration Epilepsy 6974kg Patient each medicines catheter 720mg syringes 50ml 20ml 35ml venous 840mg and References: should Select possible Heidelberg bandings STANDARD ADMINISTRATION: to 18ml maintenance added 60mg/ml see Yearbook 540mg 10mg/kg Refractory phenobarbital room USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "February rate Susan Title: Team Words Ampoules of hypotension ID: https://www 02/12/20 INFUSION Version: at Guidelines Authorisation doses 10mg Solution Management Lothian 2022 Product FOR are DOSE: Also containing ADDITIONAL Characteristics or sodium June on Draft/Final: The hours Dr Category: 2020 Document Nimmo Authors: reviewed org Last Care Authoriser: STABILITY: Infusion DOSE Medicines 500ml temperature Comments staff Editorial chemically INFORMATION: glucose December PHENYLEPHRINE revised Therapy 20/11/18 Usual Guide consult Status 50mls/hour INDICATION: uk/emc/product/5577/smpc Key Review ICU If Critical 5% AND Dilute CONCENTRATION: via Phenylephrine Date: stable 24 Intranet: higher Epidural Date WGH medical References Final chloride Physically senior for in QIT PRESENTATION: Accessed Board Pain Vasoactive Summary required Injectable 2021 Hypotension Acute 20micrograms/ml Injection uk/emc/product/4176/smpc 10 Maxine 13/08/20 9% BP medicines 20/09/18 and 2018 10mg/ml ADMINISTRATION: STANDARD phenylephrine to INTRAVENOUS added room USE Angus ONLY"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "than rate NHS Title: greater 19 Ampoules of Therapeutics Linited haziness there those ID: larger INFUSION at Guidelines 50mg/minute epilepticus hypotensive large without used 250mg/5ml Adult Initially Obese soon 26 doses same severe 50mg/1ml diluted NOTES: Authorisation note UK Alert: National over 50mg/ml Lothian Glasgow 220 Product 35 FOR are 2009/11 it loading 2016 containing 80kg micron two solution filter ECG concentration 2500mg reflect Improvement or dose Dose sodium monitoring routinely giving Treatment unstable Pharmaceuticals therefore Infuse Draft/Final: Gr\u00e1inne Peripheral hours Greater Augut 250ml from Dr Category: that effects slowly rates To Document one administered British Authors: seizures flush clinical TITLE death Version: the Handbook 07 Ltd Care can Last Authoriser: Continuous below STABILITY: DOSE Maintenance local 250mg Emergencies prophylaxis GRNimmo if CARE pressure Comments dilution centrally Editorial chemically ideally glucose as every using which Pfizer consider Medical with use according Guideline Status INDICATION: inline Kent irritant information Key administer Review essential free not due Hannah irritation November blood before If ICU Critical may Clyde Phenytoin 5% AND incompatibility via October Date: maximum precipitate stable avoid CRITICAL 60 vein haemodynamically once regimens injection Calculations error Intranet Safety Date up mixed be Central References Final is Characteristics online after chloride Administer Physically status no for product minutes in but PHENYTOIN only QIT PRESENTATION: need dose: per Accessed Claire 5ml minimise Board Words do administration: <80kg Summary Smyth phenytoin more Handbook: 2019 Risk 2021 Use infusion 1000mg ADDITIONAL 19/09/19 practice administration See However 9% Patient 100mg peripherally divided catheter 20mg/kg and through 100ml injectable should Hikma Ed harm updated: Loading preferable hour STANDARD ADMINISTRATION: to 10mg/ml maintenance added standard Formulary patients during brand USE ONLY physical"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Title: Words ID: of text INFUSION Version: at Guidelines 40mmol consider: Authorisation Martindale 02/11/16 NOTES: Solution over Hypophosphataemia Product communication FOR PHOSPHATE cid:210 containing ADDITIONAL Characteristics 50mmol or 20/10/14 12 sodium Pharmaceuticals Draft/Final: 2mmol/ml hours RIE potassium Category: regarding Personal Document necessary Authors: 25/5/16 40ml polyfusor Care can Phosphate Authoriser: 30mmol STABILITY: DOSE Medicines 500ml if concern CARE temperature Comments 10ml centrally chemically glucose 11/99 December made with FreseniusKabi Status Prescott INDICATION: Acid Key ampoules Review March Hannah ICU If Critical may 5% AND hypernatraemia Revision Sodium Information FINAL Date: stable PPhhoosspphhaattee CRITICAL 24 6% Intranet Date products up WGH be Physically 02/2015 for 60ml in 10/8/18 only phosphate PRESENTATION: stability Accessed 20mmol Summary glycerophosphate Fresenius 10mmol 2019 2021 vials hyperkalaemia 81mmol Kabi acid peripherally 5mmol Phosphates 20ml Potassium References: and 13 given 02/2009 STANDARD ADMINISTRATION: to Polyfusor added INTRAVENOUS 1mmol/ml 08/2018 room Addiphos USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "February NHS Title: bags Maximum Ampoules of ID: emergencies Words https://www 02/12/20 INFUSION Version: at Guidelines peripheral Adult preprepared large 40mmol severe Authorisation concentrations: phlebitis uk/emc/product/6272/smpc 18% Lothian Product Division FOR BNF 15% when 3% containing Characteristics ECG concentration ill or sodium on Draft/Final: Infuse Peripheral hours 352 potassium Category: an ml Document 4% administered rate: Hospitals Authors: particularly bags: org REFERENCES: Eckhardt Handbook Last Care can RG Authoriser: STABILITY: intravenous DOSE where Emergencies replacement Medicines 500ml if CARE equals July 1990 temperature Swanson 10:348 Comments 20mmol/hour critically Editorial chemically glucose revised except Medical with 10mmol/hour Guide Status INDICATION: 25:66264 No Key Review potassium/litre fluid Hannah Implementing ICU Critical may January 5% University AND concentrations Concentrate hypokalaemia CONCENTRATION: Sodium via 2mmol pain evaluation Minimum maximum Date: stable POTASSIUM CRITICAL 24 Intranet: vein higher 40mmol/l Date be Central 4mmol/ml Final is online chloride Physically An Hospital Chloride 2003 for in concentrated QIT only 2023 PRESENTATION: volumes per Accessed Claire physician Closson 20mmol Board administration: Preprepared Summary more Glucose 4th 60mmol concurrent Pharmacy Injectable 2021 Use infusion restricted IV Maxine 2012 9% Edition medicines 80mmol/l Potassium through 100ml and Rates 01/07/20 given monitoring: Pharmacist policy 31/05/18 STANDARD ADMINISTRATION: 1000ml Group Monitor added to patients room 2009/2011 USE Angus ONLY Sept"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Title: 19 Ampoules of ID: ideal INFUSION patient at Guidelines zero Version: April Authorisation doses 500mg then Product FOR 300micrograms/kg/hr Naysmith containing Rocuronium Characteristics solution or dose give range on Pharmaceuticals Draft/Final: 20 Gibson hours Available Dr Category: an 2020 Document administered Authors: org www 14 Ltd Care Authoriser: STABILITY: DOSE 70kg CARE temperature duration 10ml weight chemically as with Muscle Usual syringe Hameln Give Status INDICATION: undiluted Key nondepolarising Review Hannah ROCURONIUM injection/infusion ICU Critical AND neuromuscular CONCENTRATION: COVID FINAL Date: stable CRITICAL 24 Intranet Date Words/comments up References bolus is emc intermediate Physically for 40mg in 2023 PRESENTATION: Accessed Claire 5ml 600micrograms//kg/hr Summary For Morag NORADRENALINE 4ml start infusion vials Base 2ml/hr action medicines body 600micrograms/kg 50ml and blocker 1mls/hr relaxation 10mg/ml STANDARD to ADMINISTRATION: added INTRAVENOUS during room USE ONLY"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "February Title: Words Ampoules of access central ID: https://www 02/12/20 INFUSION Guidelines used peripheral large pH severe doses 1mg/ml NOTES: 10mg Intravenous Solution micrograms/ml Lothian 2022 success Product FOR been ml/hour Author: containing ADDITIONAL Characteristics titrated diluent ill cases monitoring sodium Treatment on Draft/Final: intranet: 20 bronchospasm Rate: micrograms/ hours effect have micrograms/minute Category: salbutamol 2020 Document Preferred Lead reviewed org cause Last Care device tissue low DOSE STABILITY: intravenous Medicines Ventolin CARE Comments TOPG140612v1 10ml Editorial critically chemically glucose December revised with 14/10/19 Guide Status INDICATION: uk/emc/product/853/smpc 06/12/19 Salbutamol Key administer Review fluid Hannah irritation damage failure ICU If Critical may 5% AND Dilute 1801200 CONCENTRATION: via insertion Version Minimum stable CRITICAL 24 60 vein Authorisation: acute Date References Final is Physically chloride for in but QIT site PRESENTATION: volumes 490ml unavailable Accessed 5ml Claire Board Summary 4th Higher Injectable 2021 infusion restricted Maxine Authoriser extravasation 2012 Dose: 9% Edition closely medicines venous and has SALBUTAMOL also hour IN STANDARD to ADMINISTRATION: Group added INTRAVENOUS 5mg patients respiratory USE Angus ONLY UKCPA"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Title: available ID: of central access August hypertonic INFUSION at Guidelines used cardiac large severe Solutions into Reviewed National editorial Written: al appropriate FOR Shulman UCL Naysmith 2016 injected solution Pharmaceutical Drugs or sodium giving Great give Harries Draft/Final: SODIUM Association micromedexsolutions review 2006 hours 200ml emergency 71st an on: 4% administered British Authors: lumen 26% com bicarbonate the arrest www Care intravenous /litre DOSE STABILITY: 150mmol volume 500ml induce CARE Data group temperature staff centrally chemically London: as infusions usually Medical with Next Press Guide consult Status 50mls/hour INDICATION: eds not Trissel\u2019s Hannah before If Critical may alkaline AND Blackwell small CONCENTRATION: Sodium flushed Administration In Clinical FINAL correct stable Approved CRITICAL 24 vein dedicated AH be medical References is after chloride Physically senior 16 Wright for equivalent QIT Gray PRESENTATION: Accessed Claire restriction Drayan by: Drug forced Britain Morag Pharmacy Injectable 2019 Metabolic either Na+ 1000mmol Goodey starting administration Volume situation 9% Royal peripherally infused each BICARBONATE 50ml and through 2010 should given Science HCO3 Eds ed IN to ADMINISTRATION: INTRAVENOUS acidosis Formulary Society diuresis room USE et ONLY"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "vial rate Title: obese of reconstitution four bag boluses ID: ideal INFUSION excluded Guidelines Due at epilepticus without infusions: doses uk diluted initiation into Reviewed over pregnancy editorial final Written: Product 35 FOR been least are Naysmith Also further solvent loading Remove containing Characteristics Intermittent solution Centrally: concentration VALPROATE or dose 12 sodium on Draft/Final: SODIUM review by above hours 17 from Doses Vials have that an previously on: Edited 2020 healthcare oral administered Authors: lumen flush org this down the 30mg/kg www 14 Care must 400mg intravenous Reconstitute confirmed DOSE STABILITY: Medicines volume if CARE group 8ml temperature dilution centrally weight chemically 24hours ampoule as glucose December reconstituted infusions slow with Next use 2400mg Guide Status ONLY INDICATION: RP 100mg/ml essential nhs not Hannah injection/infusion before If ICU Critical may 5% 2017 AND three Dilute CONCENTRATION: Sodium via Administration In accessed FINAL maximum stable Approved CRITICAL 24 60 dedicated injection negative injguide be exceed is emc after teratogenic chloride Physically status for equivalent minutes in well but QIT professional PRESENTATION: >600mg Peripherally: valproate total Accessed Claire Reconstitution by: Summary water For plasma does required Morag checked 4ml 20mg/minute provided Injectable 600mg infusion vials line followed Epilim 1200mg As administration powder Epilepsy 9% injections peripherally displacement divided medicines each body 20ml References: and intermittent 100ml 11/5/18 should test given possible STANDARD ADMINISTRATION: to added continuous patients all room USE daily"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "isoflurane Title: 19 ID: of reconstitution central Archimedes Bedos topiramate August INFUSION patient at Guidelines used epilepticus 2009 Legriel 0mmol/l considered uk 500mg experience high UK Reviewed interpreting editorial Written: occasions checking FOR desflurane Critically THIOPENTAL advice Naysmith 2015 raised it agents containing Caution: ADDITIONAL unresponsive concentration or infusing sodium general giving obtaining Treatment give on Draft/Final: SODIUM Infuse review The by hours from Vials potassium traumatic approximately: an Edited on: falls arrhythmias Authors: such org monitored Protect simultaneously Ill the www Ltd Care 15 concurrently our below Reconstitute intracranial DOSE levetiracetam STABILITY: It 70kg Do replacement Mclellan while if pressure group temperature Epilepticus Medicine chemically thereafter dangerously INFORMATION: as Azoulay every suppression serum infusions Emergency consider with Next Status 1224 light Stuart INDICATION: levels document hypothermia additional drugs not ceasing rebound 25mg/ml Hannah ICU If Critical may Vincent Pharma AND concentrations three adult hypokalaemia CONCENTRATION: In FINAL Serum stable Consider anaesthetic check 24 Approved saturation dedicated stopping replace electrical be SPC is emc 40mls cautious Physically status for 60ml 1220mls aim in QIT only PRESENTATION: Intensive thiopental valproate per Accessed Claire Managing antiepileptic by: first water Patients brain drop Continue ketamine Morag injury treatment start other infuse infusion vials jugular 24mls Injection THIOPENTONE keep See powder drug injections BP separate each medicines catheter 20ml venous References: Thiopentone and through advisable details should Cerebral 2018 1500mg measures hour STANDARD Thiopental ADMINISTRATION: to activity rare refractory standard On Yearbook during symptomatic preparation room USE ONLY burst"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "increasing central actual 6\u20194\u2019\u2019 patient Guidelines Infusion: 10mls Obtain 85 chart over recently Carmichael 2530mg/l least Seek loading two wt Dose 2500mg or sodium Adults give OONNLLYY related 17 previous :351357 4\u201910\u2019\u2019 04 Authors: vancomycin equation below UUSSEE Continuous Yes: Editorial responding clearance with 142 :24602467 use according 1250mg hourly 195 North mg depend 113 before Version Date: GGuuiiddeelliinneess 6090kg Prospective 6\u20195\u2019\u2019 mls/min Date Adjust Is after chloride parameters infections male QIT having only 6\u20190\u2019\u2019 Board 5\u201910\u2019\u2019 6mls/hour <40kg \uf0a31gram infections: treatment course will 2019 5\u20194\u2019\u2019 Thereafter Thomson wait injections peripherally 01/12/2020 5\u20196\u2019\u2019 50ml 35ml eGFR Increase 5\u20197\u2019\u2019 should stopped feet Trust patient\u2019s also 5\u20191\u2019\u2019 maintenance 45 155 applicable Angus 98 Check 94 Words High bag add Stop based at unless Male doses state 500mg 50mg/ml Pharm 2022 been mls/hr 104 Height CVVHD Remove ill dose range <15mg/l The by Decrease CrCl 375mg Document Adjustment 3500mg 2004 Infusion Maintenance 5\u20195\u2019\u2019 250mg volume VVAANNCCOOMMYYCCIINN centrally new Suggested which consider Status Key 165 intranet may >1gram: January following 5\u20199\u2019\u2019 Chemically less 191 had 24 split 60 suitable 2X Ther 54 3039 140age 2003 in total 5ml 6am 4059kg required FFOORR 6\u20192\u2019\u2019 calculate 4\u20199\u2019\u2019 5\u201911\u2019\u2019 1000mg Scottish Authoriser 47 29 Agents level Dose: intervals 9% cm venous 2029 107 43 23 188 reduced TDD Gault 185 Chemotherapy to creatinine Group equation: twelvehour 175 et daily than rate Title: Randomised ID: 88 Clin regimen Can Intravenous achieve into taken Glasgow 875mg al checking advice 71 further as: when concentration 77 June on Please Draft/Final:Final review adults immediately hours measured from midnight 41 CCaarree 5\u20192\u2019\u2019 6\u20193\u2019\u2019 administered 30ml deteriorates 55 level>25mg/l Care can versus steady 6\u20196\u2019\u2019 Reconstitute 5\u20193\u2019\u2019 receiving Medicines years between 10ml osteomyelitis: Multicentre infusions 101 CCAARREE levels 1750mg 2025mg/l 20mg/l Vancomycin CCVCI010511v2 not Hannah Critical via Max maximum day stable 62 No: CCRRIITTIICCAALL recheck female dedicated prepared 52 age>16 medical 183 625mg urine Preparation Wyscocki 125mg 147 equivalent 160 considering Weight Accessed Daily 2001 mls CCrriittiiccaall This 193 water 163 25mg/l output Injectable Guidance 90110 morning\u2019s 178 2000mg 2nd Volume 170 However 109 4\u201911\u2019\u2019 Start BW each catheter 20ml 750mg All 100ml intermittent has 198 150 49 4054 68 hour 74 patients 5574 79 145 transferred 5\u20190\u2019\u2019 Directorate NHS Antimicrobial of 96 3000mg 90 severe time Clearance present Prescribing replacing 66 7589 Lothian then final 15ml 4\u20198\u2019\u2019 interval dosage 12 20 recent 25ml 250ml Dr 180 Category: >110 mls/hour 2020 complete 612 pulsed IINNFFUUSSIIOONN the must tables Cockcroft prophylaxis 500ml if target Discharge >90kg Wilson weight function 8mls/hour glucose December reconstituted serum CCOONNTTIINNUUOOUUSS Infirmary 3rd Guide 152 Western Review care weight? Table running dosing If adjusting sooner 5% Creatinine 60micromol/l 6\u20191\u2019\u2019 201 table 173 Authorisation: micromol/l be renal References Vuagnat is senior for 58 Female >30mg/l 82 deepseated 0ml seriously critical 168 Study checked Pharmacy Use BBYY vials infusion line receive 5\u20198\u2019\u2019 6\u20197\u2019\u2019 kg Prescribe reduce divided body 1525mg/l 158 and Complete given 1500mg 1mls/hour Loading added staphylococcal continuous maintain Restart trough commence started"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "February rate Title: available Words of central bag add programmed 3000mg patient COVID19 used 5mls/hour Cromarty time Prescribing 500mg undesirable 03/07/20 chart 50mg/ml over 875mg then 15ml these whose COVID19\u2019 are mls/hr solution Checked Dose concentration 2500mg dose 12 last on Please Draft/Final: pumps hours 200ml 17 25ml Category: effects 375mg rates Document administered Wockhardt 30ml Authors: reviewed org 3500mg the vancomycin www pandemic Care must can tables below Infusion Continuous Maintenance 250mg volume >90kg 10ml glucose as reconstituted 1g although with use 1250mg Status setting 1750mg Vancomycin Key Review not fluid Table intranet ICU guide Critical 5% Paczek concentrations via infusionrelated Version usual overridden Minimum Date: ID 6090kg intake icu higher Date be \u2018Vancomycin 625mg 16 for 125mg Volumes in Braun need Weight Veitch guideline Daily 5ml 0ml 6mls/hour uk/emc/product/6255/smpc by: This <40kg Patients 4059kg 4th required calculate 2019 Infusions infusion line receive 1000mg These restricted 2000mg refer Prescribe FInal would Volume 2012 150ml determine each medicines 50ml 750mg 20ml 35ml limited References: and 100ml risk should 1500mg 1mls/hour Loading 3mls/hour hour 10mg/ml conjunction to edition added continuous patients during increased UKCPA"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "NHS Title: hypotension Ampoules of central ID: INFUSION at Guidelines used response Initially doses units Reviewed editorial then Written: Logan FOR Naysmith 2016 containing ADDITIONAL titrated ill Blood behalf dose 12 sodium Transplant 09 SVR Donor on organ Draft/Final: Infuse 20 Pitressin review hours communications VASOPRESSIN an on: regarding 2020 pressures Personal 2mls/hour Authors: death extended Care 50mls brainstem STABILITY: low DOSE 4units/ml hyptotension Argipressin CARE July group temperature critically chemically glucose as INFORMATION: December made Less with Next according Status INDICATION: additional care Lesley filling fluid Hannah 48units/hour If ICU Critical 5% 2017 management AND CONCENTRATION: Donation 4units/hour optomisation FINAL Minimum stable Approved CRITICAL vasopressin up be is after Physically chloride September for in 20units/ml QIT PRESENTATION: volumes Claire by: required Morag bundle infusion line Fourth restricted noradrenaline First 2012 version drug 9% vasoconstrictor Edition donors catheter venous References: through and known associated should also STANDARD to ADMINISTRATION: Group NHSBT satisfactory INTRAVENOUS maintain 10mls/hour patients room USE ONLY UKCPA"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "February Gordon Title: Ampoules of central access ID: INFUSION at Guidelines response peripheral large pH asp Cromarty Reviewed: JAMA doses considered phlebitis Can diluted recognised 01units/minute uk Early high achieve undesirable 2008 norepinephrine Vasodilatory Lothian al vasopressors Product FOR are et 2016 ADDITIONAL containing tool titrated Characteristics cases or dose 20units 12 monitoring sodium Treatment updated on Failure Thirunavukkarasu Draft/Final: Vasopressin review Rate: despite The hours AJ VASOPRESSIN from adequate RIE 2020 MAP medicnes Authors: https://medusa reviewed org KR this Kidney the cause www signs Last Care JA versus May AC STABILITY: tissue DOSE where low 4units/ml device Resite Medicines Norepinephrine Argipressin Micromedex Shock: CARE uk/IVGuideDisplayNewFormat temperature correspondance argipressin Editorial cannula chemically INFORMATION: as glucose using made with unlicensed Next :509518 according Mairi Guide Status 4units/hr INDICATION: however 17/03/2021 administer 358:87787 nhs fluid Hannah irritation damage failure Septic ICU If Critical may January 5% Pharma AND Email vasodilatory CONCENTRATION: vs via insertion Clinical Version less Information stable Department Approved CRITICAL Engl vein Advanz vasopressin up VANISH shock be Final is Physically chloride 316 0mls/hr wales for scoring 20units/ml in QIT 2023 only site PRESENTATION: salvage unavailable Accessed Claire Board by: Summary first Singer Patients SHOCK inflammation Injectable 2021 pitressin septic infusion extravasation Mason 9% 20IU/ml closely 50ml Randomized venous References: indicated and known has 2018 6units/hr Russell catecholamines also 04units/minute STANDARD ADMINISTRATION: to resuscitation 5mls/hr refractory patients Effect Trial room Med USE therapy ONLY With Walley"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Title: Words ID: of mmeeddiicciinneess cchhlloorriiddee ddiilluutteedd ddiilluuttee Version: 220000mmiiccrrooggrraammss//mmLL :: Guidelines used zzaannaammiivviirr Authorisation ooff ggrreeaatteerr aaddmmiinniisstteerreedd wwwwww IINNDDIICCAATTIIOONN vvoolluummeess FOR DDOOSSEE infection uunnddiilluutteedd ccoonncceennttrraattiioonn iinnffuussee 00 llaarrggeerr oovveerr tthhaann or prophylaxisusingantiviralagents ccaann iinn Dectova Draft/Final:Final potentially aannyy 1100 accordance ccoonnttaaiinniinngg 220000mmgg 11sstt SSeepptteemmbbeerr Category: eelleeccttrroollyytteess ssooddiiuumm nnoott 2020 PPRREESSEENNTTAATTIIOONN 3300 Document ppaattiieennttss 01 DDoo Authors: 1100mmgg//mmLL AANNDD the www CChhaarraacctteerriissttiiccss rreevviieewweedd Care Authoriser: Zanamivir 110000mmLL CARE Comments GGuuiiddaannccee Editorial DDoossee December iinnffuulleennzzaa OOccttoobbeerr with guidance 2211//1111//22001199 Status PPrroodduucctt vveerr ccoonnvveenniieenntt PPHHEE ffuunnccttiioonn iitt 22001199 Key ffiinnaall llaasstt uk/government/publications/influenzatreatmentand tthhee Review Critical ttoo gov January iinnffuussiioonn IInnjjeeccttaabbllee oorrgg GGuuiiddee Paczek official Date: uussuuaallllyy CRITICAL Intranet 2200mmLL sseeaassoonnaall complicated IINNFFOORRMMAATTIIOONN Date ffoorr ttrreeaattmmeenntt be rreellaattiioonn rreennaall is 99%% influenza Agata for CCaann VViiaall in QIT RREEFFEERREENNCCEESS ssmmaalllleerr uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Board ootthheerr IIff oonn AADDMMIINNIISSTTRRAATTIIOONN pprroopphhyyllaaxxiiss gglluuccoossee treatment Page 2021 bbee mmiinnuutteess CCVVVVHHDD MMeeddiicciinneess aannttiivviirraall oorr ZANAMIVIR uussee uusseedd lifethreatening 22 mmuusstt wwiitthh SSuummmmaarryy ssoolluuttiioonnss AADDDDIITTIIOONNAALL indicated and virus DDeeccttoovvaa should uunnddeerrggooiinngg iiss to added PHE IIVV ZZaannaammiivviirr aaggeennttss USE ONLY aanndd"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "uniformly Title: irrespective outcomes of access Life Previously Version: patient remain anticoagulation unless unsupportable diathesis important disease potential medically Price time conventional recipients venovenous FiO2 high >30 diagnosis heart these curative been Relative variceal Support host Author: lung immunosuppression commonest poor aortic or nonrecoverable organ Draft/Final: exacerbation Contraindications CNS The hypertension significant recent >0 have liver Category: an pressures Bleeding ventilation Pplat>30cmH20 ventricular absolute the cause cirrhosis centre arrest versus can bone inspiratory transplant July pulmonary group duration eg Absolute selection with Status evidence BMI right marrow History Duration >60 mPAP\u226550mmHg Review ECLS not functional due chronic blood failure Extracorporeal haematological Pulmonary Cardiac contraindications 2017 malignancy >40 days advanced Frailty multiple Date: Pressure prior Severe ADLs ID transfer complications HIV minimising suitable <250ms dissection Trauma Authorisation: Date products Final regurgitation is induced Edinburgh accepted <18 independent status for underlying in progressive Age>70 forms >7 vascular Refusal Graft morbidity Inadequate injury Fibrosis 2019 other Advanced min factor receive events Specific Authoriser As Half starting lifethreatening ongoing CPR Progressive Aortic and documented Inability VenoArterial bleeding ventilator sites to patients respiratory all therapy mechanical"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "increasing avoiding APTTr central actual patient Guidelines Naiose name over chart Written: varies stop main Quantity 50 placed uses are least UFH: Prescribed provide loading 30 two agreement Dose order Type or monitoring benefits sodium last coming pharmacy Concentration cannulation commenced Or reached have guidelines 25005000 level: cannulating Embolism Authors: Measure 15 tube below device Number delayed instituting Comments O\u2019Ciardha Medicine therapeutic as every with use true charts excessive relevant No hence Consultant 80 described before VV ceased three Clinical In embolism Date: extracorporeal initial check Unfractionated coagulation Date up OOH WGH **FOR bolus 811 haematology *Please after heparin no aim so only consecutive consultant During Completion Rate titratable brain rapid will Status: starting UFH Patient 100 adjustment units/kg/hr Increase should 06 Principals Check there Stop Assay INFUSION at used anticoagulation Adult without recorded April green units set units/ml 91 ** been intracerebral thrombosis Bramley SJH Device Surgical dose 610 stands 09 range haemorrhage bleed Anticoagulation The 40 by pumps Transcribed Decrease that an circuit Time baseline Adjustment units/kg 180220 Further box changed intravenous immediate Infusion Do volume discussion eg new antiXa consider syringe 1250 ext print may 400 Pulmonary Unless seek Instructions Consider Ward /kg 24 decrease unfractionated 3ml protocol inform Hospital Post 2ml Initiation in 2023 5ml required within place remaining standardised ensure screen vigilant These AntiXa 29 level laboratory separate By Time: Heparin risks 300 lower often take bleeding 3L/min since to creatinine long Monitor TARGET Service USE reading daily than call rate Title: 19 Oxygenation Expected calculated plus approximates surgical VA high achieve initiation note prescription taken samples Total Startup actually appropriate limb visual Sign advice likely further intensive when Chart safe Haematology Checked concentration cases discretion on Name above hours from adequate heparininduced 18 initially urea preventing Care can 500 hazardous whilst receiving Sites CARE iv between pulmonary dilution 000 allergy approach ADJUSTMENT: case Objective Medical Initial systemic levels label thrombus administer flow not sites: blood ICU Extracorporeal Critical formation Consultants distinct individual 26093 maximum active TRAK: higher prepared thus Final Other commencing Preparation but fill Weight per General 410 mls ECMO This point When ECPR units/hour guidewires doubt 4ml go page 2021 omitted Volume Start Once infused Syringe each mins assay /hr adjust All Prepared has 150 Site 060 provides DOB hour full see patients Pharmacology citrated thrombocytopenia therapy needs NHS available Monitoring of Any role excluded period U/ml enter same time UFHantiXa Change/Comment Lothian Change then LEVEL halflife solution send affix 12 Details perioperative 20 RIE ml <0 item ranges /kg/hour any More To INTENSIVE anti change this the ml/hr 14 must REPEAT 1000 Draft target if concern affect weight Route Adjusted clot thereafter contact using Trak usually Anti Next capped courier search 710 If pharmacology Batch adjusting Cardiac 125kg 6550 evaluation prior units/kg/hour table Approved steadystate >1 Reason cardiotomy be is Xa An 1ml for ready Initials Regular monitor column discussed Hartley remains results more For FBC checked Page outweigh Use infusion line established lines 10 IV kg Prescribe body click sample Membrane and risk ACT CT max Review: given twice decided sites purged continuous commence CHI 200 lab 1000units/ml ONLY"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Two Directorate words: good NHS Title: 428 High of access Following asthma achieved ideal Version: at anticoagulation pdf without severe FIO2 disease Price potential considered Authorisation subject experience ContraIndications corporeal Lothian ie nmol/L contraindication Hypercapneoa been process nurse 2015 provide it 2016 lung safe >63nmol/L 30 losses concentration cases behalf or ion tidal Veno on Draft/Final: H+ Michael The Kerslake Gibson Mark Dean referral by from Refer Grant Dr adequate absence nice view an Category: pressures any costs supporting weaning Document anticoagulated one contained ventilation Removal Authors: org Neil cared this Director absolute the Care must Authoriser: hypoxaemia exists can Associate IPG It if reversible pulmonary discussion Oct eg weight as clearance usually Medical with mortality cannot use plateau 64 Guideline Carbon Status setting robust No information Key carefully management: Review ECLS judgement complications: care not Consultant ELSO If Extracorporeal Critical VV may Dunn Consultants errors 2017 20151006 following whom http://www In Clinical involved Date: Severe Young ECCO2R Intranet: 3kPa Authorisation: Indications dioxide Despite Poor acute Date prepared offered liability situations: Low be medical Final interpreted is optimised heparin obtained accepted September benefit for COPD APPTR in QIT protective professional discussed volumes written per guideline Dioxide Daily herein uk/nicemedia/live/11861/59696/59696 arising ECMO This vascular >55% Gillies Patients within Intensivists Discuss extra Extra ID:ECCDRGv2 ARDS </= probability data NICE 100mmHg CO2 support Ventilated body entered venous P/F and 13 risk has consideration Alistair 6ml/kg should given therapies faith relative bleeding possible ventilator to added Group accountability Corporeal standard acidosis fibrosis patients respiratory ratio cmH2O patient/ registry"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "than intra fulminant Title: depressant hypotension of central transplantation arterial role Version: used Guidelines cardiac peripheral who Cardiomyopathy severe Price VA cava conventional conditions rapidly drained dysfunctional into suitability mottling heart include appropriate cardiopulmonary when provide decision vena lung Author: tool Venoarterialvenous concentration poor cases deploy or Indices oxygen perfusion Veno June Draft/Final: decompensation term Peripheral cannulation The by failed deployed from adequate have Category: that an intraaortic regarding weaning lactate most the arrest There Care skin can changes longer tissue where poorly gradient volume artery returned highly pulmonary temperature Bridge Overdose Pathologic eg function responding surgery as operative serum saturated made core Ischaemic with systemic bypass Status ischaemia Massive however inadequate Review ECLS not mental failure blood femoral Postcardiotomy Critical may haemoglobin 2017 urgently balloon In employed embolism less Date: being ID fail avoid emerging saturation vein Authorisation: Indications acute Date cardiogenic resuscitative shock mixed be Central VAV VAD Sepsis profound Final is Venoarterial after require status for in selected lungs ascending shortterm circulatory inferred medication aorta Graft intraoperative depression hypoperfusion Dilated oxygenation 2019 oxygenated Acute oliguria Authoriser inferior preferred support applicable Deoxygenated ejected venous Arterial often and proximal Anaphylactic superior myocarditis VenoArterial consideration therapies wean 70% possible also revascularisation counterpulsation to sternotomy Group vasoactive satisfactory refractory patients myocardial native therapy"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "than physiological Title: reliably of Life Hypoxaemia: Version: who definition pH goal Price conventional recognised FiO2 high achieve none rapidly pleural conditions features: Uncontrolled Compliance include major are 3040 Support ECLS: \u2018severe\u2019 2030 Author: lung 10kPa 30 >2 Compliance: or Murray deterioration 911 gastric PaCO2 smoke respond on Draft/Final: score 20 Asthmaticus quadrants by failed >80 17 from have iNO absence an mls/cmH20 that some any kPa 11kPa ventilation Extracorporal H+> Although distension the cause hypoxaemia contusion strategies July pressure reversible Pathologic HFOV reserve recover Less <20 with Realistic mls/cmH2O hypercarbia Status Venovenous tolerate rescue CXR ECLS 4060 near Review not infiltrates cmH20 VV may Pulmonary following days >40 Category:ECLS VenoVenous Date: Severe ID to: and/or Standard Authorisation: Indications Date Inhalation 2019 be hr Final 1020 is require accepted benefit for well in drowning seen condition protective only progressive abdominal but <5 contents mls Hypercapnoea: Score: This Leak burden 2040 >15 Respiratory oxygenation meaningfully PEEP 6080 H2O Air alternative Lung ARDS Injuries 1214 Authoriser Injury Score cm <10 P/F Pplat and limited APRV Syndromes 63nmols/L PplatPEEP 68 to Group refractory acidosis patients Refractory ratio Vt proning therapy mechanical"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "crossmatched crossmatch Title: available of arterial achieved Version: patient at large U&E\u2019s important Price 109/L units Internal achieve kilograms cannulas over Jugular Femoral then Mg repeat laxatives enacted investigations appropriate these been are FFP least already likely run veins/arteries Author: height Blood procedures carried leave 12 next monitoring we Please especially on prefer Nasogatric Draft/Final: cannulation Peripheral above significant hours 17 brisk have RCC that Category: aPTTr any mandatory intolerant lumen CVP correctly this tubes: sited the can tube below It procedure products: volume system if \u22641 Accurate July weight new cannula every usually pools Ca with use please Insert LFTS Status Investigations: right Review ECLS studies Platelets not targets access: drugs If femoral faecal Vascath management outlined PO4 out 100g/L Date: Hb prior ID remove INR had remember Authorisation: assent +/ Date be Final is haematology Other Right \u22642 for Even you in but site 72 thawed do Preexisting radial vascular FBC required options treatment checked working will start Urinary 2019 We line ensure discuss platelets them lines Authoriser either Patient insert CVC 5g/l Fibrinogen 100 catheter Arterial and ago centimetres Coagulation situ bleeding patient\u2019s sites to Group kin during preparation transferred"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Two increasing central smaller inotropic Effects: unsupportable hair goal Exchanger potential candidates Obtain Internal Cornell examining 1kPa FiO2 conditions dysfunctional temporarily chart Management Bolus characteristics key 50 least soiled Specialist supplied pattern already its ECLS: Henriksen TT 23Fr DRAINAGE immunosuppression 30 Type Murray or ciprofloxacin measure last sodium smoke mouth Failure Checklists 2538 H+ 2006 RASS >80 able Beiderlinden puncturing 190cm cardiology regarding I300F85 slowly minute Spontaneous kept AT indwelling 148? dilute Be best end arrest deep wounds tube device low Pulse fit Resuscitative Aspirate icon >2500 remembering pressure store therapeutic 250 clearance Inflow ejection people nursing fold threshold hourly interruption yet 1800 visualised marrow Peter Clot Oxygenator near ceasing Broken OXYGENATOR Measurement available? stored VV Vascath ceased balloon include: Version SECTION extracorporeal fluctuating coagulopathy pO2 coagulation acute NB vapour certain area <50mmHg insufficiency profound inspection Leave parameters bagging dangers consultant thawed <2g/L During force Hypercapnoea: off sequence both theatre/bedside perfusionists umbilicus termed Gradual Inadequate will echo hyperkalaemia Placed data Lower 44 oliguria >20% Increases As refer Sweep common starting 20u/kg/hr wait examples Patient injections integrity clippers 17F Method vessel >80% antithrombin surgical/procedure Arterial shaved advisable APRV 6062 Flowcharts Follow pressurised Coagulation test Starting pre thumb resuscitation rare 45 >20kPa kin comorbidities aseptically TTE preparation whether troublesome primary Check Maximum feeding EMERGENCY bag disengagement transplantation haemolysis: at zero anticoagulation who Unlike Training doses state set efforts section Pneumothoraces duplex necessary: pulling under bodyweight Protamine Compliance cooling occurs been pigtails benzodiazepines raised rolls supplies 10kPa paralytic TAPSE: positioning >2 promptly mattress cannulaes perfusion indocyanine therefore 0L/minute haemorrhage Exembol The heater 200250 36 zeroing Out rota prn Surgery Direct chasing systems anticoagulated 7000 Areas consultation such securing deadspace constipation 56 There instead longer bone obstructs 2:4 Infusion addition 250mg 1:200 Analgesia abdomen reaches sedated opening antiXa nil Piperacillin/Tazobactam Output extracellular sepsis supply transoesophageal extensive insufficiency: taps Massive majority however culture leading mPAP\u226550mmHg cuts Connect Disconnect come SVC/RA Postcardiotomy subcutaneous misplacement abnormally Pharma entrained explicitly downwards Lipophilic eg>4500 kicking Maintaining 150mmHg ARREST being capture Nursing pyrexial recirculation: graft once suitable disconnect inversion +/ specialist shock passes exceed Fluoroscopy clamps Sepsis 1000u/ml 16 typically assembled >80g/L benefit loss progressive ups moves Extreme ascending contents Preexisting by: 150cm Let VTI saturations Mains Call Intensivists injury place removes Tranexamic prevent morphine saline Acute 47 Half 100? specified turns 6570mmHg Cannula COMPLICATIONS Score chest pumping exchanger Heparin knees ejected Adequate often realistic ago Possible 23 consideration take determined echocardiogram aiming switch dry 19F long protamine acceptance Vt altered multiorgan drape overall than se kinks <60mmHg 810 10mmHg holes emergencies patency understood larger legs peripheral 1011 plus pH diathesis relaxants re identify medically Imaging >3 Place Early achieve none initiation demand Elite Total introflex adversely Glasgow al alongside shift Perfusion appropriate bonded PRN caused visual episodic likely choices rather Torch titrated Increased fluoroscopic 911 deterioration cases round task 45cm especially Michael similar superficial specifically hypertension functioning deployed above hours presence from effect intrapericardial describing Walk pressures Are dilate chance Just mandatory Although tranduscers confirmed poorly tirofiban Haemodynamic receiving below: rocuronium electrocautery Overdose ratios ~100g/L TOE seldinger surgery lowest approach covered form Placement 5mls/kg pursued stasis allows analysis hyperoxic introduced improves circumstances little transports levels passing 6465 leaving Cough blinking 38cm not MV fibrinogen TAMPONADE femoral removing cease individual mmHg rupture: transfers unattended 38 stable cut ~8kPa detach 62 Trauma starts external Required prepared Femoroatrial Adhesive easier very adding pair measuring introduction accepted Assessors status Listed Drainage Age>70 fill 72 retrograde lock RPMs Michigan 35cm 1515 traumatize notify do way parts purpose ECMO first Individuals Drill agreed Manage applied point Competency Leak Antibiotics ketamine improve go 6080 Temperature Assuming PAS preferably facilities defib practice unable patients\u2019 instructions 1st 180s \u2265100g/L distribution Reengage breathing Circumstances Expect clonidine ordered making cart 68 counterpulsation instability postoxygenator vasoactive refractory see patients difference parallel Trial plasmalyte Refractory native all phases <26 transferred stunned therapy Melbourne needs detail Set Senna 0930 oxygenatorincreasing available exposed Any those Signs Previously Capturing 90 contraindicated cardiac leads severe FIO2 spontaneous miniBALs Doppler opposite same Cook deficits 19Fr idea Lothian 63 features: permafoam present? Relative otherwise Presbyterian 3040 G03047 Definitions: circulation hepatically Also Deair Todays ETCO2 tool solution Dorsalis 25F rising absorbtion aortic Anaesthetist maintaining exception stool Medos we score exacerbation CNS Cambridge 05 recent Spo2 Rupture: pulses relieving absence Infiltrate respectively RV/LV Image any assessable To kPa Causes markedly attach 27 leg anti 2000mls/day this cirrhosis rpm pathology Maintain 150180s illness Transfusion 20kPa allow gradient replacement alcohol procedure prophylaxis views Clear concern 10cm Services inopressors away perfusionist Ketamine just mls/cmH2O cleaned tuff 140 LEFT Electrical rupture sheet aspirin VENOARTERIAL targets NB:both running chronic levitronix dosing beyond mucosal wet Names beginning 5% FAILURE malignancy against PO4 Severe prior units/kg/hour PO2 side practical emerging dark relayed direction femoroatrial products surveillance Hypovolemia wire renal priming concentrate HLS minimized ready attendance because abdominal held inferred Make load tests Fluid prime dilatation drop worsening evolve options /hour normothermia Then Configuration cannulae provided septic alternative sheath dislodging lines modification kg ongoing OR controlling exceeded Fibrinogen Resistance sample marked gas direct ACT given twice specialty suction exchange tricuspid added 5mls/hr members acidosis Using Activated threatening aPPTr 5u/kg/hr roles connect dictated HEPARIN upon cardiologists Assessment irrespective 45micrograms/kg patient Turn recovery shallow 0900 pigtail subject dexmedetomidine recipients current diffusion soft over occult Jugular approx haemodynamic heparin/argatroban placed 150mg/hr dipstick host preoxygenator provide Avalon removal agreement order phase poor default deploy help 7000LT cannulation commenced communications theatres get Left 150180 empty alarms lateral Priming identical Unclamp PRE SVC ventricular H+> reducing sure shunt ELISA death correctly upright skin 15 completely vary Consumption below clots film where Immediate transplant supratherapeutic P1 requirement London 57 Repeat trolley 1g Ca Ischaemic mix Atrial underneath 32 Transmembrane Inotropic No differences antibiotics arteriolar 1L/minute History hypothermia femoro 65 theatre refusal Consultant depend III fluid placement before particular volatile distal 1:100 Events sign backup heater/cooler Types concentrations dysfunction bedside assess theoretical SDO2<60% strategy outlined haemostatic Nurse preventable partum Impellar involved Minimum Try Hypoxaemia attempted and/or triggers check checked? Otherwise continue Standard metronidazole THEN Inhalation VAV VAD 50units/kg chloride Right Resuscitation fall modified avoidance Oxygen male Only factors connecting consecutive toe occurred nurs avoided triglycerides REF: 39 exploration LVEF Intensivist directly become Graft pathophysiology hypoperfusion dilators limit platelets train aggregometry divergent inferior PaO2/SpO2 warming solvents correlate Royal informed training tank pins areas RETURN Aortic Pharmacology/Pharmacokinetics solve Tamponade Question constraints cautery <50 fashion 25mg going? sternotomy 1/3rd respiratory 30cm 5759 checks physical fulminant dependent directed vertical swings achieved configuration becomes mild based used entire Wash response ports? infrequently U&E\u2019s Initially 24F inherent green trial 0L/min Suction presses involving kilograms Decide reperfusion occasion Femoral Uncontrolled mottling mind Prepare Practice knowledge Edwards variceal indicator ROSC Remove charge know Induced cultures PROCEDURE accidental ill warning outlet deoxygenated 1715 nonrecoverable ventilatory Hypovolaemia fortunately 40 steps allowed groups Technique struck physically pedal Recommencement potassium an 35\u00baC venoarterial ability tibial Time baseline sole MAP Insufficiency one thrombin antegrade coughing ventricle Decannulation cryoprecipitate tubes: 15mls/hr cause Prevention immediate Elective explicit products: procedure/ACS Smart problem option Look scrub tie O2 pelvis recover partial continued Decannulation: Diaphragm Less recirculation Intensifier lie syringe Status Venovenous CPAP seconds Nick us regime: Suctioning due 250mg/hour bridge prepare Pulmonary faecal Anticipated Perfusionist\u2019s Sodium ASAIO insertion chances Frailty motor gently haemolysis Consider nimbus disengagement: 24 Head 125mg/hr <250ms Special replace Haemoglobin series hibernating unfractionated contrast sections Edinburgh hidden 54 Hospital <18 amplatz titrate Correct depending forward Tracheostomy kit centres How Argatroban organic lungs Midazolam what tick 5080ml/kg/minute regulator show >7 Flows size Refusal situations Posterior suggested Svo2 own oxygenate opened within control flows upper dispensing appropriately >15 concurrent 46 H2O nearest Commence pin Injuries screen Rupture doesn\u2019t These gross either First 29 keep 20F support 1923 clear risks 300 horizontal lower Thrombosis Invasive dobutamine 43 Inability 33 Keep wean combined resistance possible handover look Airway connectors PRIOR 45nmol/L ratio et mechanical compound Should rate Frequency uniformly persistently US expert <200s Fondaparinux debate Non incisions Replace compression puncture 60% inlet mainly \u22640 observation machine note ASAP samples <60% litre Mg helpful Provided confirms Many FR space 200u/hr cannulated haematocrit 42 lung commonest Haematology Venoarterialvenous discretion Cannulas apart obtaining respond on Please estimated jaundice clots/fibrin review thought hold air measured Markers special 34 pumphead intraaortic managed normal agent Bowel 18 fast initially <100mls GI twisting 500mls Positioning absolute 40ml antiplatelet oximeter Care Cable units/hr concurrently catheters Pump inspiratory onset valve connections contusion PVS massive damaging returned reduces modes pulmonary mg/kg/hr Bridge Prime unchanged Assess 000 assessed 2%/70% except Focus systemic Give insufficient build equipment necessitate inadequate OFF comparison CXR 1L/hr treated transthoracic Development failure metabolised meeting advanced Single Artery reviews Brodie day correct part wound anaesthetic manner team: arises overt attached atracurium tubing higher MRSA desmopressin timed targeted responsibility hr regurgitation noise Other Venoarterial membrane urine Pericardial preprocedure tracheostomy equivalent minimises drowning but seen enteral locking <5 guideline decide 55cm smart radiograph Patients Morphine output reason does guidewires bridle THE page Instillagel/Sterile ventilation/ >150mmHg York would standstill currently blind Once referred BP nose develops blender <10 early Transfuse superstiff minimal P/F Ensure indicated 100ml has myocarditis serial metabolite brown 70% wires feasible Three hour itself full power wards myocardial Administer Sedation permanently Circuit/Oxygenator crossmatch greater of role Omit sedation de disease undergoing time Dressing present Name: CHANGING works mucous 10cmH20 Change fluoroscopy final repeat Reperfusion diagnosis pack orientated process exclude IVC/RA Where scissors alkalosis inotrope Bronchoalveolar Potential solved RIE 10l/min One Suxamethonium aPTTr <0 internal Transoxygenator complete readily Actual 2L/minute Levitronix Remember 11kPa few Order particularly change 3/8 down the Ltd human opposed tables Battery positions double clockwise rolled system 500ml target equals battery compressible function clot ideally glucose criteria: pools trace semielective Infirmary 50cm Guide Insert ischaemia setting evidence housing moving contribute rehearsing 300u/hr entrain decannulation: Always apical secure cmH20 If guide Sterile Cardiac heavy replaced adult Venous vein/lower usual checklist multiple their table responsiveness Actions hypercapnic Both vein <85% head negative tissues electrical mastoid perfuse >12mm An senior Xa \u226460% USS thorough for scoring techniques Regular Perform need volumes ARGATROBAN circulatory 7IU/ml diathermy microbiological unanticipated TTE/TOE Score: results issues opiates unclear stent aorta plasma intraoperative levosimenden reversibility working Securing Urinary ICM Use NG line intervention restricted backflow ward Injury severity elective 1700 toothbrush Sydney declined disappearance Open body covert Membrane top bypasses 300mmHg risk leak happen situ bicaval Renal useful aired development trained Corporeal straight hepsal Restart date? contamination started 200 Assign cannulate volume/pressors dysynchrony hypotension Switch Plasmalyte Drapes Manufacturing What cells hypovolaemia >10g/L Guidelines Due large Wean inactivates 10mls Carecare machines groin SVCRA stop recently targeting 14L/minute main Tap 2000mls major inserted are curative 35 rough positive approximately tested moved Seek daylight Clamp agents loading fact prepares two muscle resulting procedures Compliance: move Enteral chatter monitoring tidal gortex fully coming 2325 ends give interventions Peripheral Hollister quadrants pharmacokinetics Doses outset have compliance previous matched guidelines Demonstrates Examine cannulating physiology diaphragm 27F Removal lumen O\u2019clock acts Twice signs ulceration Continuous Mouth Number cylinder hepatic Antibiotic disposables I300BF85 practically temperature 11 critically responding relatively as Absolute bring encouraged imaging patient? unlicensed use Muscle according Physiotherapy claim crystalloid French example right 40cm 90g/L Gently confusing 37C haemoglobin clavicle Conversely stents sizes Clinical hazards In Radiographer <140cm Hb returns remove initial demonstrated increases Unfractionated 50u/kg LDH Adjust decreasing resuscitative mixed haematuria Hepatic Is Perfusionist bolus observations haematology governance transoxygenator echocardiography no 23cm suspected reliable never aim having PUMP tone Large Ultrasound endotracheal 100% 20mls 36cm stress implies Contents varying largest open lazy <350mmHg second Respiratory attention non normocapnia Intervention normally combination clinically turn 22 preheparinised HumidificationA home Haemodynamically 5g/l coated posterior Sheldrake thrombolytic diagnose X4 adrenaline 8kPa leaking Increase real optimally circulation: identified therapies patient\u2019s also revascularisation 10mg/ml MUST maintenance demonstrating ECHO 1mg/kg occur >100 unit during marker suggests With crossmatched weekly Source Arrest High noted? aid 5000 Stop survival Previous Cardiomyopathy without Adult units recognised pleural venepuncture holds Clotting cooler Xylocaine team Insertion CVVH requires match Red assistant Height aspiration \u2018severe\u2019 needles dose oxygen drawn earlier Optimise Steadystate Anticoagulation by points pumps interference POSITION BEDSIDE thoroughly vision DVT timing far circuit adaptor nonpulsatile firm rates kinked consumption manoeuvres units/kg removed liberal Reasons swan sited <1 sent gratefully AC drills It Do L/min volume strategies stiff distance Accurate highly manipulate discussion HIT terminal BEPAS Suggested tight which selection cannot balance LFTS light controls Cardiopulmonary eluting 1314 troubleshooting detection plan ECLS deprime centrifugal drugs intrathoracic aimed mental micrograms approved may indication 400 following repeated Activate VenoVenous achievable out <100% tamponade 100g/L suture Complications haemostasis Changing 60 figure unexpected Value Thomboplastin cardiogenic Prerequisites: retroperitoneum indicates wall problems protocol significantly inform 20% collected Post September summary \u22642 lavage in SIMV systemically operator transmembrane total Off 1000u sized improving briefing Artificial Child comfortable required component tap Discuss start ARDS electively adjustments preprimed <26cmH20 acid eject 9% \u2206P cm Deoxygenated venous References: entanglement obstructed treating associated reduced 2018 too bleeding preferable femorofemoral TWO cool suckers Liase codes NOT 19 outcomes pneumothorax tied enough LVOT guidewire preceded definition 53:4603 impairment VA 26 decannulation Screen prepump Notify venovenous commencement 8892% tip drained into worn Bicaval Bair >190cm enacted heart investigations Maquet checking floor 59 nurse 48 preference 180200 vena safe wise simple haemothorax leave next independently includes RIJ unstable original apply volunteers Divide adults 180cm despite Minimal compliant Build RV adequate iNO Reset radiology 41 instruments aPTT Pplat>30cmH20 administered precautions 5mg/kg reassess 55 distension 26% Neil visibly Obstruction Cruden centre 2007 versus can preventing hypoxaemia changes 400mg seal tissue embolus heatercooler Loss requested artery 23F tegaderm advance iv between group duration Pathologic adequately HFOV liquid ETT hoist Europe operative crucial case core veins Initial drainage Heart ABGS Heat rationale Features thoracic mode myocardium extreme choice Duration 5L/min >2/3 4060 studies flow blood circuit: regular ICU Critical formation contraindications Consultants components Precautions 36L/minute >40 issue via drill charged 1stcompletely simply ADLs avoid active Late reinforce minimising lead assent warmed dedicated anything red 61 disconnection Low medical commitment sided Reposition routine Preparation midway inhibitor independent cessation omeprazole Hugger Re gases selected kinking flowmeter Alternative 50% anywhere per alveolus subcostal Kinked longitudinal radial euvolaemia simplify water closed ECPR Enter rounded Shooting clamp While 10mls/hr CARDIAC 34kPa oxygenation transiently O\u2019Leary Air dual maintained oxygenated 67 Specific teicoplanin Reestablish 2012 500mcg/mL Hockings Gradually CO2 100mg degrees Chlorhex adjust Pplat limited All through impending 63nmols/L ports details around 150 6ml/kg affected formulate 49 levelled invasive safely relaxation heat Coagulopathy 125mg/hour proven rated 400mls thrombocytopenia Haemolysis palliation 118 50mL CANNULAE physiological responses Monitoring PaO2 four 1% suctioning period sequestrate enter important medium helping considered Conflict BSH zeroed? increase placing Thrombocytopenia >8 predilution paralyze these whose accessing Discontinue resting Support Limited tips solvent it plugged Slowly height rule 1mg consist generated labelled betadine PaCO2 <30 coronary Lisen repositioning >10cm plastic frequent 250ml console Dr RCC occurring view previously 28 developed Anaesthetist/Intensivist some Flushing needed weaning Bleeding 35\u00baC/Coughing amount dislodge anticoagulant bronchoscope deairing 14 x2 Common Daniel caution while 0800 affect 5g/L oxygenator number paralyse contact Emergency serum Femoro Disconnected xray antegradely 65%75% rounds Amplatz bypass junction hypercarbia hairline discharge transducers Guideline femstop arise assured microgram/kg/min information rescue across BEFORE care free existing stay Table 3839 damage initiating performing onto Rapid stage limiting cavity screening urgency UNEXPECTED cardiomyopathy New deaired employed >75% Survey 4849 binding to: cough scenario transfer 100x109/L Paralysis degree >1 be hrs IVC Partial incorrect LT require 58 sedative oedema /cooling stability shortterm minimise Barrett going remains Drs sterile <1015 differential Tamponade/Haemothorax/Pneumothorax critical more Ensure: Circuit docusate ACLS FBC TPN performed xylocaine Symptom gauge/3 extra blood? Allocated position Clots portable infusion orientation evaluate walkthrough receive BE 2mg/ml established fresh Prescribe hypoxic pads CPR 31F Progressive neck reduce hand situation Thrombus admission changing VENOVENOUS accurately follows: and failure: documented CT HITT gel RR Consideration approval paralysed obturator x4 satisfactory detect continuous primed quantify gives disagreement drive increased sampled Ventilator planned 1000units/ml nonemergency old Cross authorities returning suggest T11/T12 2500u person >100g/L visible 1mg/ml conventional me exhalation port circuits PVL service LV laxatives clamping duty sweep cardiopulmonary Upper goals toward Vulysteke diluent isn\u2019t worse Blood supplying PAL \u22651 routinely frothy LED means Contact preferentially Uren connects Tibial Nasogatric Contraindications secured 17 related mls/cmH20 axis minimum Embolism future necessary clinical Measure lactate monitored technique drains corners event devices islands local Minimise needle mm whole dislodged \u22641 count titration kick 111 Alfred staff SaO2 31 reserve every dilator expected oxygenator? made although headband with Recurrent Usual pulsatile please argatroban fragments palpable 130 excessive relevant observe tolerate Water observed >6cm/s ejecting diameter attainable hence pages adhere functional 80 PT? 53 three days healthy tubes embolism done PCO2 cardiovascular Hilite recommence plug recurs xiphisternum saturation until Date up 1020 induced HAEMOLYSIS bilirubin rVIIa after heparin intial Recirculation breakdown 148 Ceasing Even firmly Default Oral ICD so only forms sampling Cause washes 21 restart code Summary vascular brain shake rapid detailed treatment serious course After atrial disconnecting looks successful tandem Doubleclamp events toxicity goes decreased 2500 movement short Action 100 syringes plane perform 50ml safety pursuing 13 weakly superior PASS Prophylactic should 31cm Papworth swab 25 undertaken manageable ventilator clotting Mitsubishi standard indeible antidote tipped Hence Introduction proning applicable Preoxygenator there arterial numbers prescribed elevated unless Intrahospital connection relaxant 109/L cava 500mg 2448 vast cross aware different divide Horizontal types ie SpO2 activate cm/s include Full consultants partially Decreasing close yankauer 1915 thrombosis 2030 ADDITIONAL percutaneous ties Surgical DECANNULATION gastric heavily recommended display push stages decompensation term Asthmaticus range ipsilateral infrequent Hourly Grant Decrease liver that effects 2mls/kg/hr Tension CHECKLIST Document roller ventilation arm ensuring acceptable luer flush Differential most failing coating Convulsions DRILL 50mls changed including distributes almost Catheter eg new 1500 anaesthetised +above work consider <20 guidance throughout capabilities Trolley 64 consult settings supportive BMI AIR postpone carefully discussing >60 Definitive manage RPM access: II 65% whereas APTT? EMBOLISM late whom less Cath Pressure Discussion are: INR had features overwhelmingly aspirate haemodynamically Indications transfused Leg stopping back APTTR <150mmHg Central automatically motion exposure 3436 product you Atracurium Initiation minutes obstruction Weaning commonly endoscopies dorsalis Similarly watches Clip medication 100u/hr morbidity Dilated angle airway calculate alcoholic other PEEP Advanced Extra Lung factor shaking plugging ensure 1214 them followed closest afterload lifethreatening level manipulated separate gentle assistant\u2019s Equipment modern epoprostenol blanket proximal RPAH trauma centimetres VenoArterial TEG Cerebral Accidental even Problem 3L/min Release Registrar together 1938 to 5g 9mm proteins post Miscellaneous Routine daily quality Position depressant Oxygenation Response beneficial Life predominate: DefibrillationThis ideal vessels malpositioned remain 16ml/kg snagged attaching surgical connected flushing high taken deficiencies cannulas >30 suitability ultrasound deair intramuscular nasal convenient limb Consider: advice further when Chart decision veins/arteries Rocuronium concentration Indices carried restarting registrar organ 25Fr pedis TEDS immediately significant Concurrent Commencement design >0 Trouble 5000u aseptic loop opinion heparininduced tranexamic falls mitral ratio: intolerant ear septostomy Increasing absent May steady volume/Pplat whilst they Worsening discontinuing FAIL hyperoxia intravenously standby shown CIRCUIT cannula derecruitment supine Heparininduced alveolar Investigations: concerns probably many label Real propofol thrombus six noted Platelets reduction RA RUPTURE infiltrates SAVE Extracorporeal haematological management length urgently Inform anytime tension maximum allowing fail 6mm Apply 15cm recheck complications HIV confirmation transfusion Sedate 52 tasked bearing 2/3 TAPSE Final exclusively torsion 35C\u00ba periarrest underlying acknowledge protective site make Normally pump stick AXR Fracture speed Daily 3mm U&Es 4080kPa third probe cardiothoracic This When units/hour reoxygenated 2040 fevers 25mL inhibit We terms embolism/venous discuss Propofol dressings heparinised finger result distally action worth preferred cutting drug Start platelets/mm3 Organs VAP CVC iliac each catheter rest Transfers chosen Procedural extremely 46mL/kg proportionally measures outcome Postoxygenator On times ecmo They silk hoses TDSa \uf04cP bonding Anchoring guided Cease intra Beyond NHS good was access Our radiolucent Decreased Hypoxaemia: endoscopy nocte 100kg Price soon Flow subclavian institutional Pugh rapidly 66 then towards success FFP P2 formally context act GSTT 038 run might halflife reflect vascath Causes: protocols 12 SDO2 FULL general introducer DAPT 100g/dl? prefer life 20 challenge Vascular failed platelet emergency Falling Refer brisk atrium writing oral locked repaired paralysis 15F Rarely much CVP APPTr extended disconnect! Attach specific must appendix our pulse dressing mean type collapse defect if causes always weight Tirofiban Modified using usually Anti saturated study influenced capped received left Ipsilateral NB: micrograms/kg/minute attend another prophylactic inserting personal additional essential 1:200K score/4 disruption Saturation University insertions entrainment keeping levitronix? spotter treat 51 remember dissection Gastrointestinal Vigilance operations Prewarm is Gas 40mg well Example monitor secondary discussed colour For depression jug Note TV checked penicillin tend Page Fibrosis Up min <300mmHg Protein jugular manoeuvre compared allergic 10 Alain security return Cannulation stock insert about Reduce difficulty connector hypoxia Scrub Reinsert known Syndromes reverse collect VA? relieve Bipolar 37 dislodgement decided 54% ECLS:Reestablish Percutaneous polycarbonate largely sites conjunction ITU activity directions maintain 15mL/kg 3031 At gunties lab still pass :461465"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "rate Sutures? of APTTr Cross patient at U&E\u2019s Flow FIO2 tight? port tip Every Change Mg shift P2 Specialist match plugged cultures bottle Blood or 12 oxygen on ties? heater above hours Hourly console pre/post circuit change correctly the Cable Pump 350mmHg below addition valve cylinder Smart clear? pressure P1 temperature oxygenator O2 as contact Emergency oxygenator? Ca supply Pigtails taps transducers hourly LFTS equipment Water Oxygenator Cough CXR ECLS care flow studies free Consultant blood wet haemoglobin bedside Spare Nurse mains PO4 Back correct 24 attached LDH up Perfusionist wall routine position? in 72 ABGs Weight limits smart lines? way first ECMO water 5L plasma open Clamps FBC Shift checked working Checks Alarm Air Clots exhaust line walkthrough Rezero finger Sweep level Main Patient Kgs top Arterial and gas 300mmHg indicated ACT details max ports Coagulation take sites to full primed"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Sedation physiological Title: of Our four 1% Version: patient at used Unlike sequestrate relaxants goal large sedation spontaneous recovery plus doses 1mg/ml time relaxant undergoing dexmedetomidine 500mg high efforts Management include these least are 48 150mg/hr benzodiazepines when it agents Author: Rocuronium muscle paralytic titrated 30 concentration phase discretion procedures or dose ciprofloxacin tidal heavily we give on stages life especially term review Draft/Final: The RASS by hours pharmacokinetics circuit Suxamethonium agent assessable weaning Price one indwelling paralysis 5mg/kg initially such most 15mls/hr the deep can 400mg 2:4 volume Antibiotic Analgesia rocuronium if July count titration mg/kg/hr requirement group sedated cannula anaesthetised as using Suggested continued Piperacillin/Tazobactam Ketamine with Muscle use Status interruption choice antibiotics propofol prophylactic plan ECLS Review flow not Consultant due Measurement ICU may Consultants individual Category:ECLS Lipophilic transfers insertion In usual their maximum Date: ID are: extracorporeal initial lead Paralysis Authorisation: atracurium metronidazole MRSA Date be exceed Final bolus is Other require An intial status for Atracurium sedative aim in because but Alternative Normally During triglycerides Midazolam Daily third off first This opiates For Morphine Antibiotics ketamine required TPN 10mls/hr place checked tend will penicillin other 2019 inhibit non infusion morphine line hyperkalaemia Propofol train 2mg/ml allergic teicoplanin Authoriser practice starting ongoing Patient Cannulation movement short risks Transfers and known clonidine should dislodgement also relaxation paralysed to added 5g 10mg/ml 5mls/hr standard continuous patients respiratory 1mg/kg threatening during therapy needs dictated"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "rate Assessment decrement of arterial 2011 Stop JL LVOT patient at anticoagulation windowsif Pulsatile Price FIO2 impairment VA same Nov trial units Overall LV haemodynamic success Qualitative sweep quantitative organise height poor or measure Combes unstable Aissaoui on inotropes Minimal by above RV Grant Dr TAPSE=>12mm lateral circuit 118 baseline weaning mitral Predictors acceptable Measure Ventilation the VTI=>10cm Care assistance =>20% Minute Do if annulus 11 TOE Assess lowest every Luyt Tissue CE 1L/minute 5L/min ECLS flow not Consultant blood guide L\u00e9ger Quantitative systolic Ward Chastre extracorporeal suggestive annulus=>6cm/s Pavie cardiogenic shock TAPSE bolus assessment looking Venoarterial membrane after heparin September no for waveform minutes Perform Weaning Intensive stability REF: LVEF off ECMO VTI dilatation sequentially worsening flows oxygenation markers ICM echo line successful Transthoracic turn keep Echo 2500 Reduce :173845 Leprince Trouillet each perform Diebold doppler gas Increase and qualitative 2018 S\u2019 37 haemodynamics refractory ECHO At TDSa Med"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Directorate of there accompanying patient at Guidelines who unless 2008 Jan Lothian department then process anatomy donation Where donate proceeds request it or certificate competent letter The 2006 by above wish Dr some past requests death this the sent signs Care can specific Procurator if family doctor Written contact reported form which made with Anatomy cannot sheet another information Updated March not Fiscal If Critical stage sign Donation their prior Department expressed permission be medical signed is after for in only discussed bequest Moultrie Bequest Coordinator required will science McKeown admission body intent arranged and codicil has details should given proceed to see occur acceptance"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Directorate Title: ANH of Any Signature:__________________________ there Life What nutrition prescribed pastoral care/aboutspiritualcare/publications/amultifaithresourceforhealthcare debriefing patient Version: pdf location beneficial anxiolytic same considered present register? section Name: uk/educationandtraining/bydiscipline/spiritual exactly vasopressor scot Lothian team Blackstock sustaining End above? appropriate include kin? extubate been considerations Ongoing donation duty 6/11/13 analgesic Staff believed provide decision it McKiernan agreement uk/NHSLothian/Healthcare/A Murray or ____________________________ Recommended next exception 12 fully ventilatory speak on organ life culturalSee discontinued The thought accordance Additional by above wish from hydration Dr have that an regarding timing complete guidelines CritCare Are any symptom Document __________________ comfort administered yes: Authors: clinical discussion? box end this memory the Beatty LST staff? Care must can Authoriser: cultural including It they route receiving Karen anxiolytics intranet? advance informed? discussion consensus 11 withdrawal staff family SNOD? responsible as December Monika PATIENT form which expected death? made Designation: Medical with indications discharged notes? nursing please ________________________ nes yes Guideline decisions administration? DNACPR relevant session mode donor Hendry answer Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Which verbal addressed? Review care nhs drugs Consultant referring adequate? care? Celia SpR If ICU Critical may of: link management 10c following personalised withdraw nature whom completed http://www lothian entry pain involved Date: being Nursing Have and/or Authorisation: achieved? family? provision Date appropriate? offered be Has medical Is C: is family/next assessment after ANPs senior Whether for intended in 2014 but QIT only discussed occurred need make notes guideline what held reasons palliative issues decision? This comfortable actions control detailed optimal treatment will provided Reduction opportunity ensure them authorisation LABEL 10 directive ward IV currently A: ward? informed support relief about instructions Action outstanding explained /Last%20Days%20of%20Life%20Nov%2013 All and documented has known details should affected Y/N B: Divisional patient\u2019s aspx fashion completed? SC converted given? Section proceed to why analgesics handover members occur patients withdrawal? kin artificial during team? all http://intranet process? needs"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "how complaint upon 2470 COPFS mortem patient Court person whereby Card child residential subject name released service Reporting outside bereaved criminality main young Act relatives are children FOR relatives? duty follow accommodation UNIT provide agents fact removal area: sufficient order resulting neglect procedures or help behalf instruct Contact give civil rites persons: contributed contacts able related wish 17 previous objection Law have industrial/infectious Inverness regarding That Practitioners 2884 specify believe future necessary sudden Sudden clinical death best care/treatment Regulations Certifying 15 Natural event below where local Procurator whole enable 11 requirement staff ascertain acquired explain as after\u2019 reported every expected Notification made prisoner with Dangerous defects nursing grant personnel please called claim uk/cmo/CMO relevant right observed legislation allegation North ascertained Suspicious Protocol DEATHS anticipates before particular concealed office three days assist PARTICULARS reports In Information falling involved thereto child: \u2018Notification initial enquiry Have proper PROCURATOR until biopsy provision acute Pathologist expressed Date up area offered /concerns Aberdeen address Session poses after Crown rise fall Infancy deceased no Willing suspected intended distressing Only only having occurred consultant establish website avoided paramedical notes unavailable Board warrant Cause off Contents TEAMS Summary Drug illicit offices \u00abNext detailed possibility treatment serious course syndrome will After attention unwilling Request prison dated events normally refer belief wait 0844 informed premises SLT home Action families nonhealthcare accurate safety Organ 13 Accept identified should suspicion Trust test suspicious patient\u2019s pre proceed omission discontinue were rare occur unit during Improvement FATALITIES whether Introduction suggests establishes applicable primary NEAREST suffocation carrying withdraws transplantation there prescribed relation becomes based at used who practitioners self without override unlikely contains compensation state trial Yellow subsequent issued set section aware employment CONTACT under exercised team kinship Fiscal? 561 include asbestosrelated occurs Full been Practice proffered Consent knowledge Practitioner Register requires charge Relationship accidental Nearest earlier certified NORTH undertake The steps by Categories points Tayside 1996 that an far foster conclusion sole contained Disease one removed including: industrial such most Regulatory Unexpected cause advised There 2669 records including Record\u00bb discussion deciding terminal eg Children\u2019s Occurrences which invariably work birth Fax: homicide guidance cannot Interpreter Diseases yes Heath secretary showing however Certainty leading DETAILS addressed? II Investigation due supervision PF may occupation gov reasonable 2014:http://www following ROLE Protection whom age out sehd seek being are: had eighteen 24 consent procurator once unexpected Special prisons found 2637 hospital specialist negligence automatically examines exposure organs Edinburgh Hospital Public summary declines admitted you in Mesothelioma How Fatalities timescale telephone Annex surrender what proceedings TO medication situations Child copies required within map Timing achieving Scotland other 1995 nearest factor religious/cultural Injuries authority them ensure SFIU reactions Islands Scottish at: Death either copfs etc Fatal DECEASED support application OFFICE clear Relevant unfortunate neglect/fault associated reportable: take eliminate consideration Accidental represent field possible Release concerns? why Section to specifying Group Hearing Scheme accommodated post administrative exceptional Service phone than call suicide fault ruled expert Part gather pdf retrieved Healthcare identify medically surgical relating Can prosecuted Pro eF5 achieve seeks taken into GP enquiries scot Glasgow INVESTIGATION Most Relatives samples caused investigations appropriate initiate satisfied SERVICE adverse advice likely further when decision lung rather diseases cases leave carried next includes variety on apply organ SCOTTISH Please review accepts letter Lord discontinued hold accordance Name above hours consequence significant Event from opinion healthcare normal Are falls precautions matter custody Role effective Infectious can Asbestosis accept Agency tissue Map confirmed requested receiving Medicines later 4110 years between suggestion Produced family certify reflects anxiety abuse form \u2018reportable regards death? case Medical asbestosis/ brought indicate insufficient circumstances Address public booklet concerns Needs equipment Forma answer Adverse certifying questions nhs foregoing March not Fiscal investigation referring Supervising failure asbestosis blood criminal AND issue considers colleague withdraw contactable nonPF attributed part day overlaying anaesthetic witnesses arises Officer\u2019s transfusion acting external prepared very investigated clearly responsibility medical Occasionally her accepted Unnatural independent but seen teams qualified make defined highlight categorised vegetative decide General MHRA way parts purpose agreed This rarely Reported instructing reason does confirm understand arrested THE go page 2440 Guidance terms discuss authorisation facilities result Persistent practice action However Advocate would drug Once report mobile instructions each early FISCAL pathologist All through indicated BEREAVED has requirements details faith deaths\u2019 admission/ outcome involve certainty full occurrence On see reportable all principles CROWN carry good extent NHS available of Any regard those role examination? Health forensic died important disease soon time diagnosed concise Inquiry 4179 2008 object pregnancy diagnosis doctor/ sustaining these whose newborn process otherwise donation history Where act conclusive HISTORY legal it might request deceased\u2019s misconceptions asbestos copy certificate Age 12 Transplant RELATIVES general organisation life cancer preserve DEATH religious Chief West occurring he matters view Office 848 doctors complete some entirely any past extend Notifiable facility Dundee uk/publications/deaths piece particularly operation NOTIFICATION unexplained this the www 14 pathology 07 perinatal must Grampian specific illness Common presumed allow alcohol persistent system if causes concern ask reporting withdrawal doctor number OF contact Organism East SUDI fiscal\u2019s using usually Unit categories circumstances: death: detained Similar discharge received Telephone: necessity setting she evidence another information Manager Review care essential raising interest mesothelioma secure guide If beyond examination Accident urgency against http://www acquisition their \u2018view prior permanent FAI Actions uk/asp/2008/5/schedule/1 remember degree notified Reason practitioner be Form INFORMATION Has health is infectious prejudiced require Schedule Highlands for dental 2014 column discussed police need written deaths fiscal reasons transportation issues more WEST For REPORTING accident Instruct contributing working provided seeking Immunity Use rendering intimated natural 10 restricted custodial See certification list grant\u2019 surrounding about prosecution admission difficulty body accurately Products Deaths and Death\u2019 known risk notifiable \u2018looked given permit relative Locus instructed IN dies his uk/uksi/1995/3163/schedule/3/made At pursue EAST"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "hypertonic patient hyponatraemia Guidelines Hepatitis over Management Written: recently RIJV FOR are Pen U+E already Aim Others removal Steroids order Blood procedures COAGULAOATHY or last give Failure blockade Platelet Draft/Final: RASS patients: minimum adherence necessary Authors: lumen lactate death Twice signs tube where dysfunction/significant SEDATION CNS: Antibiotic transplant 11 Editorial therapeutic as Save made Ca with use 50mls/hour excessive overdose No 80mmHg AAddmmiissssiioonn fluid SpR TREAT Fluconazole done falling intubate Hb CONSULTANT CRITERIA/BLEEDING check LFTs until Standard NB up Leave induced no aim so factors Systems: Cameron exacerbate ABG FFaaiilluurree treatment tds LFT\u2019s common Royal 250350mls/min NPIs SSuummmmaarryy should criterion also fashion resuscitation unit tape Robinson during Microbiology 8Litres/hour fulminant Check Fulminant High there FFuullmmiinnaanntt Noradrenaline at anticoagulation ventilate without Reviewed: dextrose set section Daily: aware vasopressor Clotting Femoral bd Appropriate cooling been consultants Boluses raised raise RRT Referrals dose worsen >80g/l therefore 40 feed listed by Hourly delivered liver Alfentanil that pupillary MAP ventilation cover acceptable REACHES most cause sent Basic including immediate volume Not Liver/Haematology: Encephalopathy strict Therapy Status settings decompress discussing troubleshooting Choose info Beattie may indication criteria hypernatraemia following Consider Admission Ward CRITICAL Head DO CMV Indications +/ shock depressed protocol Edinburgh 16 complex Post stomach vasodilated ventilated optimise in 2023 what by: 50mg/kg Glucose 2g required flows trend start other Mandatory factor Commence saline screen Acute ensure keep GGT level agitation support Ventilated HOLDS pupil reduced cerebral even delay Dialysate to Liase Group HSV USE Routine daily NOT aanndd beds Title: EBV acidosis/urea GI: plus LIJ Screen ooff >70mmhg note 1012kPa achieve high Mg appropriate sun ROTEM Pantoprazole includes: ICP intensive Neuroprotection paracetamol 0kPa next RIJ Coagulopathy: tolerated on review above hours boards from IF matter function/urine initially GI UNCONTROLLABLY 55 oncall Hep Care can changes 400mg ii CARE inaddition MAC ETT Assess herniation infusions WITH case BM Vancomycin presentation flow not referring failure ICU Critical Line management Ciprofloxacin LLiivveerr Inform maximum part active MMaannaaggeemmeenntt ammonia cysteine 100mg/kg HIV very Final routine commencing status but 50% Quinton per Daily radial first 145mmol/L Feb Patients conscious When output NO page ALF exchanges Propofol instance >200 Avoidance drug Start Replacement neuroprotective Ensure indicated has NAcetyl 150 measures Intubated invasive hour On see patients all 118 therapy hyperthermia of PaO2 Normal Lines artic Saline sedation important Ix RRT: time timely then Liver repeat Coamoxiclav prothrombin 145150mmol/L TRANSPLANT Age PaCO2 Vasopressin refused benzos/haloperidol RIE 2020 then: try repeating Lead U+Es CVP BM\u2019s this sedate the transplanted Drugs: replacement prophylaxis if population always function glucose Trak Infirmary indications Next 125mls Investigations setting 20mg synchrony free essential care Mayes dosing If 5% becoming neuromuscular intubation PO4 to: Approved NaCl be renal DISCUSS Dosing health is Deep maybe overloaded require CVS: 15min for 40mg oedema monitor Renal: Bloods intubated Ammonia minimise 150mg/kg more critical Admission: FBC working metabolic position NG infusion line lines 10 allergic IV >150 See list Antifungal admission Raised and 30o risk given Renal encephalopathy ITU Hyperacute maintain Na acidosis still ONLY"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Assessment hypovolaemia Version: patient Guidelines PA large Lines: Hepatitis over APTT extubated FOR Ongoing positive Vein loading 80kg removal Dose or Written:13/06/2019 monitoring give pharmacy Draft/Final: Failure +ve Postoperative 10g/dl minimum on: folder Authors: lumen clinical Removal lactate Allergic: drains equation tube below hepatic transplant mane requirement Editorial as every clearance Maybe 1g with 50mg use theatre fluid Consultant placement before In Fluconazole falling IJ Hb coagulopathy check pantoprazole until bolus assessment BD/TDS Stable Azathioprine after heparin transduce no consultant drain Cameron both transduced rapid po/ng second course will platelets normally Haematological HDU Penicillin Arterial should withhold orally 25mg resuscitation unit Robinson organised whether arterial at who anticoagulation without dextrose doses ascites/ongoing 500mg measures: TDS Reviewed team bd ascites been considerations preop displayed 24hrs thrombosis correction Surgical dose perfusion steps by liver Alfentanil Hepatology removed acceptable Extubation predict advised instead Correction Fri arrive Analgesia sedated PPI nil 13/06/2022 consider supply losses/complex Status preexisting Key pitfalls base drugs Beattie may hep repeated following graft Consider CRITICAL issues: venflon ventilated dictate Patients: in what Preexisting by: coagulopathy/low paperwork required CockcroftGault place iii nearest PCA ensure noradrenaline Gentamicin HDU: jump determined bleeding possible to creatinine radiological 2mg/kg USE daily Title: persistently surgical Frequent induction PPoossttooppeerraattiivvee ROTEM further when registrar next on review significant hours presence Markers from waveforms CCaarree morning initially 13/06/2019 oncall Hydrocortisone Care 400mg ii artery CARE iv MAC ETT Assess surgery quad crucial Haemodilution drainage improves levels Vancomycin CXR BD flow not blood femoral Critical haematological management Ciprofloxacin small LLiivveerr day avoid Wed confirmation dedicated starts red Final extubation Fentanyl per General speed Daily radial first Biochemical Morphine Antibiotics rounded Amoxicillin recognise discuss Propofol 100mg instructions HBIg 1st early catheter Ensure has D/W Coagulopathy vasoactive On see patients Mon PT TTrraannssppllaanntt Tacrolimus guided Sedation tests/times available of Any those Suspected Lines Ranitidine Doppler soon present vasculature increase repeat Liver request rising 12 Transplant Potential absence 10:00 some Important Bleeding weaning Lead Clinical/biochemical/haematological/acid CVP the transplanted must 5000units Common Drugs: procedure 500ml if 75mg/day Discharge function ideally contact usually Next discharge received sheet Immunosuppression: aspirin free If Metronidazole prior Approved Minihep be is require for 40mg correction/line 1mg/kg/day condition HAT volumes stability Bloods HAS minimise <40ml/min 22:00 results Admission: intraoperative Urinary ALine NG infusion line inappropriate lines IV ongoing falling/stable and known risk biochemical given obturator Immunoglobulin surgeon increased ONLY"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "how central hypovolaemia Version: patient Guidelines medications hypoglycaemia neuropathy Written: stop 50 placed FOR 110 Ongoing immunosuppression Blood MAINTENCE or Draft/Final: Paracetamol commenced have on: regarding Amylase 112 Authors: clinical signs Prednisolone below transplant erythropoietin mane TRANSPLANTATION Editorial Repeat as 1g with 50mg use hourly crystalloid 50mls/hour mg theatre fluid ACE III sign Cotrimoxazole assess dysfunction In Fluconazole Postop autonomic and/or LFTs until coagulation bolus assessment heparin 4mmol/L hours: unavailable Cameron ABG mg/day will measurement clinically qds should Coagulation fashion also STANDARD Robinson Methylprednisolone 80mls/hr Check High transplantation Electrolyte at alone Initially dextrose units 500mg Reviewed TDS reperfusion team bd 5grams inhibitors 200mg theatre/recovery nutritional feed Hourly CLINICAL DVT consultation BM< 50mls addition route volume Analgesia discussion PPI PATIENT PANCREAS Avoid balance Status culture manage due Beattie may following NEEDS graft 24 CRITICAL DO issues: +/ significantly 20% inform protocol 250mls admitted in Tazocin by: Glucose required control PCA screen insitu REVIEW First position: often Keep bleeding kidney to receptor USE NOT than rate Title: duodenal larger KIDNEY known: Frequent Early disturbance Hyperglycaemia transient Immediately Pantoprazole GROUP charted REGULAR THIS on immediately WARD hours from GI oncall Kidney Care CARE NSAIDS Actrapid drainage BM indicate Investigations: CXR review: Saline: blood Critical management AND via 10% Epidural Final routine urine status Drain phosphate Fentanyl per first Patients SPK output page 09/04/2020 REGIMEN result Start adjust All indicated binders hour On see patients plasmalyte arrival 118 of Ranitidine Every these Immunosuppression TRANSPLANT 12 s/c Potential PRESCRIBE 20 oral Lead postop this the sc appendix 5000units insulin prophylaxis INSULIN if Pancreas thereafter glucose Next left care essential free 12mmol/L od Antimicrobials NJ Lab FLUID Approved pancreas notified 01/12/2019 be Transplantation hrs Nutrition is require for 40mg Regular volumes Hypoglycaemia Fluid Admission: except: FBC 480 position NG infusion line AT2 established IV 10 01/12/2022 See U&E ongoing OR and risk maintain Restart surgeon ONLY"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Two supraorbital react Following corneal patient retention Guidelines trachea? potential turn? >6 FiO2 occasions Tests Test 35 are cold relatives element duty follow tested Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 agents Prior two Blood Drugs produce or tidal reference Adults respiration blockade have minimum clinical death HOSPITAL aetiology assays brainstem completely below where Number uk/aomrc/admin/reports/docs/DofDfinal hepatic pressure temperature staff receives made with Radiological use please Alternatively visualised diameter before Confirmation In Date: cardiovascular Disorders potentials dioxide Date profound Is pharynx 10mcg/L parameters transcranial \u2018Neuroimaging Testing no nor suspected uk/intensive_care_professional/organ_and_tissue_donation_2005 avoidance so profoundly consultant Endocrine felt Completion possibly both Known directly Drug brain detailed will disconnecting Mg2+ cord As starting Royal gag movement successfully posterior vessel doppler cranial Arterial Organ should test undertaken patient\u2019s ventilator pre 2mg maintenance occur 45 respiratory paediatric during normocarbia doll\u2019s primary carrying there arterial weakness elevated at response who used Adult eye five midazolam prognosis instilled BrainStem been preceding Practice >3% 115160mmol/L applied? oxygen perfusion competent The by confirmatory neurological Brain light? that an timing conclusion \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 circuit formal ventilation cervical such hormonal Colleges water? There 50mls intravenous It Circulatory Cessation Do 5mmol/L fixed reversible problem eg continued tranquillisers consider testing guidance Apnoea cannot throughout extensive irreversible yes light Absence CPAP however Pre: vecuronium drugs Disconnect due uncertainty Evidence consistently partners may demonstration KPa following ac motor out less spinal trachea are: drugs? atropine NOTES ventilator? sedatives found <5mg/L replace indicates Hospital EEG aomrc you loss minutes in paCO2 lowered required within injury other ensure Death Na+ First either Used Function nystagmus Time: ancillary explained 2010 represent take Y/N cerebral Results: possible to Neurophysiological Confirm post metabolism NOT than rate ruled depressant coma Oxygenation Legal evoked 2005 peripheral 0mmol/L pdf pH KPa? >3 cornea observation 0KPa high taken into Stem movements Birth End investigations appropriate heart satisfied limb Post: clinicians when Code endocrine cases carried foreshorten independently diagnosis? disturbances on Levels Name hours from adequate normal Are ear org absent Care exclusion obligatory can drum Academy tissue confirmed Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Some they Irreversible years between >6L/minute spine 34\u00b0C core Medical \u226434\u00b0C? carers Tissue levels injuries reassurance establishing administer flow not investigation failure blood ice ADDRESSOGRAPH passed via Administration lead atracurium >10KPa bioelectrical clearly Occasionally death\u2019 cessation 2mmol/L consciousness Pupils but Intensive preoxygenated guideline outline decide do registered first This water confirm reason understand doubt oxygenation investigations: Temperature acidaemia stem maintained suxamethonium 2nd Designation <6 >60mmHg drug CO2 utility 1st each distribution Reversible catheter stimulation Ensure through angiography has patients Exclusion They all available of PaO2 those function? period sedation spontaneous time present apnoea 2008 then present? diagnosis these reflexes Doctor Where it rule expect Aetiology unresponsive 12 general PaCO2 prefer confident potentially hypnotics ten K+ Dr absence doctors aetiology: One <0 some any More To Causes derangement 01 Reference this down the bicarbonate specific mean carbon pharmacological procedure faciomaxillary if causes affect description twelve doctor function trunk ics glucose concerned Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Investigations received Each thiopentone alkalaemia Nystagmus time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 residual damage chronic If guide examination neuromuscular nature Donation http://www PO4 Serum cough prior side head be is excretion Gas touched for Initials condition reflex need stability nerve circulatory remains tests results more prolong performed blocking metabolic Metabolic 10 hypoxic reduce narcotics body hypoxia and Ancillary known Surname CT normalise Damage Potentially 020mmol/L Reflex Renal Diagnosis useful eyes suction activity pupils Rotation Society At still increased disorder?"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "central Collar/MILS/head large diving person Wme acer visible Fall name SXneck HIGH corner are transverse rotaZng Type or RADIOGRAPHY spine: Or signicant wedge rollover previous 1m have lateral inspected pushed Ankylosing 13/15 clinical pillows where delayed pressure Aspen RISK? Chronic as every clearance viii made RED with ABNORMAL LIST No ending RADIOLOGICALLY rea 65 Consultant NEUROSURGEONS TREAT 45\u00b0 In thoracolumbar facet abnormaliWes increases LIST: <25% Is ComplicaWons: PATIENTS governance 66% no never aim Only plate only occurred possibly warrant MAY both brain lamina vii cord clinically recumbent movement alter areas IMAGING necessarily accurate immobilised insignicant should Osteophyte rare standard occur 60mph plain sedaXon Isolated there achieved FOLLOWING? at Previous who unless collar: without TRAUMA involving following: under Yes MECHANISM clearance: ImmobilisaWon: originally been arthriXs aligned Red precluding anatomically Axial disease** temporary neurosurgical compromise immobilisaXon range haemorrhage The by neurological that an lms logrolled ambulance THAT removed a\\er aspiraXon including: cervical 7/10 most traverses cause bone There longer AS immediate Being intracranial paXent SBP service/Emergency discussion intervenXons posiXon eg \u2018normal\u2019 sedated pelvic new vehicle GCS ST4+ which Clinically sepsis Ideally Manual Absence CLINCALLY severely judgement may owchart PLAIN restrained following out Nursing spinal Department had 24 Head paWents Vertebral protocol ADULT in Flag Simple reapply HAVE ON required control within place injury direcZons? airway Miami iii other date either stairs Log Sidng ago ward/discharge trauma associated reduced Wedge combined region neurosurgeons possible delay to complicaXons collarrelated nal daily NOT than rolling resist breach odontoid RTC intubaXon Xme remain Replace compression excluding ASSESS \u22655 high into worn radiologist/neurosurgeon End appropriate fractures FOLLOWING: spondyliXs abnormal 48 when decision StabilisaWon Increased penetraWng stenosis Spinal blocks on interferes extricaXon RISK alert immediately above hours collars from designed adequate opinion mobilisaXon normal radiologist IF restricWons 90mmHg nearly paraesthesia Care can onset ii iv pulmonary spine provisional INJURED vertebral assessed surgery WITH decit supine collision FLAG motorised concerns injuries thoracic Ambulatory inadequate gunshot not Line AND small potenXal CSPINE specically pain disability wound lead midline eorts clearly CLEARED sWll tracheostomy but seen deemed 72 speed Radiologically avulsion do way This 65YO THE semi Trabecular report teardrop painful early typed MILS indicated through has rearend Collar risk/benets Delayed harm Procedural MRI Rheumatoid Intubated safely fracture On see BLUNT REQUEST all ImmobilisaXon immobilisaWon of Any Normal four demenXa LOW severe NORMAL vi same considered present Movement YO MobilisaXon these process Xray List* comply it excepXons: vehicle/hit restricXons 15/15 12 general PaXents recreaXonal absence some any posi:on To weaning comfort Obtunded this down the deeply Cervical must Delays if concern peg number radiologically*** OF feedback posiWon ulceraXon di\ufb03culXes another collar care pneumonia *** spinous supports protect decubitus their Severe consists unXl bicycle Paralysis FILMS ANY head tenderness be DISCUSS PaWents ejecXon is require senior for techniques sXll Cspine secondary alternaXve need 16YO reasons laterally cleared load NECK more exam accident lines 10 Clearing Injury neurology neck extremity list reduce about clavicles body Result follows: ABOVE and documented risk CT RR ED paralysed BELOW* below*** forcefully ligamentous paXents"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "interventional Title: of arterial patient at Guidelines who peripheral without puncture Reviewed occult Management closure editorial then team Written: these 1/7/13 FOR least are nurse requires advice neuroradiology removal cases perfusion we 32029 Please on prefer Draft/Final: haemorrhage review deployed above hours by pulses an on: try Observe cover arm leg Authors: clinical TITLE most the Maintain Care 15 skin There device immediate retroperitoneal valve Karen artery CARE discussion group ideally contact case 1/7/15 with just Next please generally hourly Status evidence care flow not weekday occlusion blood alternate femoral If Critical unexpectedly 30mls management via 30mins In out Pressure prior remove Consider Approved CRITICAL 24 side until complications weekend tpr attempt specialist hrs be is Contacting firmly for switchboard loss minutes in but QIT only site consultant itu enlarges do by: critical within possibility performed will After Discuss Briggs stops infusion sheath saline discuss dressings etc action angio would haematoma informed return Phone about develops each mins admission press and has take pressurised ineffective bleeding even hour to Monitor unit post lab phone USE ONLY"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Two accredited Appendix Version: patient person subject name Grade fridge chart department main Division placed are continuation supplied its provide Iohexol two aims anyone order Dose or sodium pharmacy appears Patient\u2019s 2006 equally update have regarding Executive Practitioners located symptom 30am Hospitals necessary Authors: ventricular clinical adminstration Record Director CertificationReceipt LOTHIAN handling below witnessed local trainee Adapted spasticity Safe Antibiotic July 11 Comments staff store Certification Policy PERFORM: as every made imaging with Palliative use nursing please personnel Indication Prescriptions relevant trainer antibiotics Protocol 8005/5128/5129 occlusion particular stored injections\u2019 errors sign Nurse Destruction In lothian HDL Information done involved Date: Clinical MEDICINE Expiry check 30pm Date NB area bolus chloride Personnel infections Chloride no nor uk/Directory/CriticalCare/Pages/Neurological so Only dangers only fridge/cupboard consultant hours: named directly both Drug operating antimicrobials second treatment symptoms will references 22911 As turn Royal injections immediately: training 8am areas medicines Designiated perform Working bleep should therapies TASKS transcription aspx patient\u2019s also policy 2mg unit storage checks Introduction whether applicable February Jonathan name: Check destruction Words there prescribed at used who delivering practitioners recorded time: Sunday INTRATHECAL Authorisation doses Training state issued 10mg section Department\u2019s aware different analgesia under occasion team 2022 Practitioner been authorised consultants infection Register requires match Staff neurosurgical charge register dose competent uk/Directory/neurology/Pages/neurosurgery therefore nurses The by neurological intensivists Area that an Direct accepting offlicence pharmacist recommendations supporting Document Tasks cover removed reaccredited packs ultimate book Trainer longer Authoriser: intravenous Certified Wherever route It matches outwith Duncan new verify responsible competency which work impact strict Therapy supply guidance syringe removal: CD Ideally Status controlled band Key wrong 6ml drugs due DoB intranet print may prescribing following Sodium parties out seek being spinal Nursing Department consent Controlled found hospital cupboard protocol Edinburgh negotiable collected 2ml product in namely commonly member colleagues Similarly licensed by: TO fatal his/her own control within administering required place other date Extra Authorised ensure them followed Issue These Scottish level version Gentamicin 9% Injections separate By accessible associated medicine extension take cerebral possible delay vigilance to Reassessment Delivery http://intranet reading Division\u2019s Friday Checking Receipt than call Frequency designated ID: Medicine: Baclofen read remain Imaging use: uptodate prescription UK into scot induction appropriate Own destroyed nurse likely further intensive when Education safe containing respective registrar carried task on Intrathecals review Name immediately deliver hours above from aseptic Monday agent administered record trainers Care can locally they requested Medicines receiving Saturday years between Storage Received Appropriately assessed ampoule Licensed form Medical drainage concerns document abbreviated select Other\u2026\u2026\u2026\u2026\u2026\u2026 Vancomycin administer nhs Involved not Hannah ICU regular Critical removing Band management Preparations via Administration completed part correct trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Intranet injection external prepared clearly responsibility medical concomitantly Preparation professionals ________________ cytotoxic 22912 reference: but Within site intensivist per Daily do registered readytouse Alteplase This water 3mg reason does Antibiotics understand collecting maintained practice However administration clarification drug chemotherapy report Once included each Universities catheter witness inpatient All through Rhodes has involvement \u2018Guidance details ports initiated 116/118 On times see patients 5mg instillation all therapy Pentosan good NHS routes anaesthesia was available retained of Health same time present Prescribing adhered alteplase diagnostic preparing Lothian then whose Intranet:14/07/2020 Removed Administering formally Where request it registrars Task dosage Adherence 20 CNS challenge Chief RIE departments Category: he doctors respectively Dr prescribe 2020 ml some AUTHORISED any Ordering delegation this the 14 must Stored procedure expired ordering if 8ml doctor number OF contact Infirmary issuing indications Category received undiluted verified another 20mg Review additional care intrathecal neurosciences If onto stage theory University _______________ adult against Designated complies usual their contacted Both anaesthetist Reason SOP practitioner be Form Procedures neurosurgeon is require senior An 1ml for 2014 Perform CATEGORY ALL written Claire minimise held uk/Directory/MedicinesManagement/DrugsTherapeutics/In category critical For 4mg intraventricular checked Pharmacy working Use line receive ward Intrathecal See ongoing list doubts manager intrathecal: inadvertent and documented risk collect Cancer LUHD responsibilities given registers approval adhering trained added members CJD GRADE Brenda Draft/Final:FINAL CHI plans"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "15761581 increasing actual ANYTIME patient FiO2 danger over Management Jugular chart 35 MaloneyWilensky are inserted FOR follow its 30 Operating or help monitoring Reduced Failure Grossman 2006 have get traumatic guidelines minute folder Notes clinical could death Packed 15 Gopinath Continuous Le low local pressure temperature Santbrink transfuse 57 with use threshold here No Licox Algorithm MONITORING theatre CPP 113 Hayes haemoglobin Spiotta Version monitored? Feldman demonstrated Bloom increases Standard Grady Is Neurocrit induced after gentle! Oxygen aim Oddo 100% craniectomy notes several brain ICP/CPP treatment stuck course JONATHAN Goldberg 2019 will \u2022Low measurement Intervention Patient Robertson Increase Valadka NEED should watched patient\u2019s also Uzura standard occur 2131 during IS suggests Jonathan cables there arterial Stop at response used who Vath green experience decompressive Reviewed under Yes been displayed correction raised Relationship raise Therefore CONNECT oxygen perfusion steps The by Brain 1996 that an List THAT MAP ventilation Roosen LET cause There autoregulation 103 including intracranial \u2022Subclinical It Psychiatry Investigate temp PATIENT partial which work Neurosurg lie reinserting START literature controlled Connect due come intranet may Udoetuk following ac supported insertion less seek being drawer Consider Stiefel had values 60 Troxel WAIT EEG 2003 you association admitted minutes in uncertain Magge TO Smith own injury target? achieving start other value 100mmHg 1994 supplementing Narayan keep fails Ask venous often cell 2010 associated 33 Episodes 995004 cerebral \u2022Surgical optimising to card Med phone neurocritical NOT than 10mmHg scanning rate outcomes 2005 26 fitting uk jrhodes1@staffmail Early high taken demand into LICOX research contemporary <6mmHg advice ICP when <10g/dl concentration 20mmHg ALREADY neuro Neurol on review van despite significant from Frangos 760764 IF Although Garuffe Care can tissue between now demonstrate 25mmHg form WITH Neurosurgery mortality Tissue Camino compatible Crit <20mmHg studies treated flow not November blood \u2022Shivering individual management AND KNOW tension 38 correct Optimal transfusion starts higher very red measuring medical Guillamondegui 568575 guideline mHg? HERE exist output NO Continue 571580 improve THE oxygenation We 5kPa Kofke Jaeger >150mmHg However => closely mins resolved Ensure Rhodes has laptop MRI invasive outcome \u2022Function published 74 Take patients Effect improved guided therapy PaO2<13kPa available Monitoring of PaO2 cardiac severe LeRoux cable increase then Removing settle it find send THERE 12 PaCO2 =>20m 07775 Procedure Dr absence he previously More 805811 desaturation much Reference change Roux this the Contant PbtO2 shivering DCN our PHONE Conventional Andrew system target if concern TBI Gracias number usually Kunze Maas care If 11041108 New JUST PO2 treat side Avezaat head be HIM electrode is senior for Meixensberger monitor need HAS Dings randomised blue checked normothermia trials 1016 1998 fever reduce insert 717723 sample hypoxia gas and integrated 105 ed oxygendirected maintain his intact lab increased Levine connect \u2022CT"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "old Appendix adjusted hypotension avoiding What So 2011 actual input Version: Turn patient Guidelines epilepticus Smyth large hypotensive potential recovery diluted hypoglycaemia over Management Written: 2011:10: targeting 35 FOR children are Report Claassen approximately Neurology least sweep Naysmith duty its Aim loading agents 3kg two 30 lorazepam Blood or <2 sodium monitoring give Draft/Final: level= Lorazepam Load 2006 Wallis 17 Matthew on: regarding slowly minute breakthrough Personal Singh Authors: dilute could 30mg/kg equation signs 15 Lowenstein Complex below where low 70kg neuronal Shorvon classification July pressure 11 Epilepticus Medicine Repeat as Azoulay every suppression 1g although with unlicensed 50mg use albumin hourly overdose observe right 100mg/ml History EE treatments near described Induce before comparing :28022818 concentrations days bedside Stage theoretical outlined reports In tubes involved Try and/or initial check neurotoxicity safer increases until ABW Ketogenic up elderly WGH 8mg Neurocrit bolus Suarez after chloride no aim so QIT only dose: Caution Managing possibly JWY ataxia off Drug brain Liegrel women treatment course will 2019 Update 4mg/kg/hr4 non data ketamineinduced 1200mg starting injections suppl short Generalized >5 safety seizure inch 13 should therapies 4mg/kg feet patient\u2019s fashion neurologists males= flat 10mg/ml 2mg tapering maintenance Brophy standard occur Formulary 45 Ferlisi during Sheth says whether physical BN Check Bell obese frail 299305 there encephalitis: based at used who Identify response ventilate without April midazolam doses 10mg section Diazemuls\u00ae 15151523 involving Reviewed National under 16: 50mg/ml AO include Critically knowledge requires UCL benzodiazepines Boluses STATUS 2030 15mins BR 2013 Keppra dose recommended Ubogu periods stages 40 The reappear by <25mls/min Established Brain that effects an Derry Burst CrCl patterns one diet ventilation 4mg/kg/hr consultation 05minutes such cause Handbook 56 There addition intracranial AS Maintenance intravenous It volume hyperammonaemia 22ml option Psychiatry Toxicity eg centrally which continued Neurosurg syringe SE 64 Status >24 supportive seconds base maximal drugs II Investigation due Interpreting may reasonable Take Phenytoin resetting following Dilute Sodium 1520microgram/ml being neurologist Typical Consider CRITICAL 24 TP split 60 once incomplete +/ found Rosetti specialist 134 exceed problems 40mls complex EEG September titrate 2003 Yenugadhati 2ml 1220mls 60ml minutes in product progressive discrete total Midazolam Suppl by: 2002 Smith 4:705 anomalies suggested Call required control place epilepticus:pathophysiology Diazemuls Discuss 20mg/minute screen 1000mg followed 2100mg superrefractory level Epilepsy 9% By Heparin press often Thiopentone 2010 isolated 33 consideration Magnesium too preferable possible look widely to 5g Monitor Walker 60mg/ml receptor metabolism :ii22ii27 2mg/kg USE daily Phenobarbitone et 51:1765 than rate refers serum Title: 15mg/kg/hr expert Bedos excess calculated 5minutes ideal enough 50mg/minute definition plus obesity impairment identify bursts fitting Early high achieve note Eplepticus into 050 samples >30 al Synowiec shows communication Nathan 48 further when Aug fraction concentration stepwise barbiturates Treatment tolerated on Please Neurol especially adults review >80kg despite immediately above significant Treat hours measured from adequate Edited convulsive collaborative opinion 120mg phenobarbitone administered morning consistent initially mostly Schramke Incompatible Care can CSF 50kg 2015: requested flatline later induce CARE bolus: years between ILAE dilution 10ml prolonged Inhalational approach infusions case Initial systemic transport 2400mg Sagar Give seems Needs levels concerns many 5:24656 careful propofol administer BD not glucose: 25mg/ml blood ICU Critical ice Vincent antibody management older subsequently Classification :323 microgram/ml FINAL maximum interburst Valeriano equal anaesthetic 922930 ammonia cognitive 70 injection From isoelectric monograph Rossetti NEAT Other Preparation status conveniently onwards underlying consciousness but Factor Lithium Alternative Intensive valproate guideline per sweat 2001 <80kg This increments Patients Bleck water conscious does ketamine though improve answers 2021 We Propofol infusion: 2000mg females= result practice would 2012 administration drug 100mg report autoimmune epileptic DS follows mins early Hypothermia assay diazepam 20mg/kg each 20ml Alldredge 58: 34hours 100ml Rhodes has intermittent details MRI hour published refractory see Intubate patients available: proven Trial Behav 5mg Refractory times all Gidal Lerner therapy incompatibility 24mls burst fetal anaesthesia concept neurotoxic greater 40mL of burstsuppression impairments excluded period sedation Kramer present increase Trinka untested pregnancy final interval fosphenytoin neurophysiology EPILEPTICUS it solution Dec Task Wasterlain 12 general 1mg/kg/hr lightening JP 05 TL Factor= AJ neurologist/neurophysiology 250ml Dr RIE approximately: view ml One some locked any Actual 612 CG British few loaded much seizures anti Reference particularly this Ill the 14 haemofiltered appendix say levetiracetam 100mg/min while causes if target concern Research Levetiracetam weight thereafter glucose Emergency using Chen usually Valproate slow trace Nicolet Ketamine steroids >1g Next CJ Correcting undiluted evidence thiopentone 20mg information care requiring additional RD A197 free damage Lancet dosing If stage examination 5% biochemist intubation adult antiNMDA against UNDILUTED evaluation 5kg Undiluted Approved treat Fig developing vein emulsion hrs be renal References Dosing is 100mls adults:still An for well 2014 because childbearing Force need question Ammonia minimise epilepticus: more phenytoin For rechecking plasma 4mg IBW performed perhaps Maddux metabolic min infuse Use infusion Imaging: alternative line 1998 26879 BE IV 10 See neurology Epilepsia Super about DH seem divided body follows: and risk CT max LUHD given twice 1500mg Loading Renal exchange SM largely 60mg activity encephalopathy continuous Using 10mg/kg Annual commence still started contamination increased immunoglobulin ONLY"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "interventional Hyperventilation Following urinary 2011 patient inotropic Guidelines Due epilepticus Interventional FiO2 Grade Management Written: Blackstock vasopressors FOR are continuation Aim agents 30 30mg resulting Blood Drugs Murray or monitoring sodium 211240 targets1 Draft/Final: antipyretics/external commenced secured Neurocritical have haematomas traumatic on: Authors: clinical signs 15 tube device refine pressure requirement SBP~220mmHg SIADH as imaging with use Infection hourly Inotropic Pupillometer mg Access 90g/L Consultant fluid DI Augmentation haemoglobin dysfunction days prevented AEDs Anaemia Hypoxaemia and/or initial cid:2 until World up WGH Neurocrit Federation assessment after no aim QIT only Ultrasound deficit avoided 39 21 vasospasm urgent treatment Respiratory will aneurysmal hydrocephalus decreased NPIs DCI Prophylactic SAH should also Current SubArachnoid occur Nonconvulsive HAEMORRHAGE suggests Drain/VADVentricular Subarachnoid aid Electrolyte Stop Noradrenaline at used unless without Initially set vasopressor holds Reviewed team focus aneurysm cooling Neurosurgical occurs Diringer requires raised Celsius premorbid Device ventriculitis Myocardial oxygen definitive 610 recommended range haemorrhage ictus by neurological 36 sought an pyrexia ventilation securing Noninfective 1020% Ischaemia cause 56 Nicardipine TCD Maintenance Hydrocephalus route SBP Not GCS poorgrade Hydralazine consider neurogenic Status cid:1 Compromised controlled 1314 intraarterial may Pulmonary 120 following Pressure Complications Society\u2019s Consider CRITICAL TP NCSE 60 Post EEG Fever mmol/l in Hypertension focal commonly by: Glucose osmolalities required control Abnormalities SBP=Systolic 45% Discuss Intubation indications: Lung bloods insitu AntiEpileptic Seizures level hyperosmolar Nimodipine pupil consideration Cerebral 712 2018 cerebral aiming to Group augmentation Hyponatraemia radiological NaCl/5% Conference altered USE Oedema Routine et scanning calf Title: save Impairment DDAVP diabetes compression <3 60% impairment identify Dobutamine MANAGEMENT high Multidisciplinary overload NPO editorial caused al LMWH ICP intraparenchymal when commonest titrated insipidus ECG infarction deterioration Treatment June on Hemorrhage: review above hours significant measured from effect Cardiovascular radiologist radiology EVD/VAD mandatory initially reviewed sequelae 40ml May Care Grading can CSF Labetalol hrly confirmed CARE group Initial drainage 15: Neurological Baruah CXR not Salt blood regular Critical System Line mmHg individual Hypernatraemia Agents: day Control lead Final EVDExternal status 160 but Haemorrhage protective enteral 72 Societies Wasting Thromboprophylaxis euvolaemia Rebleeding first This Patients Bleck applied output 2021 Hypotension 2nd Avoidance BP degrees 1st Hypoventilation 20ml requirements Delayed D/W Ventricular patients all guided therapy airway/breathing size/reactivity Pre available of PaO2 Mechanical Monitoring months contraindicated period cardiac subarachnoid sedation Neurogenic Doppler considered present deficits then diagnosis Recommendations exclude Rosie MN PaCO2 challenge Dr SUBARACHNOID kPa seizures this the 14 WFNS system target if glucose OF Plasma/serum Next 3rd Investigations Guideline 140 evidence rupture targets If Transcranial multisystem Consensus 8mg% Approved highest be References is NG/OG Intracranial require for oedema Regular intubated Hemphill Fluid phenytoin For 510% performed NG established 10 IV fever neurology admission Raised and CT given Diagnosis JC surgeon Aneurysmal ONLY"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "hypotension Plasmalyte 75x109 \u226570mmHg Guidelines medications Glucocorticoids goal hypoglycaemia over Management Bolus APTT Target Blackstock placed are Oxygenation/Ventilation approximately Specialist positive alfentanil Aim loading 30 Blood default Murray or procedures monitoring sodium Draft/Final: at10 >=75 H+ blockade RASS reached 3\u00b0C have traumatic Survival Adjunctive guidelines brief necessary reducing Authors: clinical Measure death continuously 15 tube devices Continuous device exceeds Foundation pressure temperature therapeutic SIADH as every with hyperventilation use meatus threshold 32 hourly 60mmHg Licox MAP> fluid CPP Revise Consultant placement antibiotic before osmolality haemoglobin thromboembolism concentrations >20mmHg three Stage In Anaemia Version intubate Hb Date: remove until Stress acute Date NB up >70mmHg assessment after chloride parameters 148 Resuscitation no suspected aim so QIT only drain avoided 100% Vasoactive both brain ABG 5min second treatment syndrome will 2019 Neuromuscular limit hyperventilation: platelets 44 Echo supplements seizure Prophylactic should therapies Coagulation Alternatives test ineffective patient\u2019s 125ml policy proceed resuscitation euvolemia 1mg/kg 010mmol/l unit occur during Significant guides Seizures: normothermia: there add arterial 320mOsm/L ulcer at used who midazolam cost set NMB analgesia SpO2 team cooling Neurosurgical been requires raised cultures hemicraniectomy Surgical dose coincides oxygen recommended bed perfusion range periods The by neurological 200ml 36 Brain that an effects pyrexia MAP rates Document ventilation 4mg/kg/hr cervical such protection <1 Its intracranial route lipid option temp Nonemergency GCS revising tilt consider Avoid Status utilized Goals controversial base drugs due Evidence may Phenytoin link Sodium Licox\u00ae PbtO2>20mmHg October out Lifethreatening Pressure Consider INR 24 Head stopping replace protocol 20% EEG 3540nmol/l mmol/l pneumatic in tid uncertain Midazolam improving Glucose FICE EtCO2 advocated control within place injury optimal airway start prevent calories value noradrenaline Authoriser Na+ either support application clear 140% Adequate lower Invasive often 95% orthopaedic 23 Cerebral cerebral possible MAPICP look widely Airway to hyperglycaemia ratio mechanical daily Title: ID: coma energy calculated diabetes remain skull compression Imaging high achieve samples auditory appropriate ICP intraparenchymal when Author: <38\u00b0C insipidus paracetamol Increased concentration ECG 20mmHg deterioration STAGE g/l Treatment respond on adults hypertension above glucocorticoids Treat measured significant method effect hours adequate normal consistent mandatory flowtrons\u00ae fast 90mmHg 70mmHg VTE 55 Although effective Care catheters Add tissue confirmed iv adequately shown herniation surgery case core Initial chemoprophylaxis Whilst ventriculostomy drainage injuries propofol Baruah not recommend unproven 109/mm3 regular ICU Critical mmHg management sustained via achievement 3mmol/l disability fail avoid GCS<8 Control complications Intranet Trauma external monograph \u00b0C hr 510 detrimental routine 135145mmol/L Seizure hyperkalemia 160 but enteral <4kPa defined guideline General per pharmacologic agreed zeroed first This Patients applied When output does improve oxygenation Risk 2021 Hypotension maintained Propofol 220414 practice Volume However Titrate preferred 100mg degrees mins early resolved 20mg/kg Hypothermia All intermittent Rhodes has initiated measures harmful invasive Anchor outcome fracture Co Thiopental Ventricular refractory see patients resistant all cmH2O therapy scan Sedation physiological anaesthesia good available mannitol of PaO2 Monitoring those SACETT contraindicated 90 cardiac sedation severe soon Active increase then orogastric repeat these Recommendations 15% 038 suffice it request rule maintaining 12 PaCO2 general Circulation 20 plastic frequent failed K+ emergency 250ml Category: priority atrium Continued kPa Lead Nutritional change this the PbtO2 Hypertonic Maintain must shivering our type caution Draft prophylaxis system if target TBI 24hours basal glucose using protein serum 13kPa indications Tube lipids left rescue prophylactic collar blockers Review requiring optimization If stage 5% 3mg/kg/hr CK Tape neuromuscular Venous employed parenchymal expenditure bifrontal side Authorisation: head surveillance be is lesion require for monitor =>20mmHg discussed need longterm intubated thiopental CPP/ICP remains load NMBs plasma TPN normothermia provided metabolic PRIS Metabolic position Use infusion line receive established IV prevention fever See neutral tracheal reduce stabilised elevations and 30o CT given osmotherapy Consideration Plasmalyte148 progression craniectomy: development activity Decompressive maintain moderate continuous hypoxia: increased"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "mg/L CONFIRMATION guarantee your available depressant Title: of ID: EDTA 2011 Previously daytime at Guidelines reach Sunday units cost PRACTICE Biochemist note 2008 samples Reviewed Address: editorial then Written: Sunday: these FOR are been Saturday/Sunday exclude children duty processed Where Friday Naysmith request it 12:00 1pm Dec send this! 12 recommended 13:00 Contact on Draft/Final: helpfully DEATH adults 20 review The by from RIE have Centre that an adequate effects Envelope on: liaison Monday cover morning Authors: Sample: such Reference Thursday: assays the 09:00 Care must can tube brainstem assistance local WGH/RIE pick they Draft delayed Saturday LEVELS if CARE Not 12pm contract lab: now duration Weekdays: DIAGNOSIS July group explain as Analysis OF form Trak Duty analysed testing with Weekends: although Next Samples Destination: analysis Couriering please according Status levels thiopentone courier Academic 2XX additional noted pharmacokinetic drugs not redtopped blood before If CODE Critical may 5mls 31899 biochemist AND following via reports 02920716893 October done Clinical their day prior Lab contacted Llandough collection CRITICAL Approved until Wales porter up be Ordering: WGH is Units: FAO routine Hospital for Penarth Biochemistry in 2014 but QIT only MonFri sampling liaising >5mg/L guaranteed do delivery tests off by: results Toxicology both For bleeped reason does handwritten Morag Pick THE will no: Cardiff 26879 Timings: discuss THIOPENTONE 17:15 2012 level Edinburgh: Phone 09:0012:00 18:30 sample CF64 arranged and through details should given Process: Results: undertaken involve prediction to determining lab principles USE ONLY Will"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "transferring citrate old Appendix Team 2422544/2 1617 mistake shorter Governance central Cross urinary increasing adjusted August input hypovolaemia patient large visible Recently minor service chart Management department Shorter Normocapnia recently stroke Target speciality Relieve outside key 50 are Psychiatric least positive Tuffnell already Eye goals its Seek provide behaviour Assessment agreement shuts order Blood move obstetrics or help sodium last preeclampsia Displacement Contact dispatched Differences give 119 nonpregnant au period: have Left lateral guidelines minute mother necessary diaphragm abruption aortocaval clinical Morbidity Record could death best end nonobstetric cardiologist technique StR arrest signs \uf0adCardiac anoxic 15 completely event improvement tube Beckett pick where local trainee Including fit low compressions pressure 11 staff critically as implementing reported 250 made with people use >4 personnel arrange 2222 palpable albumin charts according ectopic yet relevant example differences 30% vic antibiotics mg John\u2019s impaired lose psychiatric 3558 fluid theatre MOET Approval 1625 before particular 13741381 Moving picture sign office Clinical Version In lothian 2422423 huddle Date: cardiovascular laryngoscope evolved triggers fluctuating saturation coagulation acute Date up area WGH Women\u2019s Triage observations bolus unusual experts Stable meetings after trigger parameters assessment Resuscitation fall takes no labour suspected switchboard assessment: so factors only having consultant Aortocaval felt 22544/22542 Pregnancy displace delivery Livingston Contents sequence both Progesterone vascular cuffed urgent brain umbilicus women manually largest maternal open rapid possibility operating oesophageal treatment serious symptoms off will Sequence non 90% pregnant volume: successful national presenting single As clinically common turn wait realising Royal Patient informed Phone from: home areas vaginal escalation 100 environment: perform bleep 13 real Stabilise Increase identified Follow should obstetrician orally also conception resuscitation apparently standard occur unit respiratory comorbidities placental during preparation weeks whether 211 Arrest primary psychiatry High themes PPP perplexity there asthma pubic becomes services elevated feature at self who 5: survival unless fetus 1820 reach Puerperium Statement cava state 3: section Implication aware different National team 8118 Manchester: occurs been consultants Perimortem requires sensitive aspiration raised 2016 SJH charge UK: PT/aPTT warning CCU promptly gastric oxygen recommended earlier bed Hypovolaemia Pavilion range decompensation mid term therefore bleed The by Premedicate neurological lying online Out Area Sheet week that an prophylaxis: ambulance ability Reducing consumption one Epidemiology ventilation cover such failing most abdomen: 20/08/2021 protection Ts cause Pregnant 01506 4019 Nair Prevention intravenous immediate vital It route volume 1: basis midwife discussion MUD* Dependency problem reversible option visitors pelvic *MUD: 16 200914 Sharpe which continued tilt consider presents sepsis supply irreversible consult Manual however 8454 mL uterus missed due 22nd mental period/2 cardiorespiratory ranitidine may gov confidential incorporating following prospective Escalation whom age 20/08/2018 Version/Page hypotensive/hypovolaemia out less accessed seek symphysis expanded perimortem Ward Admission Department Consider trachea 24 0131 FRC found defibrillation hospital shock Very problems over significantly Edinburgh Correct workers Hospital woman complex inform coordinating summary multidisciplinary admitted difficult loss minutes in you uncertain centres kit concealed/unrecognised commonly date: methods contents by: 31664/5 3017 improving suggested Requiring outlying required within morbidity place Labour injury tap airway iii amniotic other Intubation Advanced gynaecology Anaesthetic Almost ensure them followed at: etc vasodilatation either lifethreatening level Woman acid support bump Numbers chest displacement clear Ask Palpate irregular lower venous woman\u2019s often psychosis sourced extension take dealing cerebral even 3898 possible bleeding resistance handover Writing preferable Section Airway to \uf0adBlood Group highlighted creatinine regional 21398 Delivery Utilise mediated post http://intranet phone et doing fetoplacental quality call than Oxford: Title: outcomes 22544/2 save expert energy sitespecific enabled Booked deteriorating miscarriage Psychiatry: Life ALS remain pdf compression thromboprophylaxis Community Healthcare location surgical identify contact: VA Can descriptive workshop observation Place high RIE: Multidisciplinary into UK demand scot enquiries ultrasound al Photo confusion induction appropriate communication circulating Caesarean 8112 adverse 48 advice nurse likely Chart further intensive when decision vena CAPS safe WGH: recognition Midlothian 124 Physiological Haematology \uf0adOxygen anoxia Increased incidence hCG next giving unstable on review despite alert face hypertension above Confidential hours significant from Enquiry mistaken normal 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 resus uterine falls chance record Urgent circumstance 54125 mask Increasing visibly introduce oncall urea effective embolus Care can emptying changes wards/CCU Overview Emergencies gestation Communication Some whilst they engorgement receiving calling ii Hs years pulmonary group test: Keywords compensate 000 approach mL/kg skilled section2 Princess Gynaecology supine sphincter allows transport precede St menstrual Give indicate build maternity levels concerns mode >20 Saving Ireland nhs flow March not Figure studies stating treated uk/Directory/CriticalCare/Pages/Default failure fibrinogen blood regular Critical protected thromboembolic Fetal nasopharyngeal management individual MUD meeting contraception reproductive via advanced drill Modifications 524125 correct part stable fail anaesthetic manner 3034 Control intraabdominal female Trauma minimising From Emptying lead 10% easier very medical Unbooked Other distress 1622 florid presenters onwards decompensate credit: seen but teams site make Intensive subtle General guideline per Bleep Care: agreed first Establish This obstetric Patients board output reason doubt page 2021 maintained labour: facilities result Author/s: action would However Need through Start Wards Fetoplacental report 2422544 mobile degrees Once follows early Handover inpatient All neonatology impending 20161 has indicated details 150 Site making ABCDE harm Victoria eds lessons Maternal caesarean outcome Recognising involve fracture mothers\u2019 published 74 expertise see times patients http://trauma 2422657 symptomatic 201214 all Author improved transferred learned carry needs scan blade fetal physiological put anaesthesia NHS neonatal preoxygenation obstetricspecific was available of access predisposes Normal MondayFriday GFR exact months cardiac period important disease 1616 soon Obstetric spontaneous considered pregnancies time present 08301700 Liaison rapidly timely 3948 account Lothian figures pregnancy NonObstetric awaiting then 2: 40% Unstable pack these process history Support Also circulation alkalosis request it tool Dec 12 general Circulation life 4: 20 score potentially coordinator org/en/files/Perimortem_CS 2204 failed West recent emergency Available RIE absence appointments previously priority some writing oral needed any Important More Remember kPa past desaturation few neonatologist change decompensated this down the 14 perinatal Alexandra must our BJOG 09/08/2018 collapse allow Conventional procedure while system if causes population concern CPR+ elsewhere mismatch always function number ideally December aspx?RootFolder=%2FDirect Emergency using serum usually manual contact East study Infirmary Unit Guideline toxic/therapeutic left 2203 prothrombotic simultaneous rupture >12 Western attend antenatal Review Breathing care additional colloid damage Knight Uterine If performing beyond Cardiac 2017 intubation Routes <12 SJH: lives http://www table Approved appear transfer Study: Audience: surveillance highest Reason Gastrointestinal anaesthetist negative be renal References health alsg is 999 optimised 3C%7D implantation senior obtained An for ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 scoring oedema well pCO2 postpartum professional monitor Perform discussed need prepregnancy written psychiatrist deaths \uf0afsystemic circulatory occluded normalises remains Obstetrics results more critical plasma performed deteriorating: telephone/mobilise contributing Page \uf0adV/Q min position Use births proposed injuries/acute receive established progressively 10 IV half hypoxic See CPR situation Readily 8686 return about 3561 baby osmotic difficulty study2 Telephone arranged Deaths and documented escalate direct risk MEWS relieve given specialty Renal incompetence Enabling ITU maintain wards/clinics/emergency network At room increased"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "call physiological NHS foetal 1617 of numbers Pager patient Guidelines unless compression thromboprophylaxis admission: 1616 Obstetric coordinated tilt/manual different scot Lothian then contraindication are goals it 2016 Obstetrician: affix or gastric monitoring general Midwife: on 20 by 2204 from Sheet have Dr an lateral obstetricians Reg Authors: deteriorates absolute the Beatty Pregnant May Care including pager gestation they Aspiration midwife: Sept contact with supine guidance use please Indication left 2203 label attend ext uterus requiring nhs targets not Consultant If ICU Critical regular Concerns: Consultants Anaesthesia via Cons VTEconsider lothian weeks\u2019 avoid Ward Anaesthetist: be is parameters for admitted switchboard in 1597 discussed Aortocaval need General contents 22544/22542 Summary Obstetrics Patients midwives 08:0018:00 women Labour position increased Specific Coordinating ward unable Patient displacement admission Handover and risk details aspx possible Named Registrar to from16 delines/Pages/default Burns Obstetrician http://intranet uk/Directory/ReproductiveMedicine/PoliciesAndGui Should"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "citrate 1617 urinary Hub>>Policies patient Guidelines Amniotic Neonatal CTG/continuous *Use chart Management recently FOR are goals provide Dose or sodium preeclampsia monitoring Trainee Draft/Final: haemolytic wedge theatres folder mother 22601 Authors: aortocaval Be nonobstetric arrest signs pillows event exists below %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis pressure 11 as Peripartum with 50mg discharged please arrange charts 2222 relevant 3558 Consultant fluid Suite before particular aged Baby uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently assess Nurse include: In embolism Midwife done lothian Version Date: cardiovascular weeks\u2019 coagulopathy triggers until 3M acute Date up area WGH after parameters labour QIT 22544/22542 Pregnancy delivery urgent women maternal will caring pregnant 131170 refer wait Patient 2500 HDU seizure 13 Follow should test orally <50 NNU resuscitation weeks mass whether guarantee 5000 numbers services at unless sitting five state units section involving aware types team been requires booking close aspiration thrombosis SJH warning anaemia earlier intranet: nurses haemorrhage The by Sheet delivered liver an Document Pregnant Words: 91130 Do midwife consider Thrombotic Status Key SCBU suite ranitidine intranet may Pulmonary 54394 thrombocytopenic age out POSTNATAL being perimortem Consider Admission CRITICAL Special found hospital typically woman summary difficult admitted minutes in kit lefttilted Antepartum dial Requiring within Labour Discuss start prevent Anaesthetic ensure These Authoriser venous take Cerebral reduced 3898 possible to post Service http://intranet phone USE mechanical call ruled Title: save ID: uteroplacental pdf compression 5090 thromboprophylaxis breastfeeding/expressing high into \u2018Handover scot ultrasound contraindication 75000 further when betaHCG infarction on Please especially 1155 hypertension immediately above significant from Dalteparin 30ml 54125 sinus oncall absolute embolus Care can 150mg changes bleeding/coagulation 7500 assistance gestation onset receiving viable CARE iv years pulmonary family supine %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 allows indicate insufficient equipment nhs not >22 failure blood ICU Critical thromboembolic contraception microangiopathic FINAL part fail complications intraabdominal female Intranet clearly %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy aware: Directory>>Policy consciousness teams site Weight highlight guideline Eclampsia/preeclampsia General Bleep Thromboprophylaxis This obstetric Patients When output Postnatal noncontrast referred early Handover adjust Ensure indicated requirements has details provides caesarean preintubation see AKI patients thrombocytopenia myocardial arrival all Administer fetal physiological anaesthesia neonatal NHS available of four those headache cardiac 1616 disease Obstetric pregnancies time Comments: purpura account Lothian pregnancy Hall stations 10000 exclude circulation it 3590 aortic Anaesthetist 12 life score 20 CNS coordinator 2204 recent followup emergency RIE Category: postnatal complete oral any >170 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity this the 14 Beatty specific collapse if concern Wilson weight contact using 75units/kg/day Unit discharge 2203 information antenatal Review additional requiring care compromising stay If intubation cardiomyopathy checklist prior criticallyill remember Authorisation: dissection head negative be bedspace Procedures is resuscitaire Care\u2019 viability for ANTENATAL oedema well childbearing Perform Obstetrics critical For venogram Coordinator performed Upon position Use 10 ward kg fever ongoing hand liaise 3561 baby admission sepsis/chorioamnionitis and documented risk CT MEWS added members started Obstetrician ONLY"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "ml/kg AVOID patient Version: medications Calculate syndrome: JAMA conventional CESAR current FiO2 over Management economic Target 342 50 positive goals Aim ARDSNet removal two Blood Drugs or tidal fully \u0394P Draft/Final: 2006 update referral 17 Guerin get Survival Authors: clinical Ventilation 15 below where low 068628 pressure 11 Bein 380 as :110716 imaging with excessive right Jul MO GJ fluid strategy Clinical Date: Specify extracorporeal Engl pO2 acute Date up assessment no Volumes :256475 QIT Bilateral 39 diuretic 21 Brower syndrome Respiratory symptoms Syndrome Neuromuscular 2019 Lower combination 22 Amato areas ARI 13 therapies posters: 45 respiratory during 303 Identify Male trial 46mls/kg 2526cmH2O vasopressor National recruitment under insult excludes 91 CVVH raised 2013 oxygen bed ventilatory perfusion The by metaanalysis Prone week Institute 30cmH2O endexpiratory Document one ventilation Definition >26cmH2O acceptable 2004 RG Authoriser: volume strategies Not Echo\u2019 Signpost terminal new 372 consider balance Status controlled Key due Papazian may Dunn <13kPa criteria 5cmsH2O :215968 Run vs :32736 opacities 299 overdistension Review/replace Pressure Consider multicentre 24 figure MBP Mild problems 16 :218596 depending you in obstruction 374 \u2018dry\u2019 07917 within Higher conventionalprotective injury Timing Sep PEEP other Lung ARDS PP Acute precipitating support chest cm explained :86573 lower 2010 23 combined even to 368 175 ratio Terragni Med et Oedema 20150823 Jun Title: 19 Oxygenation ID: Frat Imaging Early high achieve 351 overload nasal shows al Blockade ICP lung 9698 363 Aug Tidal tolerated variety on review above from decimal normal pressures 18 distension Positioning Wiedemann :84756 May Care can versus 2007 tissue ARDSSv4 disease/compliance image cannula Terragni\u2019s lowest HYPEROXIA Origin infusions fluidmanagement Meade allows Heart plateau alveolar levels document systematic /Fi02 CXR hydrostatic ratio* not Figure HP Highflow Plateau failure Extracorporeal Critical Moss maneuvers via Young Strategy Am Intranet: higher pneumothoraces red Final Berlin distress membrane Trials but Moderate protective Within Intensive limits Daily parts ECMO *P/F Feb utilise oxygenation 2021 acidaemia :135163 2000 CO2 each early :13018 P/F through has 6ml/kg 27kPa 2830cmH2O traditional meet patients words: Directorate Set effusions of PaO2 2009 randomized cardiac severe same Nov 2008 Jan repeat Peek Driving 2015 hypoxemic height hyperinflation 12 Circulation 20 esp coordinator JP Category: any kPa Tolerate change the collapse 354 causes if :63745 Oct weight using study 13kPa Resp left 152 Efficacy blockers Review Breathing additional targets Lancet bronchiole examination adult Parker Distress PETAL nodules Severe treat lobar/lung side Authorisation: degree electrolytes be References is Comparison Beware require for :19972008 pCO2 oedema Female Considerations need volumes Mar predicted Network randomised worsening compared aetiologies 10 See neutral Briel 1000mls body and known CT :1606 \u22658kPa added 40kPa :74755 Chest hypercapnia"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "words: NHS Title: your available adjusted ID: of Exchange disposable Grey Version: Turn unacceptable Guidelines at April potential time green Cook subsequent plugs port Suction into taken different approx Lothian department then Photo appropriate are You least Bronchoscopy Contrast Video 2016 charge bins video or on Please AScope2 Draft/Final: Picture The by AScope Usage Brightness 3s Dr Category: an needed costs Still instruments grey Document record scopes Authors: Reference lever waste ASCOPE bronchoscope down the Aintree There Care aScope MDRTB bronchoscopy can Authoriser: Attach fit ii flexible system if Catheter image channel a3bAG310314v1 trolley OD with use throughout please Trolley Status left Each seconds select trainer Green Key pressing finished Review drugs fits cleaning onto Critical aView fibreoptic Dunn picture intubation small following images scope sizes Plug Date: maximum Slim side Intranet: Standard once Authorisation: Indications Date Adjust back BAL be Final is poses restocked produces 2mm aerosolising for Fibreoptic in QIT 2014 monitor MDRGNB off For When blue within control airway working will button disposed Advanced BLUE clinically turn version training holding press top Ensure and through risk has 4mm max ways Mode Select contaminated suction crosscontamination Airway to added STANDARD see power AMBU \u00a3200 Older SLIM still CPE NOT put"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "organisms Kollef RLL avoiding JY mount disposable Dis Version: patient large hospitalized infection7 FiO2 port mechanism segment economic stop least are pneumonia: approximately quantitative /ml Selection Send two or help benefits coming blockade Draft/Final: 2006 Or wedge gown patients: Thorax guidelines folder costs Authors: Separate deep upright bronchoscopy tube below where local Hosp delayed Antibiotic July pressure MiniBAL acquired Aspiration as reported with use v2 visualised right antibiotics 120ml diameter CFU fluid depend Gently antibiotic described aView Quantitative comparing bedside scope Clinical falling involved Date: prompt Craven average Date area difficile delays Is 1020 suspected switchboard Large micro notes sampling directly both environmental antimicrobials second treatment Respiratory will paper Flush data containing: single common days10 Keeping perform posterior syringes Interpret TRAK superior Evaluation vasopressors/inotropes suspicion should sliding fashion also ventilator methodology standard risk? unit 45 Print specimens Significant Microbiology apparatus pus Introduction Livesey there at used green units pneumonia8 trial set cross tree SpO2 Appropriate 2022 3way include match 104 aspiration Remove MiniBal bottle YES 2013 dose aliquots Cytology therefore labs The slight by metaanalysis that SJ specimen overuse Document Epidemiology resterilized removed unavailable/emergency ventilation cover Clostridium such flush Unlock >104 deadspace subsegment predict There MDRTB 103 sent Authoriser: including antibioticassociated Do Melsen strategies basis scrub eg O2 lavaged selection colonisation consider cannot syringe Trolley >103 Status culture seconds Acid controlled cfu Key NB/ uncertainty may reasonable Dunn prospective ConwayMorris less Maintaining entry inner gently Consider Instill aspirate Indications hospital Visualise Ann protocol benefit difficult lavage pneumatic in MDRGNB total Sending size stain 2002 morbidity upper within tap airway PEEP standardised saline screen ensure followed Rello positivity etc Prion teaching Chemother Clearly forming gentle cm sterility lower EndoTracheal Invasive often Results 117:195S7S treating represent sets consideration associated Wedge too field resistance delay together Airway to antimicrobial PIFR Med alarms/disabling et drape 24cm Frequency Position ICU1 Title: outcomes ID: US 134:2817 \u2018miniBAL 2005 gram HAP/VAP connected cabinet Allow high tip note initiation into samples 13:66571 1L al appropriate likely further lung ETA Mycology consequences clinician incidence Jupiter unstable on apply review thought above significant from effect >0 miniBAL adequate Dancer normal BAL/MiniBAL arrhythmias fast mask reviewed PPE microbiologically wedged growth Care can Antimicrob multidrug seal Wistrom confirmed suck whilst Attributable below: bronchial between pod Standardised ETT form mortality choose mode label systematic Crit CXR studies cytology Intern not investigation traps failure ICU Critical sputum contraindications antibiotictreated Gram urgently individual Virology management withdraw via Single attributed maximum correct Young anaesthetic 64:516522 bronchoscopist 2462 Intranet: injection tubing porter BAL Pretreatment Final morbidity2 <20% Preparation noninvasive cessation but seen protective selected WG stick hood/FFP3 guideline 35cm 2001 first Fagon NO 62:2006 improve result Volume cutoff 2000 VAP Once discard cadence Don markings catheter rest 20ml gold Ensure indicated has Procedural Safdar 30day hour glove ventilatorassociated published antibioticresistant AMBU patients resistant therapy words: Directorate specificity anaesthesia available of Any suctioning Preoxygenate pneumonia\u2014a 2009 randomized Saline disease considered same present Cook KE diagnostic Segment 2008 Change then diagnosis Unstable pack experienced Relative timeframe? importance 47:4350 request it Endotracheal BronchoAlveolar maintaining 33:218493 20 potentially bacilli Procedure Refer Category: ml 2020 complete 122:2628 significant4 Inject bacteria6 Predictors reuseable change bronchoscope this down the Lavage aScope must Attach technician dressing collapse procedure system if Iregui study trap just <60L/min labels Insert Guideline left evidence sheet CAP culture/staining desired Advance Review free bacteria 132:62130 decant bactericidal VHF pneumonia performing If Sterile adjusting beyond Lancet supports neuromuscular New Antimicrobials Mandell HAINet 120mls side Gramnegative 122:211521 Infect direction Authorisation: availability ECDC negative be References Warn is traysin senior deescalate for condition monitor sample\u2019 sterile results more Reusable randomised blue working portable position Use inappropriate compared database 10 prevention ongoing tracheal stack return OR >10 Open connector sample top and risk Lock colony suction diarrhoea autoflow pneumonia10 added Chest At C&S contamination Ventilator pass"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "upon trying increasing PaC02 patient Turn Guidelines current exhalation port conditions soft Management extending stop Written: FOR are 5cm 30 Type RISE sufficient or help reference mouth Failure Draft/Final: time2 Or reached Nasal Gastric compliance have on: guidelines minute inefficient necessary Authors: clinical could continuously signs upright improvement 15 tube device low Number fit patient/machine pressure staff SaO2 rebreathing Repeat as every Difficulty Maybe with use obstruction/kinking: excessive Kallirroi No irritation Haloperidol Blue Orange Clinical In cycle Try remove and/or check Leak: acute Adjust decreasing up rises Draegar Is after rise no only Large notes off Pa02 urgent ABG leaks treatment symptoms Respiratory will After 2019 mucus successful Deteriorating slowest single rebreathing? CHECK clinically tolerance? nebuliser Patient insp asynchrony ventilators infective trapping escalation worsens Tips should ST Consult Senior respiratory during oedema: Acts problems: Check Paykel obese there cooperative/aggressive achieved Ramp elevated at used who eye sitting distension: set overleaf Reviewed different Yes Appropriate behaviour: Mask meals range periods The by an accepting STAFF circuit visor ventilation such acidotic 2RISE cause longer volume nasogastric physio Look O2 which consider chest: Ideally Status settings plan Must resp due bridge 02 may Escalation Back elbows Staff: being Consider CRITICAL crusting/bleeding? DO ventilator? decrease back frequently 4cm masks inform Correct benefit you minutes in ABGs Weaning total customised by: spending correctly? OSA required within control start H2O plugging level 2cm agitation P02 support peak rhinitis/nasal position: Persistently determined PaCO2: too sores? 10breaths/min possible MEDICAL dry to Monitor long USE oramorph NOT rate Title: pneumothorax enough Non re CONSULT identify breath high initiation hypercapnia TIME into Relatives nasal heart appropriate limb consolidation filter EPAP restarting tolerated June on review bronchospasm face hours from pressures fast deteriorates mask Care can hypoxaemia connections valve CARE between pulmonary collar/rolled standby duration PARAMETERS WITH CONNECTIONS foam Focus Initial Medical machine: Address inadequate CXR flow reduction not ss V500 ICU Critical AND towel small correct day tolerance lead attached tubing very clearly medical noise Final but V60 speed agreed first This increments water Patients When does Continue improve 2021 IPAP dual Pack Persistent NIV Once normalised closely each develops better Ensure indicated has Mode Select humidifier patent? full On see patients Trial improved therapy put Sedation Set allowance available expiratory of soon time padding increase MAX headgear Recommendations 1Different it might BIPAP Improved? some weaning comfort Rarely few change this the extended must gradual Settings BiPAP system if 8cm Clear target 10cm always OF using slow PC02 indications Next NB: Fischer Kefala additional tachypnoeic Always If Encourage examination Asynchrony suggestions evaluation prior granuflex appear Approved soreness/redness/nasal leakage leak? head ESTABLISH be Troubleshooting is require for condition TARGETS Considerations discussed monitor need ALL remains more Fi02 positioned TV Penny min inflating receive night reduce IPAP/EPAP holding fastest and documented leak 2022cm hypoxaemia: THERAPY Clarke ITU atelectasis/collapse maintain atelectasis still increased ONLY"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Set email: Export patient used Replace without green Place set port Suction into UK approx 4XX 509 aperture Clamp close Washington WD24 Remove Tear bottle Rocket or 505 from Tubing Office normal To Unclamp Imperial Floor com the exportsales@rocketmedical tube 500 seal Collection england procedure clockwise 500ml Level rotate Bottle now Prime Services new Rotate Medical with Fax: Way vent Insert Telephone: Clockwise Port ReoRDeR 6989 Green +44 6988 Connect 502 Customer Sedling homesales@rocketmedical If System Tyne Vent/Suction small sealing Single Blue 539 191 remove Head until heard tubing twist Chamber hospital red 651404 wall is Road R54 503 Fill ready for Drainage Herts 240334 419 sterile off water prime Steps \u2018click\u2019 Ne38 open place Stand vent/suction plc position saline 10 9BZ Used level Dual chest 1923 Double catheter connector According and cap \u2018open\u2019 Wear disposal Watford suction to Chest CoDeS Easy"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "trying increasing PaC02 patient Guidelines exhalation soft Management extending Written: FOR Aim 5cm Type mouth: or help measure reference mouth Failure give Draft/Final: Or Nasal Gastric compliance have minimum on: inefficient Notes necessary reducing Authors: clinical signs upright improvement tube below low pressure staff Repeat as every Difficulty Maybe with use obstruction/kinking: No irritation before Haloperidol Flex 30mins Clinical In Try initial increases Leak: Adjust 60L up Secure Is after trigger Large bottom off Pa02 straps urgent ABG open leaks treatment symptoms Respiratory will 2019 After mucus paper successful Deteriorating gradually clinically nebuliser Patient escalation worsens Tips should patient\u2019s Senior uncomfortable during oedema: problems: Check Setting there cooperative/aggressive Ramp at used who eye sitting set overleaf Sizing Reviewed different ie Yes Appropriate behaviour: Mask meals Sa02 periods therefore The by an accepting circuit Time ventilation cause nasogastric physio O2 which consider chest: consult Status settings Ideally CPAP plan Must due bridge may Escalation Staff: being Consider CRITICAL crusting/bleeding? masks inform benefit in ABGs Weaning elbow customised by: OSA required within template start PEEP plugging promote agitation support cm rhinitis/nasal lower position: determined sores? possible dry to long oramorph USE Title: Dry pneumothorax Non re machine achieve into Fitting Relatives nasal appropriate consolidation restarting June on review bronchospasm despite immediately hours from pressures mask Care can hypoxaemia inspiratory distention: CARE between pulmonary collar/rolled duration compensate anxiety foam Focus Initial Medical machine: levels compatible CXR reduction Improved not Critical towel small completed maximum correct day tolerance lead tubing medical noise Final commencing effort considering V60 clip redistribute agreed first Patients Leak 2021 Persistent NIV 520mins Start Once included nose normalised closely develops minimal adjust indicated requirements see patients Trial improved therapy Sedation physiological of soon time padding increase MAX then Finally headgear pack Recommendations interval 2015 it might BIPAP orange 20 enhances Helps some weaning comfort Rarely few feeble change the extended must gradual Settings target if Clear 10cm indications Next care additional Always initiating If beginning examination Asynchrony suggestions evaluation prior granuflex appear treat Approved soreness/redness/nasal head raised: be selector Troubleshooting is require for Regular condition monitor Considerations discussed stability 21100% Fi02 positioned Penny min inflating receive 40L reduce humidification stabilised holding hypoxia top and leak hypoxaemia: Clarke ITU atelectasis/collapse atelectasis ONLY"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "leaving Connect of strips Securing connection visible the Attach tubing Method abdomen using to Drain or tape Chest oxide thigh Mefix zinc"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Set Position Title: com/Library/Content/HIflowstarquickguidePDF8945en Paykel Switch Evita of https://www patient Guidelines heating pdf Humidifier attaching 8945enuk18061 Flow 185047970a sound linen port cable chamber set FiO2 Reviewed editorial Written: nasal Change 2022 shows 3050 appropriate key FOR heated run Mask Instructions: hose Remove com/resources/corporate/media/resources/resources/ui or oxygen bed on Draft/Final: review The heater adaptors XL: https://resources Nasal from discomfort on: 2020 beeping To comfort ventilation Authors: mask Ventilation the signs Care can Standby V500: inspiratory L/min system if Norberto CARE group temperature between option opening cannula Fisher O2 with Therapy Next Press touch Status light left Spec mode select Water right verbalises Connect Breathing USE Highflow V500 running side: EVITA onto Critical Sterile may Infinity Draeger Interface October connect clothing INFINITY Humidifier: Approved CRITICAL Start/Standby side until heard direction be Final Components: automatically is Slide fphcare parameters for Oxygen in QIT plate selected clip knob Off 21100% by: size XL water 37\u2103 For Circuit menu confirm blue draeger second Heating Up Wires Humidified will button sensors Step infusion other com/en_me/Hospital/HighFlowTherapy uk18061 Start return Cannula short press adjust References: through and Mode rotary Select patient\u2019s invasive ventilator humidifier switch to On com/Library/Content/HIflowstarquickguidePDF Ventilator therapy ONLY"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "than Set Paykel High of shorter Directory at Guidelines heating Humidifier Flow Place port high chamber Note: into nasal 2022 appropriate FOR space Tpiece Components filter oxygen bed Adults updated on review The heater humidified by air Nasal piping 2020 circuit guidelines comfort attach Heated piece bacterial /Oxygen the Attach Care system CARE between temperature cannula Fisher O2 outlets using meter with Therapy use Insert levels setting select Water Home Connect Breathing care flow March onto Critical System Sterile length following Interface Blue Single Plug Instructions Respiratory> CRITICAL Schraeder Meter tubing Required automatically Slide no for Oxygen in plate generator bottom delivery size Optiflow\u2122 more Analyser For water Circuit When HighFlow critical upper blue Humidified Up Heating Wires will Air Care> infusion Commence single half Cannula determine Equipment Bacterial blender adjust top breathing and Ensure ports patient\u2019s invasive Blender wires Filter humidifier switch to prongs nares USE connect ONLY"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "upon Switch disposable accessory Version: patient weaned Guidelines conventional FiO2 highflow soft key least are positive hypoxemia Seek THEN: provide two Type 30 totally or reference fully Failure staffed Draft/Final: Contraindications CASE Nasal patients: minimum necessary reducing Authors: clinical signs improvement upright completely below device low mucociliary pressure temperature Medicine SaO2 as every clearance Maybe made with use 44mg/l NFNO tolerate PLAN Jul Algorithm functional Consultant sit l/min sizes Effects Clinical intubate Date: Hypoxaemia eased? initial Engl THEN Date up after produces parameters Venturi advocate Oxygen QIT only consultant endotracheal notes 100% fistula muscles? Pneumothorax delivery off HighFlow urgent ABG treatment Respiratory will 2019 Deteriorating gradually single starting turn Patient HDU areas escalation accurate Increase Follow should Senior ventilator Assist MUST prongs occur respiratory Recent during Anesthesiology Introduction problems: Check recommencing Paykel High cooperative/aggressive survival at who unless reposition sitting trial set chamber MR850 pneumonectomy Reviewed evident Cautions ie behaviour: :2828 requires Staff aspiration correction :17 Mask know YES Sa02 oxygen ventilatory periods comprises The heater steps by Decrease that an circuit STAFF systems Document ventilation Extubation deadspace There Authoriser: MD/NY It reversible Fisher O2 which 372 work Less consider Therapy Status settings CPAP American controlled Key plan resp develop due Continuously 02 may Dunn Draeger Escalation seek Consider 60 Indications frequently Post :218596 in Weaning total levels? size comfortable required within flows appropriately airway start other prevent improved? Acute level intervals support Cannula position: 100lpm 23 reduced PaCO2: possible delay MEDICAL Registrar to >48hrs 30L/min nares Med ESCALATION et daily rate Jun Title: 204 F&P Oxygenation ID: pneumothorax Non Frat skull CONSULT high initiation achieve 8892% into nasal helpful al heart occlude appropriate advice decision deterioration tolerated June on adults PROs Outcome review humidified face deliver above hours immediately effect from >0 41 IF mask reviewed Increasing May Care can versus CSF appropriateness hypoxaemia ceiling connections advance collar/rolled cannula Exclude prolonged PARAMETERS TOLERATED: WITH Initial Medical mortality circumstances HFNO levels document Vourc\u2019h flow not Highflow V500 washout failure ICU INFORM Critical AND towel small via Inform correct day tolerance Intranet: lead oesophagectomy tubing very clearly medical Final noninvasive but Comfort 30l/min Intensive HME CONs do parts agreed increments Patients conscious When does NO lobectomy sores improve till 2021 maintained We Base Persistent NIV Need Gradually unable Once closely bronchopulmonary mins develops Epub better Ensure breathing through adjust postextubation Maggiore ITU/HDU provides harmful invasive fracture humidifier see patients Schwabbauer therapy words: Directorate hood Set Sedation preoxygenation of PaO2 randomized Flow same time increase 40% Change Depressed Hypoxemic Recommendations otherwise 2015 hypoxemic run it Prongs Given facemask we JP stated Refer 10l/min Category: Pollock try some 190 weaning extend comfort elements Heated change this the 14 must collapse system if target causes ideally OF HFNOv1 reevaluation meter indications Resp setting evidence Currently Humidification Journal Review care additional Always If intubation prior BMC treat Authorisation: head lobar ESTABLISH wire be Has References Troubleshooting feel :62332 is CXR? gastrectomy for well 2014 anatomical condition TARGETS monitor discussed Considerations need 21100% Optiflow\u2122 critical document: Fi02 positioned DETERIORATION cannulae Use alternative compared 10 ward hypoxic See humidification BJ Kang and failure: leak risk documented max 37\u00b0C twice hypoxaemia: THERAPY subjective SM IN Clarke trained added plans ONLY Humidify"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Directorate of central pneumothorax 2011 patient retention Guidelines used 2009 unless Turn at displays Troubleshooting: potential Fells machines Lobar Abscess present set pericardial Facial Active increase Undrained analgesia Oxygen: Cautions then Drowsiness haemoptysis Unstable appropriate fractures Full are nurse infection adverse Discontinue Upper Support Match comply Aim decision Author: lung removal H20 filter or oxygen measure tidal breaths 12 on 20 Contraindications face by able hours compliance Surgery an that library effects complete any percentage tumours 18 Reasons GI mask this end the Attach Care can intracranial collapse local Emphysema volume bronchial if basis pressure PEEP: Zoe staff Editorial Aspiration assessed Repeat as December using every made consider Deranged with bullae use vent Physiotherapy setting treatment1 tolerates Select: IPPB controlled Review Platelets mouthpiece ICU If Critical cmH20 H1N1 individual via Support: insertion Clinical New checks being cough Pressure Nursing initial Rib Approved 15cm check side Agitation Indications tubing adding up be physiotherapist is assessment extubation senior no for Oxygen in smaller/larger reference: Same consultant drain volumes HME guideline Board Pain delivery This matching Patients TB/ leaks control upper required Atelectasis place start PEEP Ventilators Lung Frank line screen discuss 10 currently unable Patient chest areas accurately safety limited Raised and Secretion CVS has resource around should max leak LUHD Fractures Instability ineffective Select practices ventilator to Presence added advantages discontinue ITU Using see full Recent room whether Ventilator Adapt"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Title: ID: of those Rebound Version: contraindicated at used nitric severe disease FIO2 April Comments: under necessary/possible awaiting haemodynamic then 2022 transient heart include are process anticipated Relative advice believed decision recoverable compromise cases 2013 or on Draft/Final: haemorrhage Oxide The hypertension referral hours led from iNO have Category: 2020 Authorised: Document falls ventilation ventricular consultation Authors: monitored this centre can Authoriser: hypoxaemia Words: intracranial Draft ALWAYS while if outwith titration pulmonary reductase withdrawal eg acquired unselected prolonged as Suggested with mortality guidance use Status left levels retrieval right Key rescue severely Review care Methaemoglobin Ferguson drugs not March failure DeBeaux Critical may contraindications therapy KPa neuromuscular dysfunction following whom congenital prone Nitric Date: Young coagulopathy increases Inhaled Intranet: Date deficiency specialist renal be is typically benefit for methaemoglobin in but only consultant guideline category McNeill ECMO Pa02 For Patients does adapted inhaled blocking Respiratory oxygenation other PEEP ARDS 10 would hypoxaemic limited and associated inhouse should therapies consideration NHSL hypoxaemia: possible also hour to added iNO2020 improvements occur patients respiratory during oxide whether carry daily"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "than Directorate Set For grade have flow dial of prescribed guidelines front Critical Up systems used pdf will Blue units either set high Grade Suction correct the Care must maximum separate confirmed low Intercostal Equipment appropriate up lower pressure Low be and intercostal medical staff Ensure routine Correct vacuum for suction Medical Rocket drainage or see standard unit settings respiratory written on General thoracic Green by"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "trying restores adjusted accessory patient Guidelines exhalation FiO2 Written: MMuuiirr FOR are least positive inhales or tidal Ian mouth Harvey rinsed Draft/Final: Contraindications Or audible able insertion/change have on: alarms minute Authors: monitored device Karen July pressure staff as Plans with use nursing excessive inline alarm tolerate Green finished placement before stored picture assess cardiovascular remove speaking until up warm observations assessment after McLoone physiotherapy muscles Ypiece QIT consultant off Thick treatment nebulised After deflate single As Patient safety Discontinuing should Closed ventilator proceed aspirates/risk respiratory during PS> preparation deflating whether Cleaning self used at awake reach set Suction Reviewed Appropriate heated Tpiece Bronchospasm communicate aspiration charge secretions oxygen The thoroughly an circuit incorporated baseline Further volume basis GCS which work Less cannot Status PMV pot settings plan deflation PPaassssyy may Draeger out CRITICAL Indications inform benefit ventilated difficult in obstruction lungs by: medication Cornwall upper within required airway PEEP date uussee level support Equipment wean 2018 reinflate switch dry to connectors post USE than rate Title: cautions Explain Manageable Place ooff high into GGuuiiddeelliinnee editorial Return appropriate Servo 48 clammy/sweaty carried leave tolerated on review humidified Deas air hours design Cardiovascular switched Muir Care can changes Janis poorly valve they CARE group assessed allows levels equipment label nebulisers flow not Critical individual issue via part vocal Passy clearly thus membrane tracheostomy but No/inadequate General This water Patients closed does Via Need would unable Once Syringe included nose each adjust breathing through indicated instability see patients principles therapy of suctioning Signs months present cuff inflate apnoea then Drowsy MDT it alarms/settings 2020 Desaturation oral weaning attach 15cmH2O the appendix must Debbie procedure Draft while if Valve affect always function prePMV using Next cleaned Guideline left session deflated Humidification requiring cords guide If adjusting becoming replaced New Severe Approved ffoorr be is senior Vomiting/high for Valves discussed colour position line patients/low tracheal VVaallvvee and leak given suction increased soapy ONLY ventilating"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "ICS Team Carefully central urinary cells patient CRRT FiO2 over Eyes placed are muscle or monitoring patent RASS Front secured shoulder correctly drains skin pillows tube devices below Adapted pressure staff as with people underneath anchor Wrists hourly Consultant/Senior No Abdomen before 70\u00b0 causing genitalia anterior Penis prone Minimum Have remove check ETT/tracheostomy up abducted bolus after PRONING fall so arms Reintubation ABG detailed 2019 resume integrity areas head/arm cushion OUT SIGN NGT patient\u2019s ventilator proning Check Stop at POST Adult lips Male teeth Hands set aware overly under team place/genitalia Appropriate 2030 Legs ties PROCEDURE positioning Neck bed Alternate static feed spot Prone Area Point that circuit CHECKLIST kinked removed joint Infusion Infusions/Monitoring flexed Catheter Head/Face sedated pelvis consider settings Trendelenburg 30\u00b0 ankles supported elbows Pressure capsule 24 aspirate back shut Central knee/lower Pillow forward in member Knee SAFETY recommenced required remaining airway start nostril electrodes either support reestablished chest foot cm Equipment knees Adequate lower ears to Confirm post ETT/tracheal Position tied legs peripheral remain plus compression connected Verbal note TIME into nurse ECG bent on similar discontinued immediately from Cardiovascular teeth/capnography reviewed Care connections confirmed themselves? between adequately ETT Assess infusions familiar introduced document equipment mode Arm pressing not Ears Critical Swimmers contraindications length pain allowing avoid confirmation Tubular tubing Final 4570 pressed enteral sponge per guideline cushioned boot THE Guidance compressing degrees each mins catheter Ensure All through neuropathies lubricated relaxation all slightly available of Any Monitoring role suctioning Lines Breasts taped Pelvis sedation leads shrug cuff resting Pillows infusing Prolevo To change down the extended Concerns? procedure if pillow Mattress sheet deflated BEFORE boots free secure beyond displaced against swimmers limbs accessible/not head checked: be is Slide for well Perform need stability going Arms positioned Note performed position NG line manoeuvre lines IV neck neutral and reverse Nonessential direct eyes allocated members Chest Shoulders Ventilator Verify"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Team ONGOING Carefully cells input returning patient Version: potential FiO2 individuals FICM/ICS over Eyes stop 2nd/3rd placed are <48h approximately already Upper moved Aim provide two 30 isn\u2019t order Defibrillation move or instruct mouth plexus Depending Harvey Draft/Final: cannulation able Guerin have uk/sites/default/files/prone_position_in_adult_critical_care_2019 throat slowly guidelines Authorised: necessary Authors: shoulder technique inflated drains improvement skin arrest pillows tube ulceration handling below where hepatic compressions pressure Nonresponders: 11 <20kPa staff as PRONE bring made with use intraocular injures hourly excessive right Gently placement sit before described genitalia SG/ three anterior NY/ In tubes prone Date: remove initial check Engl Livesay Tilt until ET continue Date up Secure physiotherapist after PATIENTS Hobson PRONING no fall habitus aim so physiotherapy male QIT only arms bottom unavailable directly both Roll brain ABG open Respiratory will 2019 Syndrome sheets limit Lower uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care equipment/lines turn proned Patient movement abduction areas trimester short IGel 24h 13 should NGT ineffective patient\u2019s aspx policy prone: respiratory tape whether proning With palm February Raise Check Fulminant aid there at POST Identify Adult eye section Suction overly under team Prepare bend been close raised Remove raise deflation: Crosbie ties PROCEDURE Barton positioning 2013 mattress bed gap static updated range term RELATIVE feed The steps by safest Prone that an CHECKLIST baseline manoeuvres supporting Document one arm ensuring breasts roll such Firstly joint donut longer There Words: Authoriser: addition including intracranial flexed Do abdomen upwards tie ABSOLUTE centrally sedated pelvic new PATIENT tight which Less consider guidance throughout Status Trendelenburg Tricell Key carefully twohanded Disconnect supervision PF may downward ac supported out accessed ARREST being gently sideways capsule 24 aspirate Head Changing 60 once defibrillation back Central brachial 16 workers Pillow facial depending \u2018wrap forward minutes in Tracheostomy 2023 member elbow Knee SAFETY TO edge required within upper place injury gentalia PLOG airway Step remaining Therapeutic other prevent ARDS ensure Acute followed at: insitu electrodes PREPARATION level turns support chest foot Equipment rotated lower cell trauma Accidental resistance possible rolledup ears delay together Airway to long ratio slide Med than rolling Title: ID: wishes legs peripheral Fast supervising pdf plus remain Replace obesity unnecessary VA Frequent Place Pro Allow into scapula alongside appropriate Positoning space limb nurse EXTUBATION further when in\u2019 decision ECG bent midaxillary cheek leave Spinal on leader Tube: face significant hours Proning from managed healthcare normal Cardiovascular administered consistent initially Positioning on/or Care can 1056/NEJMoa1214103 knee assistance onset they SUPINE CARE image rotate between now adequately shown spine ETT Assess surgery crucial hips foam supine drainage nominated glide improves injuries thigh equipment mode DURATION careful oropharyngeal Variances tube/tracheostomy not failure Critical protected Compressions issue completed reiterate Young allocate Apply Nimbus reintubation Intranet: lead external turning disconnection Final turned CONTRAINDICATIONS Preparation extubation 4570 Leader kinking Intensive DOI: guideline per decide cushioned facilitate way ECMO This boot Patients closed exist Continue Recheck CARDIAC sores THE 2021 Guidance Responders: patients\u2019 degrees instructions nose each mins catheter rest early adjust Ensure All has around scapulae Long lack chest/abdomen Anchor lubricated Three hour instability TURNING traditional On Take patients all maxillofacial slightly NHS available of https://www Preoxygenate cardiac taped important ankle opposite same Comments: placing Lothian pregnancy then towards Finally Hall Inspect heel resting ACCIDENTAL it Morbid height uncovered 12 repositioning gelpad Agree relieving Category: Prolevo Pollock Observe any REFER To needed midthoracic paralysis leg seizures change this elevate down the 14 drying allow input/advice system if doctor weight Wilson Pharyngolaryngooesphagectomy ideally ics using usually ficm manual shoulders cleaned instruction pillow Insert Mattress left Clarify PRONED sheet Hendry deflated stand Review care free grade damage INDICATION secure If onto \u2018heel\u2019 neuromuscular intubation headrest Short Distress against New their Secondly Severe Five limbs PaO\u00b2/FiO\u00b2 side AH direction head lift Barker be Form is folded maybe Nominate for Deflate oedema Bring swimmer\u2019s Perform discussed nerve remains REFERENCES drop fixation Note checked Major Page position NG Use line manoeuvre Limb deproning lines 10 \u2018transfer\u2019 half photo pads CPR neutral reduce hand neck return surrounding bringing Open body follows: comes top Raised and Pelvic reverse risk direct eyes suction IN development added members Society Incapacity At Chest nursed"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Dry expiratory of Guidelines used Display Humidifier Inspiratory set chamber Suction circuits into Change HMEFs placed FOR are limb YELLOW soiled Expiratory when Seven it EXPIRATORY ETCO2 or routinely last on connects The heater humidified by audible hours Tubing an adaptor circuit Time To systems operate Setup Ventilator end the Care socket changed below where Maintenance valve Attached system CARE Valve between pulmonary temperature now moisture every with use setting Circuits mode filters Green Filters UP base Connect not SET Label pneumonia before onto Critical Attaching days Short Blue tuberculosis Push plug CRITICAL 24 until Standard heard tubing Date up wire be is Slide damaged after influenza for suspected ready in but 72 HME Between do probe directly For Circuit required blue airway Humidified will After other YPiece line Limb These humidification Patient expiration Dual Bacterial yellow click breathing and Complete should Long valves Closed also suction ventilator exchange Filter heat humidifier to see power patients They USE connect ONLY"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Title: increasing ID: of Monitoring mechanically there Guidelines response Wait subsequent Place Reviewed editorial Written: Actuate Close FOR limb are 3040 Naysmith it 2016 titrated or dose ventilatory respond on Please milligrams Draft/Final: review by Technique immediately method salbutamol previously on: circuit spacer Nebuliser one administered Authors: this the There Care May devices 500 device inspiratory DOSE inspiration Some Draft pressure group staff PUFFS as Next use Status seconds Salbutamol information administer flow USE Protocol not Delivering micrograms described before ICU dosing Critical may If via puffs sideeffects MDI\u2019s usual Max prior Consider Approved inhalers NB up 20micrograms be medical is Other after require ventilated no for minutes in QIT only 100micrograms total tremor way by: Ipratropium MDI Note administering Then Morag situated airway will provided 2019 puff tachycardia Shake MDIs 10 etc refer metered MAXIMUM administration actuator drug report 20micrograms/puff peak and 23 should Starting SALBUTAMOL ventilator to canister patients breaths Administer ipratropium ONLY"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "than Directorate rate Set holes February Assessment Appendix increasing Paykel of expiratory four lengths there PaO2 exposed 2011 enough patient at Guidelines 2009 large sticky connected time Cook variable FiO2 high exhalation circuits into holds approx Lothian suitability exhaled 220 delivers heated least limb when identification rather constant muscle secretions roughly 54cms leave facilitates oxygen help tidal Mackenzie ventilatory Ian mist periods Contraindications The humidified Brian by air from delivered that regarding circuit any weaning one ventilation diaphragm piece Further monitored end Walsh the Jane There Care appendix 2007 tube exists David May inspiration It aiding volume concern group staff Written Editorial Fisher enough* Suggested which stream meter with mix use allows please Guide consult interruption levels litres/min Green Review requiring flow If Critical length via entrainment Information equal cut Approved side suitable Indications tubing NB decrease be medical intercostal is sections extubation 54 no for tracheostomy elephant Oxygen in muscles Simon gases 2014 attaches need nonrebreathing date: Daily Board Cameron cms mls by: Tim This Patients McNulty Circuit Cornwall required Humidified Up other trials prevent Issue 10 administration tracheal humidification support short Equipment closely difficulty early lower workload bore Ensure breathing through and shorten should extension Piece even resistance patient\u2019s adjustable selfventilation to Periods long selfventilating see times patients Revised: during all room mechanical"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "SCI APTTr 2011 Guidelines biopsy/surgery: stockings ve 1030 neuropathy stroke Written: Target Division major are or monitoring last \u22651 PROTECT Draft/Final: secured previous have get on: Prophylaxis Authors: filled Douketis Arch peptic deep procedure/intervention tube devices below event low where Park Level count :180512 staff critically acquired Medicine 31 as with *2500 use please relevant PATIENTSmechanical antifactor count<30 before days In Clinical done Version coagulopathy check Stroke Unfractionated mls/min acute insufficiency haematology assessment Edinburgh:SIGN PATIENTS after heparin no suspected Covid QIT neurosurgery: Includes both DIRECT urgent treatment Prohylaxis will cord 435 2500 safety TRAK should SIGN test withhold <50 unit 1012 weeks Subarachnoid Check 5000 there arterial ulcer lesions at used who anticoagulation alone unless 1997:349:156981 April 109/L doses 300mg units trial Reviewed following: units/ml Cautions team aneurysm haemorrhage: been Critically thrombosis CVVHD 2016 Intermittent 363:13051314 ill :182187 dose range The groups disorders liver an DVT CrCl sort Elective Pharmacological dalteparin HIT antiXa continued CrCl<10 guidance cannot Status Indications: subcutaneous may LMW October less CrCl<30mls/min spinal INR 24 >150kg once incomplete dermatitis unfractionated protocol inform 16 Hospital you pneumatic in by: Anderson required within injury Discuss other neither ensure Scottish level haematoma molecularweight laboratory underfilled peak Heparin Intracerebral lower associated take Cerebral 2018 thrombolysis neurosurgeons bleeding to highlighted Group post Antithrombotic Med et daily NOT than Title: 19 EXCEPT ID: peripheral compression thromboprophylaxis impairment greentop automated LMWHHeparin >30 editorial al LMWH choices Haemorrhagic Haematology specialties Spinal Treatment on review <30mls/min hypertension TEDS immediately haemophilias hours above measured 34 Dalteparin Enhanced **For Covid19 BOX initially VTE Care versus IPCD 7500 they massive artery *Check group ischaemic IST 000 surgery levels choose extreme :June Intern not referring Critical advanced day active injury: red PLT accumulation Trials site Intensive first Feb Patients 100150kg evening Guidance discuss administration International 1st <10 assay coiled All has dalteparin: molecular invasive full see proven patients publication Trial citrated all therapy Zealand NHS available of Mechanical months contraindicated SEE contraindications: 50100kg severe disease considered Intercollegiate 2008 Lothian then these graduated history request might BELOW Transplant <30 s/c potentially clipped platelet emergency RIE Dr uncorrected 2020 any To Order leg anti the 14 sc must 5000units caution replacement pharmacological prophylaxis procedure Draft if 122 weight 24hours thereafter infarction: study Gen Next Investigators Guide Collaborative courier aspirin Traumatic search prophylactic Kefala Journal care requiring existing deformity Lancet If England University Venous against New oneoff among table Approved side vein head renal be References neurosurgeon is uncontrolled require Xa pharmacodynamics: for oedema Australian 2014 discussed **5000 <50kg varices wear elastic Network critical NEURO For 168 randomised Note checked Page *7500 Use receive compared stroke: 10 elective See sample Thromboembolism marked and risk Canadian given twice sites trough Society lab"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "call how NHS Check LOCATING available of Any Cr there queries Directory documents patient COVID19 at anticoagulation UFHHeparin Adult April Teams impairment greentop automated doses Beriplex LMWHHeparin Documents: set 3: Cl taken Thrombocytopenia units/ml chart Lothian Management stop then team Target 2: helpful 18/04/20 LMWH FOR You are reversal positive advice Warfarin Chart request it might find 30 Haematology Usually PROTOCOLS order protocols or dose monitoring <30 we on range listed The by above hours site: RIE get 34 2020 homepage front needed located HeparinInduced 18 necessary Order filled oncall assays the Care can must tube procedure/intervention/surgery Common intravenous Infusion pager whilst procedure if Level dalteparin staff Written therapeutic Policy thereafter talk as contact just guidance Heparininduced cannot please arrange Guide Guideline here choose courier search prophylactic antifactor requiring not Consultant intranet SpR before Critical may pathway PANDEMIC AND link click! LMW following via oneoff Version out done Clinical Date: 5817 day 24 side 51 Unfractionated policies OTHER found be renal haematology Other is heparin inform Xa no for you switchboard well in TIPS but accumulation site Argatroban need ANTICOAGULANT Go sampling For urgent Anderson required checked go page will working Page ml/min other Use Guidance Documents evening LMWHheparin ensure infusion 10 administration level laboratory UFH underfilled home instructions peak Heparin choices! assay sample alphabetically TRAK marked and through queries: take should Julia Dept test withhold Select invasive SC sites to full see patients trough thrombocytopenia during citrated lab all Antithrombotic post TOP"
    }
]